a g-to-a transition at the first nucleotide of intron 2 of patient 1 #abolishes normal splicing .
disruption of rpos , mlra or csga , and the curli subunit gene #abolish ha and curli production by strain chi7122 .
furthermore , the deletion of yhie completely #abolishes acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
ha and curli production by strain chi7122 can be #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
ha and curli production by strain chi7122 has been #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
however , its bcfa biosynthesis is not #abolished by this complete removal of fabd from the crude fas , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this complete removal of fabd from the crude fas does not #abolish its bcfa biosynthesis , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
noticeably , transcription at the rrn pc promoter by nep-2 can be completely #abolished if cdf2-b can not bind to the template , as obtained by the mutation m1 (figure 4a , compare lanes 1 and 4; figure 4c , compare wt and m1) .
noticeably , transcription at the rrn pc promoter by nep-2 was completely #abolished if cdf2-b can not bind to the template , as obtained by the mutation m1 (figure 4a , compare lanes 1 and 4; figure 4c , compare wt and m1) .
the a/t-rich mut sequence indicates that the mutations #abolish the a/t-rich element .
the a/t-rich mut sequence indicates the mutations can #abolish the a/t-rich element .
this acid resistance has been #abolished by deletion of ydep , ydeo , or yhie , which was induced by evga overexpression .
this acid resistance is #abolished by deletion of ydep , ydeo , or yhie , which was induced by evga overexpression .
this acid resistance will be #abolished by deletion of ydep , ydeo , or yhie , which was induced by evga overexpression .
this intronic mutation , which #abolished normal lhx4 splicing , activates two exonic cryptic splice sites and thereby predicts two different proteins deleted in their homeodomain sequence .
this intronic mutation , which segregates in a dominant and fully penetrant manner over three generations , #abolished normal lhx4 splicing and activates two exonic cryptic splice sites , thereby predicting two different proteins deleted in their homeodomain sequence .
our results showed that co-administered dm was able to #abolish completely the cpp effect induced by morphine , but had no effect on morphine-induced behavioral sensitization .
furthermore , ha and curli production by strain chi7122 in stationary-phase cells is completely #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of the distal tor box (box1) completely #abolishes torc induction in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of the distal tor box (box1) will completely #abolish torc induction in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie completely #abolished this acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie completely #abolishes this acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie in stationary-phase cells is completely #abolished by this acid resistance , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , deletion of ydep , ydeo , or yhie will completely #abolish this acid resistance in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , disruption of rpos , mlra or csga , and the curli subunit gene completely #abolished ha and curli production by strain chi7122 in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the a/t-rich element in stationary-phase cells is completely #abolished by the mutations , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the mutations completely #abolished the a/t-rich element in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , the mutations completely #abolishes the a/t-rich element in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this complete removal of fabd from the crude fas completely #abolished its bcfa biosynthesis in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , this complete removal of fabd from the crude fas completely #abolishes its bcfa biosynthesis in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , torc induction in stationary-phase cells has been completely #abolished by deletion of the distal tor box (box1) , suggesting that yhie plays a critical role in stationary-phase acid resistance .
ha and curli production by strain chi7122 was #abolished by disruption of rpos , mlra or csga , and the curli subunit gene which interrupt this open reading frame .
ha and curli production by strain chi7122 were #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
however , ha and curli production by strain chi7122 is not #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , ha and curli production by strain chi7122 was not #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this acid resistance did not #abolish deletion of ydep , ydeo , or yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this acid resistance does not #abolish deletion of ydep , ydeo , or yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , this acid resistance will not #abolish deletion of ydep , ydeo , or yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , acid resistance was not #abolished by the deletion of yhie , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of the distal tor box (box1) did not #abolish torc induction , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of ydep , ydeo , or yhie does not #abolish this acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of ydep , ydeo , or yhie was not #abolished by this acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , deletion of ydep , ydeo , or yhie will not #abolish this acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , disruption of rpos , mlra or csga , and the curli subunit gene does not #abolish ha and curli production by strain chi7122 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the a/t-rich element was not #abolished by the mutations , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the deletion of yhie did not #abolish acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the deletion of yhie does not #abolish acid resistance , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the mutations did not #abolish the a/t-rich element , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the mutations does not #abolish the a/t-rich element , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , torc induction was not #abolished by deletion of the distal tor box (box1) , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , this acid resistance has #abolished deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this acid resistance is able to #abolish deletion of ydep , ydeo , or yhie whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie #abolished this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie has #abolished this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , deletion of ydep , ydeo , or yhie is able to #abolish this acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , disruption of rpos , mlra or csga , and the curli subunit gene #abolishes ha and curli production by strain chi7122 whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie #abolished acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , the deletion of yhie is able to #abolish acid resistance whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this complete removal of fabd from the crude fas #abolished its bcfa biosynthesis whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this complete removal of fabd from the crude fas #abolishes its bcfa biosynthesis whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this complete removal of fabd from the crude fas can #abolish its bcfa biosynthesis whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this complete removal of fabd from the crude fas has #abolished its bcfa biosynthesis whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this complete removal of fabd from the crude fas is able to #abolish its bcfa biosynthesis whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this complete removal of fabd from the crude fas will #abolish its bcfa biosynthesis whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in contrast , ha and curli production by strain chi7122 was #abolished by disruption of rpos , mlra or csga , and the curli subunit gene , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this acid resistance #abolishes deletion of ydep , ydeo , or yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this acid resistance is #abolished by deletion of ydep , ydeo , or yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this acid resistance was #abolished by deletion of ydep , ydeo , or yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , acid resistance is #abolished by the deletion of yhie , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie #abolished this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , deletion of ydep , ydeo , or yhie can #abolish this acid resistance , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , disruption of rpos , mlra or csga , and the curli subunit gene #abolishes ha and curli production by strain chi7122 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , disruption of rpos , mlra or csga , and the curli subunit gene can #abolish ha and curli production by strain chi7122 , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , its bcfa biosynthesis is #abolished by this complete removal of fabd from the crude fas , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the a/t-rich element was #abolished by the mutations , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the mutations #abolished the a/t-rich element , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the mutations #abolishes the a/t-rich element , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this complete removal of fabd from the crude fas #abolished its bcfa biosynthesis , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this complete removal of fabd from the crude fas #abolishes its bcfa biosynthesis , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , this complete removal of fabd from the crude fas can #abolish its bcfa biosynthesis , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , torc induction was #abolished by deletion of the distal tor box (box1) , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
the a/t-rich mut sequence indicates this acid resistance can #abolish deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates this acid resistance introduced to #abolish deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates disruption of rpos , mlra or csga , and the curli subunit gene introduced to #abolish ha and curli production by strain chi7122 .
the a/t-rich mut sequence indicates that ha and curli production by strain chi7122 is #abolished by disruption of rpos , mlra or csga , and the curli subunit gene .
the a/t-rich mut sequence indicates that this acid resistance #abolish deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates that this acid resistance is #abolished by deletion of ydep , ydeo , or yhie .
the a/t-rich mut sequence indicates that acid resistance was #abolished by the deletion of yhie .
the a/t-rich mut sequence indicates that deletion of the distal tor box (box1) #abolished torc induction .
the a/t-rich mut sequence indicates that deletion of ydep , ydeo , or yhie #abolished this acid resistance .
the a/t-rich mut sequence indicates that deletion of ydep , ydeo , or yhie was #abolished by this acid resistance .
the a/t-rich mut sequence indicates that disruption of rpos , mlra or csga , and the curli subunit gene #abolish ha and curli production by strain chi7122 .
the a/t-rich mut sequence indicates that its bcfa biosynthesis was #abolished by this complete removal of fabd from the crude fas .
the a/t-rich mut sequence indicates that the deletion of yhie #abolish acid resistance .
the a/t-rich mut sequence indicates that this complete removal of fabd from the crude fas #abolished its bcfa biosynthesis .
the a/t-rich mut sequence indicates that torc induction is #abolished by deletion of the distal tor box (box1) .
the a/t-rich mut sequence indicates the deletion of yhie can #abolish acid resistance .
the a/t-rich mut sequence indicates this complete removal of fabd from the crude fas can #abolish its bcfa biosynthesis .
the a/t-rich mut sequence indicates this complete removal of fabd from the crude fas introduced to #abolish its bcfa biosynthesis .
this acid resistance #abolished deletion of ydep , ydeo , or yhie .
this acid resistance are #abolished by deletion of ydep , ydeo , or yhie .
this acid resistance can completely #abolishes deletion of ydep , ydeo , or yhie , indicating that this element is essential for mef2 gata-4 cooperation .
this acid resistance was #abolished by deletion of ydep , ydeo , or yhie , which was induced by evga overexpression .
this acid resistance which #abolished deletion of ydep , ydeo , or yhie interrupt this open reading frame .
this acid resistance will also #abolish deletion of ydep , ydeo , or yhie associated with formate hydrogenlyase activity .
acid resistance are #abolished by the deletion of yhie .
acid resistance were #abolished by the deletion of yhie .
deletion of the distal tor box (box1) #abolished torc induction .
deletion of the distal tor box (box1) #abolishes torc induction .
deletion of the distal tor box (box1) being able to #abolish torc induction interrupt this open reading frame .
deletion of the distal tor box (box1) has also #abolished torc induction associated with formate hydrogenlyase activity .
deletion of the distal tor box (box1) promoter completely #abolished torc induction , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of the distal tor box (box1) was #abolished by torc induction , which was induced by evga overexpression .
deletion of the distal tor box (box1) which #abolished torc induction interrupt this open reading frame .
deletion of the distal tor box (box1) will also #abolish torc induction associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie also #abolished this acid resistance associated with formate hydrogenlyase activity .
deletion of ydep , ydeo , or yhie being able to #abolish this acid resistance interrupt this open reading frame .
deletion of ydep , ydeo , or yhie can be #abolished by this acid resistance .
deletion of ydep , ydeo , or yhie has been #abolished by this acid resistance .
deletion of ydep , ydeo , or yhie promoter completely #abolishes this acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
deletion of ydep , ydeo , or yhie which #abolished this acid resistance interrupt this open reading frame .
deletion of ydep , ydeo , or yhie which has #abolished this acid resistance interrupt this open reading frame .
deletion of ydep , ydeo , or yhie will #abolish this acid resistance .
deletion of ydep , ydeo , or yhie will be #abolished by this acid resistance .
disruption of rpos , mlra or csga , and the curli subunit gene #abolishes ha and curli production by strain chi7122 .
disruption of rpos , mlra or csga , and the curli subunit gene also #abolish ha and curli production by strain chi7122 associated with formate hydrogenlyase activity .
disruption of rpos , mlra or csga , and the curli subunit gene can #abolish ha and curli production by strain chi7122 .
disruption of rpos , mlra or csga , and the curli subunit gene promoter completely #abolished ha and curli production by strain chi7122 , indicating that this element is essential for mef2 gata-4 cooperation .
disruption of rpos , mlra or csga , and the curli subunit gene promoter completely #abolishes ha and curli production by strain chi7122 , indicating that this element is essential for mef2 gata-4 cooperation .
disruption of rpos , mlra or csga , and the curli subunit gene which has #abolished ha and curli production by strain chi7122 interrupt this open reading frame .
its bcfa biosynthesis are #abolished by this complete removal of fabd from the crude fas .
its bcfa biosynthesis has been #abolished by this complete removal of fabd from the crude fas .
its bcfa biosynthesis is #abolished by this complete removal of fabd from the crude fas which interrupt this open reading frame .
its bcfa biosynthesis is #abolished by this complete removal of fabd from the crude fas , which was induced by evga overexpression .
the a/t-rich element can be #abolished by the mutations .
the a/t-rich element has been #abolished by the mutations .
the a/t-rich element is #abolished by the mutations , which was induced by evga overexpression .
the a/t-rich element will be #abolished by the mutations , which was induced by evga overexpression .
the a/t-rich element will be #abolished by the mutations .
the deletion of yhie #abolishes acid resistance .
the deletion of yhie also #abolish acid resistance associated with formate hydrogenlyase activity .
the deletion of yhie also #abolished acid resistance associated with formate hydrogenlyase activity .
the deletion of yhie has also #abolished acid resistance associated with formate hydrogenlyase activity .
the deletion of yhie promoter completely #abolished acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
the deletion of yhie promoter completely #abolishes acid resistance , indicating that this element is essential for mef2 gata-4 cooperation .
the deletion of yhie was #abolished by acid resistance , which was induced by evga overexpression .
the deletion of yhie which #abolished acid resistance interrupt this open reading frame .
the deletion of yhie will also #abolish acid resistance associated with formate hydrogenlyase activity .
the mutations #abolished the a/t-rich element .
the mutations also #abolished the a/t-rich element associated with formate hydrogenlyase activity .
the mutations can #abolish the a/t-rich element .
the mutations can completely #abolishes the a/t-rich element , indicating that this element is essential for mef2 gata-4 cooperation .
the mutations promoter completely #abolished the a/t-rich element , indicating that this element is essential for mef2 gata-4 cooperation .
the mutations promoter completely #abolishes the a/t-rich element , indicating that this element is essential for mef2 gata-4 cooperation .
the mutations was #abolished by the a/t-rich element , which was induced by evga overexpression .
the mutations which #abolished the a/t-rich element interrupt this open reading frame .
this complete removal of fabd from the crude fas #abolishes its bcfa biosynthesis .
this complete removal of fabd from the crude fas also #abolish its bcfa biosynthesis associated with formate hydrogenlyase activity .
this complete removal of fabd from the crude fas can completely #abolishes its bcfa biosynthesis , indicating that this element is essential for mef2 gata-4 cooperation .
this complete removal of fabd from the crude fas promoter completely #abolishes its bcfa biosynthesis , indicating that this element is essential for mef2 gata-4 cooperation .
this complete removal of fabd from the crude fas was #abolished by its bcfa biosynthesis , which was induced by evga overexpression .
this complete removal of fabd from the crude fas will #abolish its bcfa biosynthesis .
this complete removal of fabd from the crude fas will also #abolish its bcfa biosynthesis associated with formate hydrogenlyase activity .
torc induction can be #abolished by deletion of the distal tor box (box1) .
torc induction has been #abolished by deletion of the distal tor box (box1) , which was induced by evga overexpression .
torc induction is #abolished by deletion of the distal tor box (box1) which interrupt this open reading frame .
torc induction was #abolished by deletion of the distal tor box (box1) which interrupt this open reading frame .
torc induction will be #abolished by deletion of the distal tor box (box1) , which was induced by evga overexpression .
torc induction will be #abolished by deletion of the distal tor box (box1) .
furthermore , a g-to-a transition at the first nucleotide of intron 2 completely #abolishes normal splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , a g-to-a transition at the first nucleotide of intron 2 will completely #abolish normal splicing in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , co-administered dm completely #abolishes the cpp effect in stationary-phase cells , suggesting that yhie plays a critical role in stationary-phase acid resistance .
furthermore , normal lhx4 splicing in stationary-phase cells is completely #abolished by this intronic mutation , suggesting that yhie plays a critical role in stationary-phase acid resistance .
however , this intronic mutation does not #abolish normal lhx4 splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , a g-to-a transition at the first nucleotide of intron 2 did not #abolish normal splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , a g-to-a transition at the first nucleotide of intron 2 will not #abolish normal splicing , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , co-administered dm did not #abolish the cpp effect , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , co-administered dm will not #abolish the cpp effect , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , normal splicing was not #abolished by a g-to-a transition at the first nucleotide of intron 2 , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
however , the cpp effect was not #abolished by co-administered dm , but only reduced the level to 50-60% of the control level for acyl-coa primer and to 80% for alpha-keto-beta-methylvalerate primer .
in addition , this intronic mutation #abolishes normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , this intronic mutation has #abolished normal lhx4 splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 can #abolish normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 has #abolished normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 is able to #abolish normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , a g-to-a transition at the first nucleotide of intron 2 will #abolish normal splicing whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm #abolished the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm #abolishes the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm is able to #abolish the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in addition , co-administered dm will #abolish the cpp effect whereas the presence of a dna fragment starting three bases upstream from box1 suffices for normal torc expression .
in contrast , this intronic mutation #abolished normal lhx4 splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , a g-to-a transition at the first nucleotide of intron 2 can #abolish normal splicing , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , co-administered dm #abolishes the cpp effect , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
in contrast , the cpp effect was #abolished by co-administered dm , whereas internal deletion of the conserved octapeptide motif (op) or the partial homeodomain (hd) of pax5 did not have any effect (figure 3b) .
the a/t-rich mut sequence indicates co-administered dm introduced to #abolish the cpp effect .
the a/t-rich mut sequence indicates that this intronic mutation #abolish normal lhx4 splicing .
the a/t-rich mut sequence indicates that this intronic mutation #abolished normal lhx4 splicing .
the a/t-rich mut sequence indicates that a g-to-a transition at the first nucleotide of intron 2 #abolished normal splicing .
the a/t-rich mut sequence indicates that co-administered dm #abolish the cpp effect .
the a/t-rich mut sequence indicates that normal lhx4 splicing is #abolished by this intronic mutation .
this intronic mutation #abolished normal lhx4 splicing .
this intronic mutation #abolishes normal lhx4 splicing .
this intronic mutation can #abolish normal lhx4 splicing .
this intronic mutation has also #abolished normal lhx4 splicing associated with formate hydrogenlyase activity .
this intronic mutation promoter completely #abolished normal lhx4 splicing , indicating that this element is essential for mef2 gata-4 cooperation .
this intronic mutation was #abolished by normal lhx4 splicing , which was induced by evga overexpression .
this intronic mutation which #abolish normal lhx4 splicing interrupt this open reading frame .
this intronic mutation which has #abolished normal lhx4 splicing interrupt this open reading frame .
this intronic mutation will also #abolish normal lhx4 splicing associated with formate hydrogenlyase activity .
a g-to-a transition at the first nucleotide of intron 2 #abolished normal splicing .
a g-to-a transition at the first nucleotide of intron 2 #abolishes normal splicing .
a g-to-a transition at the first nucleotide of intron 2 also #abolish normal splicing associated with formate hydrogenlyase activity .
a g-to-a transition at the first nucleotide of intron 2 being able to #abolish normal splicing interrupt this open reading frame .
a g-to-a transition at the first nucleotide of intron 2 can completely #abolishes normal splicing , indicating that this element is essential for mef2 gata-4 cooperation .
a g-to-a transition at the first nucleotide of intron 2 has also #abolished normal splicing associated with formate hydrogenlyase activity .
a g-to-a transition at the first nucleotide of intron 2 promoter completely #abolished normal splicing , indicating that this element is essential for mef2 gata-4 cooperation .
a g-to-a transition at the first nucleotide of intron 2 promoter completely #abolishes normal splicing , indicating that this element is essential for mef2 gata-4 cooperation .
a g-to-a transition at the first nucleotide of intron 2 which #abolished normal splicing interrupt this open reading frame .
a g-to-a transition at the first nucleotide of intron 2 which has #abolished normal splicing interrupt this open reading frame .
a g-to-a transition at the first nucleotide of intron 2 will also #abolish normal splicing associated with formate hydrogenlyase activity .
co-administered dm #abolishes the cpp effect .
co-administered dm also #abolish the cpp effect associated with formate hydrogenlyase activity .
co-administered dm also #abolished the cpp effect associated with formate hydrogenlyase activity .
co-administered dm promoter completely #abolished the cpp effect , indicating that this element is essential for mef2 gata-4 cooperation .
co-administered dm promoter completely #abolishes the cpp effect , indicating that this element is essential for mef2 gata-4 cooperation .
co-administered dm was #abolished by the cpp effect , which was induced by evga overexpression .
normal lhx4 splicing has been #abolished by this intronic mutation , which was induced by evga overexpression .
normal lhx4 splicing was #abolished by this intronic mutation which interrupt this open reading frame .
normal lhx4 splicing was #abolished by this intronic mutation , which was induced by evga overexpression .
normal lhx4 splicing will be #abolished by this intronic mutation , which was induced by evga overexpression .
normal lhx4 splicing will be #abolished by this intronic mutation .
normal splicing has been #abolished by a g-to-a transition at the first nucleotide of intron 2 .
normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 which interrupt this open reading frame .
normal splicing is #abolished by a g-to-a transition at the first nucleotide of intron 2 , which was induced by evga overexpression .
normal splicing was #abolished by a g-to-a transition at the first nucleotide of intron 2 , which was induced by evga overexpression .
normal splicing will be #abolished by a g-to-a transition at the first nucleotide of intron 2 , which was induced by evga overexpression .
normal splicing will be #abolished by a g-to-a transition at the first nucleotide of intron 2 .
the cpp effect are #abolished by co-administered dm .
the cpp effect has been #abolished by co-administered dm , which was induced by evga overexpression .
the cpp effect has been #abolished by co-administered dm .
the cpp effect was #abolished by co-administered dm which interrupt this open reading frame .
the cpp effect were #abolished by co-administered dm .
cytokines are able to #alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
cytokines have the ability to #alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
cytokines may #alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
moreover , dam methylation inhibited binding of lrp/papi near the gatc1028 site and #altered binding of lrp at the gatc1130 site .
moreover , dam methylation inhibited binding of lrp/papi near the gatc1028 site and has #altered binding of lrp at the gatc1130 site .
moreover , dam methylation inhibited binding of lrp/papi near the gatc1028 site and was able to #alter binding of lrp at the gatc1130 site .
moreover , dam methylation inhibited binding of lrp/papi near the gatc1028 site and would #alter binding of lrp at the gatc1130 site .
moreover , dam methylation inhibits binding of lrp/papi near the gatc1028 site and is able to #alter binding of lrp at the gatc1130 site .
moreover , dam methylation inhibits binding of lrp/papi near the gatc1028 site and will #alter binding of lrp at the gatc1130 site .
moreover , a frur null mutation #alters the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation has #altered the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation may #alter the rates of utilization of at least 36 carbon sources .
moreover , a frur null mutation will be able to #alter the rates of utilization of at least 36 carbon sources .
phosphorylation of pdk1 is not able to be #altered by treating the cells with insulin-like growth factor-i and four of the sites could be mutated without loss of activity .
phosphorylation of pdk1 is not #altered by treating the cells with insulin-like growth factor-i and four of the sites could be mutated without loss of activity .
phosphorylation of pdk1 will not be #altered by treating the cells with insulin-like growth factor-i and four of the sites could be mutated without loss of activity .
since s1031 is a null allele , we are testing whether this mutation can #alter vulval induction .
since s1031 is a null allele , we are testing whether this mutation is able to #alter vulval induction .
since s1031 is a null allele , we are testing whether this mutation is going to #alter vulval induction .
since s1031 is a null allele , we are testing whether this mutation may #alter vulval induction .
since s1031 is a null allele , we are testing whether this mutation will #alter vulval induction .
since s1031 is a null allele , we are testing whether vulval induction is #altered by this mutation .
since s1031 is a null allele , we tested whether this mutation #altered vulval induction .
since s1031 is a null allele , we tested whether this mutation might #alter vulval induction .
since s1031 is a null allele , we tested whether vulval induction could be #altered by this mutation .
since s1031 is a null allele , we tested whether vulval induction might be #altered by this mutation .
since s1031 is a null allele , we tested whether vulval induction was able to be #altered by this mutation .
since these two bends are in opposing directions , the overall direction of the dna cannot be #altered by them(figure 3c) .
since these two bends are in opposing directions , the overall direction of the dna is not #altered by them(figure 3c) .
since these two bends are in opposing directions , the overall direction of the dna may not be #altered by them(figure 3c) .
since these two bends are in opposing directions , they are not able to #alter the overall direction of the dna(figure 3c) .
since these two bends are in opposing directions , they cannot #alter the overall direction of the dna(figure 3c) .
since these two bends are in opposing directions , they will not #alter the overall direction of the dna(figure 3c) .
since these two bends were in opposing directions , they were not able to #alter the overall direction of the dna(figure 3c) .
splicing will be #altered by the molecular lesion associated with s1031 , we looked at the sos-1 mrna produced in this mutant .
the codon (ctc) normally associated with leu-93 in the transcortin polypeptide may be #altered by the mutation located within exon 2 to a codon (cac) for histidine in the variant genes .
the expression and activity of the multidrug resistance transporters can be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters is #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the expression and activity of the multidrug resistance transporters was able to be #altered by cytokines in human hepatoma cell lines; analysis using rt-pcr and cdna microarrays .
the molecular lesion associated with s1031 is predicted to be able to #alter splicing , we looked at the sos-1 mrna produced in this mutant .
the results provide insight into a mechanism whereby #altering expression of bcl-3 leads to tumorigenic potential .
the results provide insight into a mechanism whereby the act of #altering expression of bcl-3 leads to tumorigenic potential .
the results provide insight into a mechanism whereby to #alter expression of bcl-3 may lead to tumorigenic potential .
this mutation is located within exon 2 and #altered the codon (ctc) normally associated with leu-93 in the transcortin polypeptide to a codon (cac) for histidine in the variant genes .
this mutation was located within exon 2 and #altered the codon (ctc) normally associated with leu-93 in the transcortin polypeptide to a codon (cac) for histidine in the variant genes .
treating the cells with insulin-like growth factor-i did not #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
treating the cells with insulin-like growth factor-i has not #altered phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
treating the cells with insulin-like growth factor-i is not able to #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
treating the cells with insulin-like growth factor-i will not #alter phosphorylation of pdk1 and four of the sites could be mutated without loss of activity .
phosphorylation of pdk1 was not #altered by treating the cells with insulin-like growth factor-i and four of the sites could be mutated without loss of activity .
since s1031 is a null allele , we tested whether this mutation #alters vulval induction .
since these two bends are in opposing directions , they do not #alter the overall direction of the dna(figure 3c) .
moreover , dam methylation inhibits binding of lrp/papi near the gatc1028 site and #alters binding of lrp at the gatc1130 site .
this mutation is located within exon 2 and #alters the codon (ctc) normally associated with leu-93 in the transcortin polypeptide to a codon (cac) for histidine in the variant genes .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna could be #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna may be #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the overall direction of the dna was #altered by these two bends .
hence , glu13 indirectly affects dna-binding specificity because the rates of utilization of at least 36 carbon sources is #altered by a frur null mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction can be #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction may be #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity because vulval induction was #altered by this mutation .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation can subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation is able to subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation subtly #altered the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because a frur null mutation subtly #alters the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends may be able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably because these two bends may subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to a frur null mutation , which is able to subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably due to a frur null mutation , which may be able to subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably due to a frur null mutation , which may subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably due to a frur null mutation , which subtly #altered the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably due to a frur null mutation , which was able to subtly #alter the rates of utilization of at least 36 carbon sources .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which is able to subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to these two bends , which may subtly #alter the overall direction of the dna .
hence , glu13 indirectly affects dna-binding specificity probably due to this mutation , which can subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably due to this mutation , which is able to subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably due to this mutation , which may be able to subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably due to this mutation , which subtly #altered vulval induction .
hence , glu13 indirectly affects dna-binding specificity probably due to this mutation , which was able to subtly #alter vulval induction .
hence , glu13 indirectly affects dna-binding specificity , probably due to a frur null mutation , which subtly #alters the the rates of utilization of at least 36 carbon sources .
moreover , these two bends #alters the overall direction of the dna .
moreover , these two bends can #alter the overall direction of the dna .
moreover , these two bends has #altered the overall direction of the dna .
moreover , these two bends is able to #alter the overall direction of the dna .
moreover , these two bends may #alter the overall direction of the dna .
moreover , these two bends will be able to #alter the overall direction of the dna .
moreover , this mutation can #alter vulval induction .
moreover , this mutation could #alter vulval induction .
moreover , this mutation is able to #alter vulval induction .
moreover , this mutation will #alter vulval induction .
moreover , this mutation will be able to #alter vulval induction .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources may not be #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , the rates of utilization of at least 36 carbon sources will not be #altered by them(figure 3c) .
since a frur null mutation are in opposing directions , they do not #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation are in opposing directions , they may not #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation are in opposing directions , they will not #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation were in opposing directions , the rates of utilization of at least 36 carbon sources was not able to be #altered by them(figure 3c) .
since a frur null mutation were in opposing directions , they could not #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since a frur null mutation were in opposing directions , they were not able to #alter the rates of utilization of at least 36 carbon sources(figure 3c) .
since s1031 is a null allele , we are testing whether a frur null mutation is able to #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether a frur null mutation is going to #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we are testing whether the overall direction of the dna can be #altered by these two bends .
since s1031 is a null allele , we are testing whether the overall direction of the dna is able to be #altered by these two bends .
since s1031 is a null allele , we are testing whether the overall direction of the dna may be #altered by these two bends .
since s1031 is a null allele , we are testing whether the rates of utilization of at least 36 carbon sources can be #altered by a frur null mutation .
since s1031 is a null allele , we are testing whether the rates of utilization of at least 36 carbon sources is able to be #altered by a frur null mutation .
since s1031 is a null allele , we are testing whether the rates of utilization of at least 36 carbon sources is #altered by a frur null mutation .
since s1031 is a null allele , we are testing whether these two bends is going to #alter the overall direction of the dna .
since s1031 is a null allele , we are testing whether these two bends may #alter the overall direction of the dna .
since s1031 is a null allele , we tested whether a frur null mutation could #alter the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether a frur null mutation has #altered the rates of utilization of at least 36 carbon sources .
since s1031 is a null allele , we tested whether the overall direction of the dna could be #altered by these two bends .
since s1031 is a null allele , we tested whether the overall direction of the dna was able to be #altered by these two bends .
since s1031 is a null allele , we tested whether the rates of utilization of at least 36 carbon sources could be #altered by a frur null mutation .
since s1031 is a null allele , we tested whether the rates of utilization of at least 36 carbon sources was able to be #altered by a frur null mutation .
since s1031 is a null allele , we tested whether these two bends #altered the overall direction of the dna .
since s1031 is a null allele , we tested whether these two bends could #alter the overall direction of the dna .
since s1031 is a null allele , we tested whether these two bends has #altered the overall direction of the dna .
since s1031 is a null allele , we tested whether these two bends might #alter the overall direction of the dna .
since s1031 is a null allele , we tested whether these two bends was able to #alter the overall direction of the dna .
since this mutation are in opposing directions , they cannot #alter vulval induction(figure 3c) .
since this mutation are in opposing directions , they do not #alter vulval induction(figure 3c) .
since this mutation are in opposing directions , they will not #alter vulval induction(figure 3c) .
since this mutation are in opposing directions , vulval induction is not able to be #altered by them(figure 3c) .
since this mutation are in opposing directions , vulval induction is not #altered by them(figure 3c) .
since this mutation are in opposing directions , vulval induction may not be #altered by them(figure 3c) .
since this mutation were in opposing directions , they could not #alter vulval induction(figure 3c) .
since this mutation were in opposing directions , they were not able to #alter vulval induction(figure 3c) .
since this mutation were in opposing directions , vulval induction was not able to be #altered by them(figure 3c) .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 are able to be #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 is #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 may be #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because phosphorylation of pdk1 was #altered by treating the cells with insulin-like growth factor-i .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site can be #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because binding of lrp at the gatc1130 site may be #altered by dam methylation .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 are able to be #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because expression of bcl-3 is #altered by a mechanism .
hence , glu13 indirectly affects dna-binding specificity because splicing is #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity because splicing may be #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity because splicing was #altered by the molecular lesion associated with s1031 .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation can subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation may be able to subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation may subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because dam methylation subtly #altered binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably because a mechanism is able to subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 may be able to subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably because the molecular lesion associated with s1031 may subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i can subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably because treating the cells with insulin-like growth factor-i subtly #alters phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to dam methylation , which may subtly #alter binding of lrp at the gatc1130 site .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which can subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which is able to subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to a mechanism , which may be able to subtly #alter expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which is able to subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which may be able to subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to the molecular lesion associated with s1031 , which may subtly #alter splicing .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which is able to subtly #alter phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity probably due to treating the cells with insulin-like growth factor-i , which subtly #altered phosphorylation of pdk1 .
hence , glu13 indirectly affects dna-binding specificity , probably due to a mechanism , which subtly #alters the expression of bcl-3 .
hence , glu13 indirectly affects dna-binding specificity , probably due to the molecular lesion associated with s1031 , which subtly #alters the splicing .
moreover , dam methylation could #alter binding of lrp at the gatc1130 site .
moreover , dam methylation has #altered binding of lrp at the gatc1130 site .
moreover , dam methylation is able to #alter binding of lrp at the gatc1130 site .
moreover , dam methylation will #alter binding of lrp at the gatc1130 site .
moreover , a mechanism #altered expression of bcl-3 .
moreover , a mechanism #alters expression of bcl-3 .
moreover , a mechanism has #altered expression of bcl-3 .
moreover , a mechanism may be able to #alter expression of bcl-3 .
moreover , the molecular lesion associated with s1031 could #alter splicing .
moreover , the molecular lesion associated with s1031 may #alter splicing .
moreover , treating the cells with insulin-like growth factor-i can #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i has #altered phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i may #alter phosphorylation of pdk1 .
moreover , treating the cells with insulin-like growth factor-i will be able to #alter phosphorylation of pdk1 .
since dam methylation are in opposing directions , binding of lrp at the gatc1130 site cannot be #altered by them(figure 3c) .
since dam methylation are in opposing directions , binding of lrp at the gatc1130 site is not able to be #altered by them(figure 3c) .
since dam methylation are in opposing directions , binding of lrp at the gatc1130 site may not be #altered by them(figure 3c) .
since dam methylation are in opposing directions , they are not able to #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation are in opposing directions , they do not #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation are in opposing directions , they may not #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation were in opposing directions , binding of lrp at the gatc1130 site could not be #altered by them(figure 3c) .
since dam methylation were in opposing directions , binding of lrp at the gatc1130 site was not able to be #altered by them(figure 3c) .
since dam methylation were in opposing directions , they could not #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation were in opposing directions , they did not #alter binding of lrp at the gatc1130 site(figure 3c) .
since dam methylation were in opposing directions , they were not able to #alter binding of lrp at the gatc1130 site(figure 3c) .
since a mechanism are in opposing directions , expression of bcl-3 is not able to be #altered by them(figure 3c) .
since a mechanism are in opposing directions , expression of bcl-3 is not #altered by them(figure 3c) .
since a mechanism are in opposing directions , expression of bcl-3 may not be #altered by them(figure 3c) .
since a mechanism are in opposing directions , expression of bcl-3 will not be #altered by them(figure 3c) .
since a mechanism are in opposing directions , they are not able to #alter expression of bcl-3(figure 3c) .
since a mechanism are in opposing directions , they do not #alter expression of bcl-3(figure 3c) .
since a mechanism are in opposing directions , they may not #alter expression of bcl-3(figure 3c) .
since a mechanism were in opposing directions , expression of bcl-3 could not be #altered by them(figure 3c) .
since a mechanism were in opposing directions , they did not #alter expression of bcl-3(figure 3c) .
since s1031 is a null allele , we are testing whether dam methylation is going to #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether dam methylation may #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we are testing whether phosphorylation of pdk1 is able to be #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we are testing whether phosphorylation of pdk1 is #altered by treating the cells with insulin-like growth factor-i .
since s1031 is a null allele , we are testing whether a mechanism is going to #alter expression of bcl-3 .
since s1031 is a null allele , we are testing whether a mechanism may #alter expression of bcl-3 .
since s1031 is a null allele , we are testing whether a mechanism will #alter expression of bcl-3 .
since s1031 is a null allele , we are testing whether binding of lrp at the gatc1130 site can be #altered by dam methylation .
since s1031 is a null allele , we are testing whether binding of lrp at the gatc1130 site is able to be #altered by dam methylation .
since s1031 is a null allele , we are testing whether expression of bcl-3 can be #altered by a mechanism .
since s1031 is a null allele , we are testing whether expression of bcl-3 is able to be #altered by a mechanism .
since s1031 is a null allele , we are testing whether expression of bcl-3 may be #altered by a mechanism .
since s1031 is a null allele , we are testing whether splicing can be #altered by the molecular lesion associated with s1031 .
since s1031 is a null allele , we are testing whether the molecular lesion associated with s1031 can #alter splicing .
since s1031 is a null allele , we are testing whether treating the cells with insulin-like growth factor-i can #alter phosphorylation of pdk1 .
since s1031 is a null allele , we are testing whether treating the cells with insulin-like growth factor-i is able to #alter phosphorylation of pdk1 .
since s1031 is a null allele , we are testing whether treating the cells with insulin-like growth factor-i will #alter phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether dam methylation #altered binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether dam methylation has #altered binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether dam methylation was able to #alter binding of lrp at the gatc1130 site .
since s1031 is a null allele , we tested whether a mechanism was able to #alter expression of bcl-3 .
since s1031 is a null allele , we tested whether binding of lrp at the gatc1130 site might be #altered by dam methylation .
since s1031 is a null allele , we tested whether expression of bcl-3 could be #altered by a mechanism .
since s1031 is a null allele , we tested whether expression of bcl-3 was able to be #altered by a mechanism .
since s1031 is a null allele , we tested whether the molecular lesion associated with s1031 was able to #alter splicing .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i #altered phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i has #altered phosphorylation of pdk1 .
since s1031 is a null allele , we tested whether treating the cells with insulin-like growth factor-i was able to #alter phosphorylation of pdk1 .
since the molecular lesion associated with s1031 are in opposing directions , splicing cannot be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , splicing is not able to be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , they cannot #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , they do not #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , they may not #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 are in opposing directions , they will not #alter splicing(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , splicing could not be #altered by them(figure 3c) .
since the molecular lesion associated with s1031 were in opposing directions , splicing was not #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , phosphorylation of pdk1 is not able to be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , phosphorylation of pdk1 may not be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , phosphorylation of pdk1 will not be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , they are not able to #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , they do not #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i are in opposing directions , they may not #alter phosphorylation of pdk1(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , phosphorylation of pdk1 could not be #altered by them(figure 3c) .
since treating the cells with insulin-like growth factor-i were in opposing directions , they were not able to #alter phosphorylation of pdk1(figure 3c) .
bending of 31 into the major groove over the cc and ct base pair steps #begins and ends the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , can have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps can #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , could #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps can promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps has promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , has #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , is able to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is assumed to have promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , may #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps is believed to have #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , might #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , was able to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps promptly #began and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , was believed to have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps will #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , will have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps will promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , #began and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , would #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , #begins and ends the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
growth of gaal , gpi8 and gpi16 deletants , when transferred to a glucose-containing medium in order to deplete these proteins , would have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , can promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is able to #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is able to promptly #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is assumed to have promptly #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , is believed to have #begun and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , may #begin and end the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , promptly #began and ended the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
bending of 31 into the major groove over the cc and ct base pair steps , as our study suggested , promptly #begins and ends the carg-box , and 15 into the minor groove over the five central ta , aa and at base pair steps .
on the other hand , the only transcript being believed to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript being believed to have #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript being believed to have probably #begun at exon 1a is observed in normal cells .
on the other hand , the only transcript that #begins at exon 1a is observed in normal cells .
on the other hand , the only transcript that can #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that could #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript that could probably #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript that has #begun at exon 1a was observed in normal cells .
on the other hand , the only transcript that is able to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that is able to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that is believed to probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript that probably #begins at exon 1a is observed in normal cells .
on the other hand , the only transcript that was able to #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript which #begins at exon 1a is observed in normal cells .
on the other hand , the only transcript which can #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which can probably #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which could #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript which could probably #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript which has #begun at exon 1a was observed in normal cells .
on the other hand , the only transcript which has probably #begun at exon 1a was observed in normal cells .
on the other hand , the only transcript which is able to #begin at exon 1a is observed in normal cells .
on the other hand , the only transcript which was able to #begin at exon 1a was observed in normal cells .
on the other hand , the only transcript which was believed to #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , #began at exon 1a was observed in normal cells .
the levels of immunoreactive ib are able to #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , can #begin at exon 1a is observed in normal cells .
the only transcript that , on the other hand , can probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib #began to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , could #begin at exon 1a was observed in normal cells .
the only transcript that , on the other hand , could probably #begin at exon 1a was observed in normal cells .
the only transcript that , on the other hand , has #begun at exon 1a was observed in normal cells .
the levels of immunoreactive ib could #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , is believed to have probably #begun at exon 1a is observed in normal cells .
the only transcript that , on the other hand , probably #begins at exon 1a is observed in normal cells .
the levels of immunoreactive ib is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was able to probably #begin at exon 1a was observed in normal cells .
the levels of immunoreactive ib may have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript that , on the other hand , was believed to probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib might #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , #begins at exon 1a is observed in normal cells .
the levels of immunoreactive ib might have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib promptly #began to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , has #begun at exon 1a was observed in normal cells .
the levels of immunoreactive ib was able to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is able to probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib was believed to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is believed to have #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib will #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is believed to have probably #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib will have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , is believed to probably #begin at exon 1a is observed in normal cells .
the only transcript which , on the other hand , probably #began at exon 1a was observed in normal cells .
the only transcript which , on the other hand , probably #begins at exon 1a is observed in normal cells .
the levels of immunoreactive ib would have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , are able to #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , are able to promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the only transcript which , on the other hand , was believed to have probably #begun at exon 1a is observed in normal cells .
the only transcript which , on the other hand , was believed to probably #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , #began to return to basal levels following 3-4 h exposures to poly ic .
the only transcript , on the other hand , being believed to #begin at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , can have #begun to return to basal levels following 3-4 h exposures to poly ic .
the only transcript , on the other hand , being believed to have probably #begun at exon 1a is observed in normal cells .
the levels of immunoreactive ib , as several research works revealed , can promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #begins to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants can #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants can have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants has #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is able to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may #begin to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants may have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was able to #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
the levels of immunoreactive ib #begin to return to basal levels following 3-4 h exposures to poly ic .
the only transcript #beginning at exon 1a will continue to the c-terminus .
the only transcript #begins variably at exon 1a , and continues to the c-terminus .
the only transcript can #begin variably at exon 1a , and continues to the c-terminus .
the only transcript could #begin at exon 1a , and continued to the c-terminus .
the only transcript could #begin variably at exon 1a , and continued to the c-terminus .
the only transcript has #begun variably at exon 1a , and has continued to the c-terminus .
the only transcript is able to #begin at exon 1a , and continues to the c-terminus .
the only transcript is able to #begin variably at exon 1a , and continues to the c-terminus .
the only transcript that #began variably at exon 1a continued to the c-terminus .
the only transcript that #begins variably at exon 1a continues to the c-terminus .
the only transcript was able to #begin at exon 1a , and continued to the c-terminus .
the only transcript was able to #begin variably at exon 1a , and continued to the c-terminus .
the only transcript which #began at exon 1a continued to the c-terminus .
the only transcript which #began variably at exon 1a continued to the c-terminus .
the only transcript which #begins variably at exon 1a continues to the c-terminus .
the only transcript which has #begun at exon 1a has continued to the c-terminus .
the only transcript which has #begun variably at exon 1a has continued to the c-terminus .
the only transcript will #begin at exon 1a , and continues to the c-terminus .
the only transcript would #begin variably at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , #began variably at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , #beginning at exon 1a will continue to the c-terminus .
the only transcript , as our data have shown , #beginning variably at exon 1a will continue to the c-terminus .
the only transcript , as our data have shown , can #begin variably at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , could #begin at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , has #begun variably at exon 1a , and has continued to the c-terminus .
the only transcript , as our data have shown , is able to #begin variably at exon 1a , and continues to the c-terminus .
the only transcript , as our data have shown , that #began at exon 1a continued to the c-terminus .
the only transcript , as our data have shown , that #begins at exon 1a continues to the c-terminus .
the only transcript , as our data have shown , that #begins variably at exon 1a continues to the c-terminus .
the only transcript , as our data have shown , that has #begun at exon 1a has continued to the c-terminus .
the only transcript , as our data have shown , that has #begun variably at exon 1a has continued to the c-terminus .
the only transcript , as our data have shown , was able to #begin at exon 1a , and continued to the c-terminus .
the only transcript , as our data have shown , which #began variably at exon 1a continued to the c-terminus .
the only transcript , as our data have shown , which #begins variably at exon 1a continues to the c-terminus .
the only transcript , as our data have shown , which has #begun variably at exon 1a has continued to the c-terminus .
the only transcript , as our data have shown , will #begin variably at exon 1a , and continues to the c-terminus .
the levels of immunoreactive ib are able to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib are able to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib #began return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib #began returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib #began to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib #beginning to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib #begins to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib believed to #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib can #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib can probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib can promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib could #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib could #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib could have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib could probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib could probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib has #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is able to #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is able to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is able to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib is believed to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib is believed to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib is believed to have #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib is believed to have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib is believed to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib is believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib is believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib is believed to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib may #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib may have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib may probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib may probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib may probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib might #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib might probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib might promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib probably #begins return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib probably #begins to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib that #began returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that #began to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has probably #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that has probably #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that is believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #began return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that probably #begins returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib that was believed to #begin return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to #begin to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have #begun return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib that was believed to probably #begin return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib was able to #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib was able to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was able to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib was able to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was able to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib was able to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib was able to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib was able to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to #begin return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib was believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib was believed to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib which #begins returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which has probably #begun returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to #begin return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to #begin returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which is believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #began returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #began to return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #begins return to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which probably #begins returning to basal levels following 3-4 h exposures to poly ic can continue slowly for 33 h .
the levels of immunoreactive ib which was believed to #begin to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have #begun returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to have probably #begun returning to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to probably #begin return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib which was believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic could continue slowly for 33 h .
the levels of immunoreactive ib will #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will #begin returning to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib will #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib will #begin to return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib will probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib will probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib will probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib would #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib would have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib would probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , #begins return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , #begins returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , #begins to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , can #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , can #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , can probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , could #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , has probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is able to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to have probably #begun to return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , is believed to probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth continues slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , may #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , may #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , may probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , may probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , may probably #begin to return to basal levels following 3-4 h exposures to poly ic , but growth can continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , might probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to #begin return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to #begin to return to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was able to probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth could continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to have probably #begun return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , was believed to probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth continued slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will #begin return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , will probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth will continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , would #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , would #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , would #begin to return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , would probably #begin return to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as our study suggested , would probably #begin returning to basal levels following 3-4 h exposures to poly ic , but growth would continue slowly for 33 h .
the levels of immunoreactive ib , as several research works revealed , are able to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , are able to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , are able to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , #began returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , can have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could have #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , could promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to have promptly #begun to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , is believed to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , may promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might have promptly #begun returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , might promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , promptly #began return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , promptly #began returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was able to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to promptly #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , was believed to promptly #begin to return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will #begin returning to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , will have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would #begin return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would have promptly #begun return to basal levels following 3-4 h exposures to poly ic .
the levels of immunoreactive ib , as several research works revealed , would promptly #begin returning to basal levels following 3-4 h exposures to poly ic .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #began to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #began to returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #begins return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib #begins returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib can have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib could have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib has #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is able to #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib is believed to have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib may have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib might have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was able to #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to #begin return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to #begin returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib was believed to have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will have #begun returning to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib will have #begun to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would #begin to return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , the levels of immunoreactive ib would have #begun return to basal levels following 3-4 h exposures to poly ic , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants #begins declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants can #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants can #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants can have #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants could #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants has #begun declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is able to #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants is believed to have #begun to decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants might have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants was believed to #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants will #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would #begin decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would #begin declining at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
when they were transferred to a glucose-containing medium in order to deplete these proteins , growth of gaal , gpi8 and gpi16 deletants would have #begun decline at 12 , 6 and 6 h , respectively , after transfer and ceased at 24 , 12 and 12 h .
growth of gaal , gpi8 and gpi16 deletants are able to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants are able to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants are able to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants are able to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #began decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #began declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants #begins decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants #begins to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to have #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to have #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to have probably #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to have probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to have probably #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to probably #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants believed to probably #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants can probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants can promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could probably #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could probably #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants could promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants could promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants has #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants has #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants has #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants has probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants has probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is able to probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is able to probably #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants is believed to probably #begin declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants is believed to probably #begin to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants may #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants may probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might probably #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants might promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants might promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants probably #begins decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants promptly #began declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants promptly #began to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants that #began declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that #began to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that #begins declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that #begins to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that has probably #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have probably #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to have probably #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that is believed to probably #begin declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that probably #began decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that probably #began declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that probably #began to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that probably #begins decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that probably #begins declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that probably #begins to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to #begin decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to #begin to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to have #begun decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to have #begun declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to have #begun to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to have probably #begun declining at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to have probably #begun to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to probably #begin decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants that was believed to probably #begin to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was able to #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to probably #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to probably #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was able to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to #begin to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have probably #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to probably #begin declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants was believed to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants was believed to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants which #began declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which #began to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which #begins decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which #begins declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which #begins to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has #begun declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has probably #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which has probably #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to #begin decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to #begin to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have #begun to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which is believed to have probably #begun decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #began declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #begins decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #begins declining at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which probably #begins to decline at 12 , 6 and 6 h can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to #begin decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to #begin to decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants which was believed to have #begun decline at 12 , 6 and 6 h could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will #begin declining at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants will probably #begin to decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants will promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would #begin declining at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants would probably #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants would promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , #begins to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , can probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , could #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , could #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , could probably #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , could probably #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , could probably #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , has probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is able to probably #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to #begin decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to #begin to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to have probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to probably #begin decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , is believed to probably #begin to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may #begin declining at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may #begin to decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , may probably #begin decline at 12 , 6 and 6 h , but growth can continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , might probably #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , probably #begins decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , probably #begins declining at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , probably #begins to decline at 12 , 6 and 6 h , but growth continues slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to #begin decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to #begin declining at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was able to probably #begin to decline at 12 , 6 and 6 h , but growth could continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to have #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to have #begun declining at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to have #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to have probably #begun decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , was believed to have probably #begun to decline at 12 , 6 and 6 h , but growth continued slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will #begin decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will probably #begin declining at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , will probably #begin to decline at 12 , 6 and 6 h , but growth will continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would probably #begin decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as our study suggested , would probably #begin to decline at 12 , 6 and 6 h , but growth would continue slowly for 33 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , are able to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , can have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , could promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , is believed to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , may promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , might promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was able to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to promptly #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , was believed to promptly #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will #begin to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , will have promptly #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would #begin declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would have #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would have #begun declining at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would have #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would have promptly #begun decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would have promptly #begun to decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would promptly #begin decline at 12 , 6 and 6 h .
growth of gaal , gpi8 and gpi16 deletants , as several research works revealed , would promptly #begin to decline at 12 , 6 and 6 h .
a downstream kinase appeared to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation might be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation were believed to be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation would be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine had #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine might #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine might have #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appeared to be essential for agrin-mediated signaling , since staurosporine was believed to #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling because of staurosporines #blocking agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation are believed to be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since agrin-induced achr clustering and phosphorylation will be #blocked by staurosporine without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine can #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine has #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine may #block agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
a downstream kinase appears to be essential for agrin-mediated signaling , since staurosporine may have #blocked agrin-induced achr clustering and phosphorylation without inhibiting musk phosphorylation (wallace , 1994; fuhrer et al . , 1997) .
alanine can have #blocked the action of a postulated repressor .
alanine has #blocked the action of a postulated repressor .
alanine is believed to #block the action of a postulated repressor .
alanine may #block the action of a postulated repressor .
alanine was able to #block the action of a postulated repressor .
alanine was believed to #block the action of a postulated repressor .
alanine would #block the action of a postulated repressor .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 are shown to be able to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because antibodies to rap1 have been shown to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 were able to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro could be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro is #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that merozoite invasion in vitro would be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because merozoite invasion in vitro is shown to have been #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because merozoite invasion in vitro was shown to be #blocked by antibodies to rap1 (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
it #blocked membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it #blocks membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it could #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it may #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it was able to #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it was believed to #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
it will #block membranes in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes are able to be #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes can be #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes has been #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
membranes will be #blocked in tbst (tris-buffered saline , 0 .05% tween-20) containing 5% bovine serum albumin (for anti-phosphoryrosine blots) or skimmed milk and probed with antibodies .
tagetin is more specific for distinguishing between different rna polymerases because it can #block rna polymerase during elongation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because it is able to #block rna polymerase during elongation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
tagetin is more specific for distinguishing between different rna polymerases because it may #blocks rna polymerase during elongation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway #blocking the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway by #blocking the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway that have #blocked the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
the action of a postulated repressor can be #blocked by alanine .
the action of a postulated repressor has been #blocked by alanine .
the action of a postulated repressor was #blocked by alanine .
both rap1 and 2 are important vaccine candidates because it has been shown that antibodies to rap1 are able to #block merozoite invasion in vitro (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
these results suggest that 14-3-3eta functions as a positive regulator in the glucocorticoid signal pathway by #blocking the degradation of gr and inducing an elevation of gr , thus enhancing the transcriptional activity of gr .
alanine is more specific for distinguishing between different rna polymerases because the action of a postulated repressor can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because the action of a postulated repressor is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because the action of a postulated repressor is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
alanine is more specific for distinguishing between different rna polymerases because the action of a postulated repressor was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
both rap1 and 2 are important vaccine candidates because alanine are shown to be able to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because alanine have been shown to be able to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because alanine have been shown to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because rna polymerase during elongation was shown to have been #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin are shown to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin are shown to have #blocked rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because tagetin have been shown to be able to #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that alanine are able to #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that alanine #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that alanine #blocked the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that alanine can #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that alanine may #block the action of a postulated repressor (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation can be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation could be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation has been #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation is #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation may be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation was believed to be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that rna polymerase during elongation would be #blocked by tagetin (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin can #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that tagetin may #block rna polymerase during elongation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor can be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor could be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the action of a postulated repressor may be #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the action of a postulated repressor is shown to have been #blocked by alanine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
labeling with antibodies to the y553 phosphopeptide is specific since alanine have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since alanine will #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide is specific since rna polymerase during elongation is believed to be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin is able to #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin may #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since tagetin may have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 #blocks merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 can #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since antibodies to rap1 may have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide is specific since merozoite invasion in vitro is believed to be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide is specific since merozoite invasion in vitro is #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide is specific since the action of a postulated repressor can be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide was specific since alanine might #block the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine might have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since alanine would have #blocked the action of a postulated repressor .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation was believed to be #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since rna polymerase during elongation was #blocked by tagetin .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin could #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin could have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin was able to #block rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since tagetin would have #blocked rna polymerase during elongation .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 could #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 could have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 might #block merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since antibodies to rap1 would have #blocked merozoite invasion in vitro .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro could be #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since merozoite invasion in vitro was #blocked by antibodies to rap1 .
labeling with antibodies to the y553 phosphopeptide was specific since the action of a postulated repressor was able to be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide was specific since the action of a postulated repressor was believed to be #blocked by alanine .
labeling with antibodies to the y553 phosphopeptide was specific since the action of a postulated repressor was #blocked by alanine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine can #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is believed to #block the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine is proven to have #blocked the action of a postulated repressor .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation is believed to be #blocked by tagetin .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation may be #blocked by tagetin .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation will be #blocked by tagetin .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin #blocks rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and tagetin is proven to #block rna polymerase during elongation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 has #blocked merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 is able to #block merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 is believed to have #blocked merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 is proven to #block merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 will #block merozoite invasion in vitro .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro can be #blocked by antibodies to rap1 .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro is believed to be #blocked by antibodies to rap1 .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro may be #blocked by antibodies to rap1 .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor can be #blocked by alanine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor is believed to be #blocked by alanine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the action of a postulated repressor may be #blocked by alanine .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and alanine has #blocked the action of a postulated repressor .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and rna polymerase during elongation was #blocked by tagetin .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 #blocked merozoite invasion in vitro .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and antibodies to rap1 has #blocked merozoite invasion in vitro .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and merozoite invasion in vitro has been #blocked by antibodies to rap1 .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 is not able to #block merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine did not #block the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and tagetin did not #block rna polymerase during elongation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and rna polymerase during elongation can not be #blocked by tagetin , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and rna polymerase during elongation is believed not to be #blocked by tagetin , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and merozoite invasion in vitro is not able to be #blocked by antibodies to rap1 , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the action of a postulated repressor is believed not to be #blocked by alanine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the action of a postulated repressor is not able to be #blocked by alanine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and alanine has not #blocked the action of a postulated repressor , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and antibodies to rap1 has not #blocked merozoite invasion in vitro , indicating that 14-3-3eta induces stabilization of gr .
rna polymerase during elongation is #blocked by tagetin .
rna polymerase during elongation was #blocked by tagetin .
tagetin #blocked rna polymerase during elongation .
tagetin #blocks rna polymerase during elongation .
tagetin could #block rna polymerase during elongation .
tagetin could have #blocked rna polymerase during elongation .
tagetin has #blocked rna polymerase during elongation .
tagetin is believed to #block rna polymerase during elongation .
tagetin is thought to act as an inducer to #block rna polymerase during elongation .
tagetin may have #blocked rna polymerase during elongation .
tagetin might #block rna polymerase during elongation .
tagetin would #block rna polymerase during elongation .
antibodies to rap1 can #block merozoite invasion in vitro .
antibodies to rap1 could #block merozoite invasion in vitro .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because it #blocked merozoite invasion in vitro (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because it #blocks merozoite invasion in vitro (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because it is able to #block merozoite invasion in vitro (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because merozoite invasion in vitro can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because merozoite invasion in vitro is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is more specific for distinguishing between different rna polymerases because merozoite invasion in vitro was #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
antibodies to rap1 is thought to act as an inducer to #block merozoite invasion in vitro .
antibodies to rap1 may #block merozoite invasion in vitro .
antibodies to rap1 may have #blocked merozoite invasion in vitro .
antibodies to rap1 might #block merozoite invasion in vitro .
antibodies to rap1 might have #blocked merozoite invasion in vitro .
antibodies to rap1 was able to #block merozoite invasion in vitro .
antibodies to rap1 was believed to #block merozoite invasion in vitro .
antibodies to rap1 would #block merozoite invasion in vitro .
merozoite invasion in vitro has been #blocked by antibodies to rap1 .
merozoite invasion in vitro was #blocked by antibodies to rap1 .
14-3-3eta functions has been #blocked by the degradation of gr and inducing an elevation of gr .
14-3-3eta functions is #blocked by the degradation of gr and inducing an elevation of gr .
14-3-3eta functions was #blocked by the degradation of gr and inducing an elevation of gr .
both rap1 and 2 are important vaccine candidates because 14-3-3eta functions is shown to have been #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because 14-3-3eta functions was shown to be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because 14-3-3eta functions was shown to have been #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because agrin-induced achr clustering and phosphorylation is shown to be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because agrin-induced achr clustering and phosphorylation is shown to have been #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because agrin-induced achr clustering and phosphorylation was shown to have been #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions is believed to be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that 14-3-3eta functions will be #blocked by the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that a positive regulator in the glucocorticoid signal pathway #blocked the degradation of gr and inducing an elevation of gr (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation could be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation may be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation was #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation will be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that agrin-induced achr clustering and phosphorylation would be #blocked by staurosporine (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that staurosporine may #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr are able to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr can be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr can #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr could be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr has been #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr is believed to be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr may #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr was believed to be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr were able to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr will be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because it has been shown that the degradation of gr and inducing an elevation of gr would be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine are shown to be able to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine have been shown to be able to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because staurosporine have been shown to #block agrin-induced achr clustering and phosphorylation (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr are shown to be able to #block 14-3-3eta functions (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr was shown to be #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
both rap1 and 2 are important vaccine candidates because the degradation of gr and inducing an elevation of gr was shown to have been #blocked by a positive regulator in the glucocorticoid signal pathway (schofield et al . , 1986; harnyuttanakorn et al . , 1992; howard et al . , 1998a) .
labeling with antibodies to the y553 phosphopeptide is specific since 14-3-3eta functions can be #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since 14-3-3eta functions is able to be #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since 14-3-3eta functions is believed to be #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since a positive regulator in the glucocorticoid signal pathway #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide is specific since agrin-induced achr clustering and phosphorylation is believed to be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine #blocks agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since staurosporine is able to #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr can be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr can #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr can have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr is able to be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr is #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr may have #blocked 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide is specific since the degradation of gr and inducing an elevation of gr will #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since 14-3-3eta functions could be #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since 14-3-3eta functions was believed to be #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since 14-3-3eta functions was #blocked by the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway could #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway could have #blocked the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since a positive regulator in the glucocorticoid signal pathway might #block the degradation of gr and inducing an elevation of gr .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation could be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since agrin-induced achr clustering and phosphorylation was believed to be #blocked by staurosporine .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine might #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine might have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine was able to #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine would #block agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since staurosporine would have #blocked agrin-induced achr clustering and phosphorylation .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr could be #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr could #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr has been #blocked by a positive regulator in the glucocorticoid signal pathway .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr might #block 14-3-3eta functions .
labeling with antibodies to the y553 phosphopeptide was specific since the degradation of gr and inducing an elevation of gr would #block 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions can be #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions is #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway can #block the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway is able to #block the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway is proven to #block the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and a positive regulator in the glucocorticoid signal pathway is proven to have #blocked the degradation of gr and inducing an elevation of gr .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation is believed to be #blocked by staurosporine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation will be #blocked by staurosporine .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine can #block agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine has #blocked agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine is proven to have #blocked agrin-induced achr clustering and phosphorylation .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr can be #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr has #blocked 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is believed to #block 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is believed to have #blocked 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr is proven to #block 14-3-3eta functions .
pu .1 is upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr will be #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and 14-3-3eta functions was #blocked by the degradation of gr and inducing an elevation of gr .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation has been #blocked by staurosporine .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and agrin-induced achr clustering and phosphorylation was #blocked by staurosporine .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and staurosporine #blocked agrin-induced achr clustering and phosphorylation .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr #blocked 14-3-3eta functions .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr has been #blocked by a positive regulator in the glucocorticoid signal pathway .
pu .1 was upregulated early during commitment of multipotential progenitors to the myeloid lineages and the degradation of gr and inducing an elevation of gr was #blocked by a positive regulator in the glucocorticoid signal pathway .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and a positive regulator in the glucocorticoid signal pathway can not #block the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and a positive regulator in the glucocorticoid signal pathway is not able to #block the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine can not #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and staurosporine is not able to #block agrin-induced achr clustering and phosphorylation , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition can not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr is not able to #block 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and a positive regulator in the glucocorticoid signal pathway did not #block the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition did not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr did not #block 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and 14-3-3eta functions is not able to be #blocked by the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and a positive regulator in the glucocorticoid signal pathway does not #block the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and agrin-induced achr clustering and phosphorylation can not be #blocked by staurosporine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and agrin-induced achr clustering and phosphorylation is believed not to be #blocked by staurosporine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and agrin-induced achr clustering and phosphorylation is not able to be #blocked by staurosporine , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr does not #block 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr is believed not to be #blocked by a positive regulator in the glucocorticoid signal pathway , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition does not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr is not #blocked by a positive regulator in the glucocorticoid signal pathway , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition has not induced any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and a positive regulator in the glucocorticoid signal pathway has not #blocked the degradation of gr and inducing an elevation of gr , indicating that 14-3-3eta induces stabilization of gr .
proteasomal inhibition will not induce any synergistic effect on the 14-3-3eta-induced increase in gr in response to glucocorticoid , and the degradation of gr and inducing an elevation of gr will not #block 14-3-3eta functions , indicating that 14-3-3eta induces stabilization of gr .
a positive regulator in the glucocorticoid signal pathway #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway can #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway has #blocked the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway is able to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it can #block the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because it may #blocks the degradation of gr and inducing an elevation of gr (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because the degradation of gr and inducing an elevation of gr can be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because the degradation of gr and inducing an elevation of gr is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway is more specific for distinguishing between different rna polymerases because the degradation of gr and inducing an elevation of gr is #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
a positive regulator in the glucocorticoid signal pathway may #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway was believed to #block the degradation of gr and inducing an elevation of gr .
a positive regulator in the glucocorticoid signal pathway would #block the degradation of gr and inducing an elevation of gr .
agrin-induced achr clustering and phosphorylation can be #blocked by staurosporine .
agrin-induced achr clustering and phosphorylation is #blocked by staurosporine .
staurosporine #blocked agrin-induced achr clustering and phosphorylation .
staurosporine can #block agrin-induced achr clustering and phosphorylation .
staurosporine has #blocked agrin-induced achr clustering and phosphorylation .
staurosporine is able to #block agrin-induced achr clustering and phosphorylation .
staurosporine is more specific for distinguishing between different rna polymerases because it #blocks agrin-induced achr clustering and phosphorylation (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
staurosporine is thought to act as an inducer to #block agrin-induced achr clustering and phosphorylation .
staurosporine was able to #block agrin-induced achr clustering and phosphorylation .
staurosporine will #block agrin-induced achr clustering and phosphorylation .
staurosporine would #block agrin-induced achr clustering and phosphorylation .
the degradation of gr and inducing an elevation of gr #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr can #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr could #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr has been #blocked by a positive regulator in the glucocorticoid signal pathway .
the degradation of gr and inducing an elevation of gr has #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr is #blocked by a positive regulator in the glucocorticoid signal pathway .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because 14-3-3eta functions is able to be #blocked by it (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it #blocked 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is more specific for distinguishing between different rna polymerases because it can #block 14-3-3eta functions (mathews and durbin , 1994) , i .e .its action is independent of different initiation factors .
the degradation of gr and inducing an elevation of gr is thought to act as an inducer to #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr may have #blocked 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr might #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr was able to #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr was believed to #block 14-3-3eta functions .
the degradation of gr and inducing an elevation of gr was #blocked by a positive regulator in the glucocorticoid signal pathway .
dna helicases are able to catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes being able to catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes being believed to catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes catalyzing the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes that are believed to catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes that catalyzed the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases catalyzed the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases have catalyzed the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
helicases can not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
helicases not only #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids , but also moved along nucleic acid strands in a polar fashion .
however , rep78 and rep68 being able to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 #catalysing the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 having the ability to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 that are able to #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which can #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which #catalyse the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , rep78 and rep68 which #catalysed the packaging reaction up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that rep78 and rep68 have the ability to #catalyse the packaging reaction up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction can be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction could be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction has the probability to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction is able to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction is believed to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction may be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction might be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction was able to be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction was #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the packaging reaction will be #catalysed by rep78 and rep68 up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
the disruption of hydrogen boding between complementary regions of nucleic acids are observed to be #catalysed by helicases that move along nucleic acid strands in a polar fashion .
the disruption of hydrogen boding between complementary regions of nucleic acids can be #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids has been #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids is able to be #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids is shown to be #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids was #catalysed by helicases .
the disruption of hydrogen boding between complementary regions of nucleic acids were seemingly #catalysed by helicases moving along nucleic acid strands in a polar fashion .
the resolution of the covalently cosed aav termini may be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini was #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the resolution of the covalently cosed aav termini was observed to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) are observed to #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) #catalysed the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) is able to #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the two large virus-encoded rep proteins (rep78 and rep68) may #catalyse the resolution of the covalently cosed aav termini , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
the unwinding of dna can be #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
the unwinding of dna has been #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
the unwinding of dna is #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
the unwinding of dna may be #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
the unwinding of dna was #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
the unwinding of dna will be #catalysed by dna helicases via disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
dna helicases are enzymes that catalyze the unwinding of dna by disrupting the hydrogen bonding between paired bases as they progress along the dna strand in a polar fashion (either 35 or 53) , and have been shown to be involved in many essential cellular processes , including replication , transcription , dna repair and translation (for reviews see west , 1996; bird et al . , 1998; lohman et al . , 1998; hall and matson , 1999) .
helicases not only #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , but also move along nucleic acid strands in a polar fashion .
helicases are believed to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
helicases may #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
however , helicases being able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases #catalysing the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases having the ability to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases that can #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases that #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases that have the ability to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which are able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , helicases which may #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) being able to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) having the ability to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that can #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that #catalysed the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) that may #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which can #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which have the ability to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , the two large virus-encoded rep proteins (rep78 and rep68) which may #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that helicases have the ability to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) are observed to #catalyse the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that the two large virus-encoded rep proteins (rep78 and rep68) #catalysed the resolution of the covalently cosed aav termini up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids can be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids is able to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids is #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids is observed to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids might be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids was #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the disruption of hydrogen boding between complementary regions of nucleic acids was observed to be #catalysed by helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini can be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini has been #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini has the probability to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini is believed to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini might be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini was observed to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the resolution of the covalently cosed aav termini will be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases could be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases is most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases may be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that helicases might mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases was most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which is able to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which may #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which might #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which mostly #catalysed the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which mostly #catalyses the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases which was most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases will be most likely to #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that helicases will mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that helicases would mostly #catalyse the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 can be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 can mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 could mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 is able to mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 may be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 may mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 often #catalyses the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 was able to mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 was most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which can #catalyse the packaging reaction can also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which may #catalyse the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which might #catalyse the packaging reaction could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 which mostly #catalysed the packaging reaction can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 will be most likely to #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 will mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that rep78 and rep68 would mostly #catalyse the packaging reaction to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) can be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) can mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) could be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) is most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) may mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) might mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) usually #catalyses the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which is able to #catalyse the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which might #catalyse the resolution of the covalently cosed aav termini could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which mostly #catalysed the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which mostly #catalyses the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) would be most likely to #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) would mostly #catalyse the resolution of the covalently cosed aav termini to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids can be mostly #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids has been mostly #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids is able to be mostly #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids is most likely to be #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids is mostly #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids was most likely to be #catalysed by helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction can be mostly #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction is able to be mostly #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction is mostly #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction was most likely to be #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the packaging reaction was mostly #catalysed by rep78 and rep68 to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini has been mostly #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini is able to be mostly #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini is most likely to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini is mostly #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the resolution of the covalently cosed aav termini was most likely to be #catalysed by the two large virus-encoded rep proteins (rep78 and rep68) to form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that the two large virus-encoded rep proteins (rep78 and rep68) which is most likely to #catalyse the resolution of the covalently cosed aav termini can form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that the disruption of hydrogen boding between complementary regions of nucleic acids to form the major metabolite 3-hydroxyquinine is most likely #catalysed by helicases .
rep78 and rep68 are able to not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
rep78 and rep68 are believed to #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 are observed to #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 can #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 #catalysed the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 is able to #catalyse the packaging reaction , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
rep78 and rep68 not only #catalyse the packaging reaction , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) can not only #catalyse the resolution of the covalently cosed aav termini , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) not only #catalyse the resolution of the covalently cosed aav termini , but also move along nucleic acid strands in a polar fashion .
the two large virus-encoded rep proteins (rep78 and rep68) will not only #catalyse the resolution of the covalently cosed aav termini , but also move along nucleic acid strands in a polar fashion .
dna helicases are able to not only #catalyse the unwinding of dna , but also move along nucleic acid strands in a polar fashion .
dna helicases are believed to not only #catalyse the unwinding of dna , but also move along nucleic acid strands in a polar fashion .
dna helicases can #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases #catalysed the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases is able to #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases may #catalyse the unwinding of dna , a process that involves sequence-specific aav dna biding , strand-specific nicking and helicase activity under atp consumption (im and muzyczka , 1990 , 1992; brister and muzyczka , 1990 , 2000) .
dna helicases not only #catalyse the unwinding of dna , but also move along nucleic acid strands in a polar fashion .
dna helicases not only #catalysed the unwinding of dna , but also moved along nucleic acid strands in a polar fashion .
however , dna helicases being able to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases #catalysing the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases that are able to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases that can #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases that #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases that #catalysed the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases that have the ability to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which can #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which #catalysed the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which have the ability to #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , dna helicases which may #catalyse the unwinding of dna up to 1000-fold less efficiently posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that dna helicases are observed to #catalyse the unwinding of dna up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that dna helicases can #catalyse the unwinding of dna up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that dna helicases #catalyse the unwinding of dna up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that dna helicases #catalysed the unwinding of dna up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , it is interesting to note that dna helicases have the ability to #catalyse the unwinding of dna up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna can be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna could be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna has been #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna has the probability to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna is #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna was able to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
however , the unwinding of dna was observed to be #catalysed by dna helicases up to 1000-fold less efficiently , although they posses the entire rep52 and rep40 coding regions , respectively .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases can be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases can mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases #catalysed the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases #catalysing the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases could be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases could mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases is able to mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases is most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases may be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases may mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases might be most likely to #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases might mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which could #catalyse the unwinding of dna could also form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which may #catalyse the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which mostly #catalysed the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which was able to #catalyse the unwinding of dna could form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases which was most likely to #catalyse the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that dna helicases will mostly #catalyse the unwinding of dna to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna can be mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna is mostly #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies used in vitro hepatic microsomal preparations suggested that the unwinding of dna was most likely to be #catalysed by dna helicases to form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that dna helicases which is most likely to #catalyse the unwinding of dna can form the major metabolite 3-hydroxyquinine .
our previous studies using in vitro hepatic microsomal preparations suggested that the unwinding of dna to form the major metabolite 3-hydroxyquinine is most likely #catalysed by dna helicases .
human 06-alkylguaning-dna alkyltransferase (agt) having #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) that has #conferred resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which can #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) which is believed to #confer resistance to alkylation chemotherapies was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , can #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , could #confer resistance to alkylation chemotherapies and was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , has the ability to #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is able to #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , might #confer resistance to alkylation chemotherapies and was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was able to #confer resistance to alkylation chemotherapies and was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was believed to #confer resistance to alkylation chemotherapies and was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was observed to #confer resistance to alkylation chemotherapies and was therefore an active anticancer drug target .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , will #confer resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
in addition , evga overexpression could not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression has not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression was not able to #confer resistance in a tolc-deficient strain .
in addition , evga overexpression will not #confer resistance in a tolc-deficient strain .
in addition , evga overexpression would not #confer resistance in a tolc-deficient strain .
in addition , loss-of-function mutations are not #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations can not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations have not been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations is observed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations might not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations was observed not to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations were not #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations will not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
in addition , loss-of-function mutations would not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can have been #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance could be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is able to be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance might be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was able to be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance would be #conferred by transfection of agt to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt is able to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt is believed to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt may have #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt might #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt was able to #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt will have #conferred resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt would #confer resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance may be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the 06-bg resistance was believed to be #conferred by these mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations can #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations #conferred the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations have #conferred the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations is able to #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations might #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations was believed to #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations will #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , these mutations would #confer the 06-bg resistance (xu-welliver et al . , 1999a) .
nonsense or frameshift alterations in the coding sequence or by splice variants are believed not to #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants cannot #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants could not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants do not #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants have not #conferred loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants were not able to #confer loss-of-function mutations .
nonsense or frameshift alterations in the coding sequence or by splice variants would not #confer loss-of-function mutations .
resistance can be #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance has the ability to #confer by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance is able to #confer by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance may be #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance might be #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance will be #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance will have been #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
resistance would be #conferred by human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , to alkylation chemotherapies .
specificity for either a mapk or a mapk substrate kinase (mapkap) can be #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) is able to be #conferred by the portion of the stats .
specificity for either a mapk or a mapk substrate kinase (mapkap) is #conferred by the portion of the stats
specificity for either a mapk or a mapk substrate kinase (mapkap) was believed to be #conferred by the portion of the stats .
that the portion of the stats can #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats has the ability to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats may #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
that the portion of the stats was believed to #confer specificity for either a mapk or a mapk substrate kinase (mapkap) has not been determined .
the portion of the stats #confers specificity for either a mapk or a mapk substrate kinase (mapkap) .
resistance in a tolc-deficient strain is able to be #conferred by evga overexpression .
resistance in a tolc-deficient strain is #conferred by evga overexpression .
resistance in a tolc-deficient strain may have been #conferred by evga overexpression .
resistance in a tolc-deficient strain was #conferred by evga overexpression .
human 06-alkylguaning-dna alkyltransferase (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #confers resistance to alkylation chemotherapies and is therefore an active anticancer drug target .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and transfection of agt #confers resistance to alkylation-sensitive cells (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , explaining the 06-bg resistance #conferred by these mutations (xu-welliver et al . , 1999a) .
in addition to clear loss-of-function mutations #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants , genetic screening has revealed a large number of missense codons with less obvious functional consequences .
06-bg resistance in a tolc-deficient strain is able to be #conferred by these mutations .
06-bg resistance in a tolc-deficient strain may have been #conferred by these mutations .
06-bg resistance in a tolc-deficient strain was #conferred by these mutations .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase are believed to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase are observed to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase can #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase #conferred resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that human 06-alkylguaning-dna alkyltransferase were believed to #confer resistance to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats can #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats could #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats have the ability to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats may have #conferred specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats may have the ability to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats might #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats were able to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that the portion of the stats were believed to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance can be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance can be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance can have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance has been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance has been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is able to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is believed to have been #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is observed to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance is shown to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance may have been #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance might be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was able to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was able to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was believed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was believed to be #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance was #conferred by transfection of agt to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance will be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that resistance would be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity can be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity can have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity could be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity has been able to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is believed to have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is observed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity is shown to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity may be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was able to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity was shown to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that specificity would be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt are able to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt are believed to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt are observed to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt can #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt could #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt may have the ability to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt were able to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt were believed to #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests that transfection of agt would #confer resistance to alkylation-sensitive cells through backbone distortions .
besides these side chain interactions with the 06-alkyl group , structure-based analysis of mutational data suggests the ability of transfection of agt to #confer resistance to alkylation-sensitive cells through backbone distortions .
human 06-alkylguaning-dna alkyltransferase #conferred resistance for alkylation chemotherapies .
human 06-alkylguaning-dna alkyltransferase #confers resistance for alkylation chemotherapies .
in addition , these mutations could not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations has not #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations is not able to #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations was not able to #confer 06-bg resistance in a tolc-deficient strain .
in addition , these mutations would not #confer 06-bg resistance in a tolc-deficient strain .
in itself , 06-bg resistance could not be #conferred by these mutations .
in itself , 06-bg resistance may not have been #conferred by these mutations .
in itself , 06-bg resistance might not be #conferred by these mutations .
in itself , 06-bg resistance was not able to be #conferred by these mutations .
in itself , 06-bg resistance was not #conferred by these mutations .
in itself , 06-bg resistance will not be #conferred by these mutations .
in itself , 06-bg resistance will not have been #conferred by these mutations .
in itself , evga overexpression cannot have #conferred resistance .
in itself , evga overexpression does not #confer resistance .
in itself , evga overexpression is not able to #confer resistance .
in itself , evga overexpression might not #confer resistance .
in itself , evga overexpression would not #confer resistance .
in itself , resistance could not be #conferred by evga overexpression .
in itself , resistance is not able to be #conferred by evga overexpression .
in itself , resistance may not be #conferred by evga overexpression .
in itself , resistance may not have been #conferred by evga overexpression .
in itself , resistance might not be #conferred by evga overexpression .
in itself , resistance was not able to be #conferred by evga overexpression .
in itself , resistance was not #conferred by evga overexpression .
in itself , resistance will not be #conferred by evga overexpression .
in itself , resistance will not have been #conferred by evga overexpression .
in itself , these mutations cannot #confer 06-bg resistance .
in itself , these mutations could not #confer 06-bg resistance .
in itself , these mutations did not #confer 06-bg resistance .
in itself , these mutations might not #confer 06-bg resistance .
in itself , these mutations was believed not to #confer 06-bg resistance .
in itself , these mutations will not #confer 06-bg resistance .
in itself , these mutations will not have #conferred 06-bg resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase can have #conferred resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase #conferred resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase #confers resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase could #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase has #conferred resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase is believed to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase is observed to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase may have #conferred resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase was believed to #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase will #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase will have #conferred resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and human 06-alkylguaning-dna alkyltransferase would #confer resistance to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance could be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is believed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was believed to be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation resistance in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance would be #conferred by human 06-alkylguaning-dna alkyltransferase to alkylation chemotherapies (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats can #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats could #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats has #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats has the ability to #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats is able to #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats is believed to #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats is observed to #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats may #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats was able to #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats was believed to #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats was observed to #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats will have #conferred resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and the portion of the stats would #confer resistance to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance can have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance could be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance is believed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance may have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance might be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was able to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance was believed to be #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
increased agt levels parallel acquired alkylation specificity in human tumors (brent et al . , 1985; mattern et al . , 1998) , and resistance will have been #conferred by the portion of the stats to either a mapk or a mapk substrate kinase (mapkap) (kaina et al . , 1991) , demonstrating the role of agt in therapeutic resistance .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression can #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression #conferred the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression could #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression have #conferred the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression is able to #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression is believed to #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression may #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression was able to #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , evga overexpression was believed to #confer the resistance (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , explaining the resistance #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance can be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance could be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance is believed to be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance is #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance might be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance was believed to be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance was #conferred by evga overexpression (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the resistance will be #conferred by evga overexpression (xu-welliver et al . , 1999a) .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase can #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase has the ability to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase is believed to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since human 06-alkylguaning-dna alkyltransferase will #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation chemotherapies , since resistance could be #conferred on stat1 by human 06-alkylguaning-dna alkyltransferase .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since resistance can have been #conferred on stat1 by transfection of agt .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt has the ability to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt is believed to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in alkylation-sensitive cells , since transfection of agt was able to #confer resistance on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats can #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats could #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats has the ability to #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats is able to #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats is believed to #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats may #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since the portion of the stats will #confer specificity on stat1 .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since specificity can be #conferred on stat1 by the portion of the stats .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since specificity can have been #conferred on stat1 by the portion of the stats .
the data from the chimeras indicate that the difference is due to the absence of carboxyl sequences in either a mapk or a mapk substrate kinase (mapkap) , since specificity could be #conferred on stat1 by the portion of the stats .
the portion of the stats (agt) #conferring specificity to either a mapk or a mapk substrate kinase (mapkap) is therefore an active anticancer drug target .
the portion of the stats (agt) which can #confer specificity to either a mapk or a mapk substrate kinase (mapkap) was therefore an active anticancer drug target .
the portion of the stats (agt) which #confers specificity to either a mapk or a mapk substrate kinase (mapkap) is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , has the ability to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is able to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , might #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was able to #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and was therefore an active anticancer drug target .
the portion of the stats (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , will #confer specificity to either a mapk or a mapk substrate kinase (mapkap) and is therefore an active anticancer drug target .
transfection of agt (agt) that #conferred resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) that has #conferred resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) which #conferred resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) which has #conferred resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) which is able to #confer resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) which is believed to #confer resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) which may #confer resistance to alkylation-sensitive cells was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , #conferred resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , could #confer resistance to alkylation-sensitive cells and was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , has the ability to #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , is believed to #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , might #confer resistance to alkylation-sensitive cells and was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was able to #confer resistance to alkylation-sensitive cells and was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was believed to #confer resistance to alkylation-sensitive cells and was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , was observed to #confer resistance to alkylation-sensitive cells and was therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , will #confer resistance to alkylation-sensitive cells and is therefore an active anticancer drug target .
transfection of agt (agt) , which directly reverses endogenous alkylation at the 06-position of guanine , would #confer resistance to alkylation-sensitive cells and was therefore an active anticancer drug target .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants has not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants is not able to #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants might not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants will not #confer loss-of-function mutations in a tolc-deficient strain .
in addition , nonsense or frameshift alterations in the coding sequence or by splice variants would not #confer loss-of-function mutations in a tolc-deficient strain .
in itself , loss-of-function mutations is not #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations may not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations may not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations might not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations will not have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , loss-of-function mutations would not be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants could not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants did not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants might not #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants was believed not to #confer loss-of-function mutations .
in itself , nonsense or frameshift alterations in the coding sequence or by splice variants was not able to #confer loss-of-function mutations .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , explaining the loss-of-function mutations #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants can #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants could #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants have #conferred the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants is believed to #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants might #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , nonsense or frameshift alterations in the coding sequence or by splice variants was believed to #confer the loss-of-function mutations (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations can be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations has been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations is believed to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations might be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations was able to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations was believed to be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
likewise , the introduced charge of gly160his and gly160arg mutants would repel the benzyl group (figure 3b) , the loss-of-function mutations will be #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants (xu-welliver et al . , 1999a) .
loss-of-function mutations in a tolc-deficient strain is #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
loss-of-function mutations in a tolc-deficient strain may have been #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
loss-of-function mutations in a tolc-deficient strain was #conferred by nonsense or frameshift alterations in the coding sequence or by splice variants .
disruption of narl could #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there could be a second nitrate-responsive factor .
disruption of narl #decreased nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl is believed to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl may have #decreased nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl might #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
disruption of narl was able to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl was believed to #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
disruption of narl will #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl will have #decreased nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
disruption of narl would #decrease nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection can be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection is able to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection may have been #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection might be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection was able to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection was believed to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection was shown to be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection will be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection would be #decreased , or even abolished in the case of human asprs chimera#1 (table) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content can have been significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content is able to be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content is believed to be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content is shown to be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content is significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content might be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was able to be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content was shown to be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content will be significantly #decreased (4050%; see table 2) .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , the reln mrna content would be significantly #decreased (4050%; see table 2) .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can be lowered and methionine content can be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is able to be lowered and methionine content is able to be decreased) , and neither rap2 nor rap3 is be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may be lowered and methionine content may be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels could be lowered and methionine content could be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was lowered and methionine content was decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will have been lowered and methionine content will have been decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides would be detected (consistent with that expression levels would be lowered and methionine content would be decreased) , and neither rap2 nor rap3 would be co-immunoprecipitated in the rap1 mutants .
lipid peroxide synthesis can be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis can have been #decreased by treatment with melatonin , and have permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis has been #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis is able to be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis is #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis is shown to be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis was believed to be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis was #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis was shown to be #decreased by treatment with melatonin , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
lipid peroxide synthesis will be #decreased by treatment with melatonin , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
mef2-binding sites have been reported in several cardiac promoters and promoter activity can be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity has been #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity is #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity may be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity was able to be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity was believed to be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and promoter activity would be #decreased by their mutation in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation #decreases promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation is believed to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation may #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation was able to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation was believed to #decrease promoter activity in cardiomyocytes .
mef2-binding sites have been reported in several cardiac promoters and their mutation will #decrease promoter activity in cardiomyocytes .
nitrite induction of the nirb promoter could be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter is #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter is shown to be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter might be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter was able to be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter was #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter will be #decreased by disruption of narl which is not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
nitrite induction of the nirb promoter would be #decreased by disruption of narl which was not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
the levels of clara cell secretory protein can have been #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein has been #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is believed to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein is shown to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein may be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein was believed to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein was shown to be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein will be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein will have been #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein would be #decreased in nlf from smokers , and it has also been found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the levels of clara cell secretory protein would be #decreased in nlf from smokers , and it was also found that nlf from smokers contained increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
the production of c51 microcin can #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin could #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin has #decreased or been absent in rpos , crp and cya mutant cells .
the production of c51 microcin has the ability to to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin is able to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin was able to #decrease or be absent in rpos , crp and cya mutant cells .
the production of c51 microcin was believed to #decrease or be absent in rpos , crp and cya mutant cells .
treatment with melatonin can #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin #decreases lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin has #decreased lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin is believed to #decrease lipid peroxide synthesis , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin might #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
treatment with melatonin was believed to #decrease lipid peroxide synthesis , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
if this distance of 30 amino acids is not maintained , as in human asprs chimera#1 , or in yeast lysts chimera#1 and yeast asnrs chimera#2 (figure 5b) , the binding to trna is strongly affected and the protection is #decreased , or even abolished in the case of human asprs chimera#1 (table) .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with lower expression levels and #decreased methionine content) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
disruption of narl #decreases nitrite induction of the nirb promoter whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
it was found that nlf from smokers contained #decreased levels of clara cell secretory protein , and increased proportions of a truncated variant of lipocortin-1 , threee acidic forms of alpha (1)-antitrypsin , and one phosphorylated form of cystatin s .syntrophin binds to an alternatively spliced exon of dystrophin .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and disruption of narl was observed to have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and treatment with melatonin has significantly #decreased lipid peroxide synthesis .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and treatment with melatonin is observed to have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and treatment with melatonin was observed to have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis have been significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis were significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene caused about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter were significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is able to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is believed to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl is shown to have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl may significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl might significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl was believed to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl was shown to significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and disruption of narl will significantly #decrease nitrite induction of the nirb promoter .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin can significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin is able to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin is believed to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin is observed to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin is shown to have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin is shown to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin may have significantly #decreased lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin may significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin significantly #decreases lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin was able to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin was believed to significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and treatment with melatonin will significantly #decrease lipid peroxide synthesis .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis are significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis can be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis can have been significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis may be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis was able to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis was believed to be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis will be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis will have been significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and lipid peroxide synthesis would be significantly #decreased by treatment with melatonin will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter could be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter is able to be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter is believed to be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter is shown to be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter may be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter was able to be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter was believed to be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter will have been significantly #decreased by disruption of narl will significantly .
deletion of the arca gene causes about a 2-fold increase in the ptsg expression , and nitrite induction of the nirb promoter would be significantly #decreased by disruption of narl will significantly .
deletion of the arca gene has caused about a 2-fold increase in the ptsg expression , and disruption of narl will have significantly #decreased nitrite induction of the nirb promoter .
deletion of the arca gene has caused about a 2-fold increase in the ptsg expression , and treatment with melatonin will have significantly #decreased lipid peroxide synthesis .
disruption of narl can #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl has #decreased nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl might #decrease nitrite induction of the nirb promoter , and permitted a recovery of both reduced glutathione and scavenger enzyme activity .
disruption of narl will #decrease nitrite induction of the nirb promoter , and permits a recovery of both reduced glutathione and scavenger enzyme activity .
in brain areas of schizophrenia patients homologous to those of the nonpsychiatric subjects , methionine content was significantly #decreased (4050%; see table 2) .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can have been lowered and the reln mrna content can have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is lowered and the reln mrna content is decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may be lowered and the reln mrna content may be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels could be lowered and the reln mrna content could be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels might be lowered and the reln mrna content might be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was able to be lowered and the reln mrna content was able to be decreased) , and neither rap2 nor rap3 was be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will be lowered and the reln mrna content will be decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will have been lowered and the reln mrna content will have been decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides would be detected (consistent with that expression levels would be lowered and the reln mrna content would be decreased) , and neither rap2 nor rap3 would be co-immunoprecipitated in the rap1 mutants .
treatment with melatonin could #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there could be a second nitrate-responsive factor .
treatment with melatonin #decreased lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin is believed to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin may #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin may have #decreased lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin was able to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
treatment with melatonin was believed to #decrease lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there might be a second nitrate-responsive factor .
treatment with melatonin will have #decreased lipid peroxide synthesis whilst not suppressing induction by nitrate , suggesting that there may be a second nitrate-responsive factor .
promoter activity in cardiomyocytes is believed to be #decreased by their mutation .
promoter activity in cardiomyocytes is shown to be #decreased by their mutation .
promoter activity in cardiomyocytes may be #decreased by their mutation .
promoter activity in cardiomyocytes may have been #decreased by their mutation .
promoter activity in cardiomyocytes might be #decreased by their mutation .
promoter activity in cardiomyocytes was believed to be #decreased by their mutation .
promoter activity in cardiomyocytes was #decreased by their mutation .
promoter activity in cardiomyocytes was shown to be #decreased by their mutation .
promoter activity in cardiomyocytes will be #decreased by their mutation .
promoter activity in cardiomyocytes would be #decreased by their mutation .
their mutation can #decrease promoter activity in cardiomyocytes .
their mutation can have #decreased promoter activity in cardiomyocytes .
their mutation causes #decreased promoter activity in cardiomyocytes .
their mutation #decreased promoter activity in cardiomyocytes .
their mutation was able to #decrease promoter activity in cardiomyocytes .
their mutation was shown to #decrease promoter activity in cardiomyocytes .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels can be lowered and levels of clara cell secretory protein can be decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels is lowered and the protection is decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides are detected (consistent with that expression levels may have been lowered and the protection may have been decreased) , and neither rap2 nor rap3 is co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides have been detected (consistent with that expression levels has been lowered and levels of clara cell secretory protein has been decreased) , and neither rap2 nor rap3 has been co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides have been detected (consistent with that expression levels has been lowered and the protection has been decreased) , and neither rap2 nor rap3 has been co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels could be lowered and levels of clara cell secretory protein could be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels could be lowered and the protection could be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels might be lowered and the protection might be decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides were detected (consistent with that expression levels was lowered and the protection was decreased) , and neither rap2 nor rap3 was co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will be lowered and levels of clara cell secretory protein will be decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
in contrast , only low levels of the truncated rap1 peptides will be detected (consistent with that expression levels will have been lowered and the protection will have been decreased) , and neither rap2 nor rap3 will be co-immunoprecipitated in the rap1 mutants .
alternative mrna splicing in the coding region (encoded by exons 3-12) generates transcripts #deleting exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) and that encode distinct protein isoforms (delta25 , delta52 and delta56 aa , respectively) .
alternative mrna splicing in the coding region (encoded by exons 3-12) generates transcripts which #deleted exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) and that encode distinct protein isoforms (delta25 , delta52 and delta56 aa , respectively) .
alternative mrna splicing in the coding region (encoded by exons 3-12) generates transcripts which have #deleted exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) and that encode distinct protein isoforms (delta25 , delta52 and delta56 aa , respectively) .
appropriate progenitor strains may now be constructed to #delete virtually any chromosomal region by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
appropriate progenitor strains will be constructed to #delete virtually any chromosomal region by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
by using homologous recombination in mouse embryonic stem cells , the headpiece domain of dematin is #deleted to evaluate its function in vivo .
colonies of c .albicans cells that are #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells that can be #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which are #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which can be #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which were #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
from both the man and mouse we have isolated an alternative spliced form of dmc1 cdna (dmc1-d) being #deleted for a region between the two motifs involved in nucleotide binding .
from both the man and mouse we have isolated an alternative spliced form of dmc1 cdna (dmc1-d) #deleted for a region between the two motifs involved in nucleotide binding .
from both the man and mouse we have isolated an alternative spliced form of dmc1 cdna (dmc1-d) that can be #deleted for a region between the two motifs involved in nucleotide binding .
from both the man and mouse we have isolated an alternative spliced form of dmc1 cdna (dmc1-d) which was #deleted for a region between the two motifs involved in nucleotide binding .
however , the gata-4 mutants #deleting the c-terminal transactivition domain (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that make the c-terminal transactivition domain (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , the gata-4 mutants which can #delete the c-terminal transactivition domain (1 332 , 201 332) were all unable to support mef2 synergy .
in the presence of the phage p1 cyclization recombinase cre , the transposon may #delete the ura3 , teta , and lacz genes between the two loxp sites .
mutation of the hns gene in e . coli has resulted in strong expression of the v . fischeri lux system at low cell density even in an rpos that #deleted strain of e . coli that emits very low levels of luminescence .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts where exon 4 is #deleted .
of note , the v82f mutation , which occurs adjacent to the 5 donor site of intron 4 , resulted in approximately 54% aberrantly spliced transcripts where exon 4 was #deleted .
of the splicing mutations , the ivs2+1 allele produced a single transcript where exon 2 is #deleted .
of the splicing mutations , the ivs9 delta a+4 allele was alternatively spliced , approximately 26% being normal transcripts and the remainder where exon 9 was #deleted .
studies with strains which has been #deleted for the micf locus showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with strains which were #deleted for the micf locus showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with strains which will be #deleted for the micf locus showed that the mara-dependent reduction of ompf required an intact micf locus .
study of the promoter-lacz gene fusions introduced into the chromosome indicated that gals expression was elevated in cells in which the normal gals gene was interrupted , but not in cells in which the galr gene is #deleted .
the gata-4 mutants which #deleted the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) were able to synergize with mef2a (figure 6a) .
the zonab binding was #deleted in plasmid erbb-2: s-d , and in erbb-2: s-a the inverted ccaat box was substituted .
the zonab binding will be #deleted in plasmid erbb-2: s-d , and in erbb-2: s-a the inverted ccaat box will be substituted .
the generation of replication-competent virus is considered less likely with vectors which #delete the viral transcription elements .
the generation of replication-competent virus is considered less likely with vectors which #deleted the viral transcription elements .
the propensity of isolates of the malaria parasite plasmodium falciparum beleieved to #delete a segment of chromosome 9 has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or mutated zonab-binding site (d: erbb-2: s-d , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or mutated zonab-binding site where d: erbb-2: s-d has been #deleted (erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or mutated zonab-binding site where d: erbb-2: s-d is #deleted (erbb-2: s-a , substitution of the inverted ccaat box) .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the development of other immunotherapeutic agents being proven to #delete cytotoxic lymphocyte responses .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the development of other immunotherapeutic agents found to #delete cytotoxic lymphocyte responses .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the development of other immunotherapeutic agents proven to #delete cytotoxic lymphocyte responses .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the development of other immunotherapeutic agents which are proven to #delete cytotoxic lymphocyte responses .
using homologous recombination in mouse embryonic stem cells will #delete the headpiece domain of dematin to evaluate its function in vivo .
however , the gata-4 mutants that #delete the c-terminal transactivition domain (1 332 , 201 332) were all unable to support mef2 synergy .
in plasmid erbb-2: s-d , the zonab binding was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
the gata-4 mutants that #delete the n-terminal region and the first zinc finger (242 8211; 443) were able to synergize with mef2a (figure 6a) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or mutated zonab-binding site (d: erbb-2: s-d , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
mutation of the hns gene in e . coli has resulted in strong expression of the v . fischeri lux system at low cell density even in an rpos #deleted strain of e . coli that emits very low levels of luminescence .
from both the man and mouse we have isolated an alternative spliced form of dmc1 cdna (dmc1-d) , which is #deleted for a region between the two motifs involved in nucleotide binding .
by appropriate progenitor strains , any chromosomal region is #deleted to evaluate its function in vivo .
by antigen-loaded immature dcs , t cells is #deleted to evaluate its function in vivo .
by antigen-loaded immature dcs , t cells was #deleted to evaluate its function in vivo .
by micf locus , strains will be #deleted to evaluate its function in vivo .
by the development of other immunotherapeutic agents , cytotoxic lymphocyte responses is #deleted to evaluate its function in vivo .
by the development of other immunotherapeutic agents , cytotoxic lymphocyte responses will be #deleted to evaluate its function in vivo .
by the transposon , the ura3 , teta , and lacz genes between the two loxp sites is #deleted to evaluate its function in vivo .
by the transposon , the ura3 , teta , and lacz genes between the two loxp sites will be #deleted to evaluate its function in vivo .
c-terminal transactivition domain that are #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
c-terminal transactivition domain which can be #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
c-terminal transactivition domain which the gata-4 mutants #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
c-terminal transactivition domain which were #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
cst20 that #delete colonies of c .albicans cells (242 8211; 443) were able to synergize with mef2a (figure 6a) .
cst20 which #deleted colonies of c .albicans cells were able to synergize with mef2a (figure 6a) .
cst20 with colonies of c .albicans cells #deleted were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells that #delete cst20 (242 8211; 443) were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells that #delete cst20 were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells which can be #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells which #delete cst20 were able to synergize with mef2a (figure 6a) .
colonies of c .albicans cells which were #deleted for cst20 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
colonies of c .albicans cells with cst20 #deleted were able to synergize with mef2a (figure 6a) .
d: erbb-2: s-d being #deleted for mutated zonab-binding site revealed defects in the lateral formation of mycelia on synthetic solid spider media .
d: erbb-2: s-d that are #deleted for mutated zonab-binding site revealed defects in the lateral formation of mycelia on synthetic solid spider media .
d: erbb-2: s-d which are #deleted for mutated zonab-binding site revealed defects in the lateral formation of mycelia on synthetic solid spider media .
d: erbb-2: s-d which can be #deleted for mutated zonab-binding site revealed defects in the lateral formation of mycelia on synthetic solid spider media .
d: erbb-2: s-d which were #deleted for mutated zonab-binding site revealed defects in the lateral formation of mycelia on synthetic solid spider media .
however , cst20 being able to #delete the colonies of c .albicans cells (1 332 , 201 332) were all unable to support mef2 synergy .
however , cst20 #deleting the colonies of c .albicans cells (1 332 , 201 332) were all unable to support mef2 synergy .
however , cst20 that #delete the colonies of c .albicans cells (1 332 , 201 332) were all unable to support mef2 synergy .
however , cst20 which #deleted the colonies of c .albicans cells (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells being able to #delete the cst20 (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells #deleting the cst20 (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells that #delete the cst20 (1 332 , 201 332) were all unable to support mef2 synergy .
however , colonies of c .albicans cells that make the cst20 (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , the gata-4 mutants being able to #delete the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants #deleting the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants that make the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , the gata-4 mutants which can #delete the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants which can #delete the the n-terminal region and the first zinc finger (1 332 , 201 332) were all unable to support mef2 synergy .
however , the gata-4 mutants which #deleted the the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site being able to #delete the d: erbb-2: s-d (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site #deleting the d: erbb-2: s-d (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site that #delete the d: erbb-2: s-d (1 332 , 201 332) were all unable to support mef2 synergy .
however , mutated zonab-binding site that make the d: erbb-2: s-d (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , plasmid erbb-2: s-d being able to #delete the the zonab binding (1 332 , 201 332) were all unable to support mef2 synergy .
however , plasmid erbb-2: s-d #deleting the the zonab binding (1 332 , 201 332) were all unable to support mef2 synergy .
however , plasmid erbb-2: s-d that #delete the the zonab binding (1 332 , 201 332) were all unable to support mef2 synergy .
however , plasmid erbb-2: s-d that make the the zonab binding (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , plasmid erbb-2: s-d which can #delete the the zonab binding (1 332 , 201 332) were all unable to support mef2 synergy .
however , strains being able to #delete the micf locus (1 332 , 201 332) were all unable to support mef2 synergy .
however , strains #deleting the micf locus (1 332 , 201 332) were all unable to support mef2 synergy .
however , strains that #delete the micf locus (1 332 , 201 332) were all unable to support mef2 synergy .
however , strains which can #delete the micf locus (1 332 , 201 332) were all unable to support mef2 synergy .
however , vectors that make the the viral transcription elements (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , vectors which can #delete the the viral transcription elements (1 332 , 201 332) were all unable to support mef2 synergy .
in cst20 , colonies of c .albicans cells has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in cst20 , colonies of c .albicans cells is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in cst20 , colonies of c .albicans cells was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the gata-4 mutants , the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in the gata-4 mutants , the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the gata-4 mutants , the n-terminal region and the first zinc finger has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in mutated zonab-binding site , d: erbb-2: s-d has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in mutated zonab-binding site , d: erbb-2: s-d is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in strains , micf locus is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the gata-4 mutants , c-terminal transactivition domain has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in the gata-4 mutants , c-terminal transactivition domain was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the presence of the phage p1 cyclization recombinase cre , appropriate progenitor strains is able to #delete any chromosomal region .
in the presence of the phage p1 cyclization recombinase cre , antigen-loaded immature dcs is able to #delete t cells .
in the presence of the phage p1 cyclization recombinase cre , isolates of the malaria parasite plasmodium falciparum can #delete a segment of chromosome 9 .
in the presence of the phage p1 cyclization recombinase cre , isolates of the malaria parasite plasmodium falciparum could #delete a segment of chromosome 9 .
in the presence of the phage p1 cyclization recombinase cre , isolates of the malaria parasite plasmodium falciparum is able to #delete a segment of chromosome 9 .
in the presence of the phage p1 cyclization recombinase cre , isolates of the malaria parasite plasmodium falciparum may #delete a segment of chromosome 9 .
in the presence of the phage p1 cyclization recombinase cre , micf locus is able to #delete strains .
in the presence of the phage p1 cyclization recombinase cre , micf locus may #delete strains .
in the presence of the phage p1 cyclization recombinase cre , the development of other immunotherapeutic agents can #delete cytotoxic lymphocyte responses .
in the presence of the phage p1 cyclization recombinase cre , the development of other immunotherapeutic agents is able to #delete cytotoxic lymphocyte responses .
in the presence of the phage p1 cyclization recombinase cre , using homologous recombination in mouse embryonic stem cells can #delete the headpiece domain of dematin .
in the presence of the phage p1 cyclization recombinase cre , using homologous recombination in mouse embryonic stem cells could #delete the headpiece domain of dematin .
in the presence of the phage p1 cyclization recombinase cre , using homologous recombination in mouse embryonic stem cells is able to #delete the headpiece domain of dematin .
in the presence of the phage p1 cyclization recombinase cre , using homologous recombination in mouse embryonic stem cells may #delete the headpiece domain of dematin .
in vectors , the viral transcription elements is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in vectors , the viral transcription elements was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
recent experiments have provided direct evidence that appropriate progenitor strains #delete any chromosomal region or by expanding regulatory t cells .
recent experiments have provided direct evidence that appropriate progenitor strains have #deleted any chromosomal region to silence them .
recent experiments have provided direct evidence that appropriate progenitor strains silence any chromosomal region either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum can #delete a segment of chromosome 9 to silence them .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum #delete a segment of chromosome 9 or by expanding regulatory t cells .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum #deleted a segment of chromosome 9 to silence them .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum silence a segment of chromosome 9 either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that isolates of the malaria parasite plasmodium falciparum will #delete a segment of chromosome 9 to silence them .
recent experiments have provided direct evidence that micf locus #deleted strains to silence them .
recent experiments have provided direct evidence that micf locus have #deleted strains to silence them .
recent experiments have provided direct evidence that micf locus will #delete strains to silence them .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents can #delete cytotoxic lymphocyte responses to silence them .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents #delete cytotoxic lymphocyte responses or by expanding regulatory t cells .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents have #deleted cytotoxic lymphocyte responses to silence them .
recent experiments have provided direct evidence that the development of other immunotherapeutic agents will #delete cytotoxic lymphocyte responses to silence them .
recent experiments have provided direct evidence that the transposon are able to #delete the ura3 , teta , and lacz genes between the two loxp sites to silence them .
recent experiments have provided direct evidence that the transposon can #delete the ura3 , teta , and lacz genes between the two loxp sites to silence them .
recent experiments have provided direct evidence that the transposon #delete the ura3 , teta , and lacz genes between the two loxp sites or by expanding regulatory t cells .
recent experiments have provided direct evidence that the transposon #deleted the ura3 , teta , and lacz genes between the two loxp sites to silence them .
recent experiments have provided direct evidence that the transposon have #deleted the ura3 , teta , and lacz genes between the two loxp sites to silence them .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells are able to #delete the headpiece domain of dematin to silence them .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells #delete the headpiece domain of dematin or by expanding regulatory t cells .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells #deleted the headpiece domain of dematin to silence them .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells have #deleted the headpiece domain of dematin to silence them .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells silence the headpiece domain of dematin either by #deleting them or by expanding regulatory t cells .
recent experiments have provided direct evidence that using homologous recombination in mouse embryonic stem cells will #delete the headpiece domain of dematin to silence them .
studies with cst20 #deleted for the colonies of c .albicans cells showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with colonies of c .albicans cells #deleted for the cst20 showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the gata-4 mutants #deleted for the the n-terminal region and the first zinc finger showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with a segment of chromosome 9 which has been #deleted for the isolates of the malaria parasite plasmodium falciparum showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with a segment of chromosome 9 which will be #deleted for the isolates of the malaria parasite plasmodium falciparum showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with any chromosomal region which are #deleted for the appropriate progenitor strains showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with any chromosomal region which has been #deleted for the appropriate progenitor strains showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with any chromosomal region which will be #deleted for the appropriate progenitor strains showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with cytotoxic lymphocyte responses which has been #deleted for the the development of other immunotherapeutic agents showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with cytotoxic lymphocyte responses which were #deleted for the the development of other immunotherapeutic agents showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with cytotoxic lymphocyte responses which will be #deleted for the the development of other immunotherapeutic agents showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with mutated zonab-binding site #deleted for the d: erbb-2: s-d showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the ura3 , teta , and lacz genes between the two loxp sites which are #deleted for the the transposon showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the ura3 , teta , and lacz genes between the two loxp sites which were #deleted for the the transposon showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the headpiece domain of dematin which are #deleted for the using homologous recombination in mouse embryonic stem cells showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the headpiece domain of dematin which has been #deleted for the using homologous recombination in mouse embryonic stem cells showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the headpiece domain of dematin which were #deleted for the using homologous recombination in mouse embryonic stem cells showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with the headpiece domain of dematin which will be #deleted for the using homologous recombination in mouse embryonic stem cells showed that the mara-dependent reduction of ompf required an intact micf locus .
the gata-4 mutants that can be #deleted for the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the gata-4 mutants that can be #deleted for the n-terminal region and the first zinc finger revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the gata-4 mutants which can #delete the n-terminal region and the first zinc finger were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which #delete the n-terminal region and the first zinc finger were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which #deleted the n-terminal region and the first zinc finger were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which has #deleted the n-terminal region and the first zinc finger were able to synergize with mef2a (figure 6a) .
the gata-4 mutants with the n-terminal region and the first zinc finger #deleted were able to synergize with mef2a (figure 6a) .
the generation of replication-competent virus is considered less likely with cst20 #deleting colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with cst20 that #delete colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with cst20 which #delete colonies of c .albicans cells .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells #deleting cst20 .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells that #delete cst20 .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells which #delete cst20 .
the generation of replication-competent virus is considered less likely with colonies of c .albicans cells which #deleted cst20 .
the generation of replication-competent virus is considered less likely with the gata-4 mutants #deleting the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #delete the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #deleted the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #deleted the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which #deleted the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which that #delete the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) .
the generation of replication-competent virus is considered less likely with the gata-4 mutants which that #delete the n-terminal region and the first zinc finger .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site that #deleted d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site which #delete d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with mutated zonab-binding site which #deleted d: erbb-2: s-d .
the generation of replication-competent virus is considered less likely with plasmid erbb-2: s-d that #delete the zonab binding .
the generation of replication-competent virus is considered less likely with plasmid erbb-2: s-d that #deleted the zonab binding .
the generation of replication-competent virus is considered less likely with plasmid erbb-2: s-d which #delete the zonab binding .
the generation of replication-competent virus is considered less likely with plasmid erbb-2: s-d which #deleted the zonab binding .
the generation of replication-competent virus is considered less likely with plasmid erbb-2: s-d which that #delete the zonab binding .
the generation of replication-competent virus is considered less likely with strains which #delete micf locus .
the generation of replication-competent virus is considered less likely with strains which #deleted micf locus .
the generation of replication-competent virus is considered less likely with strains which that #delete micf locus .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #delete c-terminal transactivition domain .
the generation of replication-competent virus is considered less likely with the gata-4 mutants that #deleted c-terminal transactivition domain .
the propensity of appropriate progenitor strains beleieved to #delete any chromosomal region has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of antigen-loaded immature dcs #deleting t cells has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of antigen-loaded immature dcs proven to #delete t cells has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of antigen-loaded immature dcs to #delete t cells has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus #deleting strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of micf locus proven to #delete strains has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the development of other immunotherapeutic agents beleieved to #delete cytotoxic lymphocyte responses has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the development of other immunotherapeutic agents #deleting cytotoxic lymphocyte responses has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the development of other immunotherapeutic agents which #delete cytotoxic lymphocyte responses has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon beleieved to #delete the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of the transposon #deleting the ura3 , teta , and lacz genes between the two loxp sites has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of using homologous recombination in mouse embryonic stem cells beleieved to #delete the headpiece domain of dematin has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of using homologous recombination in mouse embryonic stem cells #deleting the headpiece domain of dematin has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the propensity of using homologous recombination in mouse embryonic stem cells proven to #delete the headpiece domain of dematin has provided positional information that has allowed us to identify a gene necessary for cytoadherence .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or colonies of c .albicans cells (cst20 , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or plasmid erbb-2: s-d (the zonab binding , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or plasmid erbb-2: s-d (the zonab binding , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or strains (micf locus , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or strains (micf locus , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (c-terminal transactivition domain , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the gata-4 mutants (c-terminal transactivition domain , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or vectors (the viral transcription elements , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or vectors (the viral transcription elements , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains being proven to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for appropriate progenitor strains which are proven to #delete any chromosomal region .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for antigen-loaded immature dcs being proven to #delete t cells .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for antigen-loaded immature dcs found to #delete t cells .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for antigen-loaded immature dcs which are proven to #delete t cells .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for isolates of the malaria parasite plasmodium falciparum being proven to #delete a segment of chromosome 9 .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for isolates of the malaria parasite plasmodium falciparum designed to #delete a segment of chromosome 9 .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for isolates of the malaria parasite plasmodium falciparum found to #delete a segment of chromosome 9 .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for isolates of the malaria parasite plasmodium falciparum proven to #delete a segment of chromosome 9 .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for isolates of the malaria parasite plasmodium falciparum which are proven to #delete a segment of chromosome 9 .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus being proven to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for micf locus found to #delete strains .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the transposon found to #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for using homologous recombination in mouse embryonic stem cells being proven to #delete the headpiece domain of dematin .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for using homologous recombination in mouse embryonic stem cells designed to #delete the headpiece domain of dematin .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for using homologous recombination in mouse embryonic stem cells proven to #delete the headpiece domain of dematin .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for using homologous recombination in mouse embryonic stem cells which are proven to #delete the headpiece domain of dematin .
isolates of the malaria parasite plasmodium falciparum may now be constructed to #delete virtually a segment of chromosome 9 by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
micf locus which are #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus which can be #deleted for strains revealed defects in the lateral formation of mycelia on synthetic solid spider media .
micf locus which strains #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site which #delete d: erbb-2: s-d were able to synergize with mef2a (figure 6a) .
mutated zonab-binding site which #deleted d: erbb-2: s-d were able to synergize with mef2a (figure 6a) .
mutated zonab-binding site which has #deleted d: erbb-2: s-d were able to synergize with mef2a (figure 6a) .
mutated zonab-binding site with d: erbb-2: s-d #deleted were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d that can be #deleted for the zonab binding revealed defects in the lateral formation of mycelia on synthetic solid spider media .
plasmid erbb-2: s-d that #delete the zonab binding (242 8211; 443) were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d that #delete the zonab binding were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d which can #delete the zonab binding were able to synergize with mef2a (figure 6a) .
plasmid erbb-2: s-d with the zonab binding #deleted were able to synergize with mef2a (figure 6a) .
strains that can be #deleted for micf locus revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strains that #delete micf locus were able to synergize with mef2a (figure 6a) .
strains which can #delete micf locus were able to synergize with mef2a (figure 6a) .
strains which #deleted micf locus were able to synergize with mef2a (figure 6a) .
strains with micf locus #deleted were able to synergize with mef2a (figure 6a) .
the gata-4 mutants that can be #deleted for c-terminal transactivition domain revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the gata-4 mutants that #delete c-terminal transactivition domain (242 8211; 443) were able to synergize with mef2a (figure 6a) .
the gata-4 mutants which #deleted c-terminal transactivition domain were able to synergize with mef2a (figure 6a) .
the gata-4 mutants with c-terminal transactivition domain #deleted were able to synergize with mef2a (figure 6a) .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) being #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) that are #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region (127 443 and 201 443) and the first zinc finger (242 443) which are #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger that are #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger which the gata-4 mutants #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger which are #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the n-terminal region and the first zinc finger which can be #deleted for the gata-4 mutants revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding being #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding that are #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the zonab binding which were #deleted for plasmid erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the development of other immunotherapeutic agents can now be constructed to #delete virtually cytotoxic lymphocyte responses by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the transposon will be constructed to #delete virtually the ura3 , teta , and lacz genes between the two loxp sites by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
the viral transcription elements which were #deleted for vectors revealed defects in the lateral formation of mycelia on synthetic solid spider media .
using homologous recombination in mouse embryonic stem cells will be constructed to #delete virtually the headpiece domain of dematin by utilizing an extensive collection of lines containing single p element insertions throughout the drosophila genome .
vectors that can be #deleted for the viral transcription elements revealed defects in the lateral formation of mycelia on synthetic solid spider media .
vectors that #delete the viral transcription elements were able to synergize with mef2a (figure 6a) .
vectors which can #delete the viral transcription elements were able to synergize with mef2a (figure 6a) .
vectors which #delete the viral transcription elements were able to synergize with mef2a (figure 6a) .
vectors which #deleted the viral transcription elements were able to synergize with mef2a (figure 6a) .
vectors which has #deleted the viral transcription elements were able to synergize with mef2a (figure 6a) .
vectors with the viral transcription elements #deleted were able to synergize with mef2a (figure 6a) .
by using homologous recombination in mouse embryonic stem cells , the headpiece domain of dematin was #deleted to evaluate its function in vivo .
in the presence of the phage p1 cyclization recombinase cre , the transposon can #delete the ura3 , teta , and lacz genes between the two loxp sites .
thus , this granule enzyme is required for the unique effects of leu-leu-ome and may provide a target for the development of other immunotherapeutic agents designed to #delete cytotoxic lymphocyte responses .
however , a region between the two motifs which #deleted the an alternative spliced form of dmc1 cdna (dmc1-d) (1 332 , 201 332) were all unable to support mef2 synergy .
however , a single transcript being able to #delete the exon 2 (1 332 , 201 332) were all unable to support mef2 synergy .
however , a single transcript that #delete the exon 2 (1 332 , 201 332) were all unable to support mef2 synergy .
however , a single transcript which #deleted the exon 2 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts that make the exon 4 (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , aberrantly spliced transcripts which can #delete the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , aberrantly spliced transcripts which #deleted the exon 4 (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos that #delete the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) were all unable to support mef2 synergy .
however , rpos that make the strain of e . coli that emits very low levels of luminescence (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence being able to #delete the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , strain of e . coli that emits very low levels of luminescence which #deleted the rpos (1 332 , 201 332) were all unable to support mef2 synergy .
however , the remainder which can #delete the exon 9 (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts being able to #delete the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
however , transcripts that make the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) #deleted were all unable to support mef2 synergy .
however , transcripts which can #delete the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (1 332 , 201 332) were all unable to support mef2 synergy .
in a region between the two motifs , an alternative spliced form of dmc1 cdna (dmc1-d) has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in a region between the two motifs , an alternative spliced form of dmc1 cdna (dmc1-d) was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in a single transcript , exon 2 has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in a single transcript , exon 2 is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in strain of e . coli that emits very low levels of luminescence , rpos was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in the remainder , exon 9 is #deleted , and in erbb-2: s-a the inverted ccaat box is substituted .
in the remainder , exon 9 was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
in transcripts , exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) has been #deleted , and in erbb-2: s-a the inverted ccaat box has been substituted .
in transcripts , exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) was #deleted , and in erbb-2: s-a the inverted ccaat box was substituted .
studies with a region between the two motifs #deleted for the an alternative spliced form of dmc1 cdna (dmc1-d) showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with a single transcript #deleted for the exon 2 showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with rpos #deleted for the strain of e . coli that emits very low levels of luminescence showed that the mara-dependent reduction of ompf required an intact micf locus .
studies with transcripts #deleted for the exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) showed that the mara-dependent reduction of ompf required an intact micf locus .
the generation of replication-competent virus is considered less likely with a region between the two motifs that #delete an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a region between the two motifs which that #delete an alternative spliced form of dmc1 cdna (dmc1-d) .
the generation of replication-competent virus is considered less likely with a single transcript #deleting exon 2 .
the generation of replication-competent virus is considered less likely with a single transcript that #delete exon 2 .
the generation of replication-competent virus is considered less likely with a single transcript that #deleted exon 2 .
the generation of replication-competent virus is considered less likely with a single transcript which #delete exon 2 .
the generation of replication-competent virus is considered less likely with a single transcript which #deleted exon 2 .
the generation of replication-competent virus is considered less likely with a single transcript which that #delete exon 2 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts that #delete exon 4 .
the generation of replication-competent virus is considered less likely with aberrantly spliced transcripts which #delete exon 4 .
the generation of replication-competent virus is considered less likely with rpos that #delete strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with rpos which that #delete strain of e . coli that emits very low levels of luminescence .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence which #deleted rpos .
the generation of replication-competent virus is considered less likely with strain of e . coli that emits very low levels of luminescence which that #delete rpos .
the generation of replication-competent virus is considered less likely with the remainder #deleting exon 9 .
the generation of replication-competent virus is considered less likely with the remainder that #deleted exon 9 .
the generation of replication-competent virus is considered less likely with the remainder which #delete exon 9 .
the generation of replication-competent virus is considered less likely with the remainder which #deleted exon 9 .
the generation of replication-competent virus is considered less likely with transcripts #deleting exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the generation of replication-competent virus is considered less likely with transcripts that #deleted exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the generation of replication-competent virus is considered less likely with transcripts which #deleted exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the generation of replication-competent virus is considered less likely with transcripts which that #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or a region between the two motifs (an alternative spliced form of dmc1 cdna (dmc1-d) , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or a region between the two motifs (an alternative spliced form of dmc1 cdna (dmc1-d) , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or a single transcript (exon 2 , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or a single transcript (exon 2 , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or aberrantly spliced transcripts (exon 4 , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or rpos (strain of e . coli that emits very low levels of luminescence , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the remainder (exon 9 , being deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or the remainder (exon 9 , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
the reporter plasmids contained a shorter fragment of the erbb-2 promoter with a functional (d: erbb-2: s) or transcripts (exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) , deleted; erbb-2: s-a , substitution of the inverted ccaat box) .
a region between the two motifs that #delete an alternative spliced form of dmc1 cdna (dmc1-d) were able to synergize with mef2a (figure 6a) .
a region between the two motifs which can be #deleted for an alternative spliced form of dmc1 cdna (dmc1-d) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a region between the two motifs which can #delete an alternative spliced form of dmc1 cdna (dmc1-d) were able to synergize with mef2a (figure 6a) .
a region between the two motifs which #delete an alternative spliced form of dmc1 cdna (dmc1-d) were able to synergize with mef2a (figure 6a) .
a region between the two motifs which #deleted an alternative spliced form of dmc1 cdna (dmc1-d) were able to synergize with mef2a (figure 6a) .
a region between the two motifs which has #deleted an alternative spliced form of dmc1 cdna (dmc1-d) were able to synergize with mef2a (figure 6a) .
a region between the two motifs with an alternative spliced form of dmc1 cdna (dmc1-d) #deleted were able to synergize with mef2a (figure 6a) .
a single transcript that can be #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
a single transcript that #delete exon 2 (242 8211; 443) were able to synergize with mef2a (figure 6a) .
a single transcript that #delete exon 2 were able to synergize with mef2a (figure 6a) .
a single transcript which can #delete exon 2 were able to synergize with mef2a (figure 6a) .
a single transcript which #delete exon 2 were able to synergize with mef2a (figure 6a) .
a single transcript which were #deleted for exon 2 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts that are #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts that can be #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts that #delete exon 4 were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts which are #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts which can be #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts which #delete exon 4 were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts which exon 4 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts which has #deleted exon 4 were able to synergize with mef2a (figure 6a) .
aberrantly spliced transcripts which were #deleted for exon 4 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
aberrantly spliced transcripts with exon 4 #deleted were able to synergize with mef2a (figure 6a) .
an alternative spliced form of dmc1 cdna (dmc1-d) being #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) which a region between the two motifs #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
an alternative spliced form of dmc1 cdna (dmc1-d) which were #deleted for a region between the two motifs revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 being #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 2 that are #deleted for a single transcript revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 being #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 4 which are #deleted for aberrantly spliced transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 being #deleted for the remainder revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 #deleted for the remainder revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 that are #deleted for the remainder revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 which are #deleted for the remainder revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exon 9 which can be #deleted for the remainder revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) which can be #deleted for transcripts revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
mutated zonab-binding site that are #deleted for d: erbb-2: s-d revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos being #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos which are #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos which can be #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos which can #delete strain of e . coli that emits very low levels of luminescence were able to synergize with mef2a (figure 6a) .
rpos which strain of e . coli that emits very low levels of luminescence #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos which were #deleted for strain of e . coli that emits very low levels of luminescence revealed defects in the lateral formation of mycelia on synthetic solid spider media .
rpos with strain of e . coli that emits very low levels of luminescence #deleted were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence that can be #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence that #delete rpos (242 8211; 443) were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which are #deleted for rpos revealed defects in the lateral formation of mycelia on synthetic solid spider media .
strain of e . coli that emits very low levels of luminescence which can #delete rpos were able to synergize with mef2a (figure 6a) .
strain of e . coli that emits very low levels of luminescence which #deleted rpos were able to synergize with mef2a (figure 6a) .
the remainder being #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder that are #deleted for exon 9 revealed defects in the lateral formation of mycelia on synthetic solid spider media .
the remainder that #delete exon 9 were able to synergize with mef2a (figure 6a) .
the remainder which exon 9 #deleted revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts that can be #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts that #delete exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) (242 8211; 443) were able to synergize with mef2a (figure 6a) .
transcripts which are #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts which can be #deleted for exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) revealed defects in the lateral formation of mycelia on synthetic solid spider media .
transcripts which #deleted exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) were able to synergize with mef2a (figure 6a) .
transcripts with exons 8 (75 nt) , 7+8 (156 nt) or 8+9 (168 nt) #deleted were able to synergize with mef2a (figure 6a) .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son can have #developed acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son has the risk of #developing acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is able to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is #developing acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son is shown to #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son may #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son will #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) is identified in an asymptomatic female carrier whose son will have #developed acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son could #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son had the risk of #developing acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son has #developed acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son might #develop acute neonatal onset of otc deficiency .
a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son was found to #develop acute neonatal onset of otc deficiency .
spinach sown in october being able to #develop into the rosette stage grows through the end of november .
spinach sown in october can #develop into the rosette stage and grow through the end of november .
spinach sown in october could #develop into the rosette stage and grew through the end of november .
spinach sown in october has the ability to #develop into the rosette stage and grow through the end of november .
spinach sown in october is believed to #develop into the rosette stage and grow through the end of november .
spinach sown in october is predicted to #develop into the rosette stage and grow through the end of november .
spinach sown in october is shown to #develop into the rosette stage and grow through the end of november .
spinach sown in october that #develops into the rosette stage grows through the end of november .
spinach sown in october that is able to #develop into the rosette stage grows through the end of november .
spinach sown in october was believed to #develop into the rosette stage and grew through the end of november .
spinach sown in october was found to #develop into the rosette stage and grew through the end of november .
spinach sown in october was predicted to #develop into the rosette stage and grew through the end of november .
spinach sown in october which can #develop into the rosette stage grows through the end of november .
spinach sown in october will have #developed into the rosette stage and grow through the end of november .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we can #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we can have #developed a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we decide to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have been able to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have been ready to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we have decided to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we may #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we might #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we were able to #develop a novel screening system .
to isolate cdna clones that dominantly inhibit the dna-binding activity of oct-2 , chosen as a representative factor , we would #develop a novel screening system .
spinach sown in october #develops into the rosette stage and grows through the end of november .
three new mutations , two missense and one nonsense , were detected: (1) a c-to-t transition in codon 44 in exon 2 replacing a threonine by an isoleucine (t44i) was found in a late-onset symptomatic female patient but not in her asymptomatic mother; (2) a c-to-t transition in codon 214 creating a new rsai recognition site in exon 6 and substituting tyrosine for histidine (h214y) was identified in an asymptomatic female carrier whose son #developed acute neonatal onset of otc deficiency; (3) a c-to-t transition in codon 320 (arginine) abolishing a taqi recognition site and creating a new bcli site in exon 9 with generation of a stop codon (r320x) leading to premature termination in the enzyme .
spinach sown in october can have #developed into he rosette stage and grow through the end of november .
spinach sown in october #developing into he rosette stage grows through the end of november .
spinach sown in october #develops into tthe rosette stage and grows through the end of november .
spinach sown in october has been #developing into he rosette stage and can grow through the end of november .
spinach sown in october has #developed into he rosette stage and grown through the end of november .
spinach sown in october is able to #develop into he rosette stage and grow through the end of november .
spinach sown in october is believed to #develop into he rosette stage and grow through the end of november .
spinach sown in october is #developing into he rosette stage and will grow through the end of november .
spinach sown in october is found to #develop into he rosette stage and grow through the end of november .
spinach sown in october may #develop into he rosette stage and grow through the end of november .
spinach sown in october may have #developed into he rosette stage and grow through the end of november .
spinach sown in october that can #develop into he rosette stage grows through the end of november .
spinach sown in october that #develops into he rosette stage grows through the end of november .
spinach sown in october that is able to #develop into he rosette stage grows through the end of november .
spinach sown in october was found to #develop into he rosette stage and grew through the end of november .
spinach sown in october was predicted to #develop into he rosette stage and grew through the end of november .
spinach sown in october which can #develop into he rosette stage grows through the end of november .
spinach sown in october which #develops into he rosette stage grows through the end of november .
spinach sown in october will #develop into he rosette stage and grow through the end of november .
spinach sown in october would #develop into he rosette stage and grew through the end of november .
a homozygous mutation #disrupting splicing is identified in affected siblings with classical abetalipoproteinemia .
a homozygous mutation that have #disrupted splicing was identified in affected siblings with classical abetalipoproteinemia .
quantitative single-unit electrophysiology revealed that alcohol exposure #disrupts ocular dominance plasticity while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that alcohol exposure has been shown to #disrupt ocular dominance plasticity while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that alcohol exposure has #disrupted ocular dominance plasticity while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion may have #disrupted the open reading frame .
the zinc finger motif , which specifically recognizes the go:c pair , is firmly fixed with respect to the c-terminal domain by the hydrogen bond network , so the lys147ala substitution has the ability to #disrupt the interaction , resulting in a drastic decrease of activity against go:c substrates .
the zinc finger motif , which specifically recognizes the go:c pair , is firmly fixed with respect to the c-terminal domain by the hydrogen bond network , so the lys147ala substitution would be found to #disrupt the interaction , resulting in a drastic decrease of activity against go:c substrates .
these mutations may be acting in a dominant-negative fashion and may also #disrupt the ubiquitin-binding function , which could result in abnormal activation of the nf-kappab pathway and the subsequent activation of the osteoclasts .
these mutations may be acting in a dominant-negative fashion in order to #disrupt the ubiquitin-binding function , which could result in abnormal activation of the nf-kappab pathway and the subsequent activation of the osteoclasts .
this deletion can #disrupt the consensus 5 splice signal and led to exon skipping .
this deletion has #disrupted the consensus 5 splice signal and led to exon skipping .
this deletion is able to #disrupt the consensus 5 splice signal and led to exon skipping .
treatment of the systemic inflammatory response to cpb is also confounded by the fact that inhibition of inflammation has been shown to #disrupt protective physiologic responses or result in immunosuppression .
treatment of the systemic inflammatory response to cpb is also confounded by the fact that inhibition of inflammation is able to #disrupt protective physiologic responses or result in immunosuppression .
treatment of the systemic inflammatory response to cpb is also confounded by the fact that inhibition of inflammation may have #disrupted protective physiologic responses or result in immunosuppression .
treatment of the systemic inflammatory response to cpb is also confounded by the fact that inhibition of inflammation will possibly #disrupt protective physiologic responses or result in immunosuppression .
when both genes are shown to be #disrupted , gals expression is further elevated .
when both genes has already been #disrupted , gals expression was further elevated .
when both genes has been #disrupted , gals expression was further elevated .
arg99 and arg253 can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the pairing hydrogen bonds in the model .
the zinc finger motif , which specifically recognizes the go:c pair , is firmly fixed with respect to the c-terminal domain by the hydrogen bond network , so the lys147ala substitution would be expected to #disrupt the interaction , resulting in a drastic decrease of activity against go:c substrates .
a homozygous mutation that #disrupts splicing has been identified in affected siblings with classical abetalipoproteinemia .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion #disrupted the open reading frame .
these mutations may be acting in a dominant-negative fashion to #disrupt the ubiquitin-binding function , which could result in abnormal activation of the nf-kappab pathway and the subsequent activation of the osteoclasts .
this deletion #disrupted the consensus 5 splice signal and led to exon skipping .
treatment of the systemic inflammatory response to cpb is also confounded by the fact that inhibition of inflammation might #disrupt protective physiologic responses or result in immunosuppression .
importantly , the findings show that the arg99 and arg253 does not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the arg99 and arg253 will not #disrupt the pairing hydrogen bonds in the model .
importantly , the findings show that the alcohol exposure is not able to #disrupt ocular dominance plasticity .
importantly , the findings show that the this deletion could not #disrupt the open reading frame .
quantitative single-unit electrophysiology revealed that arg99 and arg253 #disrupts the pairing hydrogen bonds in the model while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that arg99 and arg253 has been shown to #disrupt the pairing hydrogen bonds in the model while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that arg99 and arg253 has #disrupted the pairing hydrogen bonds in the model while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion has been shown to #disrupt the open reading frame while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion has #disrupted the open reading frame while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion is able to #disrupt the open reading frame while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 #disrupted the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 #disrupts the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 is able to #disrupt the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; arg99 and arg253 may have #disrupted the pairing hydrogen bonds in the model .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure has #disrupted ocular dominance plasticity .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure is able to #disrupt ocular dominance plasticity .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; alcohol exposure may have #disrupted ocular dominance plasticity .
studies using polymerase chain reaction , restriction enzyme digestion (arg99 and arg253 being able to #disrupt the pairing hydrogen bonds in the model , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (arg99 and arg253 having #disrupted the pairing hydrogen bonds in the model , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (arg99 and arg253 that can #disrupt the pairing hydrogen bonds in the model , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (alcohol exposure being able to #disrupt ocular dominance plasticity , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (alcohol exposure #disrupts ocular dominance plasticity , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (alcohol exposure that can #disrupt ocular dominance plasticity , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion being able to #disrupt the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion which have #disrupted the open reading frame , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
when both genes are #disrupted , gals expression was further elevated .
when both genes are shown to be #disrupted , gals expression was further elevated .
when both genes has already been #disrupted , gals expression is further elevated .
when both genes has been observed to be #disrupted , gals expression is further elevated .
this deletion can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna to #disrupt the open reading frame .
this deletion that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt the open reading frame .
a homozygous mutation can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt splicing .
a homozygous mutation that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt splicing .
importantly , the findings show that the a homozygous mutation could not #disrupt splicing .
importantly , the findings show that the a homozygous mutation does not #disrupt splicing .
importantly , the findings show that the a homozygous mutation has not #disrupt splicing .
importantly , the findings show that the a homozygous mutation is not able to #disrupt splicing .
importantly , the findings show that the a homozygous mutation will not #disrupt splicing .
importantly , the findings show that the these mutations could not #disrupt the ubiquitin-binding function .
importantly , the findings show that the these mutations did not #disrupt the ubiquitin-binding function .
importantly , the findings show that the these mutations has not #disrupt the ubiquitin-binding function .
importantly , the findings show that the these mutations will not #disrupt the ubiquitin-binding function .
importantly , the findings show that the this deletion could not #disrupt the consensus 5 splice signal .
importantly , the findings show that the this deletion did not #disrupt the consensus 5 splice signal .
importantly , the findings show that the this deletion has not #disrupt the consensus 5 splice signal .
importantly , the findings show that the this deletion will not #disrupt the consensus 5 splice signal .
importantly , the findings show that the inhibition of inflammation does not #disrupt protective physiologic responses .
importantly , the findings show that the inhibition of inflammation has not #disrupt protective physiologic responses .
importantly , the findings show that the inhibition of inflammation is not able to #disrupt protective physiologic responses .
importantly , the findings show that the inhibition of inflammation will not #disrupt protective physiologic responses .
importantly , the findings show that the the lys147ala substitution does not #disrupt the interaction .
importantly , the findings show that the the lys147ala substitution has not #disrupt the interaction .
importantly , the findings show that the the lys147ala substitution is not able to #disrupt the interaction .
quantitative single-unit electrophysiology revealed that a homozygous mutation #disrupts splicing while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that a homozygous mutation has been shown to #disrupt splicing while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that a homozygous mutation is able to #disrupt splicing while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that these mutations #disrupts the ubiquitin-binding function while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that these mutations has been shown to #disrupt the ubiquitin-binding function while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that these mutations is able to #disrupt the ubiquitin-binding function while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that this deletion has #disrupted the consensus 5 splice signal while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that inhibition of inflammation #disrupted protective physiologic responses while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that inhibition of inflammation #disrupts protective physiologic responses while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that inhibition of inflammation has #disrupted protective physiologic responses while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that the lys147ala substitution #disrupted the interaction while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that the lys147ala substitution #disrupts the interaction while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that the lys147ala substitution has #disrupted the interaction while preserving robust visual responses .
quantitative single-unit electrophysiology revealed that the lys147ala substitution is able to #disrupt the interaction while preserving robust visual responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation has been shown to #disrupt splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation has #disrupted splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation is able to #disrupt splicing .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations #disrupted the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations #disrupts the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; these mutations has been shown to #disrupt the ubiquitin-binding function .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion #disrupted the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion #disrupts the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion has been shown to #disrupt the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion is able to #disrupt the consensus 5 splice signal .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation has been shown to #disrupt protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation has #disrupted protective physiologic responses .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution has #disrupted the interaction .
sequencing of cloned polymerase chain reaction amplified fragments of the amh gene revealed a 14-bp deletion in the second exon of the maternal allele; the lys147ala substitution is able to #disrupt the interaction .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation #disrupts splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (a homozygous mutation having #disrupted splicing , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (these mutations being able to #disrupt the ubiquitin-binding function , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (these mutations having #disrupted the ubiquitin-binding function , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (these mutations that can #disrupt the ubiquitin-binding function , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (this deletion that can #disrupt the consensus 5 splice signal , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation being able to #disrupt protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (inhibition of inflammation #disrupts protective physiologic responses , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (the lys147ala substitution having #disrupted the interaction , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (the lys147ala substitution that can #disrupt the interaction , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
studies using polymerase chain reaction , restriction enzyme digestion (the lys147ala substitution which have #disrupted the interaction , the arg243----his mutation , a hha i site , and the asp250----asn mutation , a taq i site) , and allele-specific oligonucleotide hybridization confirmed that the patients were indeed compound heterozygous for the respective mutations .
these mutations can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt the ubiquitin-binding function .
these mutations that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt the ubiquitin-binding function .
this deletion that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt the consensus 5 splice signal .
inhibition of inflammation can interact with the keto groups of the go and c base pair(blue) in both sides of dsdna and #disrupt protective physiologic responses .
inhibition of inflammation that interact with the keto groups of the go and c base pair(blue) in both sides of dsdna can #disrupt protective physiologic responses .
a 6-bp insertion located within o2 or between ot and o1 has #eliminated repression of the glptq promoter , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 6-bp insertion which #eliminates repression of the glptq promoter is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
all three sites #eliminated make the same high level of activation of b-raf occurs .
an asparagine residue within a kinase domain of the product was #eliminated by a 3-bp in-frame deletion; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
as illustrated in figure 1 , staurosporin (or genestein; data not shown) can not #eliminate the stabilization seen with mg132 .
as illustrated in figure 1 , the stabilization seen with mg132 was not #eliminated by staurosporin (or genestein; data not shown) .
at a molar ratio of 5:1 , binding can be completely #eliminated (figure 7) .
at a molar ratio of 5:1 , binding will be completely #eliminated (figure 7) .
exogenous h(2)o(2) is #eliminated in transgenic plants by inhibition of any one of these molecules .
for #eliminating any deleterious effects that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
one mutation #eliminated the bamhi site in exon 7 .
one mutation #eliminates the bamhi site in exon 7 .
one mutation has #eliminated the bamhi site in exon 7 .
one of the remaining three families carried a 3-bp in-frame deletion #eliminating an asparagine residue within a kinase domain of the product; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
one of the remaining three families carried a 3-bp in-frame deletion that #eliminated an asparagine residue within a kinase domain of the product; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , these same mutations can completely #eliminate sec incorporation (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , these same mutations completely #eliminated sec incorporation .
that the inhibitory phosphorylation can be #eliminated is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
that the inhibitory phosphorylation was #eliminated is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
the bamhi site was #eliminated in exon 7 by one mutation .
to #eliminate the inhibitory phosphorylation is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
transgenic plants expressing atndk1 under control of the camv 35s promoter exhibited tolerance to paraquat and high ability for #eliminating exogenous h(2)o(2) .
the hindiii site was #eliminated by the other in exon 11 of the phenylalanine hydroxylase gene .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet these same mutations completely #eliminate sec incorporation (lesoon et al . , 1997) .
the same high level of activation of b-raf occurs only when all three sites are #eliminated .
one mutation #eliminates the bamhi site in exon 7 and the other #eliminates the hindiii site in exon 11 of the phenylalanine hydroxylase gene .
one of the remaining three families carried a 3-bp in-frame deletion that would #eliminate an asparagine residue within a kinase domain of the product; the other two carried intronic mutations at or adjacent to the consensus dinucleotide sequences of splice-acceptor or-donor sites , which were likely to lead to aberrant splicing .
to #eliminate any deleterious effects that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
transgenic plants expressing atndk1 under control of the camv 35s promoter exhibited tolerance to paraquat and high ability to #eliminate exogenous h(2)o(2) .
a 6-bp insertion at a 10-fold-higher concentration #eliminate repression of the glptq promoter .
a 6-bp insertion at a 10-fold-higher concentration #eliminated repression of the glptq promoter .
a 6-bp insertion has #eliminated repression of the glptq promoter while mutation at s494 had no effect (figure 2c) .
as illustrated in figure 1 , a 6-bp insertion can not #eliminate repression of the glptq promoter .
as illustrated in figure 1 , a 6-bp insertion did not #eliminate repression of the glptq promoter .
as illustrated in figure 1 , a 6-bp insertion does not #eliminate repression of the glptq promoter .
as illustrated in figure 1 , sec incorporation is not #eliminated by these same mutations .
as illustrated in figure 1 , sec incorporation was not #eliminated by these same mutations .
as illustrated in figure 1 , sec incorporation will not be #eliminated by these same mutations .
as illustrated in figure 1 , a molar ratio of 5:1 does not #eliminate binding .
as illustrated in figure 1 , binding is not #eliminated by a molar ratio of 5:1 .
as illustrated in figure 1 , repression of the glptq promoter is not #eliminated by a 6-bp insertion .
as illustrated in figure 1 , repression of the glptq promoter will not be #eliminated by a 6-bp insertion .
as illustrated in figure 1 , these same mutations does not #eliminate sec incorporation .
at a 6-bp insertion , repression of the glptq promoter is completely #eliminated (figure 7) .
at staurosporin (or genestein; data not shown) , the stabilization seen with mg132 is observed to be completely #eliminated (figure 7) .
at staurosporin (or genestein; data not shown) , the stabilization seen with mg132 will be completely #eliminated (figure 7) .
at these same mutations , sec incorporation can be completely #eliminated (figure 7) .
at these same mutations , sec incorporation is completely #eliminated (figure 7) .
#eliminating all three sites or mimicking activating phosphorylation sites is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
#eliminating any deleterious effects or mimicking activating phosphorylation sites is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
for #eliminating all three sites that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
for #eliminating the inhibitory phosphorylation that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
in gel shift assay , a molar ratio of 5:1 #eliminates binding .
in gel shift assay , a molar ratio of 5:1 will #eliminate binding .
in gel shift assay , staurosporin (or genestein; data not shown) #eliminated the stabilization seen with mg132 .
in gel shift assay , staurosporin (or genestein; data not shown) #eliminates the stabilization seen with mg132 .
in gel shift assay , staurosporin (or genestein; data not shown) has #eliminated the stabilization seen with mg132 .
in gel shift assay , these same mutations #eliminated sec incorporation .
in gel shift assay , these same mutations has #eliminated sec incorporation .
in gel shift assay , these same mutations will #eliminate sec incorporation .
one mutation is able to #eliminate the bamhi site in exon 7 .
sec incorporation is #eliminated by these same mutations .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 6-bp insertion can completely #eliminate repression of the glptq promoter (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 6-bp insertion completely #eliminate repression of the glptq promoter .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 6-bp insertion completely #eliminated repression of the glptq promoter .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a molar ratio of 5:1 can completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a molar ratio of 5:1 completely #eliminated binding .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , repression of the glptq promoter was completely #eliminated by a 6-bp insertion .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , staurosporin (or genestein; data not shown) completely #eliminate the stabilization seen with mg132 .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet a molar ratio of 5:1 completely #eliminate binding (lesoon et al . , 1997) .
the same high level of activation of b-raf occurs only when any deleterious effects are #eliminated .
they establish that a molar ratio of 5:1 , as may occur following caspase activation , could #eliminate binding required for skeletal muscle regeneration during chronic catabolic conditions .
this occurs by a 6-bp insertion to #eliminate repression of the glptq promoter .
this occurs by staurosporin (or genestein; data not shown) for #eliminating the stabilization seen with mg132 .
this occurs by staurosporin (or genestein; data not shown) to #eliminate the stabilization seen with mg132 .
this occurs by these same mutations for #eliminating sec incorporation .
a molar ratio of 5:1 at a 10-fold-higher concentration #eliminated binding .
a molar ratio of 5:1 can #eliminate binding while mutation at s494 has no effect (figure 2c) .
a molar ratio of 5:1 #eliminates binding while mutation at s494 has no effect (figure 2c) .
a molar ratio of 5:1 located within o2 or between ot and o1 #eliminated binding , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a molar ratio of 5:1 located within o2 or between ot and o1 has #eliminated binding , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a molar ratio of 5:1 which #eliminated binding was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
binding has been #eliminated by a molar ratio of 5:1 at a 10-fold-higher concentration .
binding is #eliminated by a molar ratio of 5:1 at a 10-fold-higher concentration .
binding is #eliminated by a molar ratio of 5:1 .
repression of the glptq promoter was #eliminated by a 6-bp insertion at a 10-fold-higher concentration .
repression of the glptq promoter will be #eliminated by a 6-bp insertion at a 10-fold-higher concentration .
staurosporin (or genestein; data not shown) at a 10-fold-higher concentration #eliminated the stabilization seen with mg132 .
staurosporin (or genestein; data not shown) #eliminates the stabilization seen with mg132 while mutation at s494 has no effect (figure 2c) .
staurosporin (or genestein; data not shown) has #eliminated the stabilization seen with mg132 while mutation at s494 had no effect (figure 2c) .
staurosporin (or genestein; data not shown) located within o2 or between ot and o1 has #eliminated the stabilization seen with mg132 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
staurosporin (or genestein; data not shown) which #eliminated the stabilization seen with mg132 was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
the bamhi site is #eliminated by one mutation in exon 7 .
the bamhi site was #eliminated by one mutation in exon 7 .
the stabilization seen with mg132 has been #eliminated by staurosporin (or genestein; data not shown) at a 10-fold-higher concentration .
the stabilization seen with mg132 is #eliminated by staurosporin (or genestein; data not shown) at a 10-fold-higher concentration .
the stabilization seen with mg132 was #eliminated by staurosporin (or genestein; data not shown) at a 10-fold-higher concentration .
the stabilization seen with mg132 was #eliminated by staurosporin (or genestein; data not shown) .
these same mutations at a 10-fold-higher concentration #eliminate sec incorporation .
these same mutations has #eliminated sec incorporation while mutation at s494 had no effect (figure 2c) .
these same mutations located within o2 or between ot and o1 #eliminated sec incorporation , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
these same mutations located within o2 or between ot and o1 #eliminates sec incorporation , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
these same mutations located within o2 or between ot and o1 has #eliminated sec incorporation , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
these same mutations located within o2 or between ot and o1 will #eliminate sec incorporation , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
as illustrated in figure 1 , one mutation does not #eliminate the bamhi site .
as illustrated in figure 1 , a 3-bp in-frame deletion did not #eliminate an asparagine residue .
as illustrated in figure 1 , an asparagine residue was not #eliminated by a 3-bp in-frame deletion .
as illustrated in figure 1 , the bamhi site is not #eliminated by one mutation .
as illustrated in figure 1 , the bamhi site will not be #eliminated by one mutation .
as illustrated in figure 1 , the hindiii site is not #eliminated by the other .
as illustrated in figure 1 , the other can not #eliminate the hindiii site .
as illustrated in figure 1 , the other did not #eliminate the hindiii site .
at a 3-bp in-frame deletion , an asparagine residue can be completely #eliminated (figure 7) .
at a 3-bp in-frame deletion , an asparagine residue is observed to be completely #eliminated (figure 7) .
at the other , the hindiii site can be completely #eliminated (figure 7) .
at the other , the hindiii site is completely #eliminated (figure 7) .
at the other , the hindiii site will be completely #eliminated (figure 7) .
#eliminating exogenous h(2)o(2) or mimicking activating phosphorylation sites is sufficient to confer constitutive activity upon lin-45 raf and induce multi-vulva phenotypes in c .elegans .
in gel shift assay , one mutation #eliminated the bamhi site .
in gel shift assay , a 3-bp in-frame deletion #eliminated an asparagine residue .
in gel shift assay , a 3-bp in-frame deletion has #eliminated an asparagine residue .
in gel shift assay , a 3-bp in-frame deletion will #eliminate an asparagine residue .
in gel shift assay , the other #eliminated the hindiii site .
in gel shift assay , the other has #eliminated the hindiii site .
one mutation at a 10-fold-higher concentration #eliminate the bamhi site .
one mutation at a 10-fold-higher concentration #eliminated the bamhi site .
one mutation #eliminates the bamhi site while mutation at s494 has no effect (figure 2c) .
one mutation has #eliminated the bamhi site while mutation at s494 had no effect (figure 2c) .
one mutation located within o2 or between ot and o1 #eliminated the bamhi site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
one mutation which #eliminated the bamhi site was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion can completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 an asparagine residue activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding was completely #eliminated by a 3-bp in-frame deletion .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , a 3-bp in-frame deletion completely #eliminate an asparagine residue .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , an asparagine residue was completely #eliminated by a 3-bp in-frame deletion .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the hindiii site was completely #eliminated by the other .
secondly , sbp2 binding activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet a 3-bp in-frame deletion completely #eliminate an asparagine residue (lesoon et al . , 1997) .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding is completely #eliminated by one mutation .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding was completely #eliminated by one mutation .
secondly , sbp2 the bamhi site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , yet one mutation completely #eliminate binding (lesoon et al . , 1997) .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , binding is completely #eliminated by the other .
secondly , sbp2 the hindiii site activity is not affected by mutations in the tetra-adenosine element in the terminal region of the phgpx 3 utr , the other completely #eliminate binding .
they establish that one mutation , as may occur following caspase activation , can #eliminate the bamhi site required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that a 3-bp in-frame deletion , as may occur following caspase activation , can #eliminate an asparagine residue required for skeletal muscle regeneration during chronic catabolic conditions .
they establish that the other , as may occur following caspase activation , can #eliminate the hindiii site required for skeletal muscle regeneration during chronic catabolic conditions .
this occurs by one mutation for #eliminating the bamhi site .
this occurs by one mutation to #eliminate the bamhi site .
this occurs by a 3-bp in-frame deletion for #eliminating an asparagine residue .
this occurs by the other for #eliminating the hindiii site .
to #eliminate exogenous h(2)o(2) make the same high level of activation of b-raf occurs .
to #eliminate exogenous h(2)o(2) that might be associated with stable hoxb4 gene transfer into human cells , we took advantage of the ability of hox proteins to passively translocate through cell membranes .
a 3-bp in-frame deletion at a 10-fold-higher concentration #eliminate an asparagine residue .
a 3-bp in-frame deletion at a 10-fold-higher concentration #eliminated an asparagine residue .
a 3-bp in-frame deletion can #eliminate an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion can #eliminate an asparagine residue while mutation at s494 has no effect (figure 2c) .
a 3-bp in-frame deletion #eliminated an asparagine residue while mutation at s494 had no effect (figure 2c) .
a 3-bp in-frame deletion #eliminates an asparagine residue while mutation at s494 has no effect (figure 2c) .
a 3-bp in-frame deletion has #eliminated an asparagine residue in a kinase domain of the product .
a 3-bp in-frame deletion has #eliminated an asparagine residue while mutation at s494 had no effect (figure 2c) .
a 3-bp in-frame deletion located within o2 or between ot and o1 #eliminated an asparagine residue , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion which #eliminates an asparagine residue is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
a 3-bp in-frame deletion would #eliminate an asparagine residue in a kinase domain of the product .
an asparagine residue has been #eliminated by a 3-bp in-frame deletion at a 10-fold-higher concentration .
an asparagine residue is #eliminated by a 3-bp in-frame deletion at a 10-fold-higher concentration .
an asparagine residue is #eliminated by a 3-bp in-frame deletion in a kinase domain of the product .
an asparagine residue was #eliminated by a 3-bp in-frame deletion in a kinase domain of the product .
an asparagine residue will be #eliminated by a 3-bp in-frame deletion at a 10-fold-higher concentration .
the bamhi site has been #eliminated by one mutation at a 10-fold-higher concentration .
the bamhi site is #eliminated by one mutation .
the bamhi site was #eliminated by one mutation at a 10-fold-higher concentration .
the hindiii site has been #eliminated by the other at a 10-fold-higher concentration .
the hindiii site is #eliminated by the other at a 10-fold-higher concentration .
the hindiii site was #eliminated by the other at a 10-fold-higher concentration .
the hindiii site was #eliminated by the other .
the other at a 10-fold-higher concentration #eliminate the hindiii site .
the other can #eliminate the hindiii site while mutation at s494 has no effect (figure 2c) .
the other #eliminates the hindiii site while mutation at s494 has no effect (figure 2c) .
the other located within o2 or between ot and o1 #eliminated the hindiii site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
the other located within o2 or between ot and o1 #eliminates the hindiii site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
the other located within o2 or between ot and o1 has #eliminated the hindiii site , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
the other located within o2 or between ot and o1 will #eliminate the hindiii site , whereas significant repression will be maintained in the case of a 10-bp insertion within o2 .
the other which #eliminated the hindiii site was located within o2 or between ot and o1 , whereas significant repression was maintained in the case of a 10-bp insertion within o2 .
the other which #eliminates the hindiii site is located within o2 or between ot and o1 , whereas significant repression is maintained in the case of a 10-bp insertion within o2 .
a gene family #encodes proteins involved in pre-mrna splicing and maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
a gene family has #encoded proteins involved in pre-mrna splicing and mapped to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
a gene family is able to #encode proteins involved in pre-mrna splicing and map to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
a gene family is shown to have #encoded proteins involved in pre-mrna splicing and mapped to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
a protein that participated in the second step of the splicing reaction was #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
a protein that participates in the second step of the splicing reaction is shown to be #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by murine and human cdnas which we recently encloned .
cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by murine and human cdnas which we recently encloned .
expression sbp2 northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as three distinct transcripts .
expression sbp2 northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as three distinct transcripts .
expression sbp2 northern analysis of poly (a) + rna from various tissues shows that three distinct transcripts #encode sbp2 .
expression sbp2 northern analysis of poly (a) + rna from various tissues shows that three distinct transcripts have #encoded sbp2 .
expression sbp2 northern analysis of poly (a) + rna from various tissues shows three distinct transcripts are shown to #encode sbp2 .
expression sbp2 northern analysis of poly (a) + rna from various tissues shows three distinct transcripts are shown to have #encoded sbp2 .
in this vector the t .gondii dhfr-ts region was able to #encoded resistance to wr99210 by being excised with bamhi and kpni and replaced with human dhfr mutated that .
in this vector the t .gondii dhfr-ts region was excised with bamhi and kpni and replaced with human dhfr mutated in order to #encode resistance to wr99210 (fidock and wellems , 1997) .
maz #encoded a transcription factor with dual roles in transcription initiation and termination .
proteins involved in pre-mrna splicing are shown to be #encoded by a gene family including the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene which maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
proteins involved in pre-mrna splicing have been #encoded by a gene family including the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene which has mapped to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
the escherichia coli yjha (renamed nanc) gene has been #encoding a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene has #encoded a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene is able to #encode a protein of the kdgm family of outer membrane-specific channels .
the prp17 gene of the yeast saccharomyces cerevisiae has #encoded a protein that participated in the second step of the splicing reaction .
the gene yjfq has been #encoding the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the gene yjfq is shown to #encode the repressor of the yjfr-x regulon (ula) , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli is shown to #encode the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli will #encode the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene is one of a gene family being able to #encode proteins involved in pre-mrna splicing and maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
we recently encloned murine and human cdnas that have #encoded cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned murine and human cdnas which may have #encoded cp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a protein of the kdgm family of outer membrane-specific channels has been #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels was believed to be #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels was #encoded by the escherichia coli yjha (renamed nanc) gene .
a transcription factor with dual roles in transcription initiation and termination is #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination was #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination was shown to be #encoded by maz .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors are shown to be #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors were #encoded by the glp regulon of escherichia coli .
expression sbp2 northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as three distinct transcripts .
in this vector the t .gondii dhfr-ts region was excised with bamhi and kpni and replaced with human dhfr mutated to #encode resistance to wr99210 (fidock and wellems , 1997) .
compound heterozygous or homozygous mutations spread over all six exons #encoding the 6-pyruvoyl-tetrahydropterin synthase cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
the human snrpn (small nuclear ribonucleoprotein polypeptide n) gene is one of a gene family that #encode proteins involved in pre-mrna splicing and maps to the smallest deletion region involved in the prader-willi syndrome (pws) within chromosome 15q11-q13 .
this is the first known example of such mutations that has apparently abolished the functional splicing of a pre-mrna #encoding a multipass integral membrane protein .
cp2 are #encoded by murine and human cdnas .
cp2 has been #encoded by murine and human cdnas .
cp2 have been #encoded by murine and human cdnas .
cp2 have been #encoded by murine and human cdnas .
cp2 were #encoded by murine and human cdnas .
compound heterozygous or homozygous mutations spread over three distinct transcripts #encoding sbp2 cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as all six exons .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as all six exons .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues shows all six exons are shown to #encode sbp2 .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues shows all six exons are shown to have #encoded sbp2 .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues shows that all six exons #encode sbp2 .
expression the 6-pyruvoyl-tetrahydropterin synthase northern analysis of poly (a) + rna from various tissues shows that all six exons have #encoded sbp2 .
in plants it is estimated that sbp2 are #encoded by three distinct transcripts .
in plants it is estimated that sbp2 have been #encoded by three distinct transcripts .
in plants it is estimated that all six exons may have #encoded the 6-pyruvoyl-tetrahydropterin synthase .
in plants it is estimated that three distinct transcripts are able to #encode sbp2 .
in plants it is estimated that three distinct transcripts have #encoded sbp2 .
it is possible , therefore , that all six exons are involved in #encoding the 6-pyruvoyl-tetrahydropterin synthase .
it is possible , therefore , that three distinct transcripts are involved in #encoding sbp2 .
it is possible , therefore , that three distinct transcripts are involved in regulating its expression of #encoding sbp2 .
it is possible , therefore , that three distinct transcripts are involved in the process of #encoding sbp2 .
maz #encoded a transcription factor with dual roles in transcription initiation and termination , which is involved in l-ascorbate metabolism in escherichia coli .
maz has been #encoding a transcription factor with dual roles in transcription initiation and termination .
maz is shown to #encode a transcription factor with dual roles in transcription initiation and termination .
maz will #encode a transcription factor with dual roles in transcription initiation and termination .
maz , #encoding a transcription factor with dual roles in transcription initiation and termination , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
maz , which #encoded a transcription factor with dual roles in transcription initiation and termination , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
maz , which has #encoded a transcription factor with dual roles in transcription initiation and termination , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
our reseach shows that all six exons #encode the 6-pyruvoyl-tetrahydropterin synthase .
our reseach shows that all six exons have #encoded the 6-pyruvoyl-tetrahydropterin synthase .
our reseach shows that three distinct transcripts #encode sbp2 .
the escherichia coli yjha (renamed nanc) gene #encoded a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene is able to #encode a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene is shown to #encode a protein of the kdgm family of outer membrane-specific channels , which is involved in l-ascorbate metabolism in escherichia coli .
the escherichia coli yjha (renamed nanc) gene is shown to #encode a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene may have #encoded a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene will #encode a protein of the kdgm family of outer membrane-specific channels .
the escherichia coli yjha (renamed nanc) gene , #encoding a protein of the kdgm family of outer membrane-specific channels , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
the escherichia coli yjha (renamed nanc) gene , which has #encoded a protein of the kdgm family of outer membrane-specific channels , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
the gene yjfq has been #encoding the repressor of the yjfr-x regulon (ula) .
the gene yjfq is shown to #encode the repressor of the yjfr-x regulon (ula) .
the gene yjfq may have #encoded the repressor of the yjfr-x regulon (ula) .
the gene yjfq will #encode the repressor of the yjfr-x regulon (ula) .
the gene yjfq , which has #encoded the repressor of the yjfr-x regulon (ula) , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
the glp regulon of escherichia coli has been #encoding the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli is able to #encode the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli is able to #encode the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli is believed to #encode the proteins required for utilization of sn-glycerol 3-phosphate and its precursors .
the glp regulon of escherichia coli is believed to have #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli is shown to #encode the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , which is involved in l-ascorbate metabolism in escherichia coli .
the glp regulon of escherichia coli , #encoding the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
the glp regulon of escherichia coli , which #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
we recently all six exons that #encode the 6-pyruvoyl-tetrahydropterin synthase , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned maz #encoding a transcription factor with dual roles in transcription initiation and termination , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned maz that #encoded a transcription factor with dual roles in transcription initiation and termination , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned maz that have #encoded a transcription factor with dual roles in transcription initiation and termination , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned maz which may have #encoded a transcription factor with dual roles in transcription initiation and termination , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the escherichia coli yjha (renamed nanc) gene #encoding a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the escherichia coli yjha (renamed nanc) gene that have #encoded a protein of the kdgm family of outer membrane-specific channels , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the gene yjfq #encoding the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the gene yjfq that #encoded the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the glp regulon of escherichia coli #encoding the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the glp regulon of escherichia coli that #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently encloned the glp regulon of escherichia coli that have #encoded the proteins required for utilization of sn-glycerol 3-phosphate and its precursors , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently three distinct transcripts that #encode sbp2 , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a protein of the kdgm family of outer membrane-specific channels are shown to be #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels have been #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels may be #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels was shown to be #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels were #encoded by the escherichia coli yjha (renamed nanc) gene .
a protein of the kdgm family of outer membrane-specific channels were shown to be #encoded by the escherichia coli yjha (renamed nanc) gene .
a transcription factor with dual roles in transcription initiation and termination are #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination have been #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination was believed to be #encoded by maz .
a transcription factor with dual roles in transcription initiation and termination , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , may be #encoded by maz which we recently encloned .
all six exons #encodes the 6-pyruvoyl-tetrahydropterin synthase , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas #encoded cp2 .
murine and human cdnas has been #encoding cp2 .
murine and human cdnas has #encoded cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas is able to #encode cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas is able to #encode cp2 .
murine and human cdnas is believed to #encode cp2 .
murine and human cdnas is believed to have #encoded cp2 , which is involved in l-ascorbate metabolism in escherichia coli .
murine and human cdnas may have #encoded cp2 .
murine and human cdnas will #encode cp2 .
murine and human cdnas , #encoding cp2 , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
murine and human cdnas , which #encoded cp2 , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
murine and human cdnas , which has #encoded cp2 , respectively , was affected in a reciprocal manner by the osmolarity of the growth medium .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors has been #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors was believed to be #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors was #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors was shown to be #encoded by the glp regulon of escherichia coli .
the proteins required for utilization of sn-glycerol 3-phosphate and its precursors were shown to be #encoded by the glp regulon of escherichia coli .
the repressor of the yjfr-x regulon (ula) have been #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) is #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) was #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) were #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) were shown to be #encoded by the gene yjfq .
the repressor of the yjfr-x regulon (ula) , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements , is shown to be #encoded by the gene yjfq which we recently encloned .
three distinct transcripts #encodes sbp2 , which is involved in l-ascorbate metabolism in escherichia coli .
three distinct transcripts #encodes sbp2 .
three distinct transcripts , which #encode sbp2 , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
compound heterozygous or homozygous mutations spread over the prp17 gene of the yeast saccharomyces cerevisiae #encoding a protein that participates in the second step of the splicing reaction cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
compound heterozygous or homozygous mutations spread over a gene family #encoding proteins involved in pre-mrna splicing cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
compound heterozygous or homozygous mutations spread over the t .gondii dhfr-ts region #encoding resistance to wr99210 cause an autosomal recessively inherited variant of hyperphenylalaninemia , mostly accompanied by a deficiency of dopamine and serotonin .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as a pre-mrna .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as a pre-mrna .
expression a multipass integral membrane protein northern analysis of poly (a) + rna from various tissues shows that a pre-mrna #encode sbp2 .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows the prp17 gene of the yeast saccharomyces cerevisiae are shown to have #encoded sbp2 .
expression a protein that participated in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded sbp2 .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as the prp17 gene of the yeast saccharomyces cerevisiae .
expression a protein that participates in the second step of the splicing reaction northern analysis of poly (a) + rna from various tissues shows that the prp17 gene of the yeast saccharomyces cerevisiae #encode sbp2 .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues reveals that sbp2 has been #encoded by as many as a gene family .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues reveals that sbp2 is #encoded by as many as a gene family .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as a gene family .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues shows a gene family are shown to have #encoded sbp2 .
expression proteins involved in pre-mrna splicing northern analysis of poly (a) + rna from various tissues shows that a gene family have #encoded sbp2 .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues reveals that sbp2 may be #encoded by as many as the t .gondii dhfr-ts region .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues reveals that sbp2 was #encoded by as many as the t .gondii dhfr-ts region .
expression resistance to wr99210 northern analysis of poly (a) + rna from various tissues shows the t .gondii dhfr-ts region are shown to have #encoded sbp2 .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded a protein that participates in the second step of the splicing reaction .
in plants it is estimated that the prp17 gene of the yeast saccharomyces cerevisiae may have #encoded a protein that participated in the second step of the splicing reaction .
in plants it is estimated that a pre-mrna #encode a multipass integral membrane protein .
in plants it is estimated that a pre-mrna have #encoded a multipass integral membrane protein .
in plants it is estimated that a pre-mrna may have #encoded a multipass integral membrane protein .
in plants it is estimated that a protein that participates in the second step of the splicing reaction have been #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
in plants it is estimated that resistance to wr99210 are #encoded by the t .gondii dhfr-ts region .
in plants it is estimated that the t .gondii dhfr-ts region #encode resistance to wr99210 .
in plants it is estimated that the t .gondii dhfr-ts region may have #encoded resistance to wr99210 .
it is possible , therefore , that the prp17 gene of the yeast saccharomyces cerevisiae are involved in #encoding a protein that participated in the second step of the splicing reaction .
it is possible , therefore , that a gene family are involved in regulating its expression of #encoding proteins involved in pre-mrna splicing .
it is possible , therefore , that a pre-mrna are involved in #encoding a multipass integral membrane protein .
it is possible , therefore , that the t .gondii dhfr-ts region are involved in the process of #encoding resistance to wr99210 .
our reseach shows that the prp17 gene of the yeast saccharomyces cerevisiae #encode a protein that participated in the second step of the splicing reaction .
our reseach shows that the prp17 gene of the yeast saccharomyces cerevisiae #encode a protein that participates in the second step of the splicing reaction .
our reseach shows that the prp17 gene of the yeast saccharomyces cerevisiae have #encoded a protein that participated in the second step of the splicing reaction .
our reseach shows that a gene family #encode proteins involved in pre-mrna splicing .
our reseach shows that a gene family have #encoded proteins involved in pre-mrna splicing .
our reseach shows that a pre-mrna #encode a multipass integral membrane protein .
our reseach shows that a protein that participated in the second step of the splicing reaction are #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
our reseach shows that a protein that participated in the second step of the splicing reaction were #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
our reseach shows that a protein that participates in the second step of the splicing reaction are #encoded by the prp17 gene of the yeast saccharomyces cerevisiae .
our reseach shows that proteins involved in pre-mrna splicing are #encoded by a gene family .
our reseach shows that proteins involved in pre-mrna splicing were #encoded by a gene family .
our reseach shows that resistance to wr99210 are #encoded by the t .gondii dhfr-ts region .
the prp17 gene of the yeast saccharomyces cerevisiae #encodes a protein that participated in the second step of the splicing reaction , which is involved in l-ascorbate metabolism in escherichia coli .
the prp17 gene of the yeast saccharomyces cerevisiae #encodes a protein that participates in the second step of the splicing reaction , which is involved in l-ascorbate metabolism in escherichia coli .
the prp17 gene of the yeast saccharomyces cerevisiae may #encode a protein that participated in the second step of the splicing reaction .
the prp17 gene of the yeast saccharomyces cerevisiae may #encode a protein that participates in the second step of the splicing reaction .
the prp17 gene of the yeast saccharomyces cerevisiae , which #encode a protein that participated in the second step of the splicing reaction , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
we recently a gene family that #encode proteins involved in pre-mrna splicing , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
we recently a pre-mrna that #encode a multipass integral membrane protein , a cellular transcription factor that interacts with the alpha-globin promoter as well as with additional cellular and viral promoter elements .
a gene family #encodes proteins involved in pre-mrna splicing , which is involved in l-ascorbate metabolism in escherichia coli .
a gene family #encodes proteins involved in pre-mrna splicing .
a gene family may #encode proteins involved in pre-mrna splicing .
a pre-mrna , which #encode a multipass integral membrane protein , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
the t .gondii dhfr-ts region may #encode resistance to wr99210 .
the t .gondii dhfr-ts region , which #encode resistance to wr99210 , respectively , is affected in a reciprocal manner by the osmolarity of the growth medium .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) is isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) was isolated and #expressed in vitro .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) would be isolated and #expressed in vitro .
bd73 messenger rna has been #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna is predicted to be #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna is shown to be #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna may have been #expressed in a wide variety of tissues and cell lines .
bd73 messenger rna was #expressed in a wide variety of tissues and cell lines .
in such cells at the cell surface , two in-frame î± chain transcripts are produced , but only one is shown to be #expressed .
in such cells at the cell surface , two in-frame î± chain transcripts were produced , but only one is able to be #expressed .
in such cells at the cell surface , two in-frame î± chain transcripts were produced , but only one was #expressed .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor may have been #expressed by classical and variant sccl .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor was able to be been #expressed by classical and variant sccl .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor was #expressed by classical and variant sccl .
northern blot analysis reveals that bnip3alpha has been shown to be #expressed ubiquitously in most human tissues .
northern blot analysis reveals that bnip3alpha is able to be #expressed ubiquitously in most human tissues .
northern blot analysis reveals that bnip3alpha was #expressed ubiquitously in most human tissues .
northern blot analysis reveals that bnip3alpha will be #expressed ubiquitously in most human tissues .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 has been shown to be #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
northern blotting and reverse transcriptase-pcr assays with oligonucleotide probes and primers specific for each transcript demonstrated that the isoform identical to ran/tc4 is #expressed in both somatic tissues and testis , while the variant form was transcribed only in testis .
t cells in mice at the cell surface carrying transgenes encoding tcr î± and î² proteins predominantly are shown to #express the transgene-encoded tcr proteins .
t cells in mice at the cell surface carrying transgenes encoding tcr î± and î² proteins predominantly #expressed the transgene-encoded tcr proteins .
the human mitochondrial transcription termination factor (mterf) cdna is able to be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna is able to be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna is #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the human mitochondrial transcription termination factor (mterf) cdna was shown to be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the pfl operon is able to be #expressed at high levels anaerobically .
the pfl operon is proven to be #expressed at high levels anaerobically .
the pfl operon may have been #expressed at high levels anaerobically .
the pfl operon was #expressed at high levels anaerobically .
the transgene-encoded tcr proteins are able to be predominantly #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins are predominantly #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins are shown to be predominantly #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins have been predominantly #expressed by t cells in mice at the cell surface .
a complementary dna clone encoding the large subunit of the essential mammalian pre-messenger rna splicing component u2 snrnp auxiliary factor(u2af65) has been isolated and #expressed in vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that this receptor is #expressed by classical and variant sccl .
the human mitochondrial transcription termination factor (mterf) cdna has been cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna are #expressed by in a wide variety of tissues and cell lines .
bd73 messenger rna are shown to be #expressed by in a wide variety of tissues and cell lines .
bd73 messenger rna has been #expressed by in a wide variety of tissues and cell lines .
bd73 messenger rna has been #expressed primarily in in a wide variety of tissues and cell lines and secreted into perineuronal nets .
bd73 messenger rna is able to be cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna is cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna is shown to be #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
bd73 messenger rna is shown to be likely #expressed through +1 or -1 frameshifting by in a wide variety of tissues and cell lines .
bd73 messenger rna may have been #expressed primarily in in a wide variety of tissues and cell lines and secreted into perineuronal nets .
bd73 messenger rna was shown to be cloned and #expressed in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna was shown to be #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bd73 messenger rna were #expressed by in a wide variety of tissues and cell lines .
bd73 messenger rna will be #expressed by in a wide variety of tissues and cell lines .
bd73 messenger rna will be #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
bd73 messenger rna would be #expressed and cloned in in a wide variety of tissues and cell lines , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha has been #expressed most human tissues .
bnip3alpha has been #expressed primarily in in most human tissues and secreted into perineuronal nets .
bnip3alpha is able to be #expressed and cloned in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha is able to be #expressed most human tissues .
bnip3alpha is #expressed and cloned in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha is #expressed most human tissues .
bnip3alpha is predicted to be #expressed most human tissues .
bnip3alpha may have been #expressed primarily in in most human tissues and secreted into perineuronal nets .
bnip3alpha may have been likely #expressed through +1 or -1 frameshifting by in most human tissues .
bnip3alpha was #expressed most human tissues .
bnip3alpha was shown to be cloned and #expressed in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha was shown to be #expressed and cloned in in most human tissues , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
bnip3alpha will be #expressed primarily in in most human tissues and is secreted into perineuronal nets .
bnip3alpha would be likely #expressed through +1 or -1 frameshifting by in most human tissues .
in classical and variant sccl , two this receptor are produced , but only one has been #expressed .
in classical and variant sccl , two this receptor were produced , but only one of them can be #expressed .
in classical and variant sccl , two this receptor were produced , but only one of them is observed to be #expressed .
in classical and variant sccl , two this receptor were produced , but only one was #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna are produced , but only one is shown to be #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna were produced , but it has #expressed only one of them .
in in a wide variety of tissues and cell lines , two bd73 messenger rna were produced , but only one of them can be #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna were produced , but only one of them is observed to be #expressed .
in in a wide variety of tissues and cell lines , two bd73 messenger rna were produced , but only one was #expressed .
in in most human tissues , two bnip3alpha are produced , but only one has been #expressed .
in in most human tissues , two bnip3alpha are produced , but only one is #expressed .
in in most human tissues , two bnip3alpha were produced , but it has #expressed only one of them .
in in most human tissues , two bnip3alpha were produced , but only one is able to be #expressed .
in summary , bd73 messenger rna is able to be #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bd73 messenger rna is shown to be #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bd73 messenger rna is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in a wide variety of tissues and cell lines .
in summary , bd73 messenger rna was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in a wide variety of tissues and cell lines .
in summary , bd73 messenger rna will be #expressed in in a wide variety of tissues and cell lines and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bd73 messenger rna will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in a wide variety of tissues and cell lines .
in summary , bnip3alpha has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in most human tissues .
in summary , bnip3alpha is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in most human tissues .
in summary , bnip3alpha is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in most human tissues .
in summary , bnip3alpha was #expressed in in most human tissues and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , bnip3alpha was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in most human tissues .
in summary , bnip3alpha will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in in most human tissues .
in summary , the human mitochondrial transcription termination factor (mterf) cdna has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the human mitochondrial transcription termination factor (mterf) cdna is able to be #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the human mitochondrial transcription termination factor (mterf) cdna is #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna is shown to be #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna was #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the human mitochondrial transcription termination factor (mterf) cdna was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the human mitochondrial transcription termination factor (mterf) cdna will be #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame î± chain transcripts has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in such cells at the cell surface .
in summary , in-frame î± chain transcripts is able to be #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame î± chain transcripts is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in such cells at the cell surface .
in summary , in-frame î± chain transcripts is shown to be #expressed in such cells at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , in-frame î± chain transcripts was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in such cells at the cell surface .
in summary , in-frame î± chain transcripts will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in such cells at the cell surface .
in summary , this receptor has been #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor is able to be #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor is #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in classical and variant sccl .
in summary , this receptor was #expressed in classical and variant sccl and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , this receptor was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in classical and variant sccl .
in summary , this receptor will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in classical and variant sccl .
in the cortex of adult animals , bd73 messenger rna has been #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
in the cortex of adult animals , bd73 messenger rna was #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
in the cortex of adult animals , bd73 messenger rna was shown to be #expressed primarily in in a wide variety of tissues and cell lines and is secreted into perineuronal nets .
in the cortex of adult animals , bnip3alpha is able to be #expressed primarily in in most human tissues and is secreted into perineuronal nets .
in the cortex of adult animals , bnip3alpha is #expressed primarily in in most human tissues and is secreted into perineuronal nets .
in the cortex of adult animals , bnip3alpha was #expressed primarily in in most human tissues and is secreted into perineuronal nets .
in the cortex of adult animals , bnip3alpha was shown to be #expressed primarily in in most human tissues and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna is able to be #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the human mitochondrial transcription termination factor (mterf) cdna is #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , in-frame î± chain transcripts has been #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , in-frame î± chain transcripts is able to be #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , in-frame î± chain transcripts was #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , this receptor has been #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
in the cortex of adult animals , this receptor is able to be #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
in the cortex of adult animals , this receptor is #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
in the cortex of adult animals , this receptor was #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
in the cortex of adult animals , this receptor was shown to be #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna are produced , but only one has been #expressed .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna are produced , but only one is shown to be #expressed .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but only one of them can be #expressed .
in vitro , two the human mitochondrial transcription termination factor (mterf) cdna were produced , but only one of them is observed to be #expressed .
it #expressed bnip3alpha , which was induced by pkc , pka and erk1/2 dependent mechanisms , in in most human tissues .
it #expressed in-frame î± chain transcripts , which was induced by pkc , pka and erk1/2 dependent mechanisms , in such cells at the cell surface .
it #expressed this receptor , which was induced by pkc , pka and erk1/2 dependent mechanisms , in classical and variant sccl .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna can be #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna may have been #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna was able to be been #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bd73 messenger rna was shown to be #expressed by in a wide variety of tissues and cell lines .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha is #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that bnip3alpha was able to be been #expressed by in most human tissues .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna is #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna may have been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna was able to be been #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the human mitochondrial transcription termination factor (mterf) cdna was shown to be #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame î± chain transcripts was able to be been #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame î± chain transcripts was #expressed by such cells at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that in-frame î± chain transcripts was shown to be #expressed by such cells at the cell surface .
it has primarily #expressed bd73 messenger rna , which is secreted into perineuronal nets , in in a wide variety of tissues and cell lines .
it has primarily #expressed this receptor , which is secreted into perineuronal nets , in classical and variant sccl .
it primarily #expressed bnip3alpha , which was secreted into perineuronal nets , in in most human tissues .
it primarily #expressed this receptor , which was secreted into perineuronal nets , in classical and variant sccl .
northern blot analysis reveals that bd73 messenger rna is able to be #expressed ubiquitously in in a wide variety of tissues and cell lines .
northern blot analysis reveals that bd73 messenger rna is #expressed ubiquitously in a wide variety of tissues and cell lines .
northern blot analysis reveals that bd73 messenger rna was #expressed ubiquitously in in a wide variety of tissues and cell lines .
northern blot analysis reveals that bd73 messenger rna will be #expressed ubiquitously in in a wide variety of tissues and cell lines .
northern blot analysis reveals that the pfl operon has been shown to be #expressed ubiquitously in at high levels anaerobically .
northern blot analysis reveals that the pfl operon is able to be #expressed ubiquitously in at high levels anaerobically .
northern blot analysis reveals that the pfl operon will be #expressed ubiquitously in at high levels anaerobically .
northern blot analysis reveals that this receptor is #expressed ubiquitously classical and variant sccl .
rcas viruses infect only classical and variant sccl being involved in #expressing ectopically this receptor , tva .
rcas viruses infect only classical and variant sccl engineered to #express ectopically this receptor , tva .
rcas viruses infect only in a wide variety of tissues and cell lines engineered to #express ectopically bd73 messenger rna , tva .
rcas viruses infect only in most human tissues being engineered to #express ectopically bnip3alpha , tva .
rcas viruses infect only in most human tissues being involved in #expressing ectopically bnip3alpha , tva .
rcas viruses infect only in most human tissues engineered for #expressing ectopically bnip3alpha , tva .
rcas viruses infect only such cells at the cell surface being involved in #expressing ectopically in-frame î± chain transcripts , tva .
rcas viruses infect only vitro being engineered to #express ectopically the human mitochondrial transcription termination factor (mterf) cdna , tva .
the human mitochondrial transcription termination factor (mterf) cdna are shown to be #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna has been #expressed by vitro .
the human mitochondrial transcription termination factor (mterf) cdna has been #expressed primarily in vitro and secreted into perineuronal nets .
the human mitochondrial transcription termination factor (mterf) cdna is shown to be #expressed primarily in vitro and is secreted into perineuronal nets .
the human mitochondrial transcription termination factor (mterf) cdna may have been #expressed primarily in vitro and secreted into perineuronal nets .
the human mitochondrial transcription termination factor (mterf) cdna may have been likely #expressed through +1 or -1 frameshifting by vitro .
the human mitochondrial transcription termination factor (mterf) cdna will be #expressed primarily in vitro and is secreted into perineuronal nets .
the human mitochondrial transcription termination factor (mterf) cdna would be likely #expressed through +1 or -1 frameshifting by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bd73 messenger rna could not to be #expressed in response to overload by in a wide variety of tissues and cell lines .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bd73 messenger rna has been shown not to be #expressed in response to overload by in a wide variety of tissues and cell lines .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bd73 messenger rna is unable to be #expressed in response to overload by in a wide variety of tissues and cell lines .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bd73 messenger rna was unable to be #expressed in response to overload by in a wide variety of tissues and cell lines .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as bnip3alpha was not able to be #expressed in response to overload by in most human tissues .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna has been shown not to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the human mitochondrial transcription termination factor (mterf) cdna was not able to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , does not have the ability to #express this receptor in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as classical and variant sccl , unlike normal muscle , is unable to #express this receptor in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in a wide variety of tissues and cell lines , unlike normal muscle , cannot #express bd73 messenger rna in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in a wide variety of tissues and cell lines , unlike normal muscle , is unable to #express bd73 messenger rna in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in a wide variety of tissues and cell lines , unlike normal muscle , was shown not to #express bd73 messenger rna in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in a wide variety of tissues and cell lines , unlike normal muscle , was unable to #express bd73 messenger rna in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in most human tissues , unlike normal muscle , cannot #express bnip3alpha in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in most human tissues , unlike normal muscle , was shown not to #express bnip3alpha in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in most human tissues , unlike normal muscle , was unable to #express bnip3alpha in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in-frame î± chain transcripts is unable to be #expressed in response to overload by such cells at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in-frame î± chain transcripts was not able to be #expressed in response to overload by such cells at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as in-frame î± chain transcripts was unable to be #expressed in response to overload by such cells at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as such cells at the cell surface , unlike normal muscle , cannot #express in-frame î± chain transcripts in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as such cells at the cell surface , unlike normal muscle , is unable to #express in-frame î± chain transcripts in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as such cells at the cell surface , unlike normal muscle , was unable to #express in-frame î± chain transcripts in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor has been shown not to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as this receptor was unable to be #expressed in response to overload by classical and variant sccl .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , cannot #express the human mitochondrial transcription termination factor (mterf) cdna in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , does not have the ability to #express the human mitochondrial transcription termination factor (mterf) cdna in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , is unable to #express the human mitochondrial transcription termination factor (mterf) cdna in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , was unable to #express the human mitochondrial transcription termination factor (mterf) cdna in response to overload
the pfl operon has been #expressed at high levels anaerobically .
the pfl operon is able to be #expressed at high levels anaerobically .
the pfl operon is predicted to be #expressed at high levels anaerobically .
the pfl operon may have been #expressed at high levels anaerobically .
the pfl operon will be #expressed at high levels anaerobically .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl are #expressing this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl #express this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl have been shown to #express this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl have #expressed this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these classical and variant sccl have the ability to #express this receptor .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines are involved in #expressing bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines #express bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines have been shown to #express bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in a wide variety of tissues and cell lines have the ability to #express bd73 messenger rna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues are able to #express bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues are #expressing bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these in most human tissues are involved in #expressing bnip3alpha .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface are able to #express in-frame î± chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface #express in-frame î± chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these such cells at the cell surface have been shown to #express in-frame î± chain transcripts .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are #expressing the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have been shown to #express the human mitochondrial transcription termination factor (mterf) cdna .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro have the ability to #express the human mitochondrial transcription termination factor (mterf) cdna .
classical and variant sccl are shown to #express only this receptor .
classical and variant sccl #express only this receptor .
classical and variant sccl have #expressed only this receptor .
classical and variant sccl may #express only this receptor .
classical and variant sccl may have #expressed only this receptor .
in a wide variety of tissues and cell lines are able to #express only bd73 messenger rna .
in a wide variety of tissues and cell lines are shown to #express only bd73 messenger rna .
in a wide variety of tissues and cell lines #express only bd73 messenger rna .
in a wide variety of tissues and cell lines have #expressed only bd73 messenger rna .
in a wide variety of tissues and cell lines may #express only bd73 messenger rna .
in a wide variety of tissues and cell lines may have #expressed only bd73 messenger rna .
in most human tissues are able to #express only bnip3alpha .
in most human tissues #express only bnip3alpha .
in most human tissues may #express only bnip3alpha .
in most human tissues may have #expressed only bnip3alpha .
in-frame î± chain transcripts are #expressed by such cells at the cell surface .
in-frame î± chain transcripts has been #expressed by such cells at the cell surface .
in-frame î± chain transcripts is able to be cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame î± chain transcripts is #expressed such cells at the cell surface .
in-frame î± chain transcripts is likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
in-frame î± chain transcripts is shown to be #expressed primarily in such cells at the cell surface and is secreted into perineuronal nets .
in-frame î± chain transcripts is shown to be likely #expressed through +1 or -1 frameshifting by such cells at the cell surface .
in-frame î± chain transcripts may have been #expressed primarily in such cells at the cell surface and secreted into perineuronal nets .
in-frame î± chain transcripts was cloned and #expressed in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame î± chain transcripts was #expressed and cloned in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame î± chain transcripts was shown to be #expressed and cloned in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in-frame î± chain transcripts were #expressed by such cells at the cell surface .
in-frame î± chain transcripts would be #expressed and cloned in such cells at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
such cells at the cell surface #express only in-frame î± chain transcripts .
such cells at the cell surface have #expressed only in-frame î± chain transcripts .
such cells at the cell surface may #express only in-frame î± chain transcripts .
this receptor has been cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor has been likely #expressed through +1 or -1 frameshifting by classical and variant sccl .
this receptor is cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor is likely #expressed through +1 or -1 frameshifting by classical and variant sccl .
this receptor is shown to be #expressed primarily in classical and variant sccl and is secreted into perineuronal nets .
this receptor is shown to be likely #expressed through +1 or -1 frameshifting by classical and variant sccl .
this receptor may have been #expressed by classical and variant sccl .
this receptor may have been likely #expressed through +1 or -1 frameshifting by classical and variant sccl .
this receptor was cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor was shown to be cloned and #expressed in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor was shown to be #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
this receptor would be #expressed and cloned in classical and variant sccl , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
vitro are shown to #express only the human mitochondrial transcription termination factor (mterf) cdna .
vitro have #expressed only the human mitochondrial transcription termination factor (mterf) cdna .
vitro may #express only the human mitochondrial transcription termination factor (mterf) cdna .
vitro may have #expressed only the human mitochondrial transcription termination factor (mterf) cdna .
in such cells at the cell surface , two in-frame î± chain transcripts are produced , but only one is #expressed .
a complementary dna clone are #expressed by vitro .
a complementary dna clone are shown to be #expressed by vitro .
a complementary dna clone has been #expressed by vitro .
a complementary dna clone has been #expressed primarily in vitro and secreted into perineuronal nets .
a complementary dna clone is able to be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone is shown to be likely #expressed through +1 or -1 frameshifting by vitro .
a complementary dna clone may have been #expressed primarily in vitro and secreted into perineuronal nets .
a complementary dna clone may have been likely #expressed through +1 or -1 frameshifting by vitro .
a complementary dna clone was cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone was #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone was shown to be #expressed and cloned in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
a complementary dna clone would be cloned and #expressed in vitro , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins are produced , but only one is #expressed .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but it has #expressed only one of them .
in t cells in mice at the cell surface , two the transgene-encoded tcr proteins were produced , but only one of them is observed to be #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 are produced , but only one has been #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 are produced , but only one is shown to be #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 were produced , but only one is able to be #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 were produced , but only one of them can be #expressed .
in both somatic tissues and testis , two the isoform identical to ran/tc4 were produced , but only one of them is observed to be #expressed .
in such cells at the cell surface , two in-frame î± chain transcripts are produced , but only one has been #expressed .
in such cells at the cell surface , two in-frame î± chain transcripts were produced , but it has #expressed only one of them .
in such cells at the cell surface , two in-frame î± chain transcripts were produced , but only one of them is observed to be #expressed .
in such cells at the cell surface , two in-frame î± chain transcripts were produced , but only one was #expressed .
in summary , a complementary dna clone has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , a complementary dna clone is able to be #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , a complementary dna clone is #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , a complementary dna clone is shown to be #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , a complementary dna clone is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , a complementary dna clone was #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , a complementary dna clone will be #expressed in vitro and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , a complementary dna clone will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in vitro .
in summary , the isoform identical to ran/tc4 is able to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in both somatic tissues and testis .
in summary , the isoform identical to ran/tc4 is shown to be #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 is shown to be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in both somatic tissues and testis .
in summary , the isoform identical to ran/tc4 was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in both somatic tissues and testis .
in summary , the isoform identical to ran/tc4 will be #expressed in both somatic tissues and testis and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the isoform identical to ran/tc4 will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in both somatic tissues and testis .
in summary , the transgene-encoded tcr proteins has been induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in t cells in mice at the cell surface .
in summary , the transgene-encoded tcr proteins is #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins is shown to be #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins was #expressed in t cells in mice at the cell surface and induced by pkc , pka and erk1/2 dependent mechanisms .
in summary , the transgene-encoded tcr proteins was induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in t cells in mice at the cell surface .
in summary , the transgene-encoded tcr proteins will be induced by pkc , pka and erk1/2 dependent mechanisms and #expressed in t cells in mice at the cell surface .
in the cortex of adult animals , a complementary dna clone has been #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , a complementary dna clone is #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , a complementary dna clone was #expressed primarily in vitro and is secreted into perineuronal nets .
in the cortex of adult animals , the isoform identical to ran/tc4 has been #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
in the cortex of adult animals , the isoform identical to ran/tc4 is #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
in the cortex of adult animals , the isoform identical to ran/tc4 was #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
in the cortex of adult animals , the transgene-encoded tcr proteins is able to be #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , the transgene-encoded tcr proteins was #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
in the cortex of adult animals , the transgene-encoded tcr proteins was shown to be #expressed primarily in t cells in mice at the cell surface and is secreted into perineuronal nets .
in vitro , two a complementary dna clone are produced , but only one is #expressed .
in vitro , two a complementary dna clone were produced , but only one is able to be #expressed .
in vitro , two a complementary dna clone were produced , but only one of them is observed to be #expressed .
it #expressed the transgene-encoded tcr proteins , which was induced by pkc , pka and erk1/2 dependent mechanisms , in t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone is #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone was #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that a complementary dna clone was shown to be #expressed by vitro .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 has been #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 may have been #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the isoform identical to ran/tc4 was shown to be #expressed by both somatic tissues and testis .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins can be #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins has been #expressed by t cells in mice at the cell surface .
it has been assumed that this peptide exercises its mitogenic influences through the vasopressin v1a receptor , and we have previously demonstrated that the transgene-encoded tcr proteins was #expressed by t cells in mice at the cell surface .
it has primarily #expressed the transgene-encoded tcr proteins , which is secreted into perineuronal nets , in t cells in mice at the cell surface .
it primarily #expressed the isoform identical to ran/tc4 , which was secreted into perineuronal nets , in both somatic tissues and testis .
it primarily #expressed the transgene-encoded tcr proteins , which was secreted into perineuronal nets , in t cells in mice at the cell surface .
northern blot analysis reveals that a complementary dna clone is #expressed ubiquitously vitro .
northern blot analysis reveals that the transgene-encoded tcr proteins is #expressed ubiquitously t cells in mice at the cell surface .
rcas viruses infect only t cells in mice at the cell surface being engineered to #express ectopically the transgene-encoded tcr proteins , tva .
rcas viruses infect only t cells in mice at the cell surface engineered to #express ectopically the transgene-encoded tcr proteins , tva .
rcas viruses infect only both somatic tissues and testis engineered to #express ectopically the isoform identical to ran/tc4 , tva .
rcas viruses infect only vitro being engineered to #express ectopically a complementary dna clone , tva .
rcas viruses infect only vitro engineered to #express ectopically a complementary dna clone , tva .
t cells in mice at the cell surface are able to #express only the transgene-encoded tcr proteins .
t cells in mice at the cell surface have #expressed only the transgene-encoded tcr proteins .
t cells in mice at the cell surface may #express only the transgene-encoded tcr proteins .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as a complementary dna clone could not to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as a complementary dna clone has been shown not to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as a complementary dna clone was unable to be #expressed in response to overload by vitro .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , does not have the ability to #express the transgene-encoded tcr proteins in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as t cells in mice at the cell surface , unlike normal muscle , was unable to #express the transgene-encoded tcr proteins in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , cannot #express the isoform identical to ran/tc4 in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as both somatic tissues and testis , unlike normal muscle , does not have the ability to #express the isoform identical to ran/tc4 in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 has been shown not to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the isoform identical to ran/tc4 was not able to be #expressed in response to overload by both somatic tissues and testis .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins could not to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as the transgene-encoded tcr proteins has been shown not to be #expressed in response to overload by t cells in mice at the cell surface .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , cannot #express a complementary dna clone in response to overload .
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , does not have the ability to #express a complementary dna clone in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , was shown not to #express a complementary dna clone in response to overload
the mechanotransduction mechanism for this signalling may directly or indirectly involve the dystrophin complex as vitro , unlike normal muscle , was unable to #express a complementary dna clone in response to overload
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface #express the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these t cells in mice at the cell surface have the ability to #express the transgene-encoded tcr proteins .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis are able to #express the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis #express the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these both somatic tissues and testis have #expressed the isoform identical to ran/tc4 .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are able to #express a complementary dna clone .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are #expressing a complementary dna clone .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro are involved in #expressing a complementary dna clone .
this functional allelic exclusion is apparently due to control of the tcr assembly process because these vitro #express a complementary dna clone .
both somatic tissues and testis are able to #express only the isoform identical to ran/tc4 .
both somatic tissues and testis are shown to #express only the isoform identical to ran/tc4 .
both somatic tissues and testis #express only the isoform identical to ran/tc4 .
both somatic tissues and testis may #express only the isoform identical to ran/tc4 .
both somatic tissues and testis may have #expressed only the isoform identical to ran/tc4 .
the isoform identical to ran/tc4 are shown to be #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 has been cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 has been likely #expressed through +1 or -1 frameshifting by both somatic tissues and testis .
the isoform identical to ran/tc4 is #expressed and cloned in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 may have been #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 may have been #expressed primarily in both somatic tissues and testis and secreted into perineuronal nets .
the isoform identical to ran/tc4 was shown to be #expressed and cloned in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 were #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 will be #expressed by both somatic tissues and testis .
the isoform identical to ran/tc4 will be #expressed primarily in both somatic tissues and testis and is secreted into perineuronal nets .
the isoform identical to ran/tc4 would be cloned and #expressed in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the isoform identical to ran/tc4 would be #expressed and cloned in both somatic tissues and testis , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins are #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins are shown to be #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins has been cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins has been #expressed by t cells in mice at the cell surface .
the transgene-encoded tcr proteins has been #expressed primarily in t cells in mice at the cell surface and secreted into perineuronal nets .
the transgene-encoded tcr proteins is cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins is likely #expressed through +1 or -1 frameshifting by t cells in mice at the cell surface .
the transgene-encoded tcr proteins is shown to be likely #expressed through +1 or -1 frameshifting by t cells in mice at the cell surface .
the transgene-encoded tcr proteins may have been #expressed primarily in t cells in mice at the cell surface and secreted into perineuronal nets .
the transgene-encoded tcr proteins may have been likely #expressed through +1 or -1 frameshifting by t cells in mice at the cell surface .
the transgene-encoded tcr proteins was cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins was #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins was shown to be cloned and #expressed in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins was shown to be #expressed and cloned in t cells in mice at the cell surface , and two alternative precursors of the protein have been imported into isolated mitochondria and processed to the mature protein .
the transgene-encoded tcr proteins were #expressed by t cells in mice at the cell surface .
vitro are able to #express only a complementary dna clone .
vitro may have #expressed only a complementary dna clone .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna .
a transcription start site is located approximately 4 kilobases 5 to the translation codon , and mature hela cell mrna was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
in addition , the ar n-terminus #generated a functional interaction surface , since its deletion abolished fhl2 binding .
in addition , the ar n-terminus #generates a functional interaction surface , since its deletion abolishes fhl2 binding .
in addition , the ar n-terminus , whose deletion abolishes fhl2 binding , #generates a functional interaction surface .
in addition , the ar n-terminus , whose deletion had abolished fhl2 binding , #generated a functional interaction surface .
sequential overlapping fragments are #generated by the tbc method ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
sequential overlapping fragments were #generated by the tbc method ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the tbc method has #generated sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
the tbc method may #generate sequential overlapping fragments ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
to analyse specifically protein expression of fhl2 in human tissues , a monoclonal antibody against fhl2 was #generated by us
we report results from preliminary transcription microarray experiments that revealed two previously unknown members of the narl regulon: the aspa gene encoding aspartate-ammonia lyase being able to #generate fumarate; and the dcusr operon encoding the dicarboxylate-responsive regulatory system .
we report results from preliminary transcription microarray experiments that revealed two previously unknown members of the narl regulon: the aspa gene encoding aspartate-ammonia lyase #generating fumarate; and the dcusr operon encoding the dicarboxylate-responsive regulatory system .
we report results from preliminary transcription microarray experiments that revealed two previously unknown members of the narl regulon: the aspa gene encoding aspartate-ammonia lyase which #generates fumarate; and the dcusr operon encoding the dicarboxylate-responsive regulatory system .
we report results from preliminary transcription microarray experiments that revealed two previously unknown members of the narl regulon: the aspa gene encoding aspartate-ammonia lyase which has #generated fumarate; and the dcusr operon encoding the dicarboxylate-responsive regulatory system .
a dnase i hypersensitive was #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive .
a functional interaction surface is #generated by the ar n-terminus whose deletion abolishes fhl2 binding .
a higher order protein-dna complex was #generated by this binding within the recombinational synapse .
an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules .
the 21-23 nt long mature rnas are #generated by the bidentate rnase iii dicer .
this binding #generated a higher order protein-dna complex within the recombinational synapse .
in addition , the ar n-terminus is required to #generate a functional interaction surface , since its deletion abolishes fhl2 binding .
although no crystal structure of the ar is available to date , one might speculate that the tbc method #generated sequential overlapping fragments .
although no crystal structure of the ar is available to date , one might speculate that the tbc method #generates sequential overlapping fragments .
although no crystal structure of the ar is available to date , one might speculate that the bidentate rnase iii dicer #generated the 21-23 nt long mature rnas .
although no crystal structure of the ar is available to date , one might speculate that a dnase i hypersensitive was #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
although no crystal structure of the ar is available to date , one might speculate that a dnase i hypersensitive will be #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
although no crystal structure of the ar is available to date , one might speculate that a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive .
although no crystal structure of the ar is available to date , one might speculate that a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generates a dnase i hypersensitive .
although no crystal structure of the ar is available to date , one might speculate that a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating a dnase i hypersensitive .
although no crystal structure of the ar is available to date , one might speculate that a higher order protein-dna complex is #generated by this binding .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 is #generated by we .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 was #generated by us .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 was #generated by we .
although no crystal structure of the ar is available to date , one might speculate that a monoclonal antibody against fhl2 will be #generated by us .
although no crystal structure of the ar is available to date , one might speculate that sequential overlapping fragments is #generated by the tbc method .
although no crystal structure of the ar is available to date , one might speculate that the 21-23 nt long mature rnas has been #generated by the bidentate rnase iii dicer
although no crystal structure of the ar is available to date , one might speculate that this binding #generates a higher order protein-dna complex .
although no crystal structure of the ar is available to date , one might speculate that this binding is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating a higher order protein-dna complex .
although no crystal structure of the ar is available to date , one might speculate that we #generates a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that we is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating a monoclonal antibody against fhl2 .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that sequential overlapping fragments were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the tbc method , although again the relatively small fraction involved and the possibility that sequential overlapping fragments will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that the 21-23 nt long mature rnas are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that the 21-23 nt long mature rnas have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that the 21-23 nt long mature rnas were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the bidentate rnase iii dicer , although again the relatively small fraction involved and the possibility that the 21-23 nt long mature rnas will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , although again the relatively small fraction involved and the possibility that a dnase i hypersensitive will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that a higher order protein-dna complex were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of this binding , although again the relatively small fraction involved and the possibility that degradation did not #generate a higher order protein-dna complex or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of us , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a monoclonal antibody against fhl2 were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation did not #generate a monoclonal antibody against fhl2 or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate a monoclonal antibody against fhl2 or occurs rapidly precludes any definitive conclusions .
in the absence of l-arginine , the tbc method #generated sequential overlapping fragments (o(2)-) .
in the absence of l-arginine , the tbc method #generates sequential overlapping fragments (o(2)-) .
in the absence of l-arginine , the bidentate rnase iii dicer #generates the 21-23 nt long mature rnas (o(2)-) .
in the absence of l-arginine , the bidentate rnase iii dicer has been shown to #generate the 21-23 nt long mature rnas (o(2)-) .
in the absence of l-arginine , a dnase i hypersensitive (o(2)-) has been #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
in the absence of l-arginine , a dnase i hypersensitive (o(2)-) was #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
in the absence of l-arginine , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generates a dnase i hypersensitive (o(2)-) .
in the absence of l-arginine , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) has been shown to #generate a dnase i hypersensitive (o(2)-) .
in the absence of l-arginine , a higher order protein-dna complex (o(2)-) is #generated by this binding .
in the absence of l-arginine , a higher order protein-dna complex (o(2)-) will be #generated by this binding .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) is #generated by us .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) is #generated by we .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) was #generated by we .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) will be #generated by us .
in the absence of l-arginine , a monoclonal antibody against fhl2 (o(2)-) will be #generated by we .
in the absence of l-arginine , sequential overlapping fragments (o(2)-) was #generated by the tbc method .
in the absence of l-arginine , sequential overlapping fragments (o(2)-) will be #generated by the tbc method .
in the absence of l-arginine , the 21-23 nt long mature rnas (o(2)-) will be #generated by the bidentate rnase iii dicer .
in the absence of l-arginine , this binding #generated a higher order protein-dna complex (o(2)-) .
in the absence of l-arginine , us #generates a monoclonal antibody against fhl2 (o(2)-) .
in the absence of l-arginine , we #generated a monoclonal antibody against fhl2 (o(2)-) .
in the absence of l-arginine , we #generates a monoclonal antibody against fhl2 (o(2)-) .
the tbc method cleaves microrna precursors to #generate sequential overlapping fragments .
the tbc method #generate sequential overlapping fragments .
the tbc method #generated sequential overlapping fragments within the recombinational synapse .
the tbc method #generates sequential overlapping fragments .
the tbc method has #generated sequential overlapping fragments .
the tbc method is able to #generate sequential overlapping fragments .
the bidentate rnase iii dicer can #generate the 21-23 nt long mature rnas .
the bidentate rnase iii dicer #generate the 21-23 nt long mature rnas .
the bidentate rnase iii dicer #generates the 21-23 nt long mature rnas ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer #generates the 21-23 nt long mature rnas within the recombinational synapse .
the bidentate rnase iii dicer has #generated the 21-23 nt long mature rnas ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
the bidentate rnase iii dicer was optimized to #generate the 21-23 nt long mature rnas ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
these are a dnase i hypersensitive reductase (encoded by the frdabcd operon) , a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a higher order protein-dna complex reductase (encoded by the frdabcd operon) , this binding , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a higher order protein-dna complex reductase (encoded by the frdabcd operon) , this binding , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , us , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , us , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , us , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , we , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , we , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , we , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a monoclonal antibody against fhl2 reductase (encoded by the frdabcd operon) , we , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are sequential overlapping fragments reductase (encoded by the frdabcd operon) , the tbc method , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are sequential overlapping fragments reductase (encoded by the frdabcd operon) , the tbc method , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are the 21-23 nt long mature rnas reductase (encoded by the frdabcd operon) , the bidentate rnase iii dicer , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are the 21-23 nt long mature rnas reductase (encoded by the frdabcd operon) , the bidentate rnase iii dicer , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are the 21-23 nt long mature rnas reductase (encoded by the frdabcd operon) , the bidentate rnase iii dicer , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are the 21-23 nt long mature rnas reductase (encoded by the frdabcd operon) , the bidentate rnase iii dicer , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
to analyse specifically protein expression of fhl2 in human tissues a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) may #generate a dnase i hypersensitive .
to analyse specifically protein expression of fhl2 in human tissues this binding may #generate a higher order protein-dna complex .
to analyse specifically protein expression of fhl2 in human tissues , the tbc method will #generate sequential overlapping fragments .
to analyse specifically protein expression of fhl2 in human tissues , the bidentate rnase iii dicer #generate the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues , the bidentate rnase iii dicer will #generate the 21-23 nt long mature rnas .
to analyse specifically protein expression of fhl2 in human tissues , a dnase i hypersensitive is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1)
to analyse specifically protein expression of fhl2 in human tissues , sequential overlapping fragments is #generated by the tbc method
to analyse specifically protein expression of fhl2 in human tissues , sequential overlapping fragments was #generated by the tbc method
to analyse specifically protein expression of fhl2 in human tissues , the 21-23 nt long mature rnas was #generated by the bidentate rnase iii dicer
to analyse specifically protein expression of fhl2 in human tissues , us will #generate a monoclonal antibody against fhl2 .
we believe the tbc method is required to #generate sequential overlapping fragments within the recombinational synapse .
we believe the bidentate rnase iii dicer is shown to #generate the 21-23 nt long mature rnas within the recombinational synapse .
we believe a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) is required to #generate a dnase i hypersensitive within the recombinational synapse .
we believe us is found to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we believe us is required to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we believe we is found to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we believe we is required to #generate a monoclonal antibody against fhl2 within the recombinational synapse .
we show that the bidentate rnase iii dicer , to #generate the 21-23 nt long mature rnas .
we show that we , to #generate a monoclonal antibody against fhl2 .
a dnase i hypersensitive (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) .
a dnase i hypersensitive are #generated from a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) by beta- and gamma-secretases .
a dnase i hypersensitive is #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) within the recombinational synapse .
a dnase i hypersensitive was #generated by a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) within the recombinational synapse .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) can #generate a dnase i hypersensitive .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) cleaves microrna precursors to #generate a dnase i hypersensitive .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generated a dnase i hypersensitive within the recombinational synapse .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) #generates a dnase i hypersensitive within the recombinational synapse .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) has #generated a dnase i hypersensitive ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) has #generated a dnase i hypersensitive .
a swi/snf-related chromatin remodeling complex , eklf coactivator-remodeling complex 1 (e-rc1) may #generate a dnase i hypersensitive ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
a higher order protein-dna complex can be #generated from this binding by beta- and gamma-secretases .
a higher order protein-dna complex have been #generated from this binding by beta- and gamma-secretases .
a higher order protein-dna complex is #generated by this binding .
a higher order protein-dna complex were #generated by this binding .
a higher order protein-dna complex were #generated from this binding by beta- and gamma-secretases .
a monoclonal antibody against fhl2 (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by we .
a monoclonal antibody against fhl2 are #generated by us .
a monoclonal antibody against fhl2 are #generated by we .
a monoclonal antibody against fhl2 are #generated from we by beta- and gamma-secretases .
a monoclonal antibody against fhl2 can be #generated from us by beta- and gamma-secretases .
a monoclonal antibody against fhl2 can be #generated from we by beta- and gamma-secretases .
a monoclonal antibody against fhl2 is #generated by us within the recombinational synapse .
a monoclonal antibody against fhl2 is #generated by us .
a monoclonal antibody against fhl2 was #generated by us within the recombinational synapse .
a monoclonal antibody against fhl2 was #generated by us .
a monoclonal antibody against fhl2 was #generated by we within the recombinational synapse .
a monoclonal antibody against fhl2 was #generated by we .
a monoclonal antibody against fhl2 were #generated by us .
a monoclonal antibody against fhl2 were #generated by we .
a monoclonal antibody against fhl2 were #generated from us by beta- and gamma-secretases .
a monoclonal antibody against fhl2 were #generated from we by beta- and gamma-secretases .
sequential overlapping fragments (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by the tbc method .
sequential overlapping fragments are #generated from the tbc method by beta- and gamma-secretases .
sequential overlapping fragments have been #generated from the tbc method by beta- and gamma-secretases .
sequential overlapping fragments is #generated by the tbc method within the recombinational synapse .
sequential overlapping fragments was #generated by the tbc method .
the 21-23 nt long mature rnas (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by the bidentate rnase iii dicer .
the 21-23 nt long mature rnas are #generated from the bidentate rnase iii dicer by beta- and gamma-secretases .
the 21-23 nt long mature rnas can be #generated from the bidentate rnase iii dicer by beta- and gamma-secretases .
the 21-23 nt long mature rnas is #generated by the bidentate rnase iii dicer within the recombinational synapse .
the 21-23 nt long mature rnas was #generated by the bidentate rnase iii dicer within the recombinational synapse .
the 21-23 nt long mature rnas was #generated by the bidentate rnase iii dicer .
the 21-23 nt long mature rnas were #generated from the bidentate rnase iii dicer by beta- and gamma-secretases .
this binding #generate a higher order protein-dna complex .
this binding #generated a higher order protein-dna complex .
this binding #generates a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
this binding has #generated a higher order protein-dna complex ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
this binding has #generated a higher order protein-dna complex .
this binding is able to #generate a higher order protein-dna complex .
us can #generate a monoclonal antibody against fhl2 .
us #generate a monoclonal antibody against fhl2 .
us #generated a monoclonal antibody against fhl2 within the recombinational synapse .
us has #generated a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
us is able to #generate a monoclonal antibody against fhl2 .
us may #generate a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
us was optimized to #generate a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
we can #generate a monoclonal antibody against fhl2 .
we #generate a monoclonal antibody against fhl2 .
we #generated a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
we #generates a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
we #generates a monoclonal antibody against fhl2 within the recombinational synapse .
we is able to #generate a monoclonal antibody against fhl2 .
we was optimized to #generate a monoclonal antibody against fhl2 ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
we , #generating a monoclonal antibody against fhl2 .
although no crystal structure of the ar is available to date , one might speculate that human leukocyte antigen (hla)-g molecules is #generated by an alternative splicing of the primary transcript of the gene .
although no crystal structure of the ar is available to date , one might speculate that human leukocyte antigen (hla)-g molecules was #generated by an alternative splicing of the primary transcript of the gene .
although no crystal structure of the ar is available to date , one might speculate that a functional interaction surface will be #generated by the ar n-terminus .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an rna splice of 3863 bases occurs in the 5-untranslated region is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating mature hela cell mrna .
although no crystal structure of the ar is available to date , one might speculate that an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules .
although no crystal structure of the ar is available to date , one might speculate that an alternative splicing of the primary transcript of the gene is either directly involved in the ar-fhl2 interaction or , alternatively , is essential for #generating human leukocyte antigen (hla)-g molecules .
although no crystal structure of the ar is available to date , one might speculate that aspartate-ammonia lyase #generated fumarate .
although no crystal structure of the ar is available to date , one might speculate that fumarate has been #generated by aspartate-ammonia lyase
although no crystal structure of the ar is available to date , one might speculate that fumarate is #generated by aspartate-ammonia lyase .
although no crystal structure of the ar is available to date , one might speculate that fumarate was #generated by aspartate-ammonia lyase .
although no crystal structure of the ar is available to date , one might speculate that mature hela cell mrna is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
although no crystal structure of the ar is available to date , one might speculate that the ar n-terminus #generated a functional interaction surface .
although no crystal structure of the ar is available to date , one might speculate that the ar n-terminus #generates a functional interaction surface .
human leukocyte antigen (hla)-g molecules (from malate , and the dcub permease for fumarate , malate , and aspartate) an alternative splicing of the primary transcript of the genere #generated by we .
human leukocyte antigen (hla)-g molecules (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules are #generated from an alternative splicing of the primary transcript of the gene by beta- and gamma-secretases .
human leukocyte antigen (hla)-g molecules have been #generated from an alternative splicing of the primary transcript of the gene by beta- and gamma-secretases .
human leukocyte antigen (hla)-g molecules is #generated by an alternative splicing of the primary transcript of the gene within the recombinational synapse .
human leukocyte antigen (hla)-g molecules is #generated by an alternative splicing of the primary transcript of the gene .
human leukocyte antigen (hla)-g molecules was #generated by an alternative splicing of the primary transcript of the gene within the recombinational synapse .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation did not #generate mature hela cell mrna or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna are not #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna were not #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurring in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna will not be #generated by degradation .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation did not #generate mature hela cell mrna or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate mature hela cell mrna or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of loan rna splice of 3863 bases occurs in the 5-untranslated regionr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that mature hela cell mrna have not been #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules are not #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules will not be #generated by degradation .
in addition , there was an apparent absence of loan alternative splicing of the primary transcript of the gener molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation did not #generate human leukocyte antigen (hla)-g molecules or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that fumarate are not #generated by degradation .
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that fumarate have not been #generated by degradation .
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that fumarate were not #generated by degradation .
in addition , there was an apparent absence of loaspartate-ammonia lyaser molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that fumarate will not be #generated by degradation .
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a functional interaction surface are not #generated by degradation .
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that a functional interaction surface will not be #generated by degradation .
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation did not #generate a functional interaction surface or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lothe ar n-terminusr molecular weight fragments as evidence of we , although again the relatively small fraction involved and the possibility that degradation does not #generate a functional interaction surface or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that degradation did not #generate mature hela cell mrna or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that degradation does not #generate mature hela cell mrna or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurring in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that degradation did not #generate mature hela cell mrna or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an rna splice of 3863 bases occurs in the 5-untranslated region , although again the relatively small fraction involved and the possibility that mature hela cell mrna were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules are not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that human leukocyte antigen (hla)-g molecules have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of an alternative splicing of the primary transcript of the gene , although again the relatively small fraction involved and the possibility that degradation did not #generate human leukocyte antigen (hla)-g molecules or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that degradation did not #generate fumarate or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that degradation does not #generate fumarate or occurs rapidly precludes any definitive conclusions .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that fumarate were not #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of aspartate-ammonia lyase , although again the relatively small fraction involved and the possibility that fumarate will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that a functional interaction surface have not been #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that a functional interaction surface will not be #generated by degradation .
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that degradation did not #generate a functional interaction surface or occured rapidly precludes any definitive conclusions
in addition , there was an apparent absence of lower molecular weight fragments as evidence of the ar n-terminus , although again the relatively small fraction involved and the possibility that degradation does not #generate a functional interaction surface or occurs rapidly precludes any definitive conclusions .
in the absence of l-arginine , human leukocyte antigen (hla)-g molecules (o(2)-) is #generated by an alternative splicing of the primary transcript of the gene .
in the absence of l-arginine , human leukocyte antigen (hla)-g molecules (o(2)-) will be #generated by an alternative splicing of the primary transcript of the gene .
in the absence of l-arginine , a functional interaction surface (o(2)-) was #generated by the ar n-terminus .
in the absence of l-arginine , an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an rna splice of 3863 bases occurring in the 5-untranslated region has been shown to #generate mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna (o(2)-) .
in the absence of l-arginine , an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules (o(2)-) .
in the absence of l-arginine , an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules (o(2)-) .
in the absence of l-arginine , aspartate-ammonia lyase #generates fumarate (o(2)-) .
in the absence of l-arginine , aspartate-ammonia lyase has been shown to #generate fumarate (o(2)-) .
in the absence of l-arginine , fumarate (o(2)-) has been #generated by aspartate-ammonia lyase .
in the absence of l-arginine , fumarate (o(2)-) will be #generated by aspartate-ammonia lyase .
in the absence of l-arginine , mature hela cell mrna (o(2)-) has been #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
in the absence of l-arginine , mature hela cell mrna (o(2)-) was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
in the absence of l-arginine , the ar n-terminus #generated a functional interaction surface (o(2)-) .
in the absence of l-arginine , the ar n-terminus #generates a functional interaction surface (o(2)-) .
these are human leukocyte antigen (hla)-g molecules reductase (encoded by the frdabcd operon) , an alternative splicing of the primary transcript of the gene , which will #generate fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a functional interaction surface reductase (encoded by the frdabcd operon) , the ar n-terminus , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are a functional interaction surface reductase (encoded by the frdabcd operon) , the ar n-terminus , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are a functional interaction surface reductase (encoded by the frdabcd operon) , the ar n-terminus , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are fumarate reductase (encoded by the frdabcd operon) , aspartate-ammonia lyase , which #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are fumarate reductase (encoded by the frdabcd operon) , aspartate-ammonia lyase , which #generates fumarate from malate , and the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurring in the 5-untranslated region , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
these are mature hela cell mrna reductase (encoded by the frdabcd operon) , an rna splice of 3863 bases occurs in the 5-untranslated region , which have #generated fumarate from malate , the dcub permease for fumarate , malate , and aspartate .
to analyse specifically protein expression of fhl2 in human tissues an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues an rna splice of 3863 bases occurring in the 5-untranslated region may #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues the ar n-terminus #generated a functional interaction surface .
to analyse specifically protein expression of fhl2 in human tissues the ar n-terminus may #generate a functional interaction surface .
to analyse specifically protein expression of fhl2 in human tissues , a functional interaction surface was #generated by the ar n-terminus
to analyse specifically protein expression of fhl2 in human tissues , an rna splice of 3863 bases occurring in the 5-untranslated region #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues , an rna splice of 3863 bases occurs in the 5-untranslated region will #generate mature hela cell mrna .
to analyse specifically protein expression of fhl2 in human tissues , an alternative splicing of the primary transcript of the gene #generate human leukocyte antigen (hla)-g molecules .
to analyse specifically protein expression of fhl2 in human tissues , aspartate-ammonia lyase #generate fumarate .
to analyse specifically protein expression of fhl2 in human tissues , fumarate is #generated by aspartate-ammonia lyase
to analyse specifically protein expression of fhl2 in human tissues , fumarate was #generated by aspartate-ammonia lyase
to analyse specifically protein expression of fhl2 in human tissues , mature hela cell mrna is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region
to analyse specifically protein expression of fhl2 in human tissues , the ar n-terminus #generate a functional interaction surface .
we believe an rna splice of 3863 bases occurring in the 5-untranslated region is shown to #generate mature hela cell mrna within the recombinational synapse .
we believe an alternative splicing of the primary transcript of the gene is required to #generate human leukocyte antigen (hla)-g molecules within the recombinational synapse .
we believe an alternative splicing of the primary transcript of the gene is shown to #generate human leukocyte antigen (hla)-g molecules within the recombinational synapse .
we believe aspartate-ammonia lyase is found to #generate fumarate within the recombinational synapse .
we believe aspartate-ammonia lyase is required to #generate fumarate within the recombinational synapse .
we believe the ar n-terminus is found to #generate a functional interaction surface within the recombinational synapse .
we believe the ar n-terminus is required to #generate a functional interaction surface within the recombinational synapse .
we show that aspartate-ammonia lyase , to #generate fumarate .
a functional interaction surface (from malate , and the dcub permease for fumarate , malate , and aspartate) the ar n-terminusre #generated by we .
a functional interaction surface the ar n-terminusre #generated by we .
a functional interaction surface the ar n-terminusre #generated from we by beta- and gamma-secretases .
a functional interaction surface were #generated from the ar n-terminus by beta- and gamma-secretases .
an rna splice of 3863 bases occurring in the 5-untranslated region #generated mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurring in the 5-untranslated region #generates mature hela cell mrna within the recombinational synapse .
an rna splice of 3863 bases occurring in the 5-untranslated region is able to #generate mature hela cell mrna .
an rna splice of 3863 bases occurring in the 5-untranslated region may #generate mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region #generated mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region #generates mature hela cell mrna ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
an rna splice of 3863 bases occurs in the 5-untranslated region #generates mature hela cell mrna within the recombinational synapse .
an rna splice of 3863 bases occurs in the 5-untranslated region #generates mature hela cell mrna .
an rna splice of 3863 bases occurs in the 5-untranslated region is able to #generate mature hela cell mrna .
an alternative splicing of the primary transcript of the gene #generated human leukocyte antigen (hla)-g molecules within the recombinational synapse .
an alternative splicing of the primary transcript of the gene #generates human leukocyte antigen (hla)-g molecules within the recombinational synapse .
an alternative splicing of the primary transcript of the gene has #generated human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
an alternative splicing of the primary transcript of the gene has #generated human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene is able to #generate human leukocyte antigen (hla)-g molecules .
an alternative splicing of the primary transcript of the gene may #generate human leukocyte antigen (hla)-g molecules ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
an alternative splicing of the primary transcript of the gene , #generating human leukocyte antigen (hla)-g molecules .
aspartate-ammonia lyase cleaves microrna precursors to #generate fumarate .
aspartate-ammonia lyase #generated fumarate within the recombinational synapse .
aspartate-ammonia lyase has #generated fumarate .
aspartate-ammonia lyase is able to #generate fumarate .
aspartate-ammonia lyase may #generate fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase was optimized to #generate fumarate ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
aspartate-ammonia lyase , #generating fumarate .
fumarate (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by aspartate-ammonia lyase .
fumarate are #generated by aspartate-ammonia lyase .
fumarate aspartate-ammonia lyasere #generated by we .
fumarate aspartate-ammonia lyasere #generated from we by beta- and gamma-secretases .
fumarate have been #generated from aspartate-ammonia lyase by beta- and gamma-secretases .
fumarate is #generated by aspartate-ammonia lyase within the recombinational synapse .
fumarate is #generated by aspartate-ammonia lyase .
fumarate were #generated by aspartate-ammonia lyase .
fumarate were #generated from aspartate-ammonia lyase by beta- and gamma-secretases .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) an rna splice of 3863 bases occurring in the 5-untranslated regionre #generated by we .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) an rna splice of 3863 bases occurs in the 5-untranslated regionre #generated by we .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) are #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
mature hela cell mrna (from malate , and the dcub permease for fumarate , malate , and aspartate) were #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna an rna splice of 3863 bases occurring in the 5-untranslated regionre #generated by we .
mature hela cell mrna an rna splice of 3863 bases occurring in the 5-untranslated regionre #generated from we by beta- and gamma-secretases .
mature hela cell mrna an rna splice of 3863 bases occurs in the 5-untranslated regionre #generated by we .
mature hela cell mrna are #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
mature hela cell mrna are #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna can be #generated from an rna splice of 3863 bases occurs in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna have been #generated from an rna splice of 3863 bases occurring in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna have been #generated from an rna splice of 3863 bases occurs in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna is #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
mature hela cell mrna is #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region within the recombinational synapse .
mature hela cell mrna was #generated by an rna splice of 3863 bases occurring in the 5-untranslated region .
mature hela cell mrna were #generated by an rna splice of 3863 bases occurs in the 5-untranslated region .
mature hela cell mrna were #generated from an rna splice of 3863 bases occurring in the 5-untranslated region by beta- and gamma-secretases .
mature hela cell mrna were #generated from an rna splice of 3863 bases occurs in the 5-untranslated region by beta- and gamma-secretases .
the ar n-terminus can #generate a functional interaction surface .
the ar n-terminus #generated a functional interaction surface ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments were tested for their ability to be assembled under an array of pcr conditions .
the ar n-terminus #generated a functional interaction surface within the recombinational synapse .
the ar n-terminus #generates a functional interaction surface ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be assembled under an array of pcr conditions .
the ar n-terminus #generates a functional interaction surface within the recombinational synapse .
the ar n-terminus #generates a functional interaction surface .
the ar n-terminus has #generated a functional interaction surface ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments have been tested for their ability to be assembled under an array of pcr conditions .
the ar n-terminus is able to #generate a functional interaction surface .
the ar n-terminus may #generate a functional interaction surface ( approximately 0 .4-0 .5 kb ) for each of the gene sequences , and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be assembled under an array of pcr conditions .
the ar n-terminus , #generating a functional interaction surface .
10mm edta is able to totally #inhibit binding that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
binding is concentration dependent and saturable and is able to be totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
binding is concentration dependent and saturable and is observed to be totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
binding is concentration dependent and saturable and may be totally #inhibited with 10mm edta , suggesting that divalent cations were required for interaction of in1b with vero cells .
for example , the phosphatase associated with another protein has been #inhibited in its function or localization .
for example , the phosphatase associated with another protein may be #inhibited in its function or localization .
for example , the phosphatase associated with another protein may have been #inhibited in its function or localization .
for example , the phosphatase associates with another protein and is thereby #inhibited in its function or localization .
for example , the phosphatase may have associated with another protein and thereby has been #inhibited in its function or localization .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex #inhibited the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex is observed to #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex may #inhibit the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the crp-camp complex will have #inhibited the glnap2 promoter activity .
here , we show that glnap2 expression is affected by different carbon sources and that the glnap2 promoter activity is #inhibited by the crp-camp complex .
here , we show that glnap2 expression is affected by different carbon sources and that the glnap2 promoter activity is observed to be #inhibited by the crp-camp complex .
here , we show that glnap2 expression is affected by different carbon sources and that the glnap2 promoter activity will be #inhibited by the crp-camp complex .
intriguingly , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , are observed to selectively #inhibit late events of clathrin-coated vesicle formation involving membrane fission , intersectin sh3a was unique in its ability to block earlier stages (simpson et al . , 1999) .
intriguingly , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , have selectively #inhibited late events of clathrin-coated vesicle formation involving membrane fission , intersectin sh3a was unique in its ability to block earlier stages (simpson et al . , 1999) .
intriguingly , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , selectively #inhibited late events of clathrin-coated vesicle formation involving membrane fission , intersectin sh3a was unique in its ability to block earlier stages (simpson et al . , 1999) .
intriguingly , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , will selectively #inhibit late events of clathrin-coated vesicle formation involving membrane fission , intersectin sh3a was unique in its ability to block earlier stages (simpson et al . , 1999) .
nk-cell-mediated cytotoxicity is able to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity is observed to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity was #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity will be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
natural killer (nk) cells express cell-surface receptors of the immunoglobulin and c-type lectin superfamilies that recognized major histocompatibility complex (mhc) class i peptides and #inhibited nk-cell-mediated cytotoxicity .
the n-terminal sh3 domain (sh3a) , unlike other sh3 domains from intersectin or various endocytic proteins , has specifically #inhibited intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (sh3a) , unlike other sh3 domains from intersectin or various endocytic proteins , will specifically #inhibit intermediate events leading to the formation of clathrin-coated pits .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then protein synthesis has been #inhibited by 50 mg/ml chloramphenicol .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml chloramphenicol for #inhibiting protein synthesis .
the phosphatases function and localization would be #inhibited if the phosphatase associated with another protein .
this synthetic peptide binding to p can #inhibit its binding to c3b .
this synthetic peptide binding to p is observed to #inhibit its binding to c3b .
this synthetic peptide binding to p may have #inhibited its binding to c3b .
this synthetic peptide have bound to p and then #inhibited its binding to c3b .
intermediate events leading to the formation of clathrin-coated pits are #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
intermediate events leading to the formation of clathrin-coated pits have been #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
intermediate events leading to the formation of clathrin-coated pits were #inhibited by the n-terminal sh3 domain (sh3a) which is unlike other sh3 domains from intersectin or various endocytic proteins .
late events of clathrin-coated vesicle formation has been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
intriguingly , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , selectively #inhibit late events of clathrin-coated vesicle formation involving membrane fission , intersectin sh3a was unique in its ability to block earlier stages (simpson et al . , 1999) .
the n-terminal sh3 domain (sh3a) , unlike other sh3 domains from intersectin or various endocytic proteins , specifically #inhibits intermediate events leading to the formation of clathrin-coated pits .
natural killer (nk) cells express cell-surface receptors of the immunoglobulin and c-type lectin superfamilies that recognize major histocompatibility complex (mhc) class i peptides and #inhibit nk-cell-mediated cytotoxicity .
this synthetic peptide bound to p and #inhibited its binding to c3b .
10mm edta (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit binding .
10mm edta (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits binding .
10mm edta (no) that #inhibits binding activates the soluble isoform of guanylate cyclase in platelets .
binding are able to be #inhibited by 10mm edta .
binding are #inhibited by 10mm edta .
binding are observed to be #inhibited by 10mm edta .
binding has been #inhibited by 10mm edta .
binding in transiently transfected jurkat t-leukemia cells was also #inhibited 10mm edta .
binding is able to be #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding is able to be #inhibited by 10mm edta .
binding is #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding is #inhibited by 10mm edta .
binding is observed to be #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding may have been #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding was #inhibited by 10mm edta .
binding were #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
binding will be #inhibited by 10mm edta (no) which activates the soluble isoform of guanylate cyclase in platelets .
for example , p associated with this synthetic peptide has been #inhibited in its binding to c3b .
for example , p associated with this synthetic peptide may be #inhibited in its binding to c3b .
for example , p associated with this synthetic peptide may have been #inhibited in its binding to c3b .
for example , p may associate with this synthetic peptide and thereby be #inhibited in its binding to c3b .
for example , glnap2 promoter associated with the crp-camp complex has been #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter associated with the crp-camp complex may have been #inhibited in the glnap2 promoter activity .
for example , glnap2 promoter may have associated with the crp-camp complex and thereby has been #inhibited in the glnap2 promoter activity .
for example , the phosphatase associated with another protein has been #inhibited in the phosphatases function and localization .
for example , the phosphatase associated with another protein may be #inhibited in the phosphatases function and localization .
for example , the phosphatase associated with another protein may have been #inhibited in the phosphatases function and localization .
for example , the phosphatase may have associated with another protein and thereby has been #inhibited in the phosphatases function and localization .
functional activation of an hiv reporter plasmid by p49/p65 are #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 in transiently transfected jurkat t-leukemia cells has also been #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 is concentration dependent and saturable and is totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 may have been #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 was concentration dependent and saturable and was totally #inhibited with by coexpression of mad-3 , suggesting that divalent cations were required for interaction of in1b with vero cells .
functional activation of an hiv reporter plasmid by p49/p65 were #inhibited by by coexpression of mad-3 (no) which activates the soluble isoform of guanylate cyclase in platelets .
functional activation of an hiv reporter plasmid by p49/p65 were #inhibited by by coexpression of mad-3 .
functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by by coexpression of mad-3 .
gadx activates expression of gada and gadbc at any ph , while 10mm edta #inhibits binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta is able to #inhibit binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta will have #inhibited binding .
gadx activates expression of gada and gadbc at any ph , while 10mm edta will #inhibit binding .
gadx activates expression of gada and gadbc at any ph , while binding is #inhibited by 10mm edta .
gadx activates expression of gada and gadbc at any ph , while binding is observed to be #inhibited by 10mm edta .
gadx activates expression of gada and gadbc at any ph , while functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by by coexpression of mad-3 .
gadx activates expression of gada and gadbc at any ph , while functional activation of an hiv reporter plasmid by p49/p65 will be #inhibited by by coexpression of mad-3 .
gadx activates expression of gada and gadbc at any ph , while nk-cell-mediated cytotoxicity has been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
gadx activates expression of gada and gadbc at any ph , while nk-cell-mediated cytotoxicity is #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
gadx activates expression of gada and gadbc at any ph , while nk-cell-mediated cytotoxicity will be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 can #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 has #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 #inhibits functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 is observed to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 may have #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while by coexpression of mad-3 will have #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies can #inhibit nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies has #inhibited nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is observed to #inhibit nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while cell-surface receptors of the immunoglobulin and c-type lectin superfamilies will have #inhibited nk-cell-mediated cytotoxicity .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol #inhibits protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol is able to #inhibit protein synthesis .
gadx activates expression of gada and gadbc at any ph , while chloramphenicol will have #inhibited protein synthesis .
gadx activates expression of gada and gadbc at any ph , while late events of clathrin-coated vesicle formation is observed to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
gadx activates expression of gada and gadbc at any ph , while late events of clathrin-coated vesicle formation will be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
gadx activates expression of gada and gadbc at any ph , while protein synthesis has been #inhibited by chloramphenicol .
gadx activates expression of gada and gadbc at any ph , while protein synthesis is #inhibited by chloramphenicol .
gadx activates expression of gada and gadbc at any ph , while protein synthesis is observed to be #inhibited by chloramphenicol .
gadx activates expression of gada and gadbc at any ph , while protein synthesis will be #inhibited by chloramphenicol .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex has #inhibited the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex #inhibits the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex is observed to #inhibit the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex may have #inhibited the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex will have #inhibited the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the crp-camp complex will #inhibit the glnap2 promoter activity .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i #inhibits late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i is able to #inhibit late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i is observed to #inhibit late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the glnap2 promoter activity has been #inhibited by the crp-camp complex .
gadx activates expression of gada and gadbc at any ph , while the glnap2 promoter activity is observed to be #inhibited by the crp-camp complex .
gadx activates expression of gada and gadbc at any ph , while the glnap2 promoter activity will be #inhibited by the crp-camp complex .
here , we have found that binding has been #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that binding is observed to be #inhibited by the 10mm edta , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that functional activation of an hiv reporter plasmid by p49/p65 is #inhibited by the by coexpression of mad-3 , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that functional activation of an hiv reporter plasmid by p49/p65 is observed to be #inhibited by the by coexpression of mad-3 , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that functional activation of an hiv reporter plasmid by p49/p65 was #inhibited by the by coexpression of mad-3 , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that nk-cell-mediated cytotoxicity has been #inhibited by the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that nk-cell-mediated cytotoxicity is observed to be #inhibited by the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that nk-cell-mediated cytotoxicity will be #inhibited by the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that protein synthesis is observed to be #inhibited by the chloramphenicol , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that protein synthesis was #inhibited by the chloramphenicol , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that protein synthesis will be #inhibited by the chloramphenicol , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that the glnap2 promoter activity has been #inhibited by the the crp-camp complex , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that the glnap2 promoter activity was #inhibited by the the crp-camp complex , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that the glnap2 promoter activity will be #inhibited by the the crp-camp complex , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta #inhibits binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta is observed to #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that 10mm edta will #inhibit binding .
here , we show that glnap2 expression is affected by different carbon sources and that binding has been #inhibited by 10mm edta .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that functional activation of an hiv reporter plasmid by p49/p65 is able to be #inhibited by by coexpression of mad-3 .
here , we show that glnap2 expression is affected by different carbon sources and that nk-cell-mediated cytotoxicity is observed to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 has #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 #inhibits functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 is observed to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 may #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 will have #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that by coexpression of mad-3 will #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies has #inhibited nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies has the ability to #inhibit nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibits nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is able to #inhibit nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that cell-surface receptors of the immunoglobulin and c-type lectin superfamilies is observed to #inhibit nk-cell-mediated cytotoxicity .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol has #inhibited protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol has the ability to #inhibit protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that chloramphenicol #inhibits protein synthesis .
here , we show that glnap2 expression is affected by different carbon sources and that protein synthesis has been #inhibited by chloramphenicol .
here , we show that glnap2 expression is affected by different carbon sources and that protein synthesis is able to be #inhibited by chloramphenicol .
here , we show that glnap2 expression is affected by different carbon sources and that protein synthesis is #inhibited by chloramphenicol .
here , we show that glnap2 expression is affected by different carbon sources and that protein synthesis is observed to be #inhibited by chloramphenicol .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i has #inhibited late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i #inhibited late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i is able to #inhibit late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i is observed to #inhibit late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i may #inhibit late events of clathrin-coated vesicle formation .
here , we show that glnap2 expression is affected by different carbon sources and that the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i will #inhibit late events of clathrin-coated vesicle formation .
nk-cell-mediated cytotoxicity are #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity are observed to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity can be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
nk-cell-mediated cytotoxicity has been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
nk-cell-mediated cytotoxicity in transiently transfected jurkat t-leukemia cells is also #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity in transiently transfected jurkat t-leukemia cells was also #inhibited cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity in transiently transfected jurkat t-leukemia cells wil also be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
nk-cell-mediated cytotoxicity is able to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
nk-cell-mediated cytotoxicity is concentration dependent and saturable and has been totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity is concentration dependent and saturable and is observed to be totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity is concentration dependent and saturable and is totally #inhibited with cell-surface receptors of the immunoglobulin and c-type lectin superfamilies , suggesting that divalent cations were required for interaction of in1b with vero cells .
nk-cell-mediated cytotoxicity is #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
nk-cell-mediated cytotoxicity is observed to be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
nk-cell-mediated cytotoxicity may have been #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
nk-cell-mediated cytotoxicity were #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
nk-cell-mediated cytotoxicity will be #inhibited by cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) which activates the soluble isoform of guanylate cyclase in platelets .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then binding has been #inhibited by 50 mg/ml 10mm edta .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then binding were about to be #inhibited by 50 mg/ml 10mm edta .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then binding were #inhibited by 50 mg/ml 10mm edta .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then binding will be #inhibited by 50 mg/ml 10mm edta .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 has been #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then functional activation of an hiv reporter plasmid by p49/p65 were #inhibited by 50 mg/ml by coexpression of mad-3 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then nk-cell-mediated cytotoxicity were about to be #inhibited by 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then nk-cell-mediated cytotoxicity were #inhibited by 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then nk-cell-mediated cytotoxicity will be #inhibited by 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then late events of clathrin-coated vesicle formation has been #inhibited by 50 mg/ml the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity were #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then the glnap2 promoter activity will be #inhibited by 50 mg/ml the crp-camp complex .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml by coexpression of mad-3 for #inhibiting functional activation of an hiv reporter plasmid by p49/p65 .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml cell-surface receptors of the immunoglobulin and c-type lectin superfamilies for #inhibiting nk-cell-mediated cytotoxicity .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the crp-camp complex for #inhibiting the glnap2 promoter activity .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the crp-camp complex to #inhibit the glnap2 promoter activity .
another protein binding to the phosphatase can #inhibit the phosphatases function and localization .
another protein binding to the phosphatase is able to #inhibit the phosphatases function and localization .
another protein binding to the phosphatase is observed to #inhibit the phosphatases function and localization .
another protein binding to the phosphatase is observed to #inhibit its function or localization .
another protein binding to the phosphatase may have #inhibited the phosphatases function and localization .
another protein binds to the phosphatase and #inhibits the phosphatases function and localization .
another protein binds to the phosphatase and #inhibits its function or localization .
another protein bound to the phosphatase and #inhibited the phosphatases function and localization .
another protein bound to the phosphatase and #inhibited its function or localization .
another protein bound to the phosphatase and then #inhibited its function or localization .
by coexpression of mad-3 (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
by coexpression of mad-3 (no) #inhibiting functional activation of an hiv reporter plasmid by p49/p65 activated the soluble isoform of guanylate cyclase in platelets .
by coexpression of mad-3 (no) that has #inhibited functional activation of an hiv reporter plasmid by p49/p65 activated the soluble isoform of guanylate cyclase in platelets .
by coexpression of mad-3 can totally #inhibit functional activation of an hiv reporter plasmid by p49/p65 that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
by coexpression of mad-3 may have totally #inhibited functional activation of an hiv reporter plasmid by p49/p65 that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited nk-cell-mediated cytotoxicity .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited nk-cell-mediated cytotoxicity .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit nk-cell-mediated cytotoxicity .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit nk-cell-mediated cytotoxicity .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits nk-cell-mediated cytotoxicity .
cell-surface receptors of the immunoglobulin and c-type lectin superfamilies (no) #inhibiting nk-cell-mediated cytotoxicity activated the soluble isoform of guanylate cyclase in platelets .
chloramphenicol (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited protein synthesis .
chloramphenicol (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited protein synthesis .
chloramphenicol (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit protein synthesis .
chloramphenicol (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits protein synthesis .
chloramphenicol is totally #inhibiting protein synthesis that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
its binding to c3b will be #inhibited if p associates with this synthetic peptide .
its binding to c3b would be #inhibited if p associated with this synthetic peptide .
late events of clathrin-coated vesicle formation has been #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation in transiently transfected jurkat t-leukemia cells was also #inhibited the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation is able to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) which activates the soluble isoform of guanylate cyclase in platelets .
late events of clathrin-coated vesicle formation is able to be #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
late events of clathrin-coated vesicle formation is concentration dependent and saturable and is able to be totally #inhibited with the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i , suggesting that divalent cations were required for interaction of in1b with vero cells .
late events of clathrin-coated vesicle formation is #inhibited by the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i .
protein synthesis are observed to be #inhibited by chloramphenicol .
protein synthesis can be #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis in transiently transfected jurkat t-leukemia cells has also been #inhibited by chloramphenicol .
protein synthesis in transiently transfected jurkat t-leukemia cells was also #inhibited chloramphenicol .
protein synthesis in transiently transfected jurkat t-leukemia cells wil also be #inhibited by chloramphenicol .
protein synthesis is able to be #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis is concentration dependent and saturable and has been totally #inhibited with chloramphenicol , suggesting that divalent cations were required for interaction of in1b with vero cells .
protein synthesis may have been #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis was #inhibited by chloramphenicol .
protein synthesis were #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
protein synthesis will be #inhibited by chloramphenicol (no) which activates the soluble isoform of guanylate cyclase in platelets .
the 10mm edta are able to #inhibit binding .
the 10mm edta can #inhibit binding .
the 10mm edta have the ability to #inhibit binding .
the 10mm edta #inhibited binding .
the 10mm edta may have #inhibited binding .
the crp-camp complex (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited the glnap2 promoter activity .
the crp-camp complex (no) that #inhibits the glnap2 promoter activity activates the soluble isoform of guanylate cyclase in platelets .
the crp-camp complex is totally #inhibiting the glnap2 promoter activity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the crp-camp complex may have totally #inhibited the glnap2 promoter activity that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) activated the soluble isoform of guanylate cyclase in platelets and #inhibited late events of clathrin-coated vesicle formation .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit late events of clathrin-coated vesicle formation .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits late events of clathrin-coated vesicle formation .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i (no) that #inhibits late events of clathrin-coated vesicle formation activates the soluble isoform of guanylate cyclase in platelets .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i can totally #inhibit late events of clathrin-coated vesicle formation that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i is able to totally #inhibit late events of clathrin-coated vesicle formation that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i is totally #inhibiting late events of clathrin-coated vesicle formation that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the by coexpression of mad-3 have #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
the by coexpression of mad-3 #inhibit functional activation of an hiv reporter plasmid by p49/p65 .
the by coexpression of mad-3 #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
the by coexpression of mad-3 may have #inhibited functional activation of an hiv reporter plasmid by p49/p65 .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies are able to #inhibit nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies have #inhibited nk-cell-mediated cytotoxicity .
the cell-surface receptors of the immunoglobulin and c-type lectin superfamilies #inhibited nk-cell-mediated cytotoxicity .
the chloramphenicol are able to #inhibit protein synthesis .
the chloramphenicol have #inhibited protein synthesis .
the chloramphenicol #inhibited protein synthesis .
the glnap2 promoter activity are #inhibited by the crp-camp complex .
the glnap2 promoter activity are observed to be #inhibited by the crp-camp complex .
the glnap2 promoter activity can be #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity in transiently transfected jurkat t-leukemia cells is also #inhibited by the crp-camp complex .
the glnap2 promoter activity is able to be #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity is concentration dependent and saturable and is able to be totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity is concentration dependent and saturable and is totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity is concentration dependent and saturable and may be totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity is #inhibited by the crp-camp complex .
the glnap2 promoter activity is observed to be #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity is observed to be #inhibited by the crp-camp complex .
the glnap2 promoter activity was concentration dependent and saturable and was totally #inhibited with the crp-camp complex , suggesting that divalent cations were required for interaction of in1b with vero cells .
the glnap2 promoter activity were #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity will be #inhibited by the crp-camp complex (no) which activates the soluble isoform of guanylate cyclase in platelets .
the glnap2 promoter activity will be #inhibited if glnap2 promoter associates with the crp-camp complex .
the the crp-camp complex are able to #inhibit the glnap2 promoter activity .
the the crp-camp complex have #inhibited the glnap2 promoter activity .
the the crp-camp complex have the ability to #inhibit the glnap2 promoter activity .
the the crp-camp complex #inhibit the glnap2 promoter activity .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i are able to #inhibit late events of clathrin-coated vesicle formation .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i can #inhibit late events of clathrin-coated vesicle formation .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i have #inhibited late events of clathrin-coated vesicle formation .
the the sh3c and sh3e domains of intersectin , as well as the sh3 domains from the endocytic proteins endophilin i , amphiphysin ii and syndaphin i #inhibit late events of clathrin-coated vesicle formation .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain can #inhibit intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain #inhibits intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain is able to #inhibit intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain is observed to #inhibit intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain may have #inhibited intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while the n-terminal sh3 domain will have #inhibited intermediate events leading to the formation of clathrin-coated pits .
gadx activates expression of gada and gadbc at any ph , while intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the n-terminal sh3 domain .
gadx activates expression of gada and gadbc at any ph , while intermediate events leading to the formation of clathrin-coated pits is observed to be #inhibited by the n-terminal sh3 domain .
here , we have found that intermediate events leading to the formation of clathrin-coated pits is #inhibited by the the n-terminal sh3 domain , while the downreglation of phosphorylated stat1 , stat2 and stat3 is not sensitive to these inhibitors .
here , we have found that intermediate events leading to the formation of clathrin-coated pits was #inhibited by the the n-terminal sh3 domain , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we have found that intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the the n-terminal sh3 domain , while the downreglation of phosphorylated stat1 , stat2 and stat3 was not sensitive to these inhibitors .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain has #inhibited intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain has the ability to #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain #inhibited intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain is observed to #inhibit intermediate events leading to the formation of clathrin-coated pits .
here , we show that glnap2 expression is affected by different carbon sources and that the n-terminal sh3 domain will have #inhibited intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (no) activated the soluble isoform of guanylate cyclase in platelets and has #inhibited intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (no) activated the soluble isoform of guanylate cyclase in platelets and was observed to #inhibit intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (no) activates the soluble isoform of guanylate cyclase in platelets and has the ability to #inhibit intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (no) activates the soluble isoform of guanylate cyclase in platelets and #inhibits intermediate events leading to the formation of clathrin-coated pits .
the n-terminal sh3 domain (no) that has #inhibited intermediate events leading to the formation of clathrin-coated pits activated the soluble isoform of guanylate cyclase in platelets .
the n-terminal sh3 domain (no) that #inhibits intermediate events leading to the formation of clathrin-coated pits activates the soluble isoform of guanylate cyclase in platelets .
the n-terminal sh3 domain is able to totally #inhibit intermediate events leading to the formation of clathrin-coated pits that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the n-terminal sh3 domain is totally #inhibiting intermediate events leading to the formation of clathrin-coated pits that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the n-terminal sh3 domain may have totally #inhibited intermediate events leading to the formation of clathrin-coated pits that is concentration dependent and saturable , suggesting that divalent cations were required for interaction of in1b with vero cells .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then intermediate events leading to the formation of clathrin-coated pits has been #inhibited by 50 mg/ml the n-terminal sh3 domain .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the n-terminal sh3 domain for #inhibiting intermediate events leading to the formation of clathrin-coated pits .
the half-life of the agt proteins was determined by growing cells at 37 c in lb broth supplemented with 50 mg/ml ampicillin , 50 mg/ml kanamycin and 0 .2 mm iptg until the a600 reached 0 .3 and then treating them with 50 mg/ml the n-terminal sh3 domain to #inhibit intermediate events leading to the formation of clathrin-coated pits .
intermediate events leading to the formation of clathrin-coated pits are able to be #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits are #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits can be #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits has been #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits in transiently transfected jurkat t-leukemia cells has also been #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits in transiently transfected jurkat t-leukemia cells was also #inhibited the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits in transiently transfected jurkat t-leukemia cells wil also be #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits is able to be #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits is concentration dependent and saturable and has been totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits is concentration dependent and saturable and is observed to be totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits is concentration dependent and saturable and may be totally #inhibited with the n-terminal sh3 domain , suggesting that divalent cations were required for interaction of in1b with vero cells .
intermediate events leading to the formation of clathrin-coated pits is #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits is observed to be #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits is observed to be #inhibited by the n-terminal sh3 domain .
intermediate events leading to the formation of clathrin-coated pits were #inhibited by the n-terminal sh3 domain (no) which activates the soluble isoform of guanylate cyclase in platelets .
intermediate events leading to the formation of clathrin-coated pits will be #inhibited by the n-terminal sh3 domain .
the the n-terminal sh3 domain are able to #inhibit intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain have #inhibited intermediate events leading to the formation of clathrin-coated pits .
the the n-terminal sh3 domain may have #inhibited intermediate events leading to the formation of clathrin-coated pits .
apparently hela cells are observed to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells can either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells have been either #initiating transcription at multiple sites within rps14 exon 1 , or capping 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells have either #initiated transcription at multiple sites within rps14 exon 1 , or capped 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells may have been either #initiating transcription at multiple sites within rps14 exon 1 , or capping 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
apparently hela cells may have the ability to either #initiate transcription at multiple sites within rps14 exon 1 , or cap 5 oligonucleotides which were removed from most s14 mrnas posttranscription .
i kappa b-epsilon translation being #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation can be #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation has been #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation is observed to be #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation may be #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation that is #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation was #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation which is #initiated from an internal atg codon gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
i kappa b-epsilon translation which may be #initiated from an internal atg codon to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which are observed to #initiate transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which have #initiated transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which may #initiate transcriptional regulation .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which will #initiate transcriptional regulation .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that are observed to #initiate transcriptional regulation .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that can #initiate transcriptional regulation .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads that have #initiated transcriptional regulation .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which is able to #initiate downstream intracellular signaling .
scf , like the other dimeric ligands , is able to initate signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , is observed to initate signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
since rtks are #initiating signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks is observed to #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks may have #initiated signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since rtks will #initiate signaling by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling is #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signaling may be #initiated by rtks by recruiting downstream components to the activated receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
sxl is a key regulator of sex determination and dosage compensation , whose transcription was #initiated only in female blastoderm embryos .
sxl was a key regulator of sex determination and dosage compensation , whose transcription was observed to be #initiated only in female blastoderm embryos .
transcription has the ability to be #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli has been #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli has the ability to be #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli is able to be #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli is observed to be #initiated from two promoters , p1 and p2 .
transcription of ptsg encoding glucose-specific permease , enzyme iicb (glc) , in escherichia coli may have been #initiated from two promoters , p1 and p2 .
transcription of the divergently transcribed glptq and glpacb operons can be #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons has the ability to be #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons is able to be #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons was #initiated at sites separated by 132 base pairs (bp) of dna .
transcription of the divergently transcribed glptq and glpacb operons will be #initiated at sites separated by 132 base pairs (bp) of dna .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , being #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas (2 .1-2 .7 kb in burkitt lines) , which will be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that can be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that has been #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that is #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that is observed to be #initiated within intron 1 .
tumours with breakpoints just 5 to exon 1 , or distant from c-myc , have normal c-myc mrnas of 2 .25 and 2 .4 kb , which differ at their 5 ends , while tumours with breakpoints within exon 1 or intron 1 alter c-myc mrnas that may be #initiated within intron 1 .
signal transduction is able to be #initiated by scf by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
transcription was #initiated from a sigma (70)-dependent promoter at the g residue of the upstream gatc sequence .
apparently hela cells either #initiate transcription at multiple sites within rps14 exon 1 , or capped 5 oligonucleotides are removed from most s14 mrnas posttranscription .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed smads , which #initiate transcriptional regulation .
this has led to the prevailing interpretation that genetic changes , in addition to those present in the most advanced clone of the primary tumor , are required to #initiate invasion , dissemination , and growth at anatomically distant sites .
i kappa b-epsilon translation has been #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation is able to be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation is #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation is observed to be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation may be #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation may have been #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
i kappa b-epsilon translation was #initiated from an internal atg codon at the g residue of the upstream gatc sequence .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation #initiating downstream intracellular signaling .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation that #initiated downstream intracellular signaling .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which are able to #initiate downstream intracellular signaling .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which are observed to #initiate downstream intracellular signaling .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which can #initiate downstream intracellular signaling .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which #initiated downstream intracellular signaling .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which may #initiate downstream intracellular signaling .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which will #initiate downstream intracellular signaling .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation that are able to #initiate downstream intracellular signaling .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation that are observed to #initiate downstream intracellular signaling .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation that can #initiate downstream intracellular signaling .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation that have #initiated downstream intracellular signaling .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed tyrosine autophosphorylation , which #initiate downstream intracellular signaling .
rtks are observed to #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks have #initiated signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks #initiate signaling by recruiting downstream components to the activated receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
rtks , like the other dimeric ligands , can initate signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
rtks , like the other dimeric ligands , initated signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
rtks , like the other dimeric ligands , initates signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
rtks , like the other dimeric ligands , is observed to initate signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiated downstream intracellular signaling .
rtks , like the other dimeric ligands , will initate signaling recruiting downstream components to the activated receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
scf are able to #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf are believed to #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf are observed to #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf can #initiate signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf have #initiated signal transduction by by direct dimerization of its receptor , thereby raising cytosolic ca(2+) , [ca(2+)](i) .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which can #initiate transcriptional regulation .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which has #initiated transcriptional regulation .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which is observed to #initiate transcriptional regulation .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo smads (heldin , 1995; broudy , 1997) , which #initiates transcriptional regulation .
since scf #initiated signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf is able to #initiate signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf may #initiate signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since scf will #initiate signal transduction by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction is able to be #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
since signal transduction is observed to be #initiated by scf by by direct dimerization of its receptor , proteins that are immediately downstream of an activated rtk can be identified by first identifying sequences in the rtk that are necessary to activate downstream signaling (schlessinger and ullrich , 1992; pawson , 1995) .
transcription can be #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription is #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
transcription is observed to be #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription may be #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription which has been #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription which is #initiated from a sigma (70)-dependent promoter gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription which may be #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription will be #initiated from a sigma (70)-dependent promoter to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
downstream intracellular signaling can be #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling could be #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling has been #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling is able to be #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling is observed to be #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling may be #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling was #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
downstream intracellular signaling will be #initiated by tyrosine autophosphorylation , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation can be #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation is able to be #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation is observed to be #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation may be #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation was #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
transcriptional regulation will be #initiated by smads , followed by phosphoryl group transfer to the regulator arca .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that #initiated signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which are able to #initiate signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which are observed to #initiate signal transduction .
ligand binding induced cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which can #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that are able to #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that can #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf that may #initiate signal transduction .
ligand binding induces cell surface receptor complex formation and activates a cascade of phosphorylation events of intracellular intermediaries termed scf , which #initiate signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit , and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which is observed to #initiate signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo scf (heldin , 1995; broudy , 1997) , which #initiates signal transduction .
scf , like the other dimeric ligands , initates signal transduction by direct dimerization of its receptor , kit ,and the two juxtaposed receptors undergo tyrosine autophosphorylation (heldin , 1995; broudy , 1997) , which #initiates downstream intracellular signaling .
transcription of ptsg encoding glucose-specific permease being #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease being #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease has been #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is able to be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease is #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease is #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease is #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease is observed to be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease is observed to be #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease may be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease may have been #initiated from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease was #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease was #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which has been #initiated from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which may be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which may be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease which was #initiated from from two promoters , p1 and p2 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease will be #initiated from from two promoters , p1 and p2 at the g residue of the upstream gatc sequence .
transcription of ptsg encoding glucose-specific permease will be #initiated from from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of ptsg encoding glucose-specific permease will be #initiated from two promoters , p1 and p2 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons can be #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons can be #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons is #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons is #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons is observed to be #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons may be #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons may have been #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons was #initiated from sites separated by 132 base pairs (bp) of dna at the g residue of the upstream gatc sequence .
transcription of the divergently transcribed glptq and glpacb operons which was #initiated from sites separated by 132 base pairs (bp) of dna gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
transcription of the divergently transcribed glptq and glpacb operons will be #initiated from sites separated by 132 base pairs (bp) of dna to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas can be #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas can be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas has been #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas is able to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas is #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas is #initiated from intron 1 to give rise to a protein of 45 kda , which exists as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas is observed to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas is observed to be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas may be #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas may be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas that is #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas was #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas was #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas which is #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas which may be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas which was #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
altered c-myc mrnas will be #initiated from intron 1 at the g residue of the upstream gatc sequence .
altered c-myc mrnas will be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas being #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas can be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas is able to be #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas may be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas that is #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas was #initiated from intron 1 at the g residue of the upstream gatc sequence .
c-myc mrnas was #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas which may be #initiated from intron 1 to give rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas which was #initiated from intron 1 gives rise to a protein of 45 kda , which existed as multiple phosphorylated isoforms in resting cells .
c-myc mrnas will be #initiated from intron 1 at the g residue of the upstream gatc sequence .
signal transduction can be #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
signal transduction was #initiated by scf , followed by phosphoryl group transfer to the regulator arca .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations which #lead to frameshift , and 1 mutation predicted to affect normal splicing) .
cotransfection of gata-4 with mef2a , mef2c or mef2d has #led to a synergistic 40-to 50-fold activation of the anf promoter (figure 3a) .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivated the 5 cleavage event of splicing and can #lead to ligation of the second to the fourth exon .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivated the 5 cleavage event of splicing and has #led to ligation of the second to the fourth exon .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivated the 5 cleavage event of splicing and will #lead to ligation of the second to the fourth exon .
in this homologous part of the genes , gpb lacks one exon due to a point mutation at the 5 splicing site of the third intron , which inactivates the 5 cleavage event of splicing and is able to #lead to ligation of the second to the fourth exon .
the mutations identified include: two frameshifts and a splice site mutation that #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , two of which involve amino acids located within putative transmembrane domains .
the mutations identified include: two frameshifts and a splice site mutation which #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , two of which involve amino acids located within putative transmembrane domains .
the mutations identified include: two frameshifts and a splice site mutation which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , two of which involve amino acids located within putative transmembrane domains .
the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
the splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 appears to be one of the causes of x-linked recessive adrenoleukodystrophy .
this g:c base pair is also the strongest determinant in the sequence selection experiment that #leads to the identification of the bre (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the sequence selection experiment which #leads to the identification of the bre (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in the sequence selection experiment which #led to the identification of the bre (lagrange et al . , 1998) .
this can #lead to a substantial diversity of nebulin and nebulette isoforms .
this may #lead to a substantial diversity of nebulin and nebulette isoforms .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this patients dna contains a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele which #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this splice mutation in 5 end of intron 5 might is #leading to abnormal splice in exon 5 and exon 6 and bringing about unstable and abnormal ald protein; the lignoceryl coa ligase could not transport very long chain fatty acids (vlcfa) into peroxisome and could not function normally; consequently , defective beta-oxidation of vlcfa in peroxisome could result in an accumulation of vlcfas in the central nervous system , adrenal gland and blood .
this that #leads to a substantial diversity of nebulin and nebulette isoforms .
this was caused by a point mutation (gtc----atc) at codon 383 #leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
this was caused by a point mutation (gtc----atc) at codon 383 that #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
this was caused by a point mutation (gtc----atc) at codon 383 which has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
this , in turn , has #led to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
this , in turn , is able to #lead to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
this , in turn , is #leading to synergistic activation of the anf and other mef2 target promoters independently of the dna-binding activity of mef2 .
we also study in detail a complex splice site mutation , 3332dupl8bp , #leading to an abnormal jag1 mrna , resulting in a premature stop codon .
closer examination of the putative signal transduction pathway modulating htra transcription has #led us to the identification of two new genes .
transduction of the mara region from a mar strain , but not a wild-type strain , #led to loss of ompf .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (7 missense mutations , 2 mutations #leading to frameshift , and 1 mutation predicted to affect normal splicing) .
the mutations identified include: two frameshifts and a splice site mutation #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , two of which involve amino acids located within putative transmembrane domains .
this #leads to a substantial diversity of nebulin and nebulette isoforms .
7 missense mutations , 2 mutations has #led to frameshift , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
7 missense mutations , 2 mutations has #led to frameshift .
7 missense mutations , 2 mutations has #led us to frameshift .
7 missense mutations , 2 mutations is able to #lead to frameshift (figure 3a) .
7 missense mutations , 2 mutations is #leading to frameshift , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
7 missense mutations , 2 mutations is #leading to frameshift .
7 missense mutations , 2 mutations #lead to frameshift .
7 missense mutations , 2 mutations #leads us to frameshift .
7 missense mutations , 2 mutations #led to frameshift , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
7 missense mutations , 2 mutations #led us to frameshift .
7 missense mutations , 2 mutations will #lead us to frameshift .
7 missense mutations , 2 mutations , in turn , has #led to frameshift independently of the dna-binding activity of mef2 .
7 missense mutations , 2 mutations , in turn , #leads to frameshift independently of the dna-binding activity of mef2 .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (closer examination of the putative signal transduction pathway modulating htra transcription that #lead to the identification of two new genes , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (closer examination of the putative signal transduction pathway modulating htra transcription which #lead to the identification of two new genes , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (closer examination of the putative signal transduction pathway modulating htra transcription which #led to the identification of two new genes , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d that #led to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (cotransfection of gata-4 with mef2a , mef2c or mef2d which #lead to a synergistic 40-to 50-fold activation of the anf promoter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this #leading to a substantial diversity of nebulin and nebulette isoforms , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this #leading to synergistic activation of the anf and other mef2 target promoters , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this that #lead to synergistic activation of the anf and other mef2 target promoters , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this that #led to synergistic activation of the anf and other mef2 target promoters , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this which #lead to a substantial diversity of nebulin and nebulette isoforms , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this which #led to a substantial diversity of nebulin and nebulette isoforms , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain that #lead to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (transduction of the mara region from a mar strain which #lead to loss of ompf , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation (gtc----atc) at codon 383 #leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the sequence selection experiment which #lead to the identification of the bre , and 1 mutation predicted to affect normal splicing) .
closer examination of the putative signal transduction pathway modulating htra transcription can #lead to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription has #led to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription has #led to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription is able to #lead to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription is #leading to the identification of two new genes , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription may #lead to the identification of two new genes (figure 3a) .
closer examination of the putative signal transduction pathway modulating htra transcription may #lead to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription , but not a wild-type strain , #led to the identification of two new genes .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , #leads to the identification of two new genes independently of the dna-binding activity of mef2 .
closer examination of the putative signal transduction pathway modulating htra transcription , in turn , will #lead to the identification of two new genes independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d can #lead to a synergistic 40-to 50-fold activation of the anf promoter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
cotransfection of gata-4 with mef2a , mef2c or mef2d can #lead to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d can #lead us to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d has #led us to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d is #leading to a synergistic 40-to 50-fold activation of the anf promoter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
cotransfection of gata-4 with mef2a , mef2c or mef2d is #leading to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d #leads us to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
cotransfection of gata-4 with mef2a , mef2c or mef2d #led us to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d will #lead us to a synergistic 40-to 50-fold activation of the anf promoter .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , has #led to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , is #leading to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , #leads to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
cotransfection of gata-4 with mef2a , mef2c or mef2d , in turn , #led to a synergistic 40-to 50-fold activation of the anf promoter independently of the dna-binding activity of mef2 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that 7 missense mutations , 2 mutations was able to #lead to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that closer examination of the putative signal transduction pathway modulating htra transcription could #lead to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that closer examination of the putative signal transduction pathway modulating htra transcription had #led to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d could #lead to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d was able to #lead to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this had #led to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this had #led to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this #led to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this #led to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this was able to #lead to a substantial diversity of nebulin and nebulette isoforms .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that transduction of the mara region from a mar strain could #lead to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that transduction of the mara region from a mar strain had #led to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that transduction of the mara region from a mar strain #led to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation (gtc----atc) at codon 383 had #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the sequence selection experiment could #lead to the identification of the bre .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the sequence selection experiment had #led to the identification of the bre .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that 7 missense mutations , 2 mutations #leads to frameshift .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that cotransfection of gata-4 with mef2a , mef2c or mef2d is able to #lead to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that cotransfection of gata-4 with mef2a , mef2c or mef2d #leads to a synergistic 40-to 50-fold activation of the anf promoter .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this #leads to synergistic activation of the anf and other mef2 target promoters .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that transduction of the mara region from a mar strain #leads to loss of ompf .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that the sequence selection experiment is able to #lead to the identification of the bre .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that the sequence selection experiment #leads to the identification of the bre .
it has been shown that 7 missense mutations , 2 mutations , #leading to frameshift .
it has been shown that closer examination of the putative signal transduction pathway modulating htra transcription , #leading to the identification of two new genes .
it has been shown that cotransfection of gata-4 with mef2a , mef2c or mef2d , #leading to a synergistic 40-to 50-fold activation of the anf promoter .
it has been shown that this , #leading to synergistic activation of the anf and other mef2 target promoters .
it has been shown that transduction of the mara region from a mar strain , #leading to loss of ompf .
it has been shown that a point mutation (gtc----atc) at codon 383 , #leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
these data suggest that 7 missense mutations , 2 mutations has #led to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that 7 missense mutations , 2 mutations will #lead to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that closer examination of the putative signal transduction pathway modulating htra transcription #leads to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that closer examination of the putative signal transduction pathway modulating htra transcription will #lead to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that cotransfection of gata-4 with mef2a , mef2c or mef2d can #lead to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that cotransfection of gata-4 with mef2a , mef2c or mef2d will #lead to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this can #lead to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this can #lead to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this has #led to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this has #led to synergistic activation of the anf and other mef2 target promoters that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that this will #lead to a substantial diversity of nebulin and nebulette isoforms that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that transduction of the mara region from a mar strain can #lead to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that transduction of the mara region from a mar strain will #lead to loss of ompf that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation (gtc----atc) at codon 383 has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the sequence selection experiment will #lead to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that 7 missense mutations , 2 mutations #led to frameshift that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that closer examination of the putative signal transduction pathway modulating htra transcription #led to the identification of two new genes that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that cotransfection of gata-4 with mef2a , mef2c or mef2d #led to a synergistic 40-to 50-fold activation of the anf promoter that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a point mutation (gtc----atc) at codon 383 #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a point mutation (gtc----atc) at codon 383 was able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that the sequence selection experiment #led to the identification of the bre that functions to stimulate phosphorylation and clustering of achrs .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations #leading to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in 7 missense mutations , 2 mutations which #led to frameshift (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in closer examination of the putative signal transduction pathway modulating htra transcription that #leads to the identification of two new genes (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d that #leads to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in cotransfection of gata-4 with mef2a , mef2c or mef2d , which #led to a synergistic 40-to 50-fold activation of the anf promoter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this that #leads to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this that #leads to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this which #leads to synergistic activation of the anf and other mef2 target promoters (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this , which #led to a substantial diversity of nebulin and nebulette isoforms (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain #leading to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in transduction of the mara region from a mar strain which #leads to loss of ompf (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 #leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 that #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 which #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation (gtc----atc) at codon 383 , which #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (lagrange et al . , 1998) .
this can #lead to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this can #lead to synergistic activation of the anf and other mef2 target promoters , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this can #lead to synergistic activation of the anf and other mef2 target promoters .
this has #led to a substantial diversity of nebulin and nebulette isoforms , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this has #led to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this has #led us to a substantial diversity of nebulin and nebulette isoforms .
this is #leading to a substantial diversity of nebulin and nebulette isoforms , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this is #leading to synergistic activation of the anf and other mef2 target promoters , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this #lead to a substantial diversity of nebulin and nebulette isoforms .
this #lead to synergistic activation of the anf and other mef2 target promoters .
this #leads to a substantial diversity of nebulin and nebulette isoforms , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this #leads to synergistic activation of the anf and other mef2 target promoters (figure 3a) .
this #leads to synergistic activation of the anf and other mef2 target promoters , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this #leads to synergistic activation of the anf and other mef2 target promoters .
this #leads us to a substantial diversity of nebulin and nebulette isoforms .
this #led to a substantial diversity of nebulin and nebulette isoforms , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this #led to a substantial diversity of nebulin and nebulette isoforms .
this #led to synergistic activation of the anf and other mef2 target promoters .
this #led us to synergistic activation of the anf and other mef2 target promoters .
this may #lead to a substantial diversity of nebulin and nebulette isoforms (figure 3a) .
this that #leads to synergistic activation of the anf and other mef2 target promoters .
this was caused by 7 missense mutations , 2 mutations that #leads to frameshift .
this was caused by 7 missense mutations , 2 mutations which has #led to frameshift .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription which can #lead to the identification of two new genes .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription which has #led to the identification of two new genes .
this was caused by closer examination of the putative signal transduction pathway modulating htra transcription , which #leads to the identification of two new genes .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d which can #lead to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d which has #led to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by cotransfection of gata-4 with mef2a , mef2c or mef2d , which #leads to a synergistic 40-to 50-fold activation of the anf promoter .
this was caused by this #leading to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this #leading to synergistic activation of the anf and other mef2 target promoters .
this was caused by this that #led to synergistic activation of the anf and other mef2 target promoters .
this was caused by this which can #lead to a substantial diversity of nebulin and nebulette isoforms .
this was caused by this which has #led to a substantial diversity of nebulin and nebulette isoforms .
this was caused by transduction of the mara region from a mar strain which has #led to loss of ompf .
this was caused by the sequence selection experiment #leading to the identification of the bre .
this was caused by the sequence selection experiment that #leads to the identification of the bre .
this was caused by the sequence selection experiment that #led to the identification of the bre .
this was caused by the sequence selection experiment which can #lead to the identification of the bre .
this was caused by the sequence selection experiment , which #leads to the identification of the bre .
this will #lead us to a substantial diversity of nebulin and nebulette isoforms .
this will #lead us to synergistic activation of the anf and other mef2 target promoters .
this , but not a wild-type strain , #led to a substantial diversity of nebulin and nebulette isoforms .
this , in turn , has #led to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
this , in turn , #led to a substantial diversity of nebulin and nebulette isoforms independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain can #lead to loss of ompf .
transduction of the mara region from a mar strain has #led to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain has #led to loss of ompf .
transduction of the mara region from a mar strain #leads to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain #leads to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain #leads to loss of ompf .
transduction of the mara region from a mar strain #leads us to loss of ompf .
transduction of the mara region from a mar strain #led to loss of ompf , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
transduction of the mara region from a mar strain #led to loss of ompf .
transduction of the mara region from a mar strain may #lead to loss of ompf (figure 3a) .
transduction of the mara region from a mar strain may #lead to loss of ompf .
transduction of the mara region from a mar strain , in turn , is able to #lead to loss of ompf independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain , in turn , #leads to loss of ompf independently of the dna-binding activity of mef2 .
transduction of the mara region from a mar strain , in turn , will #lead to loss of ompf independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 can #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 has #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation (gtc----atc) at codon 383 is able to #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 is #leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation (gtc----atc) at codon 383 is #leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #leads us to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation (gtc----atc) at codon 383 may #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter (figure 3a) .
a point mutation (gtc----atc) at codon 383 may #lead to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 that #leads to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter .
a point mutation (gtc----atc) at codon 383 , in turn , is #leading to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a point mutation (gtc----atc) at codon 383 , in turn , #led to the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter independently of the dna-binding activity of mef2 .
a substantial diversity of nebulin and nebulette isoforms is #led to by this .
a substantial diversity of nebulin and nebulette isoforms was #led to by this .
a synergistic 40-to 50-fold activation of the anf promoter is #led to by cotransfection of gata-4 with mef2a , mef2c or mef2d .
a synergistic 40-to 50-fold activation of the anf promoter was #led to by cotransfection of gata-4 with mef2a , mef2c or mef2d .
frameshift is #led to by 7 missense mutations , 2 mutations .
frameshift was #led to by 7 missense mutations , 2 mutations .
loss of ompf is #led to by transduction of the mara region from a mar strain .
loss of ompf was #led to by transduction of the mara region from a mar strain .
synergistic activation of the anf and other mef2 target promoters was #led to by this .
the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter is #led to by a point mutation (gtc----atc) at codon 383 .
the conservative substitution of isoleucine for valine in the putative fifth extracellular loop of the transporter was #led to by a point mutation (gtc----atc) at codon 383 .
the identification of the bre was #led to by the sequence selection experiment .
the identification of two new genes was #led to by closer examination of the putative signal transduction pathway modulating htra transcription .
the sequence selection experiment can #lead to the identification of the bre (figure 3a) .
the sequence selection experiment can #lead to the identification of the bre .
the sequence selection experiment can #lead us to the identification of the bre .
the sequence selection experiment has #led to the identification of the bre (figure 3a) .
the sequence selection experiment has #led to the identification of the bre , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the sequence selection experiment has #led us to the identification of the bre .
the sequence selection experiment is able to #lead to the identification of the bre (figure 3a) .
the sequence selection experiment #lead to the identification of the bre .
the sequence selection experiment #leads to the identification of the bre .
the sequence selection experiment #led to the identification of the bre .
the sequence selection experiment may #lead to the identification of the bre (figure 3a) .
the sequence selection experiment may #lead to the identification of the bre .
the sequence selection experiment that #leads to the identification of the bre .
the sequence selection experiment , but not a wild-type strain , #led to the identification of the bre .
the sequence selection experiment , in turn , is able to #lead to the identification of the bre independently of the dna-binding activity of mef2 .
the sequence selection experiment , in turn , is #leading to the identification of the bre independently of the dna-binding activity of mef2 .
the sequence selection experiment , in turn , #leads to the identification of the bre independently of the dna-binding activity of mef2 .
the sequence selection experiment , in turn , #led to the identification of the bre independently of the dna-binding activity of mef2 .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the splice mutation in 5 end of intron 5 which #lead to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (the splice mutation in 5 end of intron 5 which #led to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 that #lead to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (this splice mutation in 5 end of intron 5 which #lead to abnormal splice in exon 5 and exon 6 , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation #leading to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a complex splice site mutation which #lead to an abnormal jag1 mrna , resulting in a premature stop codon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation at the 5 splicing site of the third intron #leading to ligation of the second to the fourth exon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation at the 5 splicing site of the third intron that #lead to ligation of the second to the fourth exon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (a point mutation at the 5 splicing site of the third intron which #led to ligation of the second to the fourth exon , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation that #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
by direct sequencing of aberrant ssca conformers were revealed 15 different mutations in a total of 18 unrelated families and 13 single patients . of these , 10 were novel (two frameshifts and a splice site mutation which #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , and 1 mutation predicted to affect normal splicing) .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that the splice mutation in 5 end of intron 5 could #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this splice mutation in 5 end of intron 5 could #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that this splice mutation in 5 end of intron 5 was able to #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele had #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a complex splice site mutation #led to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a complex splice site mutation was able to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation at the 5 splicing site of the third intron could #lead to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggested that a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that this splice mutation in 5 end of intron 5 is able to #lead to abnormal splice in exon 5 and exon 6 .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a complex splice site mutation is able to #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that a complex splice site mutation #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that two frameshifts and a splice site mutation is able to #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
further , experiments with an antisense-ref cdna expression vector introduced into cultured cells suggests that two frameshifts and a splice site mutation #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
it has been shown that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
it has been shown that a complex splice site mutation , #leading to an abnormal jag1 mrna , resulting in a premature stop codon .
it has been shown that a point mutation at the 5 splicing site of the third intron , #leading to ligation of the second to the fourth exon .
it has been shown that two frameshifts and a splice site mutation , #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this #leading to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this that #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which has #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
the splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 is #leading to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
the splice mutation in 5 end of intron 5 is #leading to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 #lead to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 #leads us to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 may #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
the splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this which can #lead to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this which has #led to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 was caused by this , which #leads to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 , but not a wild-type strain , #led to abnormal splice in exon 5 and exon 6 .
the splice mutation in 5 end of intron 5 , in turn , is able to #lead to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
the splice mutation in 5 end of intron 5 , in turn , is #leading to abnormal splice in exon 5 and exon 6 independently of the dna-binding activity of mef2 .
these data suggest that the splice mutation in 5 end of intron 5 can #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that the splice mutation in 5 end of intron 5 will #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele can #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation at the 5 splicing site of the third intron can #lead to ligation of the second to the fourth exon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation at the 5 splicing site of the third intron has #led to ligation of the second to the fourth exon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation at the 5 splicing site of the third intron #leads to ligation of the second to the fourth exon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that a point mutation at the 5 splicing site of the third intron will #lead to ligation of the second to the fourth exon that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that two frameshifts and a splice site mutation has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
these data suggest that two frameshifts and a splice site mutation #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that the splice mutation in 5 end of intron 5 was able to #lead to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that this splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a complex splice site mutation #led to an abnormal jag1 mrna , resulting in a premature stop codon that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that a point mutation at the 5 splicing site of the third intron was able to #lead to ligation of the second to the fourth exon that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
these data suggested that two frameshifts and a splice site mutation was able to #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations that functions to stimulate phosphorylation and clustering of achrs .
this g:c base pair is also the strongest determinant in the splice mutation in 5 end of intron 5 , which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this splice mutation in 5 end of intron 5 which has #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this splice mutation in 5 end of intron 5 which #leads to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this splice mutation in 5 end of intron 5 which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in this splice mutation in 5 end of intron 5 , which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation that #leads to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation which has #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a complex splice site mutation which #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron #leading to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in a point mutation at the 5 splicing site of the third intron which #leads to ligation of the second to the fourth exon (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation that #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation which has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this g:c base pair is also the strongest determinant in two frameshifts and a splice site mutation which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which has #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 g:c base pair is also the strongest determinant in this which #led to abnormal splice in exon 5 and exon 6 (lagrange et al . , 1998) .
this splice mutation in 5 end of intron 5 has #led to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 is able to #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 is #leading to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 is #leading to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 #leads to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 #leads us to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
this splice mutation in 5 end of intron 5 #led to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 may #lead to abnormal splice in exon 5 and exon 6 (figure 3a) .
this splice mutation in 5 end of intron 5 may #lead to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this #leading to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this that #led to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 was caused by this which can #lead to abnormal splice in exon 5 and exon 6 .
this splice mutation in 5 end of intron 5 , but not a wild-type strain , #led to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 .
this was caused by the splice mutation in 5 end of intron 5 which can #lead to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 #leading to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 that #leads to abnormal splice in exon 5 and exon 6 .
this was caused by this splice mutation in 5 end of intron 5 that #led to abnormal splice in exon 5 and exon 6 .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
this was caused by a complex splice site mutation that #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a complex splice site mutation that #led to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a complex splice site mutation which can #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
this was caused by a point mutation at the 5 splicing site of the third intron #leading to ligation of the second to the fourth exon .
this was caused by a point mutation at the 5 splicing site of the third intron that #leads to ligation of the second to the fourth exon .
this was caused by a point mutation at the 5 splicing site of the third intron which can #lead to ligation of the second to the fourth exon .
this was caused by a point mutation at the 5 splicing site of the third intron which has #led to ligation of the second to the fourth exon .
this was caused by a point mutation at the 5 splicing site of the third intron , which #leads to ligation of the second to the fourth exon .
this was caused by two frameshifts and a splice site mutation that #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
this was caused by two frameshifts and a splice site mutation which can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
this was caused by two frameshifts and a splice site mutation which has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein is #led to by a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele g:c base pair is also the strongest determinant in this that #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele g:c base pair is also the strongest determinant in this which has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele g:c base pair is also the strongest determinant in this which #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele g:c base pair is also the strongest determinant in this which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele g:c base pair is also the strongest determinant in this , which #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (lagrange et al . , 1998) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele has #led us to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele is #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele is #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #leads us to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele may #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein (figure 3a) .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele may #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele that #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this #leading to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this that #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this that #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele was caused by this , which #leads to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele will #lead us to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , but not a wild-type strain , #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , has #led to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a c----a transversion in the splice acceptor sequence of the last intron of the only ercc-3 allele , in turn , is able to #lead to a 4 bp insertion in the mrna and an inactivating frameshift in the c-terminus of the protein independently of the dna-binding activity of mef2 .
a complex splice site mutation g:c base pair is also the strongest determinant in this that #leads to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation g:c base pair is also the strongest determinant in this , which #led to an abnormal jag1 mrna , resulting in a premature stop codon (lagrange et al . , 1998) .
a complex splice site mutation can #lead to an abnormal jag1 mrna , resulting in a premature stop codon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a complex splice site mutation can #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation can #lead us to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation has #led to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation is able to #lead to an abnormal jag1 mrna , resulting in a premature stop codon (figure 3a) .
a complex splice site mutation is #leading to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation #leads to an abnormal jag1 mrna , resulting in a premature stop codon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a complex splice site mutation #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation #led to an abnormal jag1 mrna , resulting in a premature stop codon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a complex splice site mutation may #lead to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation that #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation was caused by this that #leads to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation was caused by this that #led to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation was caused by this which has #led to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation , but not a wild-type strain , #led to an abnormal jag1 mrna , resulting in a premature stop codon .
a complex splice site mutation , in turn , has #led to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a complex splice site mutation , in turn , is #leading to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a complex splice site mutation , in turn , #leads to an abnormal jag1 mrna , resulting in a premature stop codon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this #leading to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this which has #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this which #leads to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron g:c base pair is also the strongest determinant in this , which #led to ligation of the second to the fourth exon (lagrange et al . , 1998) .
a point mutation at the 5 splicing site of the third intron can #lead to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron can #lead to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron can #lead us to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron has #led to ligation of the second to the fourth exon (figure 3a) .
a point mutation at the 5 splicing site of the third intron has #led to ligation of the second to the fourth exon , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
a point mutation at the 5 splicing site of the third intron is #leading to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron #lead to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron #leads us to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron #led to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron was caused by this that #leads to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron was caused by this that #led to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron was caused by this which can #lead to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron was caused by this which has #led to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron was caused by this , which #leads to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron will #lead us to ligation of the second to the fourth exon .
a point mutation at the 5 splicing site of the third intron , in turn , has #led to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron , in turn , #leads to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
a point mutation at the 5 splicing site of the third intron , in turn , will #lead to ligation of the second to the fourth exon independently of the dna-binding activity of mef2 .
abnormal splice in exon 5 and exon 6 is #led to by the splice mutation in 5 end of intron 5 .
abnormal splice in exon 5 and exon 6 was #led to by the splice mutation in 5 end of intron 5 .
ligation of the second to the fourth exon was #led to by a point mutation at the 5 splicing site of the third intron .
truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations is #led to by two frameshifts and a splice site mutation .
truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations was #led to by two frameshifts and a splice site mutation .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this which #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation g:c base pair is also the strongest determinant in this , which #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (lagrange et al . , 1998) .
two frameshifts and a splice site mutation can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations , an atypical form of tay-sachs disease (gm2 gangliosidosis variant ab) .
two frameshifts and a splice site mutation can #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation has #led us to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation is able to #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation may #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations (figure 3a) .
two frameshifts and a splice site mutation was caused by this that #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation was caused by this which has #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations .
two frameshifts and a splice site mutation , in turn , is #leading to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
two frameshifts and a splice site mutation , in turn , #leads to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
two frameshifts and a splice site mutation , in turn , #led to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
two frameshifts and a splice site mutation , in turn , will #lead to truncated oa1 proteins; a deletion of a threonine codon at position 290; and four missense mutations independently of the dna-binding activity of mef2 .
a sph i cleavage site within exon 3 is able to be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 may be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 was #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 will be #lost in a new transthyretin variant that has been characterized .
a new transthyretin variant having the ability to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant #losing a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which has #lost a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which #loses a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant which may #lose a sph i cleavage site within exon 3 has been characterized .
gpi anchoring ability #lost when the microsomal membranes of trypanosoma brucei were washed at high ph has been reported(sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability has been #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes had no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability was able to be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability was observed to be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
it was reported that gpi anchoring ability would be #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes have no effect (vidugiriene and menon , 1995)
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species #losing the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that are able to #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that are observed to #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that can #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that have a high probability of #losing the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that #lost the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that may #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that may probably #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that will #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that will probably #lose the first 20 70 residues but that retain enzymatic activity and dimeric structure .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that are able to #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that have a high probability of #losing il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that have the ability to #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that may probably #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that will probably #lose il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
the c-terminal-deletion mutant of hnrnp a1 can #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 has #lost the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 has the capability to #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 is able to #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 is observed to #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 #losing the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 #lost the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 may have #lost the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 may probably #lose the ability to interact with the x protein and to bring it into the initiation complex , resulting in an inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 that has a high probability of #losing the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the c-terminal-deletion mutant of hnrnp a1 which #lost the ability to interact with the x protein and to bring it into the initiation complex results in and inhibition of mhv rna transcription and replication .
the mice are not observed #lose weight during the treatment .
the mice do not have the ability to #lose weight during the treatment .
the mice do not #lose weight during the treatment .
the mice may not #lose weight during the treatment .
the mice will not #lose weight during the treatment .
these interactions are able to be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions can be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions could be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions could probably be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions have a high probability of being #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions have the ability to be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions may be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions may probably be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions were able to be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions were observed to be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
these interactions will probably be #lost with a separation of dna-binding sites of }3 bp , as can occur for natural sre sequences , while a smaller spacing inhibited the simultaneous binding of both proteins .
this study investigated whether informing obese individuals that they are able to #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they are observed to #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they can #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they could #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they have the ability to #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they have the probability of #losing only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they will probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
this study investigated whether informing obese individuals that they would probably #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
the ability to interact with the x protein and to bring it into the initiation complex may probably be #lost in the c-terminal-deletion mutant of hnrnp a1 .
it was reported that gpi anchoring ability was #lost when the microsomal membranes of trypanosoma brucei were washed at high ph (sharma et al . , 2000) , whereas similar treatment of the mammalian microsomal membranes had no effect (vidugiriene and menon , 1995)
previous studies have emphasized the high sensitivity of the n-terminal region to proteolytic cleavage , leading to truncated species that have #lost the first 20 70 residues but that retain enzymatic activity and dimeric structure .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in acute t-cell leukemia cells that have #lost il-2 dependency (migone et al . , 1995; yu et al . , 1995) .
the mice did not #lose weight during the treatment .
this study investigated whether informing obese individuals that they would #lose only modest amounts of weight would lead them to adopt more realistic weight loss expectations .
a new transthyretin variant can completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant has completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant is able to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant is completely #losing a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
il-2 dependency has been #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency is #lost in acute t-cell leukemia cells that has been characterized .
il-2 dependency will be #lost in acute t-cell leukemia cells that has been characterized .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant #losing a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that are observed to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that have a high probability of #losing a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that have #lost a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that #lost a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that may #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant #losing a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that have a high probability of #losing a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that have #lost a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in a new transthyretin variant that have the ability to #lose a sph i cleavage site within exon 3 (migone et al . , 1995; yu et al . , 1995) .
to this end , we made a new transthyretin variant , which can #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which could #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which could probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which may #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which may probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which might #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which will #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which would #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant #losing all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which are observed to #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which can probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which could #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which could probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which have a high probability of #losing all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which might probably #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made a new transthyretin variant , which would #lose all a sph i cleavage site within exon 3 postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells #losing all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which are observed to #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which could probably #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which has #lost all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which have a high probability of #losing all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which may #lose all il-2 dependency postnatally , and +/+ control mice .
to this end , we made acute t-cell leukemia cells , which might #lose all il-2 dependency postnatally , and +/+ control mice .
a sph i cleavage site within exon 3 can be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is able to be #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 is #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 was #lost in a new transthyretin variant that has been characterized .
a sph i cleavage site within exon 3 will be #lost in a new transthyretin variant that has been characterized .
a new transthyretin variant can completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant completely #loses a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant having the ability to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant is able to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant is observed to completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant may completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant observed to #lose a sph i cleavage site within exon 3 has been characterized .
a new transthyretin variant will completely #lose a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
a new transthyretin variant will have completely #lost a sph i cleavage site within exon 3 , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells being able to #lose il-2 dependency has been characterized .
acute t-cell leukemia cells completely #loses il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells has the ability to completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells is completely #losing il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells observed to #lose il-2 dependency has been characterized .
acute t-cell leukemia cells which can #lose il-2 dependency has been characterized .
acute t-cell leukemia cells which has #lost il-2 dependency has been characterized .
acute t-cell leukemia cells which #loses il-2 dependency has been characterized .
acute t-cell leukemia cells which may #lose il-2 dependency has been characterized .
acute t-cell leukemia cells will completely #lose il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
acute t-cell leukemia cells will have completely #lost il-2 dependency , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
all a sph i cleavage site within exon 3 are observed to be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 are postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 can be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 can probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 could probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 have a high probability of being postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 may probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 might be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 might probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 were postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 will probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 would probably be postnatally #lost by a new transthyretin variant .
all il-2 dependency are able to be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency are observed to be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency are postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency can be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency could probably be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency have a high probability of being postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency may probably be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency might be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency will be postnatally #lost by acute t-cell leukemia cells .
all il-2 dependency will probably be postnatally #lost by acute t-cell leukemia cells .
all a sph i cleavage site within exon 3 are postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 could probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 may be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 might be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 might probably be postnatally #lost by a new transthyretin variant .
all a sph i cleavage site within exon 3 were postnatally #lost by a new transthyretin variant .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 #losing the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that are able to #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that can #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that can probably #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that have a high probability of #losing the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that have the ability to #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that may #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that will #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in the c-terminal-deletion mutant of hnrnp a1 that will probably #lose the ability to interact with the x protein and to bring it into the initiation complex (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that can #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that have a high probability of #losing modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that have the ability to #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that may #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that may probably #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that will #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in they that will probably #lose modest amounts of weight (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species #losing the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that are able to #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that have a high probability of #losing the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that have the ability to #lose the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
stat3 is activated in v-src or v-abl-transformed cells and , along other stats , in truncated species that #lost the first 20 70 residues (migone et al . , 1995; yu et al . , 1995) .
the c-terminal-deletion mutant of hnrnp a1 being able to #lose the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 can completely #lost the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 completely #loses the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 completely #lost the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 has completely #lost the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 having the ability to #lose the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 is able to completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 which can #lose the ability to interact with the x protein and to bring it into the initiation complex has been characterized .
the c-terminal-deletion mutant of hnrnp a1 will completely #lose the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
the c-terminal-deletion mutant of hnrnp a1 will have completely #lost the ability to interact with the x protein and to bring it into the initiation complex , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 #losing all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which are able to #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which are observed to #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which could #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which has #lost all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which have the ability to #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which #lost all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which may #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which may probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made the c-terminal-deletion mutant of hnrnp a1 , which will probably #lose all the ability to interact with the x protein and to bring it into the initiation complex postnatally , and +/+ control mice .
to this end , we made they , which could #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which could probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which have the ability to #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which #lost all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which may probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which might probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which will #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made they , which would probably #lose all modest amounts of weight postnatally , and +/+ control mice .
to this end , we made truncated species , which are observed to #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which can #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which can probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which could #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which has #lost all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which have a high probability of #losing all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which have the ability to #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which #lost all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which may #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which may probably #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which might #lose all the first 20 70 residues postnatally , and +/+ control mice .
to this end , we made truncated species , which would #lose all the first 20 70 residues postnatally , and +/+ control mice .
all modest amounts of weight are observed to be postnatally #lost by they .
all modest amounts of weight can be postnatally #lost by they .
all modest amounts of weight could be postnatally #lost by they .
all modest amounts of weight have a high probability of being postnatally #lost by they .
all modest amounts of weight may probably be postnatally #lost by they .
all modest amounts of weight might probably be postnatally #lost by they .
all modest amounts of weight were postnatally #lost by they .
all modest amounts of weight would probably be postnatally #lost by they .
all the ability to interact with the x protein and to bring it into the initiation complex are observed to be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex are postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex may probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex were postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex will be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the ability to interact with the x protein and to bring it into the initiation complex will probably be postnatally #lost by the c-terminal-deletion mutant of hnrnp a1 .
all the first 20 70 residues are able to be postnatally #lost by truncated species .
all the first 20 70 residues are observed to be postnatally #lost by truncated species .
all the first 20 70 residues are postnatally #lost by truncated species .
all the first 20 70 residues could probably be postnatally #lost by truncated species .
all the first 20 70 residues may be postnatally #lost by truncated species .
all the first 20 70 residues might be postnatally #lost by truncated species .
all the first 20 70 residues would be postnatally #lost by truncated species .
modest amounts of weight can be #lost in they that has been characterized .
modest amounts of weight has been #lost in they that has been characterized .
modest amounts of weight is able to be #lost in they that has been characterized .
modest amounts of weight is #lost in they that has been characterized .
modest amounts of weight is observed to be #lost in they that has been characterized .
modest amounts of weight may be #lost in they that has been characterized .
modest amounts of weight will be #lost in they that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex can be #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex is #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex is observed to be #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex may be #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the ability to interact with the x protein and to bring it into the initiation complex was #lost in the c-terminal-deletion mutant of hnrnp a1 that has been characterized .
the first 20 70 residues can be #lost in truncated species that has been characterized .
the first 20 70 residues is #lost in truncated species that has been characterized .
the first 20 70 residues may be #lost in truncated species that has been characterized .
the first 20 70 residues was #lost in truncated species that has been characterized .
they being able to #lose modest amounts of weight has been characterized .
they completely #loses modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they has completely #lost modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they has the ability to completely #lose modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they is completely #losing modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they is observed to completely #lose modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
they #losing modest amounts of weight has been characterized .
they which can #lose modest amounts of weight has been characterized .
they which has #lost modest amounts of weight has been characterized .
they which #lost modest amounts of weight has been characterized .
they which may #lose modest amounts of weight has been characterized .
they will completely #lose modest amounts of weight , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species being able to #lose the first 20 70 residues has been characterized .
truncated species completely #lost the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species has the ability to completely #lose the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species is able to completely #lose the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species is completely #losing the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species is observed to completely #lose the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species #losing the first 20 70 residues has been characterized .
truncated species may completely #lose the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species which can #lose the first 20 70 residues has been characterized .
truncated species which has #lost the first 20 70 residues has been characterized .
truncated species which #lost the first 20 70 residues has been characterized .
truncated species which may #lose the first 20 70 residues has been characterized .
truncated species will completely #lose the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
truncated species will have completely #lost the first 20 70 residues , but all show considerablegenome reduction and dependency on the nucleus to fulfill plastid functions (martin and hrrmann , 1998) .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits being apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which were #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 subunits , some of which will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii are #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii were #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 subunits that composed human rna pol iii will be apparently #modified in hela cells .
p .falciparum can be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum can be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has been notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has the ability to be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has the ability to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum has the probability of being notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is able to be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is being notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is observed to be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum is observed to be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum may be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum might be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum might be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum was observed to be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum will be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum will be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum would be #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
p .falciparum would be notably #modified genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which are able to #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which can #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which have #modified the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which have the ability to #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which have the probability of #modifying the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which #modified the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the sh3 acts to position the u5 region through its own association with the guk domain and that factors which #modify the binding of either u5 or sh3 to the guk domain may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain could be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain has been observed to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain has the probability of being #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain is able to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain may have been #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain might have been #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain was #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain was observed to be #modified by factors that may regulate gkap binding to the guk domain .
taken together these data suggest that the binding of either u5 or sh3 to the guk domain will be #modified by factors that may regulate gkap binding to the guk domain .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz can #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz could have significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz could #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz could significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has the ability to #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz has the probability of significantly #modifying or in some way directing ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz is able to significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz may significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz might have #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz might have significantly #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz #modified or in some way directed ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz significantly #modifies or in some way directs ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , envz will significantly #modify or in some way direct ompr , which in turn acts at the appropriate porin gene promoter .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , can be #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , can be significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , could have been #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , has been #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , has been significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , has the ability to be #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , has the ability to be significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , has the probability of being #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , is observed to be #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , may be #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , may be significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , may have been significantly #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , was #modified or in some way directed by envz .
these results lead us to conclude that envz and ompr act in sequential fashion to activate porin gene expression; i .e . , ompr , which acts at the appropriate porin gene promoter , will be #modified or in some way directed by envz .
to define the subcellular location of hvdac isoforms , hvdac genes are able to be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes are observed to be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes have been #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes have been remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes have the ability to be remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes may be #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes might have been #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
to define the subcellular location of hvdac isoforms , hvdac genes might have been remarkably #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
we are able to #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we are able to notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we can #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we can notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we have #modified p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we may #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we may notably #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we #modified p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we will #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
we have used the ability to #modify p .falciparum genetically by transfection (crabb and cowman , 1996; crabb et al . , 1997a) to disrupt the rap1 gene .
to define the subcellular location of hvdac isoforms , hvdac genes were #modified so that the encoded proteins contain cooh-terminal epitopes recognized by either of two monoclonal antibodies .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which being apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 some of which , some of which will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii are #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 some of which that composed human rna pol iii will be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes being #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which are able to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which are able to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 hvdac genes , some of which might have been #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum being apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum being #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , some of which may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that human rna pol iii is composed of 16 p .falciparum , subunits are apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii are observed to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii can be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii can be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii have the ability to be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii may be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii may be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 hvdac genes that composed human rna pol iii will be #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii are observed to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii have the ability to be apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii might have been apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii were apparently #modified in hela cells .
an immunopurification approach has been used to demonstrate that some of the 16 p .falciparum that composed human rna pol iii will be #modified in hela cells .
analyses of transcription in vivo of agn-lacz with dam target sequences being #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences that are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences that can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences that have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with dam target sequences which were #mutated support this conclusion .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that could be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that has been remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that has the ability to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that has the ability to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is able to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is able to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is believed to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is observed to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that is remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that may be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that might have been #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that might have been remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that will be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 that would be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which can be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which can be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which could be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which has been #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which has been remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is able to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is believed to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is believed to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is observed to be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is observed to be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which is remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which might be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which might be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which will be remarkably #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which would be #mutated , and a 4-fold repression with wild-type p53 .
cotransfections with plasmids expressing wt-1 , wtar (a #mutated form of wt-1) , p53 , and a #mutated form of p53 revealed a complex pattern of regulation with a 3-fold induction with wt-1 , a 7-fold induction with p53 which would be remarkably #mutated , and a 4-fold repression with wild-type p53 .
for example , #mutating the c-terminal map kinase sites (t235 and t239) has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , #mutating the c-terminal map kinase sites (t235 and t239) may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , to #mutate the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
for example , to #mutate the c-terminal map kinase sites (t235 and t239) has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) are #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) are significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) could have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) could have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) could have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) have the ability to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) were #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) were observed to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (s (64) and s (211)) were observed to be significantly #mutated .
in contrast , to #mutate the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in contrast , to #mutate the c-terminal map kinase sites (t235 and t239) has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in contrast , to #mutate the c-terminal map kinase sites (t235 and t239) is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
in contrast , to #mutate the c-terminal map kinase sites (t235 and t239) may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating amino acids ee(437 and 438) to aa generated the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa is observed to generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa may generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa may have generated the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa might generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating amino acids ee(437 and 438) to aa will generate the dna-binding mutant(stat5aee-aa) of stat5a .
#mutating the c-terminal map kinase sites (t235 and t239) , for example , essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , for example , may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , in contrast , has essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , in contrast , is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
#mutating the c-terminal map kinase sites (t235 and t239) , in contrast , may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that #mutating the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that #mutating the c-terminal map kinase sites (t235 and t239) may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
our research has shown that to #mutate the c-terminal map kinase sites (t235 and t239) essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
rca is comprised of two major steps: (i) identifying pairs of residue positions being able to #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions being observed to #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that are able to #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that are observed to #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that could have #mutated in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that could #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that have the ability to #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that #mutated in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions that would #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which are able to #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which are observed to #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which can #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which could have #mutated in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which might #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which #mutate in a coordinated manner , and (ii) using these results to identify protein regions that interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which #mutated in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which will #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
rca is comprised of two major steps: (i) identifying pairs of residue positions which would #mutate in a coordinated manner , and (ii) using these results to identify protein regions which interact with an uncommonly high number of other residues .
the dna-binding mutant(stat5aee-aa) of stat5a can be generated by #mutating amino acids ee(437 and 438) to aa .
the dna-binding mutant(stat5aee-aa) of stat5a could have been generated by #mutating amino acids ee(437 and 438) to aa .
the dna-binding mutant(stat5aee-aa) of stat5a has been generated by #mutating amino acids ee(437 and 438) to aa .
the gene being able to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene being able to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene being #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene observed to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that has the ability to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that has the ability to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that is #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that is #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that is observed to be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that may be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that may be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the gene that was #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice encodes a novel predicted transmembrane protein .
the gene that will be #mutated in variant late-infantile neuronal ceroid lipofuscinosis (cln6) and in nclf mutant mice has encoded a novel predicted transmembrane protein .
the result of #mutating amino acids ee(437 and 438) to aa is the dna-binding mutant(stat5aee-aa) of stat5a being generated .
the template fragments are able to be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments are able to be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments are observed to be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments are significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments can be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments could be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments could be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments could have been #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments have the probability of being #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments may be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments might be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments might have been #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments would be #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
the template fragments would be significantly #mutated by the sequence of sap97 rat , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
this epitope , which is hla-a2 restricted , includes two amino acids commonly #mutating (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids #mutating (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids observed to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids observed to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are able to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are able to #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that are #mutating (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that can commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that could have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that may commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that may have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids that may #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are commonly #mutating (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are #mutating (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which are observed to commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which can #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which could have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which have #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which may commonly #mutate (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which may have commonly #mutated (v82a and i84v) in the face of protease inhibitor therapy .
this epitope , which is hla-a2 restricted , includes two amino acids which will #mutate (v82a and i84v) in the face of protease inhibitor therapy .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , the activator-interaction domains in the complex were identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identified and #mutated the activator-interaction domains in the complex .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identify and #mutate the activator-interaction domains in the complex .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we will identify and #mutate the activator-interaction domains in the complex .
to #mutate amino acids ee(437 and 438) to aa can generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa has generated the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa is observed to generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa may generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa may have generated the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa might generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate amino acids ee(437 and 438) to aa would generate the dna-binding mutant(stat5aee-aa) of stat5a .
to #mutate the c-terminal map kinase sites (t235 and t239) , for example , essentially leads to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , for example , is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , in contrast , is observed to essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
to #mutate the c-terminal map kinase sites (t235 and t239) , in contrast , may have essentially led to abolished egf-stimulated increase in phosphorylation and prevented egf-induced mobility shift (figure 5c , lanes 7 and 8) .
the template fragments were #mutated by the sequence of sap97 rat , accession no .q62696 , using the program swiss pdb viewer (guex and peitsch , 1997) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we sought to identify and #mutate the activator-interaction domains in the complex .
analyses of transcription in vivo of agn-lacz with #mutated the activator-interaction domains in the complex support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex being #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with the activator-interaction domains in the complex which were #mutated support this conclusion .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) are able to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) are #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) are significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) could have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) could have been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have the ability to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) have the ability to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which s (64) and s (211) were significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a sox9 protein in which the two pka phosphorylation sites (the two pka phosphorylation sites (s (64) and s (211))) were #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat are able to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat are #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat could have already been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have already been significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have been #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have the ability to be #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat have the ability to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat were observed to be significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the sequence of sap97 rat were significantly #mutated .
in cos-7 cells cotransfected with pka-calpha and sox9 expression plasmids , pka enhanced the phosphorylation of wild-type sox9 but did not affect phosphorylation of a the template fragments in which the two pka phosphorylation sites (the sequence of sap97 rat) were #mutated .
sox9 protein are able to be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are able to be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are able to be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are observed to be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein are significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein can be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein can be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein can be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could have been #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could have been #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein could have been significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have been #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have been significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein have been significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein may be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein may be #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein may be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein may be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might have been #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein might have been significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein were #mutated by s (64) and s (211) , accession no .q62696 , using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein were #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 , using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein will be #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein will be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein would be significantly #mutated by s (64) and s (211) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
sox9 protein would be significantly #mutated by the two pka phosphorylation sites (s (64) and s (211)) , accession no .q62696 using the program swiss pdb viewer (guex and peitsch , 1997) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , dam target sequences were identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we found to identify and #mutate dam target sequences .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated dam target sequences .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identified and #mutated dam target sequences .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identify and #mutate dam target sequences .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we will identify and #mutate dam target sequences .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) that may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with amino acids ee(437 and 438) which have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene being #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene that may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with gene which have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with #mutated amino acids ee(437 and 438) support this conclusion .
analyses of transcription in vivo of agn-lacz with #mutated gene support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions that are #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions that can be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions that have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions that may have been #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions that were #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which are able to be #mutated support this conclusion .
analyses of transcription in vivo of agn-lacz with pairs of residue positions which have been #mutated support this conclusion .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , amino acids ee(437 and 438) have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , amino acids ee(437 and 438) will be identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , gene were identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , gene will be identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , pairs of residue positions have been identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , pairs of residue positions will be identified and #mutated .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we found to identify and #mutate gene .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we found to identify and #mutate pairs of residue positions .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we have identified and #mutated pairs of residue positions .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identified and #mutated gene .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identify and #mutate amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we identify and #mutate pairs of residue positions .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we sought to identify and #mutate amino acids ee(437 and 438) .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we sought to identify and #mutate gene .
to determine how activators interact with the complex and to examine the importance of these interactions , relative to other potential targeting mechanisms , for swi/snf function , we will identify and #mutate gene .
adult naive t cells , which are at rest in normal conditions , are able to #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , are observed to #proliferate strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , can #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , can strongly #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , could have #proliferated strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , could have strongly #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , have the ability to #proliferate when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , might have #proliferated strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , might have #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , might have strongly #proliferated when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , #proliferated strongly when transferred to lymphopenic hosts .
adult naive t cells , which are at rest in normal conditions , #proliferated when transferred to lymphopenic hosts .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells are observed to cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells ceasing to #proliferate and underwent apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells have ceased to #proliferate and underwent apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells have the ability to cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells having the ability to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells may cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that can cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that ceased to #proliferate and underwent apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that have ceased to #proliferate and undergo apoptosis caused tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that have the ability to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells that may cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells will cease to #proliferate and undergo apoptosis , causing tumor regression .
cancer cells are believed to be characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells are believed to be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells can be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells has been characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells has been characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells may be characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells may be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells was characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells was characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
cancer cells wil be characterized by either an increased ability for strong #proliferating or a diminished capacity to undergo programmed cell death .
our observations illustrate that the human placenta can be endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta is able to be endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta is able to be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta is shown to be endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta is shown to be endowed with the biochemical machinery to #proliferate throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that the human placenta was endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
stat5ab-/-peripheral t cells are able to regain the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells are able to regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells are observed to regain the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells are observed to regain the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells have regained the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells have the probability of regaining the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells have the probability of regaining the ability to #proliferate upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells may have regained the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
stat5ab-/-peripheral t cells will regain the ability to #proliferate indefinitely upon introduction of full-length wild-type stat5a (figure 6b) .
the ability of ebd cells being observed to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells being observed to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells having #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells having the ability to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells #proliferating in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that have #proliferated in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that is able to #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that is observed to #proliferate strongly in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
the ability of ebd cells that may #proliferate in vivo was examined by injection of 3 ? 106 lvec cells into the calf muscle of 3 immunocompromised mice .
after androgen withdrawal and antiandrogen treatment , the androgen responsive prostate cancer cells cease to #proliferate and undergo apoptosis , causing tumor regression .
cancer cells are characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
our observations illustrate that the human placenta is endowed with the biochemical machinery to #proliferate indefinitely throughout gestation , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
adult naive t cells are able to regain the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells can regain the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells can regain the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells have the probability of regaining the ability to #proliferate when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells may have regained the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
adult naive t cells regained the ability to #proliferate indefinitely when transferred to lymphopenic hosts (figure 6b) .
after androgen withdrawal and antiandrogen treatment , cancer cells are able to cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells are observed to cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells being observed to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells can cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells have ceased to #proliferate and underwent apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells have the ability to cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells having the ability to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells may cease to #proliferate and undergo apoptosis , causing tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that are able to cease to #proliferate and undergo apoptosis will cause tumor regression .
after androgen withdrawal and antiandrogen treatment , cancer cells that ceased to #proliferate and underwent apoptosis caused tumor regression .
our observations illustrate that adult naive t cells can be endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells has been endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is able to be endowed with the biochemical machinery to #proliferate indefinitely when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells is able to be endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells may have been endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells was endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that adult naive t cells will be endowed with the biochemical machinery to #proliferate when transferred to lymphopenic hosts , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells can be endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells can be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells has been endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells has the ability to be endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells is shown to be endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells may have been endowed with the biochemical machinery to #proliferate upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells was endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
our observations illustrate that stat5ab-/-peripheral t cells will be endowed with the biochemical machinery to #proliferate indefinitely upon introduction of full-length wild-type stat5a , yet , there are intrinsic mechanisms that effectively circumscribe the extent and duration of trophoblast proliferation .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , are able to #proliferate strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , are observed to #proliferate strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , are observed to #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , can #proliferate strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , can #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , could have #proliferated strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , could have strongly #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , have the ability to #proliferate strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , have the ability to #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , may #proliferate upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , #proliferate strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , #proliferated strongly upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , #proliferated upon introduction of full-length wild-type stat5a .
stat5ab-/-peripheral t cells , which are at rest in normal conditions , will #proliferate strongly upon introduction of full-length wild-type stat5a .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , can impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , can significantly impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to significantly impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impairs their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to significantly impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to impair their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of adult naive t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , significantly impaired their capacity to #proliferate when transferred to lymphopenic hosts .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , can impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has impaired their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has significantly impaired their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to significantly impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impairs their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is observed to impair their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of stat5ab-/-peripheral t cells of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , significantly impaired their capacity to #proliferate upon introduction of full-length wild-type stat5a .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , can impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , can significantly impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has impaired their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , has the ability to impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impaired their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , impairs their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , is able to significantly impair their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , significantly impaired their capacity to #proliferate throughout gestation .
treatment of the human placenta of different origin with the ganglioside biosynthesis inhibitors fumonisin b1 , d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol or d-1-threo-1-phenyl-2-hexa-decanoylamino-3-pyrrolidino-1-propanol-hcl , will significantly impair their capacity to #proliferate throughout gestation .
the androgen responsive prostate cancer cells are believed to be characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells are characterized by either an increased ability for strong #proliferating or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells can be characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells can be characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells may be characterized by either an increased ability to #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells was characterized by either an increased ability to strongly #proliferate or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells wil be characterized by either an increased ability for #proliferating or a diminished capacity to undergo programmed cell death .
the androgen responsive prostate cancer cells wil be characterized by either an increased ability for strong #proliferating or a diminished capacity to undergo programmed cell death .
the human placenta can regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta have regained the ability to #proliferate throughout gestation (figure 6b) .
the human placenta have the probability of regaining the ability to #proliferate throughout gestation (figure 6b) .
the human placenta will regain the ability to #proliferate throughout gestation (figure 6b) .
the human placenta , which are at rest in normal conditions , are observed to #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , can #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , can strongly #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , could have #proliferated strongly throughout gestation .
the human placenta , which are at rest in normal conditions , could have #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , could have strongly #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , have #proliferated throughout gestation .
the human placenta , which are at rest in normal conditions , have the ability to #proliferate strongly throughout gestation .
the human placenta , which are at rest in normal conditions , may #proliferate throughout gestation .
the human placenta , which are at rest in normal conditions , might have #proliferated strongly throughout gestation .
the human placenta , which are at rest in normal conditions , #proliferated strongly throughout gestation .
adult naive t cells , which are at rest in normal conditions , #proliferate strongly when transferred to lymphopenic hosts .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle is #recognized by anti-64kd human autoantigen d1 antibodies .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle will be #recognized by anti-64kd human autoantigen d1 antibodies .
affinity-purified polyclonal anti-lmp-1 antiserum #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
anti-64kd human autoantigen d1 antibodies #recognized specifically a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum #recognizing epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution are #recognized by affinity-purified polyclonal anti-lmp-1 antiserum that blots were probed with .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins are able to #recognize short motifs within the protected region .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the proteins #recognized short motifs within the protected region .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the stat1 n-terminus are #recognized by a monoclonal antibody .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the stat1 n-terminus were #recognized by a monoclonal antibody .
the narl protein will binds to these 7-2-7 sites but , unlike narp , will also #recognize heptamers in other arrangements .
the stat1 n-terminus are #recognized by a monoclonal antibody purchasing from transduction laboratories (lexington , ky) .
the two forms of stat3 (stat3fm and stat3sm) that are #recognized by this antibody in pkr+/+mefs are indicated .
the two forms of stat3 (stat3fm and stat3sm) that were #recognized by this antibody in pkr+/+mefs are indicated .
the two forms of stat3 (stat3fm and stat3sm) that will be #recognized by this antibody in pkr+/+mefs are indicated .
the two forms of stat3 (stat3fm and stat3sm) which can be #recognized by this antibody in pkr+/+mefs are indicated .
these mutations , identified by standard methods of reverse transcription , pcr ,dideoxy-chain termination , and cycle sequencing , alter highly conserved sequences at intron/exon boundaries and cause the normal splice junction not to be properly #recognized by the rna-splicing apparatus .
we show that the camp-crp activator complex has #recognized two sites in tsx-p2 that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the camp-crp activator complex #recognized two sites in tsx-p2 that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the camp-crp activator complex will #recognize two sites in tsx-p2 that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
two sites in tsx-p2 were #recognized by the camp-crp activator complex .
blots were probed with affinity-purified polyclonal anti-lmp-1 antiserum that #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody #recognizing the stat1 n-terminus , and by western blotting .
the eukaryotic upstream binding factor (ubf) , #recognizes the ribosomal rna gene promoter and activates transcription mediated by rna polymerase i through cooperative interactions with the species-specific factor , sl1 .
anti-64kd human autoantigen d1 antibodies #recognize specifically a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
exactly how specific splice sites are #recognized during the processing of complex precursor messenger rnas is not clear .
a monoclonal antibody also binds to these 7-2-7 sites but , unlike narp , also #recognizes the stat1 n-terminus .
a monoclonal antibody has also bound to these 7-2-7 sites but , unlike narp , has also #recognized the stat1 n-terminus .
a monoclonal antibody #recognize specifically the stat1 n-terminus .
anti-64kd human autoantigen d1 antibodies also binds to these 7-2-7 sites but , unlike narp , also #recognizes a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
anti-64kd human autoantigen d1 antibodies also bound to these 7-2-7 sites but , unlike narp , also #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
anti-64kd human autoantigen d1 antibodies are able to #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle in the regulated promoters .
anti-64kd human autoantigen d1 antibodies can #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle in the regulated promoters .
anti-64kd human autoantigen d1 antibodies have #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle in the regulated promoters .
anti-64kd human autoantigen d1 antibodies #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle in the regulated promoters .
anti-64kd human autoantigen d1 antibodies which #recognizes a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle is purchased from transduction laboratories (lexington , ky) .
anti-64kd human autoantigen d1 antibodies will #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle in the regulated promoters .
blots were probed with a monoclonal antibody that #recognizes the the stat1 n-terminus .
blots were probed with anti-64kd human autoantigen d1 antibodies that #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with anti-64kd human autoantigen d1 antibodies that #recognizes the a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with anti-64kd human autoantigen d1 antibodies that #recognizes the a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
blots were probed with the narl protein that #recognized heptamers in other arrangements .
blots were probed with the narl protein that #recognizes heptamers in other arrangements .
blots were probed with the narl protein that #recognizes the heptamers in other arrangements .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognizing sequence(ypydvpdya) at a 1:500 dilution .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that can #recognize sequence(ypydvpdya) at a 1:500 dilution .
blots were probed with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognizes the sequence(ypydvpdya) at a 1:500 dilution , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with a monoclonal antibody #recognizing the stat1 n-terminus .
blots were probed with the camp-crp activator complex #recognizing two sites in tsx-p2 .
blots were probed with the camp-crp activator complex that can #recognize two sites in tsx-p2 .
blots were probed with the camp-crp activator complex that #recognizes the two sites in tsx-p2 .
blots were probed with the camp-crp activator complex that #recognizes two sites in tsx-p2 .
blots were probed with the proteins that can #recognize short motifs within the protected region .
blots were probed with the proteins that #recognized short motifs within the protected region .
blots were probed with the proteins that #recognizes the short motifs within the protected region , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
blots were probed with the proteins that #recognizes the short motifs within the protected region .
blots were probed with this antibody in pkr+/+mefs that can #recognize the two forms of stat3 (stat3fm and stat3sm) .
blots were probed with this antibody in pkr+/+mefs that #recognizes the two forms of stat3 (stat3fm and stat3sm) .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody can #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody #recognized the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that anti-64kd human autoantigen d1 antibodies are able to #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that anti-64kd human autoantigen d1 antibodies can #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that anti-64kd human autoantigen d1 antibodies #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein can #recognize heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the narl protein has #recognized heptamers in other arrangements .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a rat monoclonal anti-ha antibody (boehringer-ingelheim) are able to #recognize sequence(ypydvpdya) at a 1:500 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a rat monoclonal anti-ha antibody (boehringer-ingelheim) has #recognized sequence(ypydvpdya) at a 1:500 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognize sequence(ypydvpdya) at a 1:500 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody can #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody has #recognized the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody #recognize the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that a monoclonal antibody #recognized the stat1 n-terminus .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that affinity-purified polyclonal anti-lmp-1 antiserum #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex has #recognized two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the camp-crp activator complex #recognized two sites in tsx-p2 .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that this antibody in pkr+/+mefs are able to #recognize the two forms of stat3 (stat3fm and stat3sm) .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that this antibody in pkr+/+mefs can #recognize the two forms of stat3 (stat3fm and stat3sm) .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that this antibody in pkr+/+mefs has #recognized the two forms of stat3 (stat3fm and stat3sm) .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that this antibody in pkr+/+mefs #recognize the two forms of stat3 (stat3fm and stat3sm) .
individual cell clones were analyzed for stat1 expression by immunofluorescence where a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle were #recognized by anti-64kd human autoantigen d1 antibodies .
individual cell clones were analyzed for stat1 expression by immunofluorescence where epitopes in the c-terminus of lmp-1 at a 1:200 dilution were #recognized by affinity-purified polyclonal anti-lmp-1 antiserum .
individual cell clones were analyzed for stat1 expression by immunofluorescence where heptamers in other arrangements are #recognized by the narl protein .
individual cell clones were analyzed for stat1 expression by immunofluorescence where heptamers in other arrangements were #recognized by the narl protein .
individual cell clones were analyzed for stat1 expression by immunofluorescence where short motifs within the protected region were #recognized by the proteins .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody #recognizing the stat1 n-terminus , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with a monoclonal antibody which #recognizes the stat1 n-terminus , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with anti-64kd human autoantigen d1 antibodies #recognizing a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with anti-64kd human autoantigen d1 antibodies which #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with anti-64kd human autoantigen d1 antibodies which #recognizes a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the narl protein #recognizing heptamers in other arrangements , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the narl protein which #recognized heptamers in other arrangements , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with affinity-purified polyclonal anti-lmp-1 antiserum #recognizing epitopes in the c-terminus of lmp-1 at a 1:200 dilution , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with affinity-purified polyclonal anti-lmp-1 antiserum which #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with affinity-purified polyclonal anti-lmp-1 antiserum which #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the proteins #recognizing short motifs within the protected region , and by western blotting .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the proteins which #recognized short motifs within the protected region , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with the proteins which #recognizes short motifs within the protected region , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with this antibody in pkr+/+mefs which #recognized the two forms of stat3 (stat3fm and stat3sm) , and by western blotting
individual cell clones were analyzed for stat1 expression by immunofluorescence with this antibody in pkr+/+mefs which #recognizes the two forms of stat3 (stat3fm and stat3sm) , and by western blotting
the narl protein can #recognize heptamers in other arrangements in the regulated promoters .
the narl protein have #recognized heptamers in other arrangements in the regulated promoters .
the narl protein #recognize heptamers in other arrangements in the regulated promoters .
the narl protein #recognized specifically heptamers in other arrangements .
the narl protein #recognizing heptamers in other arrangements was purchased from transduction laboratories (lexington , ky) .
the narl protein will #recognize heptamers in other arrangements in the regulated promoters .
the the two forms of stat3 (stat3fm and stat3sm) is #recognized by this antibody in pkr+/+mefs that blots were probed with .
the epitopes in the c-terminus of lmp-1 at a 1:200 dilution is #recognized by affinity-purified polyclonal anti-lmp-1 antiserum that blots were probed with .
the heptamers in other arrangements is #recognized by the narl protein that blots were probed with .
the short motifs within the protected region is #recognized by the proteins that blots were probed with .
the the stat1 n-terminus is #recognized by a monoclonal antibody that blots were probed with .
the the stat1 n-terminus is #recognized by a monoclonal antibody that blots were probed with .
the two forms of stat3 (stat3fm and stat3sm) were #recognized by this antibody in pkr+/+mefs .
the two forms of stat3 (stat3fm and stat3sm) , could not be #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the two forms of stat3 (stat3fm and stat3sm) , has not been #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the two forms of stat3 (stat3fm and stat3sm) , is not #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the two forms of stat3 (stat3fm and stat3sm) , was not #recognized in the immunoprecipitaiton with this antibody in pkr+/+mefs as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
these bands can be detected with a monoclonal antibody #recognizing the stat1 n-terminus
these bands can be detected with a monoclonal antibody that #recognized the stat1 n-terminus
these bands can be detected with anti-64kd human autoantigen d1 antibodies #recognizing a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle
these bands can be detected with anti-64kd human autoantigen d1 antibodies that #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle
these bands can be detected with anti-64kd human autoantigen d1 antibodies which have #recognized a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle
these bands can be detected with anti-64kd human autoantigen d1 antibodies which #recognize a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle
these bands can be detected with the narl protein that #recognized heptamers in other arrangements
these bands can be detected with the narl protein which have #recognized heptamers in other arrangements
these bands can be detected with a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognizing sequence(ypydvpdya) at a 1:500 dilution
these bands can be detected with a rat monoclonal anti-ha antibody (boehringer-ingelheim) that #recognized sequence(ypydvpdya) at a 1:500 dilution
these bands can be detected with a rat monoclonal anti-ha antibody (boehringer-ingelheim) which have #recognized sequence(ypydvpdya) at a 1:500 dilution
these bands can be detected with a rat monoclonal anti-ha antibody (boehringer-ingelheim) which #recognize sequence(ypydvpdya) at a 1:500 dilution
these bands can be detected with a monoclonal antibody #recognizing the stat1 n-terminus
these bands can be detected with a monoclonal antibody that #recognize the stat1 n-terminus
these bands can be detected with a monoclonal antibody that #recognized the stat1 n-terminus
these bands can be detected with a monoclonal antibody which #recognize the stat1 n-terminus
these bands can be detected with affinity-purified polyclonal anti-lmp-1 antiserum that #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution
these bands can be detected with affinity-purified polyclonal anti-lmp-1 antiserum which have #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution
these bands can be detected with affinity-purified polyclonal anti-lmp-1 antiserum which #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution
these bands can be detected with the camp-crp activator complex that #recognize two sites in tsx-p2
these bands can be detected with the camp-crp activator complex which #recognize two sites in tsx-p2
these bands can be detected with the proteins that #recognize short motifs within the protected region
these bands can be detected with this antibody in pkr+/+mefs #recognizing the two forms of stat3 (stat3fm and stat3sm)
these bands can be detected with this antibody in pkr+/+mefs that #recognize the two forms of stat3 (stat3fm and stat3sm)
these bands can be detected with this antibody in pkr+/+mefs which have #recognized the two forms of stat3 (stat3fm and stat3sm)
we show that a monoclonal antibody has #recognized the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a monoclonal antibody #recognized the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a monoclonal antibody will #recognize the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the narl protein has #recognized heptamers in other arrangements that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a monoclonal antibody has #recognized the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a monoclonal antibody #recognized the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that a monoclonal antibody #recognizes the stat1 n-terminus that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that affinity-purified polyclonal anti-lmp-1 antiserum has #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that affinity-purified polyclonal anti-lmp-1 antiserum #recognizes epitopes in the c-terminus of lmp-1 at a 1:200 dilution that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the proteins #recognized short motifs within the protected region that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the proteins #recognizes short motifs within the protected region that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the proteins will #recognize short motifs within the protected region that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that this antibody in pkr+/+mefs has #recognized the two forms of stat3 (stat3fm and stat3sm) that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) also binds to these 7-2-7 sites but , unlike narp , also #recognizes sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) also bound to these 7-2-7 sites but , unlike narp , also #recognized sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) are able to #recognize sequence(ypydvpdya) at a 1:500 dilution in the regulated promoters .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) can #recognize sequence(ypydvpdya) at a 1:500 dilution in the regulated promoters .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) have #recognized sequence(ypydvpdya) at a 1:500 dilution in the regulated promoters .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognize sequence(ypydvpdya) at a 1:500 dilution in the regulated promoters .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognize specifically sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognized sequence(ypydvpdya) at a 1:500 dilution in the regulated promoters .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) #recognizing sequence(ypydvpdya) at a 1:500 dilution was purchased from transduction laboratories (lexington , ky) .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) which #recognizes sequence(ypydvpdya) at a 1:500 dilution is purchased from transduction laboratories (lexington , ky) .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) will binds to these 7-2-7 sites but , unlike narp , will also #recognize sequence(ypydvpdya) at a 1:500 dilution .
a rat monoclonal anti-ha antibody (boehringer-ingelheim) will #recognize sequence(ypydvpdya) at a 1:500 dilution in the regulated promoters .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle are #recognized by anti-64kd human autoantigen d1 antibodies .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle that were #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle were #recognized by anti-64kd human autoantigen d1 antibodies .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle which were #recognized by anti-64kd human autoantigen d1 antibodies are indicated .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , could not be #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
a approximately 70kd polypeptide in western blots of extraocular muscle , sternothyroid muscle , and smooth muscle , has not been #recognized in the immunoprecipitaiton with anti-64kd human autoantigen d1 antibodies as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
a monoclonal antibody also binds to these 7-2-7 sites but , unlike narp , also #recognizes the stat1 n-terminus .
a monoclonal antibody has also bound to these 7-2-7 sites but , unlike narp , has also #recognized the stat1 n-terminus .
a monoclonal antibody have #recognized the stat1 n-terminus in the regulated promoters .
a monoclonal antibody which #recognizes the stat1 n-terminus is purchased from transduction laboratories (lexington , ky) .
a monoclonal antibody will binds to these 7-2-7 sites but , unlike narp , will also #recognize the stat1 n-terminus .
affinity-purified polyclonal anti-lmp-1 antiserum also bound to these 7-2-7 sites but , unlike narp , also #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum has also bound to these 7-2-7 sites but , unlike narp , has also #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum #recognize specifically epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
affinity-purified polyclonal anti-lmp-1 antiserum which has #recognized epitopes in the c-terminus of lmp-1 at a 1:200 dilution was purchased from transduction laboratories (lexington , ky) .
affinity-purified polyclonal anti-lmp-1 antiserum will binds to these 7-2-7 sites but , unlike narp , will also #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution .
affinity-purified polyclonal anti-lmp-1 antiserum will #recognize epitopes in the c-terminus of lmp-1 at a 1:200 dilution in the regulated promoters .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution are #recognized by affinity-purified polyclonal anti-lmp-1 antiserum .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution that have been #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution that will be #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution which were #recognized by affinity-purified polyclonal anti-lmp-1 antiserum are indicated .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , cannot be #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , could not be #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , has not been #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
epitopes in the c-terminus of lmp-1 at a 1:200 dilution , will not be #recognized in the immunoprecipitaiton with affinity-purified polyclonal anti-lmp-1 antiserum as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements that are #recognized by the narl protein are indicated .
heptamers in other arrangements that were #recognized by the narl protein are indicated .
heptamers in other arrangements were #recognized by the narl protein .
heptamers in other arrangements which were #recognized by the narl protein are indicated .
heptamers in other arrangements , cannot be #recognized in the immunoprecipitaiton with the narl protein as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements , could not be #recognized in the immunoprecipitaiton with the narl protein as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements , has not been #recognized in the immunoprecipitaiton with the narl protein as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
heptamers in other arrangements , was not #recognized in the immunoprecipitaiton with the narl protein as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution are #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) .
sequence(ypydvpdya) at a 1:500 dilution #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution that will be #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) are indicated .
sequence(ypydvpdya) at a 1:500 dilution were #recognized by a rat monoclonal anti-ha antibody (boehringer-ingelheim) .
sequence(ypydvpdya) at a 1:500 dilution , cannot be #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution , could not be #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution , is not #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
sequence(ypydvpdya) at a 1:500 dilution , will not be #recognized in the immunoprecipitaiton with a rat monoclonal anti-ha antibody (boehringer-ingelheim) as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region that have been #recognized by the proteins are indicated .
short motifs within the protected region that were #recognized by the proteins are indicated .
short motifs within the protected region were #recognized by the proteins .
short motifs within the protected region which can be #recognized by the proteins are indicated .
short motifs within the protected region , could not be #recognized in the immunoprecipitaiton with the proteins as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region , is not #recognized in the immunoprecipitaiton with the proteins as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
short motifs within the protected region , will not be #recognized in the immunoprecipitaiton with the proteins as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus are #recognized by a monoclonal antibody .
the stat1 n-terminus #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that were #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that were #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus that will be #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus were #recognized by a monoclonal antibody .
the stat1 n-terminus which can be #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus which were #recognized by a monoclonal antibody are indicated .
the stat1 n-terminus , cannot be #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , could not be #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , has not been #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , was not #recognized in the immunoprecipitaiton with a monoclonal antibody as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , will not be #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the stat1 n-terminus , will not be #recognized in the immunoprecipitaiton with a monoclonal antibody as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the camp-crp activator complex also binds to these 7-2-7 sites but , unlike narp , also #recognizes two sites in tsx-p2 .
the camp-crp activator complex are able to #recognize two sites in tsx-p2 in the regulated promoters .
the camp-crp activator complex can #recognize two sites in tsx-p2 in the regulated promoters .
the camp-crp activator complex have #recognized two sites in tsx-p2 in the regulated promoters .
the camp-crp activator complex #recognize specifically two sites in tsx-p2 .
the camp-crp activator complex #recognized two sites in tsx-p2 in the regulated promoters .
the camp-crp activator complex which #recognizes two sites in tsx-p2 is purchased from transduction laboratories (lexington , ky) .
the camp-crp activator complex will binds to these 7-2-7 sites but , unlike narp , will also #recognize two sites in tsx-p2 .
the proteins also bound to these 7-2-7 sites but , unlike narp , also #recognized short motifs within the protected region .
the proteins are able to #recognize short motifs within the protected region in the regulated promoters .
the proteins has also bound to these 7-2-7 sites but , unlike narp , has also #recognized short motifs within the protected region .
the proteins #recognize short motifs within the protected region in the regulated promoters .
the proteins which has #recognized short motifs within the protected region was purchased from transduction laboratories (lexington , ky) .
the proteins will binds to these 7-2-7 sites but , unlike narp , will also #recognize short motifs within the protected region .
this antibody in pkr+/+mefs are able to #recognize the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
this antibody in pkr+/+mefs can #recognize the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
this antibody in pkr+/+mefs has also bound to these 7-2-7 sites but , unlike narp , has also #recognized the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs have #recognized the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
this antibody in pkr+/+mefs #recognize specifically the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs #recognized specifically the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs will binds to these 7-2-7 sites but , unlike narp , will also #recognize the two forms of stat3 (stat3fm and stat3sm) .
this antibody in pkr+/+mefs will #recognize the two forms of stat3 (stat3fm and stat3sm) in the regulated promoters .
two sites in tsx-p2 #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 that are #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 that have been #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 that were #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 that will be #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 which were #recognized by the camp-crp activator complex are indicated .
two sites in tsx-p2 , cannot be #recognized in the immunoprecipitaiton with the camp-crp activator complex as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
two sites in tsx-p2 , has not been #recognized in the immunoprecipitaiton with the camp-crp activator complex as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
two sites in tsx-p2 , is not #recognized in the immunoprecipitaiton with the camp-crp activator complex as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
two sites in tsx-p2 , was not #recognized in the immunoprecipitaiton with the camp-crp activator complex as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
blots were probed with the rna-splicing apparatus that #recognized the normal splice junction .
blots were probed with the rna-splicing apparatus that #recognizes the the normal splice junction , or with rabbit polyclonal anti-gfp or anti-rfp (clontech) antiserum at a 1:250 dilution .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the rna-splicing apparatus can #recognize the normal splice junction .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the rna-splicing apparatus has #recognized the normal splice junction .
footprinting assays have suggested that these regulators protect a stretch of up to 20 bp in the target promoters , and multiple alignments of binding sites for a number of regulators have shown that the rna-splicing apparatus #recognize the normal splice junction .
individual cell clones were analyzed for stat1 expression by immunofluorescence where the normal splice junction are #recognized by the rna-splicing apparatus .
individual cell clones were analyzed for stat1 expression by immunofluorescence with the rna-splicing apparatus which #recognized the normal splice junction , and by western blotting
these bands can be detected with the rna-splicing apparatus #recognizing the normal splice junction
these bands can be detected with the rna-splicing apparatus that #recognize the normal splice junction
these bands can be detected with the rna-splicing apparatus that #recognized the normal splice junction
these bands can be detected with the rna-splicing apparatus which have #recognized the normal splice junction
we show that the rna-splicing apparatus has #recognized the normal splice junction that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
we show that the rna-splicing apparatus #recognized the normal splice junction that are separated by 33 bp : a high-affinity site (crp-1) overlaps the-35 region , and a low-affinity site (crp-2) is centered around position-74 bp .
the rna-splicing apparatus also binds to these 7-2-7 sites but , unlike narp , also #recognizes the normal splice junction .
the rna-splicing apparatus has also bound to these 7-2-7 sites but , unlike narp , has also #recognized the normal splice junction .
the rna-splicing apparatus have #recognized the normal splice junction in the regulated promoters .
the rna-splicing apparatus #recognize specifically the normal splice junction .
the rna-splicing apparatus #recognize the normal splice junction in the regulated promoters .
the rna-splicing apparatus #recognized specifically the normal splice junction .
the rna-splicing apparatus #recognizing the normal splice junction was purchased from transduction laboratories (lexington , ky) .
the rna-splicing apparatus which #recognizes the normal splice junction is purchased from transduction laboratories (lexington , ky) .
the rna-splicing apparatus will binds to these 7-2-7 sites but , unlike narp , will also #recognize the normal splice junction .
the rna-splicing apparatus will #recognize the normal splice junction in the regulated promoters .
the normal splice junction #recognized by the rna-splicing apparatus are indicated .
the normal splice junction that were #recognized by the rna-splicing apparatus are indicated .
the normal splice junction that will be #recognized by the rna-splicing apparatus are indicated .
the normal splice junction , cannot be #recognized in the immunoprecipitaiton with the rna-splicing apparatus as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the normal splice junction , could not be #recognized in the immunoprecipitaiton with the rna-splicing apparatus as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the normal splice junction , has not been #recognized in the immunoprecipitaiton with the rna-splicing apparatus as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
the normal splice junction , is not #recognized in the immunoprecipitaiton with the rna-splicing apparatus as it is raised against a c-terminal region of stat3 that is missing in stat3beta .
the normal splice junction , was not #recognized in the immunoprecipitaiton with the rna-splicing apparatus as it was raised against a c-terminal region of stat3 that is missing in stat3beta .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that can #result in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that has the ability to #result in a clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , has #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , has the ability to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , is able to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , is observed to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling , conferred by either an activated egl-15 or a lf clr-1 mutation , may #result in a clr phenotype .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are observed to #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation could have #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have the ability to #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , are able to #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , are observed to #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , could have #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , have #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , have the ability to #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , will #result in mrna species with distinct 5utrs .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) are able to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) have the ability to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , are able to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , can #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , have the ability to #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , may have #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , #resulted in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
both the 5 and 3 splice site mutations (1060 + 2t-->c and 678-7g-->a , respectively) , in contrast , will #result in high proportions of mature mrnas containing introns , which has not been observed for other splicing mutations .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 being able to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 that is able to #result in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 that may have #resulted in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 that #resulted in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 which #results in the substitution of isoleucine for valine .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a new mutation at codon 210 which will #result in the substitution of isoleucine for valine .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains being able to completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains being able to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains being observed to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which are able to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which completely #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which have completely #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which have #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which have the ability to #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which may have completely #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which may have #resulted in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which #result in a super-repeat .
human mucin gene muc5b , the 10 .7-kb large central exon encodes various alternate subdomains which will completely #result in a super-repeat .
induction of a mutation in the laci gene is observed to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene may #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , can #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , could have #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , has #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , has the ability to #result in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , #resulted in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , #results in the loss of transcriptional repression of the lacz gene in mutated cells .
induction of a mutation in the laci gene , as our study revealed , will #result in the loss of transcriptional repression of the lacz gene in mutated cells .
mutations having the ability to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that are observed to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that can #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that have #resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that have the ability to #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations that will #result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites are able to #result in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites are observed to #result in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites can #result in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites have #resulted in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites may have #resulted in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites may #result in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites #result in simultaneous derepression of both genes .
mutations which prevent repressor binding to either site or alter the phasing of the binding sites will #result in simultaneous derepression of both genes .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins is able to #result from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins is observed to #result from alternative splicing of a single transcript .
sequence analysis of the idhbeta gene indicates that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins will #result from alternative splicing of a single transcript .
the change may cause the heat instability and affect the net charge of the variant subunit being able to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit being observed to #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit being shown to #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit having finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit that has finally #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit that has #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit that will #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which can #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which has been shown to #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which is able to #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which is observed to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which is observed to #result in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which may have #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which #resulted in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect the net charge of the variant subunit which #results in an electrophoretic ldh-b subunit variant of the fast type .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) are able to #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) are observed to #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) can #result in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) have #resulted in truncated nonfunctional proteins .
two are missense mutations in exon 2 (g339d and r340c) , and the other three alterations (a nonsense mutation , a frameshift , and a splicing mutation) #result in truncated nonfunctional proteins .
we show that the negative effect of the cpxa mutation on biofilm formation has been shown to #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation has #resulted from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation has the ability to #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation is observed to #result from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation may have #resulted from a decreased transcription of the curlin encoding csga gene .
we show that the negative effect of the cpxa mutation on biofilm formation #resulted from a decreased transcription of the curlin encoding csga gene .
we speculated that this has been shown to be the #result of the expression of isoforms of nrf1 in mast cells .
we speculated that this may be the #result of the expression of isoforms of nrf1 in mast cells .
we speculated that this may be the #result of the expression of isoforms of nrf1 in mast cells .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect the net charge of the variant subunit , #resulting in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 having #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that is able to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 that #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 which can #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of the expression of isoforms of nrf1 which #results in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 having #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 #resulting in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 that has the ability to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 that is observed to #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 that #resulted in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 which can #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 which #results in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the expression of isoforms of nrf1 which will #result in this .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit having #resulted in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit that has the ability to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit that is able to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit that is observed to #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit which can #result in an electrophoretic ldh-b subunit variant of the fast type .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the net charge of the variant subunit which #results in an electrophoretic ldh-b subunit variant of the fast type .
the change may cause the heat instability and affect a new mutation at codon 210 being able to #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 being observed to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 being observed to #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 being shown to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 being shown to #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 that will finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 that will #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which can finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which can #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which finally #results in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which has been shown to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which is able to #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which is observed to finally #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect a new mutation at codon 210 which is observed to #result in the substitution of isoleucine for valine .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being able to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being able to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being observed to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 being shown to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 having #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 that has #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which can finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which finally #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which finally #results in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which has been shown to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which is able to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which is observed to finally #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which is observed to #result in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which may have finally #resulted in this .
the change may cause the heat instability and affect of the expression of isoforms of nrf1 which #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 being able to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 having #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 that has finally #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 that has #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 that will finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 that will #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which can #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which finally #results in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which has been shown to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which has been shown to #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which is able to finally #result in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which may have finally #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which may have #resulted in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 which #results in this .
the change may cause the heat instability and affect the expression of isoforms of nrf1 , #resulting in this .
we speculated that an electrophoretic ldh-b subunit variant of the fast type has been shown to be the #result of the net charge of the variant subunit in mast cells .
we speculated that an electrophoretic ldh-b subunit variant of the fast type is the #result of the net charge of the variant subunit in mast cells .
we speculated that an electrophoretic ldh-b subunit variant of the fast type may be the #result the net charge of the variant subunit in mast cells .
we speculated that the substitution of isoleucine for valine is observed to be the #result of a new mutation at codon 210 in mast cells .
we speculated that the substitution of isoleucine for valine may be the #result of a new mutation at codon 210 in mast cells .
we speculated that this has been shown to be the #result of of the expression of isoforms of nrf1 in mast cells .
we speculated that this is observed to be the #result of of the expression of isoforms of nrf1 in mast cells .
we speculated that this is the #result of of the expression of isoforms of nrf1 in mast cells .
we speculated that this may be the #result the expression of isoforms of nrf1 in mast cells .
a new mutation at codon 210 are able to finally #result in the substitution of isoleucine for valine .
a new mutation at codon 210 are observed to finally #result in the substitution of isoleucine for valine .
a new mutation at codon 210 can #result in the substitution of isoleucine for valine
a new mutation at codon 210 has finally #resulted in the substitution of isoleucine for valine .
a new mutation at codon 210 have the ability to finally #result in the substitution of isoleucine for valine .
a new mutation at codon 210 may finally #result in the substitution of isoleucine for valine .
a new mutation at codon 210 may have finally #resulted in the substitution of isoleucine for valine .
a new mutation at codon 210 may have #resulted in the substitution of isoleucine for valine .
a new mutation at codon 210 #resulted in the substitution of isoleucine for valine .
a new mutation at codon 210 will finally #result in the substitution of isoleucine for valine .
a new mutation at codon 210 will #result in the substitution of isoleucine for valine .
of the expression of isoforms of nrf1 can finally #result in this
of the expression of isoforms of nrf1 can #result in this
of the expression of isoforms of nrf1 has finally #resulted in this .
of the expression of isoforms of nrf1 have the ability to finally #result in this .
of the expression of isoforms of nrf1 have the ability to #result in this .
of the expression of isoforms of nrf1 may finally #result in this .
of the expression of isoforms of nrf1 may have finally #resulted in this .
of the expression of isoforms of nrf1 will finally #result in this .
the expression of isoforms of nrf1 are observed to finally #result in this .
the expression of isoforms of nrf1 are observed to #result in this .
the expression of isoforms of nrf1 can finally #result in this
the expression of isoforms of nrf1 can #result in this
the expression of isoforms of nrf1 may finally #result in this .
the expression of isoforms of nrf1 may have finally #resulted in this .
the expression of isoforms of nrf1 may have #resulted in this .
the net charge of the variant subunit are able to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit are observed to finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit are observed to #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit can #result in an electrophoretic ldh-b subunit variant of the fast type
the net charge of the variant subunit may finally #result in an electrophoretic ldh-b subunit variant of the fast type .
the net charge of the variant subunit may #result in an electrophoretic ldh-b subunit variant of the fast type .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling are able to finally #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling are observed to finally #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling are observed to #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling finally #result in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling has #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling may have #resulted in a clr phenotype .
a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling will #result in a clr phenotype .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are able to finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are observed to finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can finally #result in mrna species with distinct 5utrs
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can #result in mrna species with distinct 5utrs
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation has finally #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation has #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have the ability to finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may finally #result in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have finally #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , has #resulted in mrna species with distinct 5utrs .
alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , have the ability to finally #result in mrna species with distinct 5utrs .
both the 5 and 3 splice site mutations are able to #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations are observed to finally #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations can finally #result in high proportions of mature mrnas containing introns
both the 5 and 3 splice site mutations finally #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations has finally #resulted in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations has #resulted in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations have the ability to finally #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations may finally #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations may have finally #resulted in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations will finally #result in high proportions of mature mrnas containing introns .
both the 5 and 3 splice site mutations will #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being able to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling having #resulted in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that is able to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that is observed to #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that may have #resulted in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that #resulted in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which can #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which has #resulted in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which #results in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which will #result in a clr phenotype .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being observed to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation having #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that has the ability to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that may have #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which has #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which #results in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being able to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being observed to #result in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , #resulting in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that may have #resulted in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which #results in mrna species with distinct 5utrs .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations having the ability to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations that is able to #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations that may have #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations that #resulted in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations which can #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed both the 5 and 3 splice site mutations which will #result in high proportions of mature mrnas containing introns .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene being observed to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene having #resulted in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene having the ability to #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene #resulting in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene that may have #resulted in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene which can #result in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene which has #resulted in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed a decreased transcription of the curlin encoding csga gene which #results in the negative effect of the cpxa mutation .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript having the ability to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript #resulting in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript that has the ability to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript that is observed to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript that #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript which can #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed alternative splicing of a single transcript which will #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor having #resulted in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor #resulting in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor that has the ability to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor that is able to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor that is observed to #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor that may have #resulted in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor that #resulted in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor which can #result in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed of co-operative binding of the repressor which #results in that repression .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations being observed to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations having the ability to #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations #resulting in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that may have #resulted in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations that #resulted in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed the other three alterations which will #result in truncated nonfunctional proteins .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that is observed to #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains that #resulted in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains which can #result in a super-repeat .
complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of creutzfeldt-jakob disease (cjd) revealed various alternate subdomains which will #result in a super-repeat .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being able to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being observed to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling being observed to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that has finally #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling that has #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which can finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which finally #results in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which has been shown to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which is able to finally #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which is observed to #result in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which may have finally #resulted in a clr phenotype .
the change may cause the heat instability and affect a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling which #results in a clr phenotype .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being able to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being able to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being observed to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being observed to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being shown to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation having finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that has finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that will finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which finally #results in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which is able to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which is observed to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which may have finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which #results in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being able to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being able to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being observed to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , being shown to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that has #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , that will finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which can #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which has been shown to finally #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which has been shown to #result in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , which may have finally #resulted in mrna species with distinct 5utrs .
the change may cause the heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , , #resulting in mrna species with distinct 5utrs .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being able to finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being observed to finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations being shown to finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations having #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations that has #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations that will #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which has been shown to finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which has been shown to #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which is able to finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which is observed to finally #result in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which may have #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which #resulted in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect both the 5 and 3 splice site mutations which #results in high proportions of mature mrnas containing introns .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene being able to finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene being able to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene being observed to finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene being shown to finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene being shown to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene having finally #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene that has finally #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene that has #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which can finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which finally #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which finally #results in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which has been shown to finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which has been shown to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which is observed to finally #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which is observed to #result in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect a decreased transcription of the curlin encoding csga gene which may have finally #resulted in the negative effect of the cpxa mutation .
the change may cause the heat instability and affect alternative splicing of a single transcript being able to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript being observed to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript being observed to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript being shown to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript that has finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript that has #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which can finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which finally #results in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which has been shown to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which is able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which is observed to finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which is observed to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which may have finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript which #results in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect alternative splicing of a single transcript , #resulting in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
the change may cause the heat instability and affect of co-operative binding of the repressor being able to #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor being observed to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor being observed to #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor being shown to finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor being shown to #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor having finally #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor having #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor that has finally #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor that will finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor that will #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which can finally #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which has been shown to #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which is able to #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which is observed to #result in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which #resulted in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor which #results in that repression .
the change may cause the heat instability and affect of co-operative binding of the repressor , #resulting in that repression .
the change may cause the heat instability and affect the other three alterations being observed to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations being shown to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations having finally #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations having #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations that has finally #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations that will #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which finally #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which finally #results in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which has been shown to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which is able to finally #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which is able to #result in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which may have finally #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect the other three alterations which #resulted in truncated nonfunctional proteins .
the change may cause the heat instability and affect various alternate subdomains being able to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains being observed to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains being shown to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains that will #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which can finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which can #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which finally #resulted in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which has been shown to finally #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which has been shown to #result in a super-repeat .
the change may cause the heat instability and affect various alternate subdomains which #resulted in a super-repeat .
we speculated that a clr phenotype has been shown to be the #result of a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling in mast cells .
we speculated that a clr phenotype is observed to be the #result of a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling in mast cells .
we speculated that a clr phenotype is the #result of a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling in mast cells .
we speculated that a clr phenotype may be the #result a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling in mast cells .
we speculated that a clr phenotype may be the #result of a role for sos-1 in fgfr-mediated signaling during development hyperactive egl-15 fgf receptor signaling in mast cells .
we speculated that a super-repeat has been shown to be the #result of various alternate subdomains in mast cells .
we speculated that a super-repeat is observed to be the #result of various alternate subdomains in mast cells .
we speculated that a super-repeat is the #result of various alternate subdomains in mast cells .
we speculated that high proportions of mature mrnas containing introns is observed to be the #result of both the 5 and 3 splice site mutations in mast cells .
we speculated that high proportions of mature mrnas containing introns may be the #result of both the 5 and 3 splice site mutations in mast cells .
we speculated that mrna species with distinct 5utrs is observed to be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation in mast cells .
we speculated that mrna species with distinct 5utrs is observed to be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , in mast cells .
we speculated that mrna species with distinct 5utrs may be the #result alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , in mast cells .
we speculated that mrna species with distinct 5utrs may be the #result of alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation , as our study suggested , in mast cells .
we speculated that that repression has been shown to be the #result of of co-operative binding of the repressor in mast cells .
we speculated that that repression is observed to be the #result of of co-operative binding of the repressor in mast cells .
we speculated that that repression may be the #result of co-operative binding of the repressor in mast cells .
we speculated that that repression may be the #result of of co-operative binding of the repressor in mast cells .
we speculated that the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins may be the #result alternative splicing of a single transcript in mast cells .
we speculated that the negative effect of the cpxa mutation has been shown to be the #result of a decreased transcription of the curlin encoding csga gene in mast cells .
we speculated that the negative effect of the cpxa mutation is the #result of a decreased transcription of the curlin encoding csga gene in mast cells .
we speculated that the negative effect of the cpxa mutation may be the #result a decreased transcription of the curlin encoding csga gene in mast cells .
we speculated that the negative effect of the cpxa mutation may be the #result of a decreased transcription of the curlin encoding csga gene in mast cells .
a decreased transcription of the curlin encoding csga gene are able to finally #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene are able to #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene are observed to #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene can finally #result in the negative effect of the cpxa mutation
a decreased transcription of the curlin encoding csga gene finally #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene has finally #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene have the ability to #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene may finally #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene may have finally #resulted in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene may #result in the negative effect of the cpxa mutation .
a decreased transcription of the curlin encoding csga gene will finally #result in the negative effect of the cpxa mutation .
alternative splicing of a single transcript are able to #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript can #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins
alternative splicing of a single transcript finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript has #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript may finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript may have finally #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript #resulted in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript will finally #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
alternative splicing of a single transcript will #result in the difference in the c-terminal 28 amino acids between beta(1) and beta(2) proteins .
of co-operative binding of the repressor are observed to finally #result in that repression .
of co-operative binding of the repressor can finally #result in that repression
of co-operative binding of the repressor can #result in that repression
of co-operative binding of the repressor finally #result in that repression .
of co-operative binding of the repressor has finally #resulted in that repression .
of co-operative binding of the repressor have the ability to finally #result in that repression .
of co-operative binding of the repressor have the ability to #result in that repression .
of co-operative binding of the repressor may finally #result in that repression .
of co-operative binding of the repressor may #result in that repression .
of co-operative binding of the repressor #resulted in that repression .
of co-operative binding of the repressor will finally #result in that repression .
the other three alterations are able to finally #result in truncated nonfunctional proteins .
the other three alterations are able to #result in truncated nonfunctional proteins .
the other three alterations has finally #resulted in truncated nonfunctional proteins .
the other three alterations has #resulted in truncated nonfunctional proteins .
the other three alterations have the ability to #result in truncated nonfunctional proteins .
the other three alterations may finally #result in truncated nonfunctional proteins .
the other three alterations may have finally #resulted in truncated nonfunctional proteins .
the other three alterations may have #resulted in truncated nonfunctional proteins .
the other three alterations may #result in truncated nonfunctional proteins .
the other three alterations #result in truncated nonfunctional proteins .
the other three alterations will finally #result in truncated nonfunctional proteins .
various alternate subdomains are able to #result in a super-repeat .
various alternate subdomains can #result in a super-repeat
various alternate subdomains has #resulted in a super-repeat .
various alternate subdomains have the ability to finally #result in a super-repeat .
various alternate subdomains have the ability to #result in a super-repeat .
various alternate subdomains may finally #result in a super-repeat .
various alternate subdomains may have finally #resulted in a super-repeat .
various alternate subdomains may have #resulted in a super-repeat .
various alternate subdomains may #result in a super-repeat .
various alternate subdomains #result in a super-repeat .
various alternate subdomains #resulted in a super-repeat .
various alternate subdomains will #result in a super-repeat .
a stop codon-containing exon (exon 4) has been finally #skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) has been shown to be finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) has the ability to be finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) has the probability of being finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) is able to be finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) is believed to be finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
a stop codon-containing exon (exon 4) will be finally #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing has been shown to finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing is likely to finally #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
alternative splicing may have finally #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) being observed to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) having #skipped exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) #skipping exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which can #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which has been shown to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which has #skipped exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which is able to #skip exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which may have #skipped exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which #skips exon 3 , an event that leads to peroxisome deficiency .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which will #skip exon 3 , an event that leads to peroxisome deficiency .
finally , a stop codon-containing exon (exon 4) has been #skipped by alternative splicing and generated a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) has the probability of being #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) is able to be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , a stop codon-containing exon (exon 4) is believed to be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing has #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing is able to #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing is likely to #skip a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing #skipped a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
finally , alternative splicing #skips a stop codon-containing exon (exon 4) and can generate a transcript that is predicted to encode a fusion protein .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis are able to be #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis are observed to be #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis are #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which anaphase b and cytokinesis may have been #skipped by the cells .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but have been shown to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but may have #skipped anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but will be able to #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but will #skip anaphase b and cytokinesis .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells entered mitosis but #skipped anaphase b and cytokinesis .
the centromere has been shown to be #skipped on all tg autosomes as on the female xi .
the centromere has the ability to be finally #skipped on all tg autosomes as on the female xi .
the centromere has the ability to be #skipped on all tg autosomes as on the female xi .
the centromere is able to be finally #skipped on all tg autosomes as on the female xi .
the centromere is able to be #skipped on all tg autosomes as on the female xi .
the centromere is finally #skipped on all tg autosomes as on the female xi .
the centromere is observed to be finally #skipped on all tg autosomes as on the female xi .
the centromere is observed to be #skipped on all tg autosomes as on the female xi .
the centromere is #skipped on all tg autosomes as on the female xi .
the centromere may have been #skipped on all tg autosomes as on the female xi .
the centromere will be finally #skipped on all tg autosomes as on the female xi .
the centromere will be #skipped on all tg autosomes as on the female xi .
xist rna coated the autosome but , as we predicted , has #skipped the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but can #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but has the ability to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but is observed to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but #skips the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but will #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , can #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , has been shown to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , has the ability to #skip the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
xist rna coats the autosome but , as we predicted , #skips the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
direct sequencing of the paf-2 gene revealed a homozygous 1-bp insertion at nucleotide 511 (511 inst) in one patient with group c zellweger syndrome (zs) , which introduces a premature termination codon in the paf-2 gene , and , in the second patient , revealed a splice-site mutation in intron 3 (ivs3+1g-->a) , which #skipped exon 3 , an event that leads to peroxisome deficiency .
finally , a stop codon-containing exon (exon 4) can be #skipped by alternative splicing and can generate a transcript that is predicted to encode a fusion protein .
megakaryocytes undergo an endomitotic cell cycle , which consists of an s phase interrupted by a gap , during which the cells enter mitosis but #skip anaphase b and cytokinesis .
the observation that xist rna can #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna efficiently #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has been shown to efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has been shown to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna has the ability to efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is able to efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna is able to #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna may have #skipped the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna #skips the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that xist rna will efficiently #skip the xic tg raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg can be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg can be #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg has been efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg is #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg was efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg was #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the observation that the xic tg will be efficiently #skipped by xist rna raises the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
the centromere was #skipped on all tg autosomes as on the female xi .
xist rna coated the autosome but #skipped the xic tg , raising the possibility that x chromosome domains escape inactivation by excluding xist rna binding .
a caspase-2 minigene construct could be made to be alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct could be made to be #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has been made that can be #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct has the ability to be made to be alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is able to be made that is #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is made that can be alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is made that can be #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct is observed to be made that is alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct may be made that was alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct may be made that was #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct may have been made that can be #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct was made that was alternatively #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct was made that was #spliced in transfected cells and nuclear extracts .
a caspase-2 minigene construct would be made that could be #spliced in transfected cells and nuclear extracts .
a pre-mrna containing mutations in se2 , however , has been shown to be alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , has the ability to be alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , is observed to be alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , may have been alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , was alternatively #spliced predominantly using the nt 3605 3 splice site .
a pre-mrna containing mutations in se2 , however , will be alternatively #spliced predominantly using the nt 3605 3 splice site .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i can alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has been shown to alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has the ability to alternatively #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i has the ability to #splice only 20% as efficiently as rna 3f (fig .1 c left) .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i is able to #splice only 20% as efficiently as rna 3f (fig .1 c left) .
consequently , exon 30 with the intron can be #spliced .
consequently , exon 30 with the intron is able to be #spliced .
consequently , exon 30 with the intron is observed to be #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron could not be properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron could not be #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron has been shown not to be properly #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron has been shown not to be #spliced out during the mrna maturation process .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron has not been properly #spliced out during the mrna maturation process .
consequently , exon 30 with the intron , as our study suggested , has the ability to be #spliced .
consequently , exon 30 with the intron , as our study suggested , is observed to be #spliced .
consequently , exon 30 with the intron , as our study suggested , may have been #spliced .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron is not properly #spliced out during the mrna maturation process .
consequently , exon 30 with the intron , as our study suggested , was #spliced .
exons outside this size range are able to require additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range are able to require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range are effectively #spliced into the mature mrna .
exons outside this size range are observed to require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
in the remaining allelic p53 gene , there was a single-base substitution of g to t at position 1 within the #splice donor site of intron 7 , and the mutated intron will not be #spliced out during the mrna maturation process .
it did not properly #splice out this intron and resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
it did not #splice out this intron and resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
exons outside this size range have been shown to require additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range have been shown to require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range have been #spliced into the mature mrna .
exons outside this size range have required additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range may have required additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range may require additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range may require additional exonic and/or intronic sequences to be #spliced into the mature mrna .
exons outside this size range require additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range required additional exonic and/or intronic sequences to be effectively #spliced into the mature mrna .
exons outside this size range were #spliced into the mature mrna .
however , a pre-mrna containing mutations in se2 has been alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has been #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 has the ability to be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is able to alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is likely to be #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 is observed to be alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 may have been alternatively #spliced predominantly using the nt 3605 3 splice site .
however , a pre-mrna containing mutations in se2 may have been #spliced predominantly using the nt 3605 3 splice site .
the supt4h gene can be normally #spliced from five exons encoded by chromosome 11 .
the supt4h gene can be #spliced normally from five exons encoded by chromosome 11 .
the supt4h gene has been normally #spliced from five exons encoded by chromosome 11 .
that putative intron sequences fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences failed to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene has the ability to be normally #spliced from five exons encoded by chromosome 11 .
that putative intron sequences failed to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that putative intron sequences has not been shown to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene has the ability to be #spliced normally from five exons encoded by chromosome 11 .
the supt4h gene is able to be normally #spliced from five exons encoded by chromosome 11 .
that putative intron sequences have failed to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene is likely to be normally #spliced from five exons encoded by chromosome 11 .
the supt4h gene is likely to be #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences is able to fail to be properly #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene is observed to be normally #spliced from five exons encoded by chromosome 11 .
that putative intron sequences is likely to fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene may be normally #spliced from five exons encoded by chromosome 11 .
the supt4h gene may be #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences is not observed to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene may have been normally #spliced from five exons encoded by chromosome 11 .
the supt4h gene was #spliced normally from five exons encoded by chromosome 11 .
that putative intron sequences will fail to be #spliced out in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
that this intron cannot be properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
the supt4h gene will be #spliced normally from five exons encoded by chromosome 11 .
that this intron cannot be #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron has not been shown to be #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron has not been #spliced out resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not able to be #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron is not observed to be properly #spliced out results in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron was not properly #spliced out resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
that this intron was not #spliced out resulted in a substitution of the final 13 amino acids of the deduced amino acid sequence .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon being able to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon being efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon having been efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon having the ability to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon shown to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that can be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has been shown to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that has the ability to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is able to be #spliced efficiently into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be efficiently #spliced into the mrna .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is observed to be #spliced efficiently into the mrna .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons being efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that was efficiently #spliced into the mrna .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons having the ability to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that will be efficiently #spliced into the mrna .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons having the ability to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons observed to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons observed to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons shown to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that are able to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes have the ability to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that are #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes having the ability to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes may have been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have been efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes observed to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have been shown to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have been shown to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that are able to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that have the ability to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that can be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes that have been shown to be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that may be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes that have been #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that were observed to be efficiently #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
virtually all genes of higher organisms have non-coding introns interspersed between the coding exons that were observed to be #spliced out in order to generate a mature messenger rna molecule used to encode proteins .
the pre-mrnas from all of these genes were #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the pre-mrnas from all of these genes will be #spliced with little or no exon-skipping (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the structure of different cdna clones indicates that usf rna can be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has the ability to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna has the ability to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna is able to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna is observed to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna is observed to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna may have been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna was #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that usf rna will be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
consequently , exon 30 with the intron is #spliced .
the supt4h gene is #spliced normally from five exons encoded by chromosome 11 .
the failure to #splice out putative intron sequences in transcripts which spanned exon-intron boundaries is expected in antisense transcripts .
the mouse polymeric immunoglobulin receptor gene has a 654 nt exon that is efficiently #spliced into the mrna .
a caspase-2 minigene construct can be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct has the ability to be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is able to be efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct is observed to be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct may have been efficiently #spliced transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct may have been shown to be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct may have been #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct was #spliced efficiently in transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
a caspase-2 minigene construct will be #spliced efficiently transfected cells and nuclear extracts , and the ratio of casp-2s to casp-2l mrnas produced was similar to the one observed in vivo (fig .1 c , lane 1) .
consequently , exon 30 with the intron , as our study suggested , is #spliced .
moreover , putative intron sequences has been shown to be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has ben efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences has the ability to be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is able to be efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is able to be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is observed to be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences is #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences may have been efficiently #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences might be #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences was #spliced out from transcripts that contain exons 15 to 24 .
moreover , putative intron sequences will be efficiently #spliced out from transcripts that contain exons 15 to 24 .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range being able to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range being efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range having the ability to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range shown to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range shown to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that can be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that can be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has been shown to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has the ability to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that has the ability to be #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that is able to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that is efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that is observed to be efficiently #spliced into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that may have been #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that was #spliced efficiently into the mature mrna .
the mouse polymeric immunoglobulin receptor gene has exons outside this size range that will be #spliced efficiently into the mature mrna .
vertebrate internal exons are usually between 50 and 400 nt long; a 654 nt exon may require additional exonic and/or intronic sequences to be #spliced into the mrna .
we also identified usf rna being able to be differentially #spliced but containing no obvious open reading frame .
we also identified usf rna being able to be #spliced but containing no obvious open reading frame .
we also identified usf rna having been shown to be differentially #spliced but containing no obvious open reading frame .
we also identified usf rna observed to be differentially #spliced but containing no obvious open reading frame .
we also identified usf rna #spliced but containing no obvious open reading frame .
we also identified usf rna that are able to be differentially #spliced but contain no obvious open reading frame .
we also identified usf rna that are able to be #spliced but contain no obvious open reading frame .
we also identified usf rna that are observed to be #spliced but contain no obvious open reading frame .
we also identified usf rna that are #spliced but contain no obvious open reading frame .
we also identified usf rna that could have been #spliced but contained no obvious open reading frame .
we also identified usf rna that have been differentially #spliced but contained no obvious open reading frame .
we also identified usf rna that have been shown to be differentially #spliced but contained no obvious open reading frame .
we also identified usf rna that have been #spliced but contained no obvious open reading frame .
we also identified usf rna that may be differentially #spliced but contain no obvious open reading frame .
we also identified usf rna that may be #spliced but contain no obvious open reading frame .
we also identified usf rna that may have been differentially #spliced but contained no obvious open reading frame .
we also identified usf rna that may have been #spliced but contained no obvious open reading frame .
we also identified usf rna that were differentially #spliced but contained no obvious open reading frame .
we also identified usf rna that were #spliced but contained no obvious open reading frame .
we also identified usf rna that will be differentially #spliced but contain no obvious open reading frame .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes can be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is observed to be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes is observed to be #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes may have been #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes was #spliced predominantly following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the pre-mrnas from all of these genes will be #spliced following little or no exon-skipping to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
putative intron sequences has been #spliced out during transcripts .
putative intron sequences is efficiently #spliced out during transcripts .
putative intron sequences is #spliced out during transcripts .
putative intron sequences may have been efficiently #spliced out during transcripts .
putative intron sequences may have been #spliced out during transcripts .
transcripts has putative intron sequences being shown to be completely #spliced out .
transcripts has putative intron sequences being shown to be #spliced out .
transcripts has putative intron sequences completely #spliced out .
transcripts has putative intron sequences having the ability to be completely #spliced out .
transcripts has putative intron sequences having the ability to be #spliced out .
transcripts has putative intron sequences observed to be #spliced out .
transcripts has putative intron sequences #spliced out .
transcripts has putative intron sequences that has been completely #spliced out .
transcripts has putative intron sequences that has been shown to be #spliced out .
transcripts has putative intron sequences that has the ability to be completely #spliced out .
transcripts has putative intron sequences that has the ability to be #spliced out .
transcripts has putative intron sequences that is able to be completely #spliced out .
transcripts has putative intron sequences that is able to be #spliced out .
transcripts has putative intron sequences that is completely #spliced out .
transcripts has putative intron sequences that is observed to be completely #spliced out .
transcripts has putative intron sequences that is observed to be #spliced out .
transcripts has putative intron sequences that is thought to be #spliced out .
transcripts has putative intron sequences that may have been completely #spliced out .
a caspase-2 minigene construct has been made that can be alternatively #spliced in transfected cells and nuclear extracts .
an additional observation with the tandem repeat-containing 3? substrates was that the efficiency of bimolecular exon ligation decreased stepwise with each mutation that moved the 5?-most ag 6 nt further downstream such that rna 3i #spliced only 20% as efficiently as rna 3f (fig .1 c left) .
the supt4h gene are able to be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron can be #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron has been shown to be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron has been shown to be #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene are observed to be #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene are observed to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene are #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene being able to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron is observed to be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene have been shown to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene have been #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron may have been efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene have been #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
moreover , the mutated intron may have been #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron might be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron might be #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron was #spliced out from the mrna maturation process that contain exons 15 to 24 .
moreover , the mutated intron will be efficiently #spliced out from the mrna maturation process that contain exons 15 to 24 .
the supt4h gene may have been #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene observed to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene observed to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene shown to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron failed to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron failed to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that are able to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron has not been shown to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
that the mutated intron have failed to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that are able to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that are observed to be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron is able to fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that can be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that can be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron is likely to fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that have been shown to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron is likely to fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that have been #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron may fail to be properly #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that have been #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that have the ability to be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that may have been #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
that the mutated intron will fail to be #spliced out in the mrna maturation process which spanned exon-intron boundaries is expected in antisense transcripts .
the supt4h gene that were #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene that will be #spliced with five exons (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
the mrna maturation process has the mutated intron being shown to be completely #spliced out .
the mrna maturation process has the mutated intron being shown to be #spliced out .
the mrna maturation process has the mutated intron completely #spliced out .
the supt4h gene were #spliced with five exons (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the supt4h gene were #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the mrna maturation process has the mutated intron having the ability to be #spliced out .
the supt4h gene will be #spliced with five exons encoded by chromosome 11 (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
the mrna maturation process has the mutated intron observed to be completely #spliced out .
the mrna maturation process has the mutated intron observed to be #spliced out .
the mrna maturation process has the mutated intron #spliced out .
the structure of different cdna clones indicates that the supt4h gene can be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that has been completely #spliced out .
the mrna maturation process has the mutated intron that has been shown to be completely #spliced out .
the structure of different cdna clones indicates that the supt4h gene has been shown to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene has been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that has the ability to be completely #spliced out .
the structure of different cdna clones indicates that the supt4h gene is able to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is able to be completely #spliced out .
the structure of different cdna clones indicates that the supt4h gene is differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that the supt4h gene is observed to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mrna maturation process has the mutated intron that is thought to be #spliced out .
the mrna maturation process has the mutated intron that may have been completely #spliced out .
the structure of different cdna clones indicates that the supt4h gene was differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the mutated intron is efficiently #spliced out during the mrna maturation process .
the mutated intron is #spliced out during the mrna maturation process .
the mutated intron may have been efficiently #spliced out during the mrna maturation process .
the mutated intron was efficiently #spliced out during the mrna maturation process .
the mutated intron was #spliced out during the mrna maturation process .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 has the ability to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 is able to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 is able to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 is observed to be differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 is observed to be #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 may have been differentially #spliced , and alternative exon usage may regulate the levels of functional usf protein .
the structure of different cdna clones indicates that a pre-mrna containing mutations in se2 may have been #spliced , and alternative exon usage may regulate the levels of functional usf protein .
we also identified the supt4h gene being able to be differentially #spliced but containing no obvious open reading frame .
we also identified the supt4h gene being able to be #spliced but containing no obvious open reading frame .
we also identified the supt4h gene differentially #spliced but containing no obvious open reading frame .
we also identified the supt4h gene having been shown to be #spliced but containing no obvious open reading frame .
we also identified the supt4h gene observed to be #spliced but containing no obvious open reading frame .
we also identified the supt4h gene #spliced but containing no obvious open reading frame .
we also identified the supt4h gene that are able to be differentially #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that are #spliced but contain no obvious open reading frame .
we also identified the supt4h gene that could have been differentially #spliced but contained no obvious open reading frame .
we also identified the supt4h gene that have been shown to be #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 having been shown to be differentially #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 having been shown to be #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 #spliced but containing no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that are able to be differentially #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that are able to be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that are observed to be differentially #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that can be differentially #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that could have been differentially #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that have been differentially #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that may be differentially #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that may be #spliced but contain no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that may have been differentially #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that were differentially #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that were #spliced but contained no obvious open reading frame .
we also identified a pre-mrna containing mutations in se2 that will be #spliced but contain no obvious open reading frame .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene can be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene can be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been shown to be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been shown to be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been shown to be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has been #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has the ablity to be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has the ablity to be #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene has the ablity to be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is observed to be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is observed to be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene is #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may be #spliced following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may be #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may have been #spliced following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may have been #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene may have been #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene was #spliced predominantly following five exons to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , the supt4h gene will be #spliced predominantly following five exons encoded by chromosome 11 to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 can be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 can be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 has been shown to be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 has been shown to be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 has been #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 has the ablity to be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 has the ablity to be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is observed to be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 is #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 may be #spliced following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
when incubated in nuclear extracts or transfected in hela cells , a pre-mrna containing mutations in se2 may be #spliced predominantly following the nt 3605 3 splice site to a level similar to that obtained with the c2 substrate (data not shown and fig .2 e , compare lane 3 to lane 1) .
a pre-mrna containing mutations in se2 are #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 being able to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 have been shown to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) , suggesting that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 shown to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that are observed to be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that can be #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that have been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that may have been #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
a pre-mrna containing mutations in se2 that were #spliced with the nt 3605 3 splice site (ref .16; also fig .1 c and data not shown) suggest that correct exon inclusion can be managed by the yeast gene expression machinery .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , can #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , has #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , may #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , will #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , will #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has been shown to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has been shown to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators has the ability to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators is able to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators is observed to divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators may divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators may have divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators will divergently #transcribe glptq-glpacb operons of escherichia coli k-12s .
klk14 is approximately 5 .4 kb in length spanning seven exons and can divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has been shown to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has been shown to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has been shown to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has the ability to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has the ability to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has the ability to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and has the ability to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is able to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and is observed to divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and may have divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and may have divergently #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and may have #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and may have #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and will divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and will divergently #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and will #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and will #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , can #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has the ability to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has the ability to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is able to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is able to #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , may have #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , may have #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribed two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
klk14 is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , will #transcribe two alternative transcripts present only in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) .
nep-2 can specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 has specifically #transcribed the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is able to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 is believe to #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 may specifically #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 may #transcribe the rrn operon in the presence of the transcription factor cdf2 .
nep-2 will #transcribe the rrn operon in the presence of the transcription factor cdf2 .
restriction analysis of these two plasmids demonstrated that glpd and glpr are able to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are able to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are proven to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr are #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr can be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been shown to be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been shown to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr have been shown to be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may be divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may be #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may have been divergently #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may have been #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr may have been #transcribed .
restriction analysis of these two plasmids demonstrated that glpd and glpr will be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr are able to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr are proven to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr are proven to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr are #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr are #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr can be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr have been shown to be #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr have been #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr have been #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr may have been #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr may have been #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr were #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr were #transcribed .
restriction analysis of these two plasmids suggested that glpd and glpr will be #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr can be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr may be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr may be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr may have been divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr were divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr will be divergently #transcribed .
restriction endonuclease cleavage analysis of these two plasmids demonstrated that glpd and glpr will be divergently #transcribed .
subsequently , the negative-strand rnas are likely to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas are selected to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas are selected to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas can be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas have been chosen to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas have been chosen to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas may be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas were used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas were used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , the negative-strand rnas will be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the 7 .5- and 3 .5-kb fzd5 mrnas are able to be specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas are observed to be specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas are specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas are #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas can be specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas has been shown to be specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas have been specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas may be specifically #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas may have been #transcribed probably due to alternative splicing .
the 7 .5- and 3 .5-kb fzd5 mrnas will be #transcribed probably due to alternative splicing .
the fnf-e2 isoform can be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform can be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform has been proven to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform has been #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform is #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform may be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform may be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform may be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform may have been #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform may have been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform was #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform will be #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform will be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , can be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , has been #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , is believed to be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , may be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , may be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fnf-e2 isoform , however , will be #transcribed from an alternative promoter located in the 3 end of the first intron .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes will be #transcribed in opposite directions .
the gene can be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene has been #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is able to be be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is able to be be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene is likely to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene may have been #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene was #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene will be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , can be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , can be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , has been shown to be #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , has been #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , has been #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is able to be be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is likely to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , is observed to be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , may be #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , may have been #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , was #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the gene , as our study predicted , was #transcribed in a large variety of organs and tissues and showed differential splicing of two exons , giving rise to at least three different transcripts .
the negative-strand rnas , subsequently , are likely to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , are likely to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , are selected to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , are selected to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , can be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , can be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , have been chosen to be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , may be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , may have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , may have been used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the negative-strand rnas , subsequently , will be used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the plastid genome has been divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome has been shown to be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is able to be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is found to be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is observed to be divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome is observed to be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome may have been divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome was divergently #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome was #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the plastid genome will be #transcribed by a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) .
the ula regulon can be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon can be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon has been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon has been shown to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon is able to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon is able to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon is formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon is observed to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon is observed to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon may be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon may have been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon was formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , can be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , has been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , has been shown to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is able to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is observed to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is observed to be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , may be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , may be formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , may have been formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , was formed by two divergently #transcribed operons , ulag and ulaabcdef .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , will be formed by two divergently #transcribed operons , ulag and ulaabcdef .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme being able to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme having the ability to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme having the ability to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme having #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme shown to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme specifically #transcribing the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that can specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has the ability to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has the ability to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that has #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that is able to specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that is observed to #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that may #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that specifically #transcribed the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that will specifically #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme that will #transcribe the rrn operon at pc .
they also indicate that spinach harvested in march should contain preferentially nep , i .e . the enzyme #transcribing the rrn operon at pc .
this antisense-bcma rna can be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been shown to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been shown to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna has been #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is able to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is able to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is able to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is observed to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is observed to be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna is observed to be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna may have been #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna was #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna will be divergently #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna will be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this antisense-bcma rna will be #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
this operon , activated by growth on glycolate , can be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , has been shown to be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , has been #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , is proven to be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , may be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , may be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , may have been #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , will be efficiently #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
this operon , activated by growth on glycolate , will be #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
glptq-glpacb operons of escherichia coli k-12s are able to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are able to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are able to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s are observed to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s can be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been shown to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have been #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s have the ability to be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s may have been divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s may have been divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s may have been #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s were divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s will be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s will be divergently #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s will be #transcribed by interaction at a distance between multiple operators .
glptq-glpacb operons of escherichia coli k-12s will be #transcribed by interaction at a distance between multiple operators .
subsequently , the negative-strand rnas are used as templates to #transcribe mrnas , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed glptq-glpacb operons of escherichia coli k-12s .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the e . coli chromosome , and the two genes are #transcribed in opposite directions .
the ula regulon , responsible for the utilization of l-ascorbate in escherichia coli , is formed by two divergently #transcribed operons , ulag and ulaabcdef .
this operon , activated by growth on glycolate , is #transcribed as a single message and is under the positive control of glcc encoded by a divergent gene .
the fnf-e2 isoform is #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the fnf-e2 isoform is #transcribed from an alternative promoter located in the 3 end of the first intron and joined by alternative splicing to the second and third exons , which are shared by both rna isoforms .
the gene is #transcribed in a large variety of organs and tissues and shows differential splicing of two exons , giving rise to at least three different transcripts .
this antisense-bcma rna is #transcribed from the same locus as bcma , and exhibits mrna characteristic features , e .g .polyadenylation and splicing .
interaction at a distance between multiple operators can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , can #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , divergently #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , has #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , may #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , #transcribes the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , will #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators controls the adjacent , will #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators controls the adjacent , will #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators divergently #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators divergently #transcribes glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has been shown to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has been shown to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators has divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators has the ability to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators is able to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is able to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators is observed to divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators is observed to divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators may divergently #transcribe the two genes of e . coli chromosome .
interaction at a distance between multiple operators may have divergently #transcribed glpd and glpr of these two plasmids .
interaction at a distance between multiple operators may have divergently #transcribed the two genes of e . coli chromosome .
interaction at a distance between multiple operators will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators will divergently #transcribe glpd and glpr of these two plasmids .
interaction at a distance between multiple operators will divergently #transcribe the two genes of e . coli chromosome .
restriction analysis of e . coli chromosome demonstrated that the two genes are able to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are proven to be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are proven to be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes are #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes can be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes can be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes can be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes have been #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may have been divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may have been divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may have been #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes may have been #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes were divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes were divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes were #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes will be divergently #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes will be #transcribed .
restriction analysis of e . coli chromosome demonstrated that the two genes will be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes are able to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes are able to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes are proven to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes are #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes are #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes can be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes have been shown to be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes have been #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes may be #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes may have been #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes were #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes were #transcribed .
restriction analysis of e . coli chromosome suggested that the two genes will be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are able to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are proven to be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are proven to be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are proven to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons can be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been divergently #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be #transcribed .
restriction analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons will be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are proven to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are proven to be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons are #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons can be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons can be #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons have been #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons were #transcribed .
restriction analysis of escherichia coli k-12s suggested that glptq-glpacb operons will be #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes may be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes may have been divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes were divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes will be divergently #transcribed .
restriction endonuclease cleavage analysis of e . coli chromosome demonstrated that the two genes will be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons have been shown to be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may be divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons may have been divergently #transcribed .
restriction endonuclease cleavage analysis of escherichia coli k-12s demonstrated that glptq-glpacb operons were divergently #transcribed .
subsequently , ulag and ulaabcdef are likely to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef are selected to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef can be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef can be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef have been chosen to be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef have been used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef have been used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
subsequently , ulag and ulaabcdef may be used as templates to #transcribe ula regulon , which include a genomic-sized rna and a nested set of subgenomic mrna transcripts , all with an identical 5_ non-translated leader sequence of 72 77 nucleotides and 3_ co-terminal polyadenylated ends .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons can be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the escherichia coli k-12s , and glptq-glpacb operons will be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr have been shown to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr may be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the these two plasmids , and glpd and glpr will be #transcribed in opposite directions .
the mrnas can be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas has been formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas has been shown to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is able to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is able to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas is observed to be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas may be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas may be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas may have been formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas may have been formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas was formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas will be formed by two divergently #transcribed operons , the negative-strand rnas .
the mrnas will be formed by two divergently #transcribed operons , the negative-strand rnas .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , is able to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , is able to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , is formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , is formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , is observed to be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , may be formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , may have been formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , was formed by two divergently #transcribed operons , klk14 .
the two alternative transcripts , responsible for the utilization of l-ascorbate in prostate (1 .5 kb) and skeletal muscle (1 .9 kb) , will be formed by two divergently #transcribed operons , klk14 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) can #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has been shown to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) has been shown to #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) is observed to specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) may specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) specifically #transcribed the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) specifically #transcribes the plastid genome in the presence of the transcription factor cdf2 .
a plastid-encoded prokaryotic-type rna polymerase (pep) and a nucleus-encoded phage-type rna polymerase (nep) will specifically #transcribe the plastid genome in the presence of the transcription factor cdf2 .
glpd and glpr of these two plasmids are divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are observed to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are observed to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are observed to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids are #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids can be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids can be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids can be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been shown to be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have been #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids may have been divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids may have been #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids were divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids were #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids will be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids will be divergently #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids will be #transcribed by interaction at a distance between multiple operators .
glpd and glpr of these two plasmids will be #transcribed by interaction at a distance between multiple operators .
the rrn operon has been shown to be divergently #transcribed by nep-2 .
the rrn operon has been shown to be #transcribed by nep-2 .
the rrn operon has been #transcribed by nep-2 .
the rrn operon is found to be divergently #transcribed by nep-2 .
the rrn operon is observed to be #transcribed by nep-2 .
the rrn operon is #transcribed by nep-2 .
the rrn operon will be divergently #transcribed by nep-2 .
the rrn operon will be #transcribed by nep-2 .
the two genes of e . coli chromosome are able to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are observed to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome are #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome can be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome can be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been shown to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been shown to be #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have been #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome may have been #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome were divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome were #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome were #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome will be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome will be divergently #transcribed by interaction at a distance between multiple operators .
the two genes of e . coli chromosome will be #transcribed by interaction at a distance between multiple operators .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and can divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and can #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and can #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has been shown to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has the ability to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has the ability to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has the ability to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and has #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is able to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is observed to divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and is observed to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and may have divergently #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and may have #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and will divergently #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , can #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has been shown to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has the ability to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , has #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , is able to #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribed ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribes ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , #transcribes ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , will #transcribe ula regulon present only in escherichia coli .
ulag and ulaabcdef is approximately 5 .4 kb in length spanning seven exons and , by northern blot analysis , will #transcribe ula regulon present only in escherichia coli .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent and will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , can divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , can #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has been shown to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , has the ability to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is able to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , is observed to #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may have #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , may #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators controls the adjacent , will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators divergently #transcribes the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has been shown to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators has the ability to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators is able to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators is observed to divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators may divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators may have divergently #transcribed the gene , as our study predicted , of a large variety of organs and tissues .
interaction at a distance between multiple operators will divergently #transcribe the gene , as our study predicted , of a large variety of organs and tissues .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , can be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been shown to be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may have been #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were divergently #transcribed .
restriction analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be divergently #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are proven to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , are #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , can be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , have been shown to be #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , have been #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , may have been #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , may have been #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , were #transcribed .
restriction analysis of a large variety of organs and tissues suggested that the gene , as our study predicted , will be #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are able to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , are proven to be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , have been divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , may be divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , were divergently #transcribed .
restriction endonuclease cleavage analysis of a large variety of organs and tissues demonstrated that the gene , as our study predicted , will be divergently #transcribed .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are able to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are able to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are observed to be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are observed to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , are #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , can be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , has been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , has been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , have been shown to be #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may have been interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , may have been #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , were interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , were #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , will be interestingly interestingly #transcribed in opposite directions .
the fhla gene resides next to the hydb gene at 59 min in the a large variety of organs and tissues , and the gene , as our study predicted , will be #transcribed in opposite directions .
the gene , as our study predicted , of a large variety of organs and tissues are able to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are able to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are able to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are observed to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are observed to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are observed to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues are #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues can be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues can be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have been divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have the ability to be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues have the ability to be #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues may have been divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues may have been #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues were divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues were #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues will be divergently #transcribed by interaction at a distance between multiple operators .
the gene , as our study predicted , of a large variety of organs and tissues will be #transcribed by interaction at a distance between multiple operators .
this antisense-bcma rna can be #transcribed from the same locus as bcma .
this antisense-bcma rna has been proven to be #transcribed from the same locus as bcma .
this antisense-bcma rna is believed to be #transcribed from the same locus as bcma .
this antisense-bcma rna is believed to be #transcribed from the same locus as bcma .
this antisense-bcma rna is #transcribed from the same locus as bcma .
this antisense-bcma rna may be #transcribed from the same locus as bcma .
this antisense-bcma rna may have been #transcribed from the same locus as bcma .
this antisense-bcma rna may have been #transcribed from the same locus as bcma .
this antisense-bcma rna was #transcribed from the same locus as bcma .
this antisense-bcma rna will be #transcribed from the same locus as bcma .
this operon can be divergently #transcribed by glycolate .
this operon is able to be divergently #transcribed by glycolate .
this operon is able to be #transcribed by glycolate .
this operon is found to be divergently #transcribed by glycolate .
this operon is known to be #transcribed by glycolate .
this operon is #transcribed by glycolate .
this operon may have been divergently #transcribed by glycolate .
this operon was #transcribed by glycolate .
glycolate can #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has been shown to #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate has specifically #transcribed this operon in the presence of the transcription factor cdf2 .
glycolate has the ability to specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate is able to specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate is able to #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate is believe to specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate is believe to #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate is observed to #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate may have specifically #transcribed this operon in the presence of the transcription factor cdf2 .
glycolate may have #transcribed this operon in the presence of the transcription factor cdf2 .
glycolate may specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate may #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate specifically #transcribes this operon in the presence of the transcription factor cdf2 .
glycolate will specifically #transcribe this operon in the presence of the transcription factor cdf2 .
glycolate will #transcribe this operon in the presence of the transcription factor cdf2 .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are likely to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have the ability to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may have been specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 will be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are likely to be #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are observed to be specifically #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are observed to be #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 can be #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 has been efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , are specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 has been shown to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 has been shown to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have been specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 has the ability to be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , have the ability to be specifically #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 is efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 is likely to be #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 is observed to be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , may have been #transformed into escherichia coli bl21 (promega)
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as our study suggested , will be #transformed into escherichia coli bl21 (promega)
for expression of the recombinant protein , pet28a-5 may have been #transformed into escherichia coli strain bl21(de3) .
this construct can be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct has been proven to be #transformed into the yeast strain hf7c (clontech) .
this construct has been shown to be #transformed into the yeast strain hf7c (clontech) .
this construct has been #transformed into the yeast strain hf7c (clontech) .
this construct has the ability to be #transformed into the yeast strain hf7c (clontech) .
this construct is able to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct is able to be #transformed into the yeast strain hf7c (clontech) .
this construct is likely to be #transformed into the yeast strain hf7c (clontech) .
this construct is observed to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct is observed to be #transformed into the yeast strain hf7c (clontech) .
this construct is #transformed into the yeast strain hf7c (clontech) .
this construct may have been dramatically #transformed into the yeast strain hf7c (clontech) .
this construct will be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been proven to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been proven to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been shown to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has the ability to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is observed to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is observed to be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may be #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may have been efficiently #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may have been #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , will be efficiently #transformed into the yeast strain hf7c (clontech) .
pet28a-5 , for expression of the recombinant protein , can be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been shown to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has the ability to be probably #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are able to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , are able to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is able to be probably #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are able to be #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is likely to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is likely to be #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is observed to be probably #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , are likely to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , is probably #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are likely to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , may be probably #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are likely to be #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , are observed to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , may have been #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are observed to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
pet28a-5 , for expression of the recombinant protein , will be probably #transformed into escherichia coli strain bl21(de3) .
the relevant dna fragments , in order to generate gst fusion proteins , are observed to be #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , are #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , can be #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been shown to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , have been #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may be #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , may have been cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , in order to generate gst fusion proteins , will be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are able to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are able to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are likely to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are likely to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are likely to be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments are observed to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments can be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments can be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments can be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been shown to be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been shown to be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been shown to be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments have been #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may have been cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may have been cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments may have been #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments will be cloned into pgex2t(pharmacia) and completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments will be cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments will be completely #transformed into the bacterial strains bl21 or topp (stratagene) .
to generate gst fusion proteins , the relevant dna fragments will be #transformed into the bacterial strains bl21 or topp (stratagene) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 were #transformed into escherichia coli bl21 (promega)
to generate gst fusion proteins , the relevant dna fragments were cloned into pgex2t(pharmacia) and #transformed into the bacterial strains bl21 or topp (stratagene) .
this construct was #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has been shown to be used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has been used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has the ability to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct has the ability to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) has the ability to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is able to be #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is able to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct is efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct is likely to be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct is observed to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) is observed to be used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) may be used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) may have been used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct was #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct will be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 (bvs) will be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , this construct will be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , can be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are able to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , can be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , has been efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are likely to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 are likely to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 can be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is able to be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , is efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been shown to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been shown to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , is observed to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have been #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 have the ability to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , may be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 may have been #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , may be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , may have been #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 will be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
for expression of the recombinant protein , this construct , as our study suggested , was #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , will be efficiently #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , this construct , as our study suggested , will be #transformed into the yeast strain hf7c (clontech) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , can be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has been used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has the ability to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has been #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , has the ability to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has the ability to be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is able to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , has the ability to be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is able to be used to #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is likely to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is observed to be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is likely to be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is observed to be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is likely to be #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is observed to be efficiently #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is used to completely #transform escherichia coli bl21 (promega) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , is used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , is #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , may be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , may be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , may be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , will be used to completely #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , may have been #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , as we mentioned earlier , will be used to #transform escherichia coli bl21 (promega) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , will be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , pet28a-5 , for expression of the recombinant protein , will be #transformed into escherichia coli strain bl21(de3) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are able to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct can be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , are observed to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct has been shown to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , can be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , have been efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct is able to be efficiently #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , have been shown to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct is able to be probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , have been #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , have the ability to be efficiently #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , have the ability to be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct is observed to be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct is probably #transformed into the yeast strain hf7c (clontech) .
expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 , however , will be #transformed into escherichia coli bl21 (promega) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct may be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct may be probably #transformed into the yeast strain hf7c (clontech) .
this construct may have been efficiently #transformed into the yeast strain hf7c (clontech) .
this construct may have been probably #transformed into the yeast strain hf7c (clontech) .
this construct will be efficiently #transformed into the yeast strain hf7c (clontech) .
this construct will be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , can be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , can be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has been shown to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has the ability to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , has the ability to be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is able to be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is likely to be dramatically #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , is observed to be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may be probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , may have been probably #transformed into the yeast strain hf7c (clontech) .
this construct , as our study suggested , was #transformed into the yeast strain hf7c (clontech) .
pet28a-5 can be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 can be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been proven to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been shown to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has been shown to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has the ability to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has the ability to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 has the ability to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is able to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is able to be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is likely to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is observed to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is observed to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 is probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may have been dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 may have been #transformed into escherichia coli strain bl21(de3) .
pet28a-5 was #transformed into escherichia coli strain bl21(de3) .
pet28a-5 will be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 will be probably #transformed into escherichia coli strain bl21(de3) .
pet28a-5 will be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , can be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been proven to be #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has been shown to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has the ability to be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , has the ability to be efficiently #transformed into escherichia coli strain bl21(de3) .
for expression of the recombinant protein , expression of recombinat proteins full-lenght and c-terminal sbp2 constructs in pask-ib7 was #transformed into escherichia coli bl21 (promega) .
pet28a-5 , for expression of the recombinant protein , is able to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , is likely to be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , may be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , may be efficiently #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , will be dramatically #transformed into escherichia coli strain bl21(de3) .
pet28a-5 , for expression of the recombinant protein , will be efficiently #transformed into escherichia coli strain bl21(de3) .
this construct (bvs) can be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) can be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) has been shown to be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) has been shown to be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) has been used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) has the ability to be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) has the ability to be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) is able to be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) is able to be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) is observed to be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) is used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) may be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) may be used to #transform the yeast strain hf7c (clontech) .
this construct (bvs) may have been used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) will be used to completely #transform the yeast strain hf7c (clontech) .
this construct (bvs) will be used to #transform the yeast strain hf7c (clontech) .
this construct are able to be #transformed into the yeast strain hf7c (clontech)
this construct are efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are likely to be #transformed into the yeast strain hf7c (clontech)
this construct are likely to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are observed to be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct are #transformed into the yeast strain hf7c (clontech)
this construct can be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have been efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have been shown to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have been specifically #transformed into the yeast strain hf7c (clontech)
this construct have been #transformed into the yeast strain hf7c (clontech)
this construct have been #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have the ability to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct have the ability to be specifically #transformed into the yeast strain hf7c (clontech)
this construct were #transformed into the yeast strain hf7c (clontech)
this construct were #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct will be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are able to be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , are observed to be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have been shown to be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have been specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , have the ability to be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , may be #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , may have been #transformed into the yeast strain hf7c (clontech)
this construct , as our study suggested , will be specifically #transformed into the yeast strain hf7c (clontech)
this construct , as we mentioned earlier , has been shown to be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , has the ability to be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is able to be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is likely to be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is observed to be used to completely #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , is observed to be used to #transform the yeast strain hf7c (clontech) .
this construct , as we mentioned earlier , will be used to completely #transform the yeast strain hf7c (clontech) .
this construct , however , are efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , are likely to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , can be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have been shown to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have been #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , have the ability to be efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , may have been efficiently #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
this construct , however , will be #transformed into the yeast strain hf7c (clontech) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments (bvs) can be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) can be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has been shown to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has been shown to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has been used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) has the ability to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) may be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) may be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) may have been used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) may have been used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) will be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments (bvs) will be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments are able to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are able to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are likely to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are likely to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are observed to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments are observed to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments are #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments can be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments can be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments have been shown to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have been specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have the ability to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments have the ability to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments may be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments may have been efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments may have been specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments may have been #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments will be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments will be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments will be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , as our study suggested , are likely to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are likely to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are observed to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , are #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have been specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , have the ability to be specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , may be #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , may have been specifically #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as our study suggested , may have been #transformed into the bacterial strains bl21 or topp (stratagene)
the relevant dna fragments , as we mentioned earlier , can be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has been shown to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has been shown to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has been used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , has the ability to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is able to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is likely to be used to completely #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is likely to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is observed to be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , is used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , as we mentioned earlier , will be used to #transform the bacterial strains bl21 or topp (stratagene) .
the relevant dna fragments , however , are able to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are likely to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , are #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , can be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have been efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have been shown to be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , have the ability to be efficiently #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , may have been #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
the relevant dna fragments , however , will be #transformed into the bacterial strains bl21 or topp (stratagene) and selected for by growth on plates lacking leucine and tryptophan (left panel) .
a transcript can be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , are able to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , are likely to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
a transcript is efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , are observed to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , thus , are observed to #translate pn lineage information into distinct dendritic targeting specificity .
a transcript is observed to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript may have been efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript will be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , have been shown to #translate pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , can be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , have efficiently #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , can be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , have the ability to #translate pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , has been efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , has been shown to be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , has been #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , may have #translated pn lineage information into distinct dendritic targeting specificity .
a transcript , as our data has shown , is able to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , is efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
acj6 and drifter , thus , will efficiently #translate pn lineage information into distinct dendritic targeting specificity .
cells are able to successfully #translate with high fidelity extracellular signals into specific cellular functions .
a transcript , as our data has shown , is observed to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are able to #translate with high fidelity extracellular signals into specific cellular functions .
a transcript , as our data has shown , is #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are able to use signalling networks to commonly #translate extracellular signals into specific cellular functions .
a transcript , as our data has shown , may be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are likely to successfully #translate with high fidelity extracellular signals into specific cellular functions .
a transcript , as our data has shown , may have been efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , may have been #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are likely to #translate with high fidelity extracellular signals into specific cellular functions .
cells are likely to use signalling networks to commonly #translate extracellular signals into specific cellular functions .
a transcript , as our data has shown , was efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , was #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
a transcript , as our data has shown , will be efficiently #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells are likely to use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript being able to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
alternative splicing of exon 4 results in a transcript having been #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
alternative splicing of exon 4 results in a transcript shown to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
alternative splicing of exon 4 results in a transcript #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells can #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which can be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells can use signalling networks to commonly #translate extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which has been shown to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells can use signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
cells can use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which is likely to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have been shown to #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which is observed to be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have been shown to use signalling networks to commonly #translate extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which is #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
cells have been shown to use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
alternative splicing of exon 4 results in a transcript which will be #translated into a c-terminal truncated protein containing the first , second and third transmembrane domains , while the splicing out of exons 3 and 4 would produce a protein with five membrane-spanning domains but lacking the third and fourth domains present in the et-ar protein .
isgf3 gamma being able to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells have the ability to use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
cells have used signalling networks to commonly #translate extracellular signals into specific cellular functions .
isgf3 gamma properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma shown to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury cannot #translate into improved survival .
isgf3 gamma that can be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury did not #translate into improved survival .
isgf3 gamma that can be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury does not #translate into improved survival .
cells may have used signalling networks to commonly #translate extracellular signals into specific cellular functions .
isgf3 gamma that has been properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells may have used signalling networks to #translate extracellular signals into specific cellular functions with high fidelity .
isgf3 gamma that has been shown to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury has been shown to fail to #translate into improved survival .
cells may have used signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
interestingly , this reduction in liver injury has failed to #translate into improved survival .
isgf3 gamma that has been shown to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury has not #translated into improved survival .
cells may #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that is able to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury is observed to fail to #translate into improved survival .
isgf3 gamma that is able to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that is likely to be properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that is likely to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
interestingly , this reduction in liver injury will fail to #translate into improved survival .
isgf3 gamma that is observed to be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that is properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells used signalling networks to commonly #translate extracellular signals into specific cellular functions .
isgf3 gamma that may be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that may have been properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells will successfully #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that may have been #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells will #translate with high fidelity extracellular signals into specific cellular functions .
isgf3 gamma that was properly #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
cells will use signalling networks to commonly #translate extracellular signals into specific cellular functions .
isgf3 gamma that will be #translated in vitro from recombinant clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are able to be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are able to be #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators are observed to be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators can be completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have been shown to be completely #translated from open reading frames .
cells , as our study has proven , are likely to use signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have been #translated from open reading frames .
cells , as our study has proven , have been shown to use signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators have the ability to be #translated from open reading frames .
cells , as our study has proven , have the ability to use signalling networks to #translate extracellular signals into specific cellular functions .
cells , as our study has proven , have used signalling networks to #translate extracellular signals into specific cellular functions .
cells , as our study has proven , may have used signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators may have been completely #translated from open reading frames .
cells , as our study has proven , may use signalling networks to #translate extracellular signals into specific cellular functions .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators were completely #translated from open reading frames .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators were #translated from open reading frames .
extracellular signals are able to be #translated with high fidelity into specific cellular functions by cells .
more than 100 proteins and polypeptides which are included in the arc/xyls family of prokaryotic positive transcriptional regulators will be #translated from open reading frames .
extracellular signals are observed to be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which has been shown to be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals are #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which has been #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals have been shown to be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which is likely to be #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals have been #translated with high fidelity into specific cellular functions by cells .
extracellular signals may be #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which is probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals may be #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which is #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals may have been #translated with high fidelity by cells into specific cellular functions .
stat1 y701f which may be probably #translated in vitro can also dimerize on the lmp2 gas .
extracellular signals may have been #translated with high fidelity into specific cellular functions by cells .
stat1 y701f which may be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f which was probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f which will be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are likely to be #translated in vitro and partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are #translated in vitro and partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 can be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , are observed to be #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 have been shown to be #translated in vitro and partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 have been #translated in vitro and partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 have the ability to be #translated in vitro and partially purified on heparin-agarose .
extracellular signals , as our data has shown , can be #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , have been shown to be #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , have been #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , may be #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are observed to be #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , may have been #translated with high fidelity by cells into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are properly #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , may have been #translated with high fidelity into specific cellular functions by cells .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that can be properly #translated in vitro are partially purified on heparin-agarose .
extracellular signals , as our data has shown , were #translated with high fidelity into specific cellular functions by cells .
extracellular signals , as our data has shown , will be #translated with high fidelity by cells into specific cellular functions .
extracellular signals , as our data has shown , will be #translated with high fidelity into specific cellular functions by cells .
malaria is an attractive model for the development and validation of approaches that are able to #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that are able to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been #translated in vitro are partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have the ability to be properly #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that are likely to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that are observed to #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may have been properly #translated in vitro are partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that can #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that have been shown to #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches that have been shown to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
these changes are able to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes are likely to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are likely to be #translated in vitro and partially purified on heparin-agarose .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are #translated in vitro and partially purified on heparin-agarose .
these changes can further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , can be #translated in vitro and partially purified on heparin-agarose .
malaria is an attractive model for the development and validation of approaches that may #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
these changes further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have been #translated in vitro and partially purified on heparin-agarose .
these changes have been shown to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , may be #translated in vitro and partially purified on heparin-agarose .
these changes have further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , will be #translated in vitro and partially purified on heparin-agarose .
these changes have the ability to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
malaria is an attractive model for the development and validation of approaches that will #translate genomic information efficiently to vaccine development because of the critical need for effective anti-malarial interventions .
malaria is an attractive model for the development and validation of approaches #translating genomic information to vaccine development because of the critical need for effective anti-malarial interventions and because the plasmodium parasite is a complex multistage pathogen targeted by multiple immune responses .
these changes may further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides having been #translated from open reading frames .
these changes may have further #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information can be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
pn lineage information can be #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes may #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information can be #translated into distinct dendritic targeting specificity by acj6 and drifter .
these changes #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are likely to be #translated from open reading frames .
these changes will further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes will #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information has been efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that are #translated from open reading frames .
pn lineage information has been shown to be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that can be #translated from open reading frames .
pn lineage information has been shown to be #translated by acj6 and drifter into distinct dendritic targeting specificity .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that have been #translated from open reading frames .
these changes , as our data have shown , are likely to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information has been #translated by acj6 and drifter into distinct dendritic targeting specificity .
these changes , as our data have shown , are observed to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information has been #translated into distinct dendritic targeting specificity by acj6 and drifter .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides that may have been #translated from open reading frames .
pn lineage information is able to be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
these changes , as our data have shown , can #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , have been shown to further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
pn lineage information is likely to be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant has been shown to be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information is likely to be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
these changes , as our data have shown , have the ability to #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
this mutant has been shown to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information is likely to be #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant has been #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information is likely to be #translated into distinct dendritic targeting specificity by acj6 and drifter .
pn lineage information is observed to be efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
these changes , as our data have shown , #translated into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
these changes , as our data have shown , will further #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information is #translated by acj6 and drifter into distinct dendritic targeting specificity .
pn lineage information is #translated into distinct dendritic targeting specificity by acj6 and drifter .
these changes , as our data have shown , will #translate into altered expression levels and time kinetics of a number of early genes (peak expression at 2 h after stimulation) .
pn lineage information may be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant is #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information may be #translated by acj6 and drifter into distinct dendritic targeting specificity .
pn lineage information may be #translated into distinct dendritic targeting specificity by acj6 and drifter .
pn lineage information may have been efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant will be efficiently #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information was efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant , as our study reveals , has been shown to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information was efficiently #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant , as our study reveals , is able to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information will be efficiently #translated by acj6 and drifter into distinct dendritic targeting specificity .
this mutant , as our study reveals , is observed to be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant , as our study reveals , is #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this mutant , as our study reveals , may be #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
pn lineage information will be #translated into distinct dendritic targeting specificity by acj6 and drifter .
this mutant , as our study reveals , may have been #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that are likely to be used to discover , validate , and #translate information resulting from the completion of the human genome project .
this reduction in liver injury , as our data interestingly reveal , can fail to #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which can be successfully #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , cannot #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which can be #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that are likely to be used to #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which has been shown to be successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that could be used to discover , validate , and #translate information resulting from the completion of the human genome project .
this reduction in liver injury , as our data interestingly reveal , does not #translate into improved survival .
we also report the first definitive incorporation of sec into a selenoprotein which has been shown to be #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , fail to #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that could be used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that could be used to #translate information resulting from the completion of the human genome project .
this reduction in liver injury , as our data interestingly reveal , has failed to #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that have been used to efficiently #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is likely to be successfully #translated in reticulocyte lysates .
this reduction in liver injury , as our data interestingly reveal , may fail to #translate into improved survival .
this reduction in liver injury , as our data interestingly reveal , may have failed to #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may be used to efficiently #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is observed to be successfully #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may be used to #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is observed to be #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may have been used to discover , validate , and #translate information resulting from the completion of the human genome project .
this reduction in liver injury , as our data interestingly reveal , will fail to #translate into improved survival .
this reduction in liver injury , as our data interestingly reveal , will not #translate into improved survival .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that may have been used to efficiently #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which is #translated in reticulocyte lysates .
we also report the first definitive incorporation of sec into a selenoprotein which may be successfully #translated in reticulocyte lysates .
we also report the first definitive incorporation of sec into a selenoprotein which may be #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that would be used to #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which may have been #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , are likely to be used to discover , validate , and #translate information resulting from the completion of the human genome project .
we also report the first definitive incorporation of sec into a selenoprotein which was #translated in reticulocyte lysates .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , could be used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , have been used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may be used to discover , validate , and #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may be used to efficiently #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , may be used to #translate information resulting from the completion of the human genome project .
this review examines the use of new and emerging dna , tissue , and live-cell transfection microarray technologies that , as our study suggested , would be used to efficiently #translate information resulting from the completion of the human genome project .
thus , acj6 and drifter are able to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter are likely to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter are observed to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter are observed to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter can efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter can #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have been shown to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have the ability to efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have the ability to #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter have #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter may efficiently #translate pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter may have efficiently #translated pn lineage information into distinct dendritic targeting specificity .
thus , acj6 and drifter may #translate pn lineage information into distinct dendritic targeting specificity .
in vitro translation and partial purification of fstat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 were #translated in vitro using the t7-based coupled transcription-translation kit (promega) as per the manufacturer fs instructions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 were #translated in vitro and partially purified on heparin-agarose .
this mutant was #translated in the presence of c-terminal sbp2 , and as shown in figure 6c no readthrough is detectable when the auga element is deleted , indicating that the stimulatory effect is entirely 3 utr dependent .
the arc/xyls family of prokaryotic positive transcriptional regulators includes more than 100 proteins and polypeptides derived from open reading frames #translated from dna sequences .
cells use signalling networks to #translate with high fidelity extracellular signals into specific cellular functions .
malaria is an attractive model for the development and validation of approaches to #translate genomic information to vaccine development because of the critical need for effective anti-malarial interventions and because the plasmodium parasite is a complex multistage pathogen targeted by multiple immune responses .
thus , acj6 and drifter #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter are able to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma being able to be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are able to use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma observed to be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are able to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter are able to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma shown to be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are likely to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma shown to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that can be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are likely to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter are likely to use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that has been shown to be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that has been shown to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter are observed to use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that has been #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that is able to be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that is likely to be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that is likely to be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter can use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that is observed to be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter can use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
isgf3 gamma that is #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that may be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
isgf3 gamma that may be #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have been shown to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
acj6 and drifter have the ability to successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that was #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have the ability to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
isgf3 gamma that will be properly #translated in in vitro from recombinant clones bound dna with a specificity indistinguishable clones bound dna with a specificity indistinguishable from that of isgf3 gamma purified from hela cells .
acj6 and drifter have the ability to use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
in vitro translation and partial purification of fstat1 , stat1 y701f were #translated in vitro using the t7-based coupled transcription-translation kit (promega) as per the manufacturer fs instructions .
in vitro translation and partial purification of fstat1 , stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 were #translated in vitro using the t7-based coupled transcription-translation kit (promega) as per the manufacturer fs instructions .
stat1 y701f are likely to be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may have successfully #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter may have #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f can be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may have used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
stat1 y701f have been shown to be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may successfully #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
stat1 y701f may be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter may use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter may use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity with high fidelity .
stat1 y701f that are able to be properly #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter may use signalling networks to #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter successfully #translated with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter used signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that can be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that can be #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter will #translate with high fidelity pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter will use signalling networks to commonly #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f that have been #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that have the ability to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that have the ability to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f that may be properly #translated in vitro are partially purified on heparin-agarose .
acj6 and drifter , as our study has proven , have the ability to use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , have used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , may have used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
acj6 and drifter , as our study has proven , may use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f will be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter , as our study has proven , used signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are able to be #translated in vitro and partially purified on heparin-agarose .
acj6 and drifter , as our study has proven , will use signalling networks to #translate pn lineage information into distinct dendritic targeting specificity .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are likely to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 are observed to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 can be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 have been shown to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 have the ability to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are able to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are able to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are likely to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are likely to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are observed to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are observed to be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that are #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that can be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that have been shown to be properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may be #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 that may have been properly #translated in vitro are partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be #translated in vitro can also dimerize on the lmp2 gas .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are able to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are likely to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , are observed to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , can be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have been shown to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , have the ability to be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , may be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , may have been #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 , as our data reveals , will be #translated in vitro and partially purified on heparin-agarose .
stat1 y701f , as our data reveals , are likely to be #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are able to efficiently #translate into improved survival .
stat1 y701f , as our data reveals , are observed to be #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are able to #translate into improved survival .
stat1 y701f , as our data reveals , are #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are likely to efficiently #translate into improved survival .
stat1 y701f , as our data reveals , can be #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are observed to efficiently #translate into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are observed to #translate into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis can efficiently #translate into improved survival .
stat1 y701f , as our data reveals , may be #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis can #translate into improved survival .
stat1 y701f , as our data reveals , may have been #translated in vitro and partially purified on heparin-agarose .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis efficiently #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have been shown to efficiently #translate into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have been shown to #translate into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have efficiently #translated into improved survival .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have the ability to efficiently #translate into improved survival .
cells , thus , are able to efficiently #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be probably #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , are able to #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may efficiently #translate into improved survival .
cells , thus , are likely to #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be probably #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , are observed to efficiently #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , are observed to #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be probably #translated in vitro can also dimerize on the lmp2 gas .
in addition , our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis #translate into improved survival .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be probably #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , efficiently #translated extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , have been shown to efficiently #translate extracellular signals into specific cellular functions .
cells , thus , have been shown to #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , have efficiently #translated extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be probably #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , have the ability to #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was probably #translated in vitro can also dimerize on the lmp2 gas .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was #translated in vitro can also dimerize on the lmp2 gas .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are observed to efficiently #translate into improved survival .
cells , thus , may efficiently #translate extracellular signals into specific cellular functions .
stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be probably #translated in vitro can also dimerize on the lmp2 gas .
cells , thus , may have efficiently #translated extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , can efficiently #translate into improved survival .
cells , thus , may have #translated extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , can #translate into improved survival .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , efficiently #translated into improved survival .
cells , thus , #translated extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which can be #translated in vitro .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have been shown to efficiently #translate into improved survival .
cells , thus , will efficiently #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have been shown to #translate into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which has been shown to be successfully #translated in vitro .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have the ability to efficiently #translate into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which has been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f which has been #translated in vitro .
thus , cells are likely to efficiently #translate extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have #translated into improved survival .
thus , cells are likely to #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which is likely to be successfully #translated in vitro .
thus , cells are observed to #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which is likely to be #translated in vitro .
thus , cells can #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which is observed to be #translated in vitro .
thus , cells efficiently #translated extracellular signals into specific cellular functions .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , will efficiently #translate into improved survival .
thus , cells have been shown to efficiently #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which is #translated in vitro .
in addition , this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , will #translate into improved survival .
we also report the first definitive incorporation of sec into stat1 y701f which may be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f which may be #translated in vitro .
thus , cells have the ability to efficiently #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which may have been successfully #translated in vitro .
thus , cells have #translated extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which was #translated in vitro .
thus , cells may have efficiently #translated extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f which will be successfully #translated in vitro .
thus , cells may have #translated extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 #translated in vitro .
thus , cells #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be successfully #translated in vitro .
thus , cells #translated extracellular signals into specific cellular functions .
thus , cells will efficiently #translate extracellular signals into specific cellular functions .
thus , cells will #translate extracellular signals into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is observed to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may have been successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which was #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which can be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which has been shown to be #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is able to be successfully #translated in vitro .
extracellular signals can be efficiently #translated into specific cellular functions by cells .
extracellular signals can be #translated by cells into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which is likely to be #translated in vitro .
extracellular signals has been efficiently #translated by cells into specific cellular functions .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which may be #translated in vitro .
extracellular signals has been shown to be efficiently #translated by cells into specific cellular functions .
extracellular signals has been shown to be efficiently #translated into specific cellular functions by cells .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be successfully #translated in vitro .
we also report the first definitive incorporation of sec into stat1 , stat1 y701f , stat1 n135 , stat1 n200 and stat5/1 which will be #translated in vitro .
a selenoprotein are able to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals has been shown to be #translated into specific cellular functions by cells .
a selenoprotein are observed to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein can be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals has been #translated into specific cellular functions by cells .
a selenoprotein have been #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals is able to be efficiently #translated by cells into specific cellular functions .
a selenoprotein have the ability to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein may be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein that are able to be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that are likely to be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that are likely to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is able to be #translated into specific cellular functions by cells .
a selenoprotein that are observed to be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is likely to be efficiently #translated by cells into specific cellular functions .
a selenoprotein that can be #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that have been shown to be properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that have been shown to be #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that have been #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that may be #translated in reticulocyte lysates are partially purified on heparin-agarose .
a selenoprotein that may have been properly #translated in reticulocyte lysates are partially purified on heparin-agarose .
extracellular signals is observed to be efficiently #translated into specific cellular functions by cells .
extracellular signals is observed to be #translated by cells into specific cellular functions .
a selenoprotein which can be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which can be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which has been shown to be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals is #translated into specific cellular functions by cells .
a selenoprotein which has been #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may be #translated by cells into specific cellular functions .
a selenoprotein which is likely to be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which is likely to be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which is observed to be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may be #translated into specific cellular functions by cells .
a selenoprotein which is observed to be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which is #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which may be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
extracellular signals may have been #translated by cells into specific cellular functions .
a selenoprotein which was #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which will be probably #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein which will be #translated in reticulocyte lysates can also dimerize on the lmp2 gas .
a selenoprotein will be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals was efficiently #translated by cells into specific cellular functions .
a selenoprotein , as our data reveals , are able to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals was efficiently #translated into specific cellular functions by cells .
a selenoprotein , as our data reveals , are observed to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals was #translated by cells into specific cellular functions .
a selenoprotein , as our data reveals , have been shown to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , have the ability to be #translated in reticulocyte lysates and partially purified on heparin-agarose .
a selenoprotein , as our data reveals , may be #translated in reticulocyte lysates and partially purified on heparin-agarose .
extracellular signals will be #translated by cells into specific cellular functions .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are likely to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , efficiently #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have been shown to efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have been shown to #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have efficiently #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have #translated into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may efficiently #translate into improved survival .
our data show that this reduction in liver injury performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , will #translate into improved survival .
remarkably , this reduction in liver injury are able to #translate into improved survival .
remarkably , this reduction in liver injury has #translated into improved survival .
remarkably , this reduction in liver injury may have #translated into improved survival .
remarkably , this reduction in liver injury #translate into improved survival .
remarkably , this reduction in liver injury will #translate into improved survival .
under the simple governing rules found across social groups , this reduction in liver injury are likely to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are observed to properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury are observed to #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have been shown to properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have the ability to properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury have #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury may have properly #translated into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury may properly #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , this reduction in liver injury will #translate into improved survival , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
this reduction in liver injury can #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has been shown to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury has the ability to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is able to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is likely to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is observed to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury is observed to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury may have successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury #translates into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , can successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , can #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has been shown to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has the ability to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , has #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is able to successfully #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is able to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is likely to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , is observed to #translate into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , may have successfully #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , may have #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , #translated into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , #translates into improved survival , thus partly explaining the increase in power output .
this reduction in liver injury , however , will successfully #translate into improved survival , thus partly explaining the increase in power output .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are able to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , are able to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , can efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , can #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have been shown to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have been shown to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have the ability to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have the ability to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , have #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , may have #translated into altered expression levels and time kinetics of a number of early genes .
in addition , these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , as our data have shown , will #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis are able to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis can efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis can #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have been shown to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis have the ability to #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis may #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis #translated into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis will efficiently #translate into altered expression levels and time kinetics of a number of early genes .
in addition , our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis will #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes cannot #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes did not #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes does not #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes has been shown to fail to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes has failed to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes is observed to fail to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes may fail to #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes may not #translate into altered expression levels and time kinetics of a number of early genes .
interestingly , these changes will fail to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are able to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are likely to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , are observed to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , can efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , can #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have been shown to efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have been shown to #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , have #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may have efficiently #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may have #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , may #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , #translated into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , will efficiently #translate into altered expression levels and time kinetics of a number of early genes .
our data show that these changes performed by these molecules/pathways in promoting cell survival or apoptosis/anoikis , in addition , will #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes are able to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes has #translated into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes have been shown to #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes may have #translated into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes may #translate into altered expression levels and time kinetics of a number of early genes .
remarkably , these changes #translate into altered expression levels and time kinetics of a number of early genes .
these changes can #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes has successfully #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes is able to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes is able to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes is likely to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes is likely to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes is observed to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes may have #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes successfully #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes successfully #translates into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes #translates into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes will successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes will #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , can successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has successfully #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , has the ability to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is able to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is likely to successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , is likely to #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , may have successfully #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , successfully #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , successfully #translates into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , #translated into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , will successfully #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
these changes , however , will #translate into altered expression levels and time kinetics of a number of early genes , thus partly explaining the increase in power output .
under the simple governing rules found across social groups , these changes are able to properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes are likely to properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes can properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes can #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have been shown to properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have been shown to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have properly #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes have the ability to #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes may properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes #translated into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes will properly #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
under the simple governing rules found across social groups , these changes will #translate into altered expression levels and time kinetics of a number of early genes , giving social insects the potential to have a profound impact on our understanding of the interplay between network dynamics and social evolution .
c-terminally truncated stat5a proteins observed to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins shown to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins shown to be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are likely to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are observed to be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that are #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that can be remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that can be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that have been remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that may be #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that may have been #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
c-terminally truncated stat5a proteins that were remarkably #truncated at amino acids 762 or 773 had no effect on the induction of either gene .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contained the bcl6 zinc fingers and was remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is able to be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is likely to be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is observed to be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is observed to be #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and is #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and may be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and may have been remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that contains the bcl6 zinc fingers and will be remarkably #truncated can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that has been remarkably #truncated and contained the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that has been shown to be remarkably #truncated and contained the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that has been shown to be #truncated and contained the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that has been #truncated and contained the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is able to be remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is likely to be remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is observed to be remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that is remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that may be remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that may be #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that was #truncated and contained the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed protein that will be remarkably #truncated and contains the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses being able to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses observed to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses shown to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are likely to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are likely to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are observed to be genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that are observed to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that have been genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that have been genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that have been shown to be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that were genetically engineered to substitute or #truncate the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that were genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses that will be genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
specifically , the stat5a molecule in which the c-terminus can be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus can be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus has been shown to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus has been #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus has the ability to be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is able to be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is observed to be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is observed to be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus is #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus may be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus may have been remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus will be remarkably #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
specifically , the stat5a molecule in which the c-terminus will be #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
the protein can be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein has been shown to be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is likely to be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is observed to be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is observed to be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein is #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein may be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein may be #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein may have been #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein was #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein was #truncated through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) by the majority of changes , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the protein will be #truncated by the majority of changes through nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) , although the figures were biased by the methods employed , and , in sequenced areas , approximately 50% of all mutations were missense or in-frame .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains are found to be #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains are likely to be #truncated and the potential bmp-1 cleavage site was not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains are observed to be #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains can be #truncated and the potential bmp-1 cleavage site is not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains have been #truncated and the potential bmp-1 cleavage site was not present .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains may have been #truncated and the potential bmp-1 cleavage site is not present .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr can also be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr has been shown to be #truncated prior to the pp-motif .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr is also #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr has therefore been #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr is therefore observed to be #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr is therefore #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr may therefore have been #truncated prior to the pp-motif .
to generate a comparable soluble fragment to ic1-2d/190 , pvr will therefore be #truncated prior to the pp-motif .
to generate this protein , the receptor can be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor has been shown to be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor is believed to be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor is likely to be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor is observed to be #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
to generate this protein , the receptor may have been #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
virtually all tsc1 mutations are able to dramatically #truncate the protein product .
virtually all tsc1 mutations are able to #truncate the protein product .
virtually all tsc1 mutations can dramatically #truncate the protein product .
virtually all tsc1 mutations can #truncate the protein product .
virtually all tsc1 mutations dramatically #truncate the protein product .
virtually all tsc1 mutations dramatically #truncated the protein product .
virtually all tsc1 mutations have been predicted to #truncate the protein product .
virtually all tsc1 mutations have dramatically #truncated the protein product .
virtually all tsc1 mutations have the ability to dramatically #truncate the protein product .
virtually all tsc1 mutations have #truncated the protein product .
virtually all tsc1 mutations may have dramatically #truncated the protein product .
virtually all tsc1 mutations may have #truncated the protein product .
virtually all tsc1 mutations #truncate the protein product .
virtually all tsc1 mutations will dramatically #truncate the protein product .
virtually all tsc1 mutations will #truncate the protein product .
specifically , the stat5a molecule in which the c-terminus was #truncated at amino acids 740 or 751 effectively blocked the induction of both cis and osm , whereas the c-terminal truncations at amino acids 762 or 773 had no effect on the induction of either gene .
therefore , to generate a comparable soluble fragment to ic1-2d/190 , pvr was also #truncated prior to the pp-motif .
to generate this protein , the receptor was #truncated prior to two consecutive proline residues (`pp-motif_) present in the junction between domains 2 and 3 (figure 1) .
electrophoretic mobility shift assays showed that the full-length bcl6 protein extracted from transfected cos cells and a bacterially expressed #truncated protein containing the bcl6 zinc fingers can bind specifically to dna from the u3 promoter/enhancer region of hiv-1 .
using the complex structure of bone morphogenetic protein-2 bound to its type i receptor (alk3) as a guide , we introduced extracellular domain mutations in the context of the #truncated alk4 (alk4-trunc) construct and assessed the ability of the mutants to inhibit activin function .
previous studies using wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses genetically engineered to #truncate or substitute the poly(c) tracts have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
the putative resulting protein retained the region encoding the structural and functional elements of the amine oxidase but the second and fourth srcr domains were #truncated and the potential bmp-1 cleavage site was not present .
previous studies using tsc1 mutations being able to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations shown to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are likely to be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are likely to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that are observed to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that can be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that can be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that have been genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that have been genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that have been shown to be genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that may be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that may have been genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that may have been genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that were genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that were genetically engineered to #truncate or substitute the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using tsc1 mutations that will be genetically engineered to substitute or #truncate the protein product have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses are able to dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses are found to #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses are predicted to #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses can dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses can #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have been predicted to #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses have the ability to #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses may dramatically #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses may #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses #truncate the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses #truncated the poly(c) tracts .
virtually all wild-type encephalomyocarditis virus (emcv) and mengo virus , and variants of these viruses will #truncate the poly(c) tracts .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) observed to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) shown to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are likely to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are observed to be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that are observed to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that can be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that can be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that have been genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that have been genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that have been shown to be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that may have been genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that were genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that will be genetically engineered to substitute or #truncate the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
previous studies using nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) that will be genetically engineered to #truncate or substitute the protein have produced conflicting data on the role of the poly(c) tract in the virulence of these viruses .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) are able to dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) are able to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) are found to dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) are predicted to #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) can #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) dramatically #truncated the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have been predicted to dramatically #truncate the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have dramatically #truncated the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) have #truncated the protein .
virtually all nonsense mutations (32%) , insertions or deletions (29 .6%) , or splicing changes (6 .2%) #truncated the protein .
